(3220,'3lks','CRYSTAL STRUCTURE OF HLA B*3501 IN COMPLEX WITH INFLUENZA NP418 EPITOPE FROM 1980 STRAIN','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(3221,'3ll8','CRYSTAL STRUCTURE OF CALCINEURIN IN COMPLEX WITH AKAP79 PEPTIDE','X-RAY DIFFRACTION',2.000,'HYDROLASE/CALCIUM BINDING PROTEIN',1,1,1),(3222,'3lly','CRYSTAL STRUCTURE ANALYSIS OF MACLURA POMIFERA AGGLUTININ','X-RAY DIFFRACTION',2.250,'SUGAR BINDING PROTEIN',1,1,1),(3223,'3llz','CRYSTAL STRUCTURE ANALYSIS OF MACLURA POMIFERA AGGLUTININ COMPLEX WITH GAL-BETA-1,3-GALNAC','X-RAY DIFFRACTION',1.550,'SUGAR BINDING PROTEIN',1,1,1),(3224,'3lm1','CRYSTAL STRUCTURE ANALYSIS OF MACLURA POMIFERA AGGLUTININ COMPLEX WITH P-NITROPHENYL-GALNAC','X-RAY DIFFRACTION',2.100,'SUGAR BINDING PROTEIN',8,8,1),(3225,'3lmp','CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(3226,'3ln4','CRYSTAL STRUCTURE OF HLA-B*4103 IN COMPLEX WITH A 16MER SELF-PEPTIDE DERIVED FROM HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEINS C1/C2','X-RAY DIFFRACTION',1.300,'IMMUNE SYSTEM',1,1,1),(3227,'3ln5','CRYSTAL STRUCTURE OF HLA-B*4104 IN COMPLEX WITH A 11MER SELF-PEPTIDE DERIVED FROM S-METHYL-5-THIOADENOSINE PHOSPHORYLASE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(3228,'3lny','SECOND PDZ DOMAIN FROM HUMAN PTP1E IN COMPLEX WITH RA-GEF2 PEPTIDE','X-RAY DIFFRACTION',1.300,'SIGNALING PROTEIN/SIGNALING PROTEIN',1,1,1),(3229,'3lnz','CRYSTAL STRUCTURE OF HUMAN MDM2 WITH A 12-MER PEPTIDE INHIBITOR PMI (N8A MUTANT)','X-RAY DIFFRACTION',1.950,'LIGASE/LIGASE INHIBITOR',8,8,1),(3230,'3lon','HCV NS3-4A PROTEASE DOMAIN WITH KETOAMIDE INHIBITOR NARLAPREVIR','X-RAY DIFFRACTION',2.200,'VIRAL PROTEIN/INHIBITOR',2,2,1),(3231,'3lpr','STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS','X-RAY DIFFRACTION',2.150,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3232,'3lqi','CRYSTAL STRUCTURE OF MLL1 PHD3-BROMO COMPLEXED WITH H3(1-9)K4ME2 PEPTIDE','X-RAY DIFFRACTION',1.920,'TRANSFERASE',3,3,1),(3233,'3lqj','CRYSTAL STRUCTURE OF MLL1 PHD3-BROMO COMPLEXED WITH H3(1-9)K4ME3 PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSFERASE',2,2,1),(3234,'3lqv','BRANCH RECOGNITION BY SF3B14','X-RAY DIFFRACTION',2.380,'PROTEIN BINDING',2,2,1),(3235,'3lu9','CRYSTAL STRUCTURE OF HUMAN THROMBIN MUTANT S195A IN COMPLEX WITH THE EXTRACELLULAR FRAGMENT OF HUMAN PAR1','X-RAY DIFFRACTION',1.800,'HYDROLASE',4,2,1),(3236,'3lv3','CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED WITH A PEPTIDE DERIVED FROM THE HUMAN VOLTAGE-DEPENDENT CALCIUM CHANNEL ALPHA1 SUBUNIT (RESIDUES 513-521)','X-RAY DIFFRACTION',1.940,'IMMUNE SYSTEM',1,1,1),(3237,'3lw1','BINARY COMPLEX OF 14-3-3 SIGMA AND P53 PT387-PEPTIDE','X-RAY DIFFRACTION',1.280,'PEPTIDE BINDING PROTEIN',1,1,1),(3238,'3m4c','A ZN-MEDIATED TETRAHEDRAL PROTEIN LATTICE CAGE ENCAPSULATING A MICROPEROXIDASE','X-RAY DIFFRACTION',1.900,'ELECTRON TRANSPORT',1,1,1),(3239,'3m4w','STRUCTURAL BASIS FOR THE NEGATIVE REGULATION OF BACTERIAL STRESS RESPONSE BY RSEB','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN/SIGNALING PROTEIN',4,4,1),(3240,'3m53','SET7/9 IN COMPLEX WITH TAF10 PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.850,'TRANSFERASE',1,1,1),(3241,'3m54','SET7/9 Y305F IN COMPLEX WITH TAF10 PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.600,'TRANSFERASE',1,1,1),(3242,'3m55','SET7/9 Y305F IN COMPLEX WITH TAF10-K189ME1 PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.550,'TRANSFERASE',1,1,1),(3243,'3m56','SET7/9 Y305F IN COMPLEX WITH TAF10-K189ME2 PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.650,'TRANSFERASE',1,1,1),(3244,'3m57','SET7/9 Y245A IN COMPLEX WITH TAF10 PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.700,'TRANSFERASE',1,1,1),(3245,'3m58','SET7/9 Y245A IN COMPLEX WITH TAF10-K189ME1 PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.400,'TRANSFERASE',1,1,1),(3246,'3m59','SET7/9 Y245A IN COMPLEX WITH TAF10-K189ME2 PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.700,'TRANSFERASE',1,1,1),(3247,'3m5a','SET7/9 Y245A IN COMPLEX WITH TAF10-K189ME3 PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.750,'TRANSFERASE',1,1,1),(3248,'3m5m','AVOIDING DRUG RESISTANCE AGAINST HCV NS3/4A PROTEASE INHIBITORS','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3249,'3m5n','CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE IN COMPLEX WITH N-TERMINAL PRODUCT 4B5A','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',3,3,1),(3250,'3m5o','CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE IN COMPLEX WITH N-TERMINAL PRODUCT 5A5B','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3251,'3m61','CRYSTAL STRUCTURE OF COMPLEX OF UROKINASE AND A UPAIN-1 VARIANT(W3A) IN PH4.6 CONDITION','X-RAY DIFFRACTION',1.680,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3252,'3m7u','CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE SB1+2 R64A/E182Q MUTANT','X-RAY DIFFRACTION',1.050,'HYDROLASE',1,1,1),(3253,'3m94','COMPLEX CRYSTAL STRUCTURE OF ASCARIS SUUM EIF4E-3 WITH M2,2,7G CAP','X-RAY DIFFRACTION',2.050,'TRANSLATION',1,1,1),(3254,'3ma3','CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A NAPHTHO-DIFURAN LIGAND','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(3255,'3mat','E.COLI METHIONINE AMINOPEPTIDASE TRANSITION-STATE INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3256,'3maz','CRYSTAL STRUCTURE OF THE HUMAN BRDG1/STAP-1 SH2 DOMAIN IN COMPLEX WITH THE NTAL PTYR136 PEPTIDE','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN',1,1,1),(3257,'3me9','CRYSTAL STRUCTURE OF SGF29 IN COMPLEX WITH H3K4ME3 PEPTIDE','X-RAY DIFFRACTION',1.370,'TRANSCRIPTION',2,2,1),(3258,'3mea','CRYSTAL STRUCTURE OF THE SGF29 IN COMPLEX WITH H3K4ME3','X-RAY DIFFRACTION',1.260,'TRANSCRIPTION',1,1,1),(3259,'3met','CRYSTAL STRUCTURE OF SGF29 IN COMPLEX WITH H3K4ME2','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(3260,'3meu','CRYSTAL STRUCTURE OF SGF29 IN COMPLEX WITH H3R2ME2SK4ME3','X-RAY DIFFRACTION',1.280,'TRANSCRIPTION',2,2,1),(3261,'3mev','CRYSTAL STRUCTURE OF SGF29 IN COMPLEX WITH R2AK4ME3','X-RAY DIFFRACTION',1.830,'TRANSCRIPTION',2,2,1),(3262,'3mgo','CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',4,5,1),(3263,'3mgt','CRYSTAL STRUCTURE OF A H5-SPECIFIC CTL EPITOPE VARIANT DERIVED FROM H5N1 INFLUENZA VIRUS IN COMPLEX WITH HLA-A*0201','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',4,5,1),(3264,'3mhp','FNR-RECRUITMENT TO THE THYLAKOID','X-RAY DIFFRACTION',1.700,'OXIDOREDUCTASE',1,2,1),(3265,'3mhr','14-3-3 SIGMA IN COMPLEX WITH YAP PS127-PEPTIDE','X-RAY DIFFRACTION',1.150,'PEPTIDE BINDING PROTEIN',1,1,1),(3266,'3mjh','CRYSTAL STRUCTURE OF HUMAN RAB5A IN COMPLEX WITH THE C2H2 ZINC FINGER OF EEA1','X-RAY DIFFRACTION',2.030,'PROTEIN TRANSPORT',2,2,1),(3267,'3mk4','X-RAY STRUCTURE OF HUMAN PEX3 IN COMPLEX WITH A PEX19 DERIVED PEPTIDE','X-RAY DIFFRACTION',2.420,'PROTEIN TRANSPORT',1,1,1),(3268,'3mk8','THE MCL-1 BH3 HELIX IS AN EXCLUSIVE MCL-1 INHIBITOR AND APOPTOSIS SENSITIZER','X-RAY DIFFRACTION',2.320,'APOPTOSIS/APOPTOSIS REGULATOR',1,1,1),(3269,'3mlr','CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,2,1),(3270,'3mls','CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',4,8,1),(3271,'3mlt','CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE','X-RAY DIFFRACTION',2.490,'IMMUNE SYSTEM',2,4,1),(3272,'3mlv','CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,4,1),(3273,'3mlx','CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH AN MN V3 PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,4,1),(3274,'3mly','CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',2,4,1),(3275,'3mmg','CRYSTAL STRUCTURE OF TOBACCO VEIN MOTTLING VIRUS PROTEASE','X-RAY DIFFRACTION',1.700,'VIRAL PROTEIN, HYDROLASE',2,2,1),(3276,'3mmy','STRUCTURAL AND FUNCTIONAL ANALYSIS OF THE INTERACTION BETWEEN THE NUCLEOPORIN NUP98 AND THE MRNA EXPORT FACTOR RAE1','X-RAY DIFFRACTION',1.650,'NUCLEAR PROTEIN',1,1,1),(3277,'3mn5','STRUCTURES OF ACTIN-BOUND WH2 DOMAINS OF SPIRE AND THE IMPLICATION FOR FILAMENT NUCLEATION','X-RAY DIFFRACTION',1.500,'CONTRACTILE PROTEIN/PROTEIN BINDING',1,1,1),(3278,'3mn7','STRUCTURES OF ACTIN-BOUND WH2 DOMAINS OF SPIRE AND THE IMPLICATION FOR FILAMENT NUCLEATION','X-RAY DIFFRACTION',2.000,'CONTRACTILE PROTEIN/PROTEIN BINDING',1,1,1),(3279,'3mne','CRYSTAL STRUCTURE OF THE AGONIST FORM OF MOUSE GLUCOCORTICOID RECEPTOR STABILIZED BY F608S MUTATION AT 1.96A','X-RAY DIFFRACTION',1.960,'HORMONE RECEPTOR',1,1,1),(3280,'3mno','CRYSTAL STRUCTURE OF THE AGONIST FORM OF MOUSE GLUCOCORTICOID RECEPTOR STABILIZED BY (A611V, F608S) MUTATIONS AT 1.55A','X-RAY DIFFRACTION',1.550,'HORMONE RECEPTOR',1,1,1),(3281,'3mnp','CRYSTAL STRUCTURE OF THE AGONIST FORM OF MOUSE GLUCOCORTICOID RECEPTOR STABILIZED BY (A611V, V708A, E711G) MUTATIONS AT 1.50A','X-RAY DIFFRACTION',1.500,'HORMONE RECEPTOR',1,1,1),(3282,'3mnw','CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE IN A HELICAL CONFORMATION','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,2,1),(3283,'3mnz','CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT WITH A GP41 MPER-DERIVED PEPTIDE BEARING ALA SUBSTITUTIONS IN A HELICAL CONFORMATION','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,2,1),(3284,'3mo8','PWWP DOMAIN OF HUMAN BROMODOMAIN AND PHD FINGER-CONTAINING PROTEIN 1 IN COMPLEX WITH TRIMETHYLATED H3K36 PEPTIDE','X-RAY DIFFRACTION',1.690,'TRANSCRIPTION',1,1,1),(3285,'3moa','CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED FAB) WITH 17 AA GP41 MPER-DERIVED PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(3286,'3mod','CRYSTAL STRUCTURE OF THE NEUTRALIZING HIV ANTIBODY 2F5 FAB FRAGMENT (RECOMBINANTLY PRODUCED IGG) WITH 11 AA GP41 MPER-DERIVED PEPTIDE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,2,1),(3287,'3mp6','COMPLEX STRUCTURE OF SGF29 AND DIMETHYLATED H3K4','X-RAY DIFFRACTION',1.480,'HISTONE BINDING PROTEIN',1,1,1),(3288,'3mpj','STRUCTURE OF THE GLUTARYL-COENZYME A DEHYDROGENASE','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',1,1,1),(3289,'3mqp','CRYSTAL STRUCTURE OF HUMAN BFL-1 IN COMPLEX WITH NOXA BH3 PEPTIDE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR2930','X-RAY DIFFRACTION',2.240,'APOPTOSIS',1,1,1),(3290,'3mqr','CRYSTAL STRUCTURE OF THE USP7:HDMX(AHSS) COMPLEX','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(3291,'3mqs','CRYSTAL STRUCTURE OF THE USP7:HDM2(PSTS) COMPLEX','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,1,1),(3292,'3mr9','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE M5A VARIANT','X-RAY DIFFRACTION',1.930,'IMMUNE SYSTEM',1,1,1),(3293,'3mrb','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE A7H VARIANT','X-RAY DIFFRACTION',1.400,'IMMUNE SYSTEM',1,1,1),(3294,'3mrc','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6C VARIANT','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(3295,'3mrd','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCMV PP65-495-503 NONAPEPTIDE V6G VARIANT','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(3296,'3mre','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE','X-RAY DIFFRACTION',1.100,'IMMUNE SYSTEM',1,1,1),(3297,'3mrf','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH EBV BMLF1-280-288 NONAPEPTIDE T4P VARIANT','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(3298,'3mrg','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE','X-RAY DIFFRACTION',1.300,'IMMUNE SYSTEM',1,1,1),(3299,'3mrh','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE N3S VARIANT','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(3300,'3mri','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE G4M-V5W VARIANT','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(3301,'3mrj','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE V5M VARIANT','X-RAY DIFFRACTION',1.870,'IMMUNE SYSTEM',1,1,1),(3302,'3mrk','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH AFP137 NONAPEPTIDE','X-RAY DIFFRACTION',1.400,'IMMUNE SYSTEM',1,1,1),(3303,'3mrl','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1073-1081 NONAPEPTIDE C6V VARIANT','X-RAY DIFFRACTION',2.410,'IMMUNE SYSTEM',1,1,1),(3304,'3mrm','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS3-1406-1415 DECAPEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(3305,'3mrn','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HCV NS4B-1807-1816 DECAPEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(3306,'3mro','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',1,1,1),(3307,'3mrp','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(3308,'3mrq','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH MELAN- A MART1 DECAPEPTIDE VARIANT','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(3309,'3mrr','CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2 MOLECULE COMPLEXED WITH HUMAN PROSTAGLANDIN TRANSPORTER DECAPEPTIDE','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(3310,'3mt6','STRUCTURE OF CLPP FROM ESCHERICHIA COLI IN COMPLEX WITH ADEP1','X-RAY DIFFRACTION',1.900,'HYDROLASE/ANTIBIOTIC',28,28,1),(3311,'3mud','STRUCTURE OF THE TROPOMYOSIN OVERLAP COMPLEX FROM CHICKEN SMOOTH MUSCLE','X-RAY DIFFRACTION',2.200,'CONTRACTILE PROTEIN',2,2,1),(3312,'3muk','CRYSTAL STRUCTURE OF BRD4 BROMODOMAIN 1 WITH PROPIONYLATED HISTONE H3- K(PROP)23','X-RAY DIFFRACTION',1.750,'SIGNALING PROTEIN',1,1,1),(3313,'3mul','CRYSTAL STRUCTURE OF BRD4 BROMODOMAIN 1 WITH BUTYRYLATED HISTONE H3- K(BUTY)14','X-RAY DIFFRACTION',1.650,'SIGNALING PROTEIN',1,1,1),(3314,'3mv5','CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES','X-RAY DIFFRACTION',2.470,'TRANSFERASE',1,1,1),(3315,'3mv7','CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,3,1),(3316,'3mv8','CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,3,1),(3317,'3mvh','CRYSTAL STRUCTURE OF AKT-1-INHIBITOR COMPLEXES','X-RAY DIFFRACTION',2.010,'TRANSFERASE',1,1,1),(3318,'3mvj','HUMAN CYCLIC AMP-DEPENDENT PROTEIN KINASE PKA INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.490,'TRANSFERASE',3,3,1),(3319,'3mxc','STRUCTURES OF GRB2-SH2 DOMAIN AND AICD PEPTIDE COMPLEXES REVEAL A CONFORMATIONAL SWITCH AND THEIR FUNCTIONAL IMPLICATIONS.','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',1,1,1),(3320,'3mxy','STRUCTURES OF GRB2-SH2 DOMAIN AND AICD PEPTIDE COMPLEXES REVEAL A CONFORMATIONAL SWITCH AND THEIR FUNCTIONAL IMPLICATIONS.','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING',1,1,1),(3321,'3myj','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE WT-1 (126-134) (R1Y) PEPTIDE VARIANT.','X-RAY DIFFRACTION',1.890,'IMMUNE SYSTEM',2,2,1),(3322,'3n2d','CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE I RIBOSOME INACTIVATING PROTEIN WITH HEXAPEPTIDE SER-ASP-ASP-ASP-MET-GLY AT 2.2 A RESOLUTION','X-RAY DIFFRACTION',2.220,'HYDROLASE',1,1,1),(3323,'3n3x','CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN TYPE I RIBOSOME INACTIVATING PROTEIN AND HEXAPEPTIDE SER-ASP-ASP-ASP-MET-GLY AT 1.7 A RESOLUTION','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(3324,'3n55','SO1698 PROTEIN, AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.','X-RAY DIFFRACTION',1.570,'HYDROLASE',1,1,1),(3325,'3n5e','CRYSTAL STRUCTURE OF HUMAN THYMIDYLATE SYNTHASE BOUND TO A PEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.260,'TRANSFERASE/TRANSFERASE INHIBITOR',1,2,1),(3326,'3n7y','CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 20-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNV','X-RAY DIFFRACTION',2.020,'PROTEIN BINDING/PEPTIDE',3,3,1),(3327,'3n84','CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A 23-MEMBERED MACROCYCLIC LIGAND HAVING THE SEQUENCE PYVNVP','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING/PEPTIDE',6,6,1),(3328,'3n8m','CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH AN ACYCLIC LIGAND HAVING THE SEQUENCE PYVNVP','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING/PEPTIDE',1,1,1),(3329,'3n93','CRYSTAL STRUCTURE OF HUMAN CRFR2 ALPHA EXTRACELLULAR DOMAIN IN COMPLEX WITH UROCORTIN 3','X-RAY DIFFRACTION',2.500,'MEMBRANE PROTEIN, HORMONE',1,1,1),(3330,'3n9n','CEKDM7A FROM C.ELEGANS, COMPLEX WITH H3K4ME3K9ME2 PEPTIDE AND NOG','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',2,1,1),(3331,'3n9o','CEKDM7A FROM C.ELEGANS, COMPLEX WITH H3K4ME3 PEPTIDE, H3K9ME2 PEPTIDE AND NOG','X-RAY DIFFRACTION',2.310,'OXIDOREDUCTASE',2,1,1),(3332,'3n9p','CEKDM7A FROM C.ELEGANS, COMPLEX WITH H3K4ME3K27ME2 PEPTIDE AND NOG','X-RAY DIFFRACTION',2.390,'OXIDOREDUCTASE',2,1,1),(3333,'3n9q','CEKDM7A FROM C.ELEGANS, COMPLEX WITH H3K4ME3 PEPTIDE, H3K27ME2 PEPTIDE AND NOG','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',2,1,1),(3334,'3n9z','CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL','X-RAY DIFFRACTION',2.170,'OXIDOREDUCTASE, ELECTRON TRANSPORT',2,2,1),(3335,'3na0','CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20,22- DIHYDROXYCHOLESTEROL','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE, ELECTRON TRANSPORT',2,2,1),(3336,'3na1','CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL','X-RAY DIFFRACTION',2.250,'OXIDOREDUCTASE, ELECTRON TRANSPORT',2,2,1),(3337,'3nco','CRYSTAL STRUCTURE OF FNCEL5A FROM F. NODOSUM RT17-B1','X-RAY DIFFRACTION',1.500,'HYDROLASE',2,2,1),(3338,'3ndd','CLEAVED ANTITRYPSIN WITH P10 PRO, AND P9-P6 ASP','X-RAY DIFFRACTION',1.500,'HYDROLASE INHIBITOR',1,1,1),(3339,'3nf3','CRYSTAL STRUCTURE OF BONT/A LC WITH JTH-NB-7239 PEPTIDE','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3340,'3nfk','CRYSTAL STRUCTURE OF THE PTPN4 PDZ DOMAIN COMPLEXED WITH THE C- TERMINUS OF A RABIES VIRUS G PROTEIN','X-RAY DIFFRACTION',1.430,'PROTEIN BINDING',2,2,1),(3341,'3nfl','CRYSTAL STRUCTURE OF THE PTPN4 PDZ DOMAIN COMPLEXED WITH THE C- TERMINUS OF THE GLUN2A NMDA RECEPTOR SUBUNIT','X-RAY DIFFRACTION',1.910,'PROTEIN BINDING',4,4,1),(3342,'3nfn','RECOGNITION OF PEPTIDE-MHC BY A V-DELTA/V-BETA TCR','X-RAY DIFFRACTION',2.390,'IMMUNE SYSTEM',1,1,1),(3343,'3ngy','CRYSTAL STRUCTURE OF RNASE T (E92G MUTANT)','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(3344,'3nih','THE STRUCTURE OF UBR BOX (RIAAA)','X-RAY DIFFRACTION',2.100,'METAL BINDING PROTEIN',1,1,1),(3345,'3nii','THE STRUCTURE OF UBR BOX (KIAA)','X-RAY DIFFRACTION',2.100,'METAL BINDING PROTEIN',1,1,1),(3346,'3nij','THE STRUCTURE OF UBR BOX (HIAA)','X-RAY DIFFRACTION',2.100,'METAL BINDING PROTEIN',1,1,1),(3347,'3nik','THE STRUCTURE OF UBR BOX (REAA)','X-RAY DIFFRACTION',1.850,'METAL BINDING PROTEIN',1,3,1),(3348,'3nil','THE STRUCTURE OF UBR BOX (RDAA)','X-RAY DIFFRACTION',1.750,'METAL BINDING PROTEIN',1,2,1),(3349,'3nim','THE STRUCTURE OF UBR BOX (RRAA)','X-RAY DIFFRACTION',2.000,'METAL BINDING PROTEIN',1,2,1),(3350,'3nin','THE STRUCTURE OF UBR BOX (RLGES)','X-RAY DIFFRACTION',2.100,'METAL BINDING PROTEIN',2,2,1),(3351,'3njf','Y26F MUTANT OF SO1698 PROTEIN, AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS','X-RAY DIFFRACTION',2.470,'HYDROLASE',2,2,1),(3352,'3njg','K98A MUTANT OF SO1698 PROTEIN, AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.','X-RAY DIFFRACTION',1.920,'HYDROLASE',1,1,1),(3353,'3nji','S114A MUTANT OF SO1698 PROTEIN, AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS.','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(3354,'3njj','P115A MUTANT OF SO1698 PROTEIN, AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS','X-RAY DIFFRACTION',1.560,'HYDROLASE',1,1,1),(3355,'3njn','Q118A MUTANT OF SO1698 PROTEIN, AN ASPARTIC PEPTIDASE FROM SHEWANELLA ONEIDENSIS','X-RAY DIFFRACTION',1.250,'HYDROLASE',2,2,1),(3356,'3nk4','CRYSTAL STRUCTURE OF FULL-LENGTH SPERM RECEPTOR ZP3 AT 2.0 A RESOLUTION','X-RAY DIFFRACTION',2.000,'CELL ADHESION',2,2,1),(3357,'3nkx','IMPAIRED BINDING OF 14-3-3 TO RAF1 IS LINKED TO NOONAN AND LEOPARD SYNDROME','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING, SIGNALING PROTEIN',2,2,1),(3358,'3nmx','CRYSTAL STRUCTURE OF APC COMPLEXED WITH ASEF','X-RAY DIFFRACTION',2.300,'CELL ADHESION/CELL CYCLE',3,3,1),(3359,'3nx8','HUMAN CAMP DEPENDENT PROTEIN KINASE IN COMPLEX WITH PHENOL','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(3360,'3ny3','STRUCTURE OF THE UBR-BOX OF UBR2 IN COMPLEX WITH N-DEGRON','X-RAY DIFFRACTION',1.600,'LIGASE',1,1,1),(3361,'3nzj','CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(3362,'3nzw','CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(3363,'3o1d','STRUCTURE-FUNCTION STUDY OF GEMINI DERIVATIVES WITH TWO DIFFERENT SIDE CHAINS AT C-20, GEMINI-0072 AND GEMINI-0097.','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION/TRANSCRIPTION ACTIVATOR',1,1,1),(3364,'3o1e','STRUCTURE-FUNCTION OF GEMINI DERIVATIVES WITH TWO DIFFERENT SIDE CHAINS AT C-20, GEMINI-0072 AND GEMINI-0097.','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/TRANSCRIPTION ACTIVATOR',1,1,1),(3365,'3o2b','E. COLI CLPS IN COMPLEX WITH A PHE N-END RULE PEPTIDE','X-RAY DIFFRACTION',2.050,'PEPTIDE BINDING PROTEIN',2,2,1),(3366,'3o2h','E. COLI CLPS IN COMPLEX WITH A LEU N-END RULE PEPTIDE','X-RAY DIFFRACTION',1.700,'PEPTIDE BINDING PROTEIN',1,1,1),(3367,'3o2q','CRYSTAL STRUCTURE OF THE HUMAN SYMPLEKIN-SSU72-CTD PHOSPHOPEPTIDE COMPLEX','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,1,1),(3368,'3o34','CRYSTAL STRUCTURE OF TRIM24 PHD-BROMO COMPLEXED WITH H3(13-32)K23AC PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION/PROTEIN BINDING',1,1,1),(3369,'3o35','CRYSTAL STRUCTURE OF TRIM24 PHD-BROMO COMPLEXED WITH H3(23-31)K27AC PEPTIDE','X-RAY DIFFRACTION',1.760,'TRANSCRIPTION/PROTEIN BINDING',1,2,1),(3370,'3o36','CRYSTAL STRUCTURE OF TRIM24 PHD-BROMO COMPLEXED WITH H4(14-19)K16AC PEPTIDE','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION/PROTEIN BINDING',1,1,1),(3371,'3o37','CRYSTAL STRUCTURE OF TRIM24 PHD-BROMO COMPLEXED WITH H3(1-10)K4 PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION/PROTEIN BINDING',4,4,1),(3372,'3o3a','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,2,1),(3373,'3o3b','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-1.1','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(3374,'3o3d','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',2,2,1),(3375,'3o3e','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE PEPTIDOMIMETIC ELA-2.1','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',2,2,1),(3376,'3o40','COMPLEX OF A CHIMERIC ALPHA/BETA-PEPTIDE BASED ON THE GP41 CHR DOMAIN BOUND TO GP41-5','X-RAY DIFFRACTION',2.100,'VIRAL PROTEIN',1,1,1),(3377,'3o41','CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM/VIRAL PROTEIN',2,4,1),(3378,'3o6l','ANTI-TAT HIV 11H6H1 FAB\' COMPLEXED WITH A 15-MER TAT PEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,2,1),(3379,'3o6m','ANTI-TAT HIV 11H6H1 FAB\' COMPLEXED WITH A 9-MER TAT PEPTIDE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,2,1),(3380,'3o6q','THE STRUCTURE OF SPOIISA AND SPOIISB, A TOXIN - ANTITOXIN SYSTEM','X-RAY DIFFRACTION',2.500,'TOXIN/ANTITOXIN',2,2,1),(3381,'3o71','CRYSTAL STRUCTURE OF ERK2/DCC PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.950,'TRANSFERASE/PROTEIN BINDING',1,1,1),(3382,'3o8i','STRUCTURE OF 14-3-3 ISOFORM SIGMA IN COMPLEX WITH A C-RAF1 PEPTIDE AND A STABILIZING SMALL MOLECULE FRAGMENT','X-RAY DIFFRACTION',2.000,'PEPTIDE BINDING PROTEIN',1,1,1),(3383,'3oa6','HUMAN MSL3 CHROMODOMAIN BOUND TO DNA AND H4K20ME1 PEPTIDE','X-RAY DIFFRACTION',2.350,'DNA BINDING PROTEIN/DNA',1,1,1),(3384,'3oak','CRYSTAL STRUCTURE OF A SPN1 (IWS1)-SPT6 COMPLEX','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',2,2,1),(3385,'3oap','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 9-CIS RETINOIC ACID AND THE COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.050,'TRANSCRIPTION',1,1,1),(3386,'3ob1','CRYSTAL STRUCTURE OF C-CBL TKB DOMAIN IN COMPLEX WITH DOUBLE PHOSPHORYLATED SPRY2 PEPTIDE','X-RAY DIFFRACTION',2.200,'LIGASE/SIGNALING PROTEIN',1,1,1),(3387,'3ob2','CRYSTAL STRUCTURE OF C-CBL TKB DOMAIN IN COMPLEX WITH DOUBLE PHOSPHORYLATED EGFR PEPTIDE','X-RAY DIFFRACTION',2.100,'LIGASE/SIGNALING PROTEIN',1,1,1),(3388,'3obq','CRYSTAL STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HUMAN HRS PSAP PEPTIDE','X-RAY DIFFRACTION',1.400,'PROTEIN TRANSPORT',1,1,1),(3389,'3obu','CRYSTAL STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 PTAP PEPTIDE','X-RAY DIFFRACTION',1.600,'PROTEIN TRANSPORT',1,1,1),(3390,'3obx','CRYSTAL STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH A HIV-1 GAG P7A MUTANT PEPTIDE','X-RAY DIFFRACTION',1.600,'PROTEIN TRANSPORT',1,1,1),(3391,'3od5','CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3392,'3odi','CRYSTAL STRUCTURE OF CYCLOPHILIN A IN COMPLEX WITH VOCLOSPORIN E- ISA247','X-RAY DIFFRACTION',2.200,'ISOMERASE/IMMUNOSUPPRESSANT',10,10,1),(3393,'3odl','CRYSTAL STRUCTURE OF CYCLOPHILIN A IN COMPLEX WITH VOCLOSPORIN Z- ISA247','X-RAY DIFFRACTION',2.310,'ISOMERASE/IMMUNOSUPPRESSANT',10,10,1),(3394,'3ofi','CRYSTAL STRUCTURE OF HUMAN INSULIN-DEGRADING ENZYME IN COMPLEX WITH UBIQUITIN','X-RAY DIFFRACTION',2.350,'HYDROLASE',2,2,1),(3395,'3oiq','CRYSTAL STRUCTURE OF YEAST TELOMERE PROTEIN CDC13 OB1 AND THE CATALYTIC SUBUNIT OF DNA POLYMERASE ALPHA POL1','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING',1,1,1),(3396,'3oj3','CRYSTAL STRUCTURE OF THE A20 ZNF4 AND UBIQUITIN COMPLEX','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING/HYDROLASE',8,8,1),(3397,'3okh','CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 2-(4-CHLOROPHENYL)-1- [(1S)-1-CYCLOHEXYL-2-(CYCLOHEXYLAMINO)-2-OXOETHYL]-1H-BENZIMIDAZOLE- 6-CARBOXYLIC ACID','X-RAY DIFFRACTION',2.500,'HORMONE RECEPTOR',1,1,1),(3398,'3oki','CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH (2S)-2-[2-(4- CHLOROPHENYL)-1H-BENZIMIDAZOL-1-YL]-N,2-DICYCLOHEXYLETHANAMIDE','X-RAY DIFFRACTION',2.000,'HORMONE RECEPTOR',2,2,1),(3399,'3olf','CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4- CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2- CYCLOHEXYLACETYL}AMINO)-3-METHYLBENZOIC ACID','X-RAY DIFFRACTION',1.900,'HORMONE RECEPTOR',2,2,1),(3400,'3oll','CRYSTAL STRUCTURE OF PHOSPHORYLATED ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN','X-RAY DIFFRACTION',1.500,'HORMONE RECEPTOR/ACTIVATOR',2,2,1),(3401,'3olr','PTPN22 IN COMPLEX WITH CONSENSUS PHOSPHO-TYROSINE PEPTIDE 1','X-RAY DIFFRACTION',2.500,'HYDROLASE',4,4,1),(3402,'3ols','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR BETA LIGAND BINDING DOMAIN','X-RAY DIFFRACTION',2.200,'HORMONE RECEPTOR/ACTIVATOR',2,2,1),(3403,'3omc','STRUCTURE OF HUMAN SND1 EXTENDED TUDOR DOMAIN IN COMPLEX WITH THE SYMMETRICALLY DIMETHYLATED ARGININE PIWIL1 PEPTIDE R4ME2S','X-RAY DIFFRACTION',1.770,'TRANSCRIPTION REGULATOR',1,1,1),(3404,'3omg','STRUCTURE OF HUMAN SND1 EXTENDED TUDOR DOMAIN IN COMPLEX WITH THE SYMMETRICALLY DIMETHYLATED ARGININE PIWIL1 PEPTIDE R14ME2S','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',2,2,1),(3405,'3omk','CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH (2S)-2-[2-(4- CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2-CYCLOHEXYL-N-(2- METHYLPHENYL)ETHANAMIDE','X-RAY DIFFRACTION',1.900,'HORMONE RECEPTOR',2,2,1),(3406,'3omm','CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4- CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2- CYCLOHEXYLACETYL}AMINO)-3-FLUOROBENZOIC ACID','X-RAY DIFFRACTION',2.100,'HORMONE RECEPTOR',2,2,1),(3407,'3omo','FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS','X-RAY DIFFRACTION',2.210,'PROTEIN BINDING',2,2,1),(3408,'3omp','FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS','X-RAY DIFFRACTION',2.050,'PROTEIN BINDING',2,2,1),(3409,'3omq','FRAGMENT-BASED DESIGN OF NOVEL ESTROGEN RECEPTOR LIGANDS','X-RAY DIFFRACTION',1.970,'PROTEIN BINDING',2,2,1),(3410,'3onw','STRUCTURE OF A G-ALPHA-I1 MUTANT WITH ENHANCED AFFINITY FOR THE RGS14 GOLOCO MOTIF.','X-RAY DIFFRACTION',2.380,'SIGNALING PROTEIN',2,2,1),(3411,'3oof','CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4- CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2- CYCLOHEXYLACETYL}AMINO)BENZOIC ACID','X-RAY DIFFRACTION',2.290,'HORMONE RECEPTOR',2,2,1),(3412,'3oog','HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH A SMALL FRAGMENT','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(3413,'3ook','CRYSTAL STRUCTURE OF HUMAN FXR IN COMPLEX WITH 4-({(2S)-2-[2-(4- CHLOROPHENYL)-5,6-DIFLUORO-1H-BENZIMIDAZOL-1-YL]-2- CYCLOHEXYLACETYL}AMINO)-3,5-DIFLUOROBENZOIC ACID','X-RAY DIFFRACTION',2.290,'HORMONE RECEPTOR',2,2,1),(3414,'3oqs','CRYSTAL STRUCTURE OF IMPORTIN-ALPHA BOUND TO A CLIC4 NLS PEPTIDE','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT',1,1,1),(3415,'3oqy','SEMI-SYNTHETIC RIBONUCLEASE S: PARA-CYANO-PHENYLALANINE AT POSITION 8','X-RAY DIFFRACTION',1.490,'HYDROLASE',2,2,1),(3416,'3oqz','SEMI-SYNTHETIC RIBONUCLEASE S: META-CYANO-PHENYLALANINE AT POSITION 8','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(3417,'3or0','SEMI-SYNTHETIC RIBONUCLEASE S: CYANYLATED HOMOCYSTEINE AT POSITION 13','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,2,1),(3418,'3os5','SET7/9-DNMT1 K142ME1 COMPLEX','X-RAY DIFFRACTION',1.690,'TRANSFERASE',1,1,1),(3419,'3osz','CRYSTAL STRUCTURE OF THE COMPLEX OF PROTEINASE K WITH AN ANTIMICROBIAL NONAPEPTIDE, AT 2.26 A RESOLUTION','X-RAY DIFFRACTION',2.260,'HYDROLASE',1,1,1),(3420,'3ots','MDR769 HIV-1 PROTEASE COMPLEXED WITH MA/CA HEPTA-PEPTIDE','X-RAY DIFFRACTION',1.700,'HYDROLASE/PEPTIDE',1,2,1),(3421,'3oty','MDR769 HIV-1 PROTEASE COMPLEXED WITH RT/RH HEPTA-PEPTIDE','X-RAY DIFFRACTION',1.750,'HYDROLASE/PEPTIDE',1,2,1),(3422,'3ou1','MDR769 HIV-1 PROTEASE COMPLEXED WITH RH/IN HEPTA-PEPTIDE','X-RAY DIFFRACTION',1.800,'HYDROLASE/PEPTIDE',1,2,1),(3423,'3ou3','MDR769 HIV-1 PROTEASE COMPLEXED WITH PR/RT HEPTA-PEPTIDE','X-RAY DIFFRACTION',1.700,'HYDROLASE/PEPTIDE',1,2,1),(3424,'3ou4','MDR769 HIV-1 PROTEASE COMPLEXED WITH TF/PR HEPTA-PEPTIDE','X-RAY DIFFRACTION',1.600,'HYDROLASE/PEPTIDE',1,2,1),(3425,'3oua','MDR769 HIV-1 PROTEASE COMPLEXED WITH P1/P6 HEPTA-PEPTIDE','X-RAY DIFFRACTION',1.700,'HYDROLASE/PEPTIDE',1,2,1),(3426,'3oub','MDR769 HIV-1 PROTEASE COMPLEXED WITH NC/P1 HEPTA-PEPTIDE','X-RAY DIFFRACTION',1.600,'HYDROLASE/PEPTIDE',1,2,1),(3427,'3ouc','MDR769 HIV-1 PROTEASE COMPLEXED WITH P2/NC HEPTA-PEPTIDE','X-RAY DIFFRACTION',2.000,'HYDROLASE/PEPTIDE',1,2,1),(3428,'3oud','MDR769 HIV-1 PROTEASE COMPLEXED WITH CA/P2 HEPTA-PEPTIDE','X-RAY DIFFRACTION',1.800,'HYDROLASE/PEPTIDE',1,2,1),(3429,'3oux','STRUCTURE OF BETA-CATENIN WITH PHOSPHORYLATED LEF-1','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING',1,1,1),(3430,'3ov1','CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A PYXN- DERIVED TRIPEPTIDE','X-RAY DIFFRACTION',1.600,'SIGNALING PROTEIN/ANTAGONIST',1,1,1),(3431,'3ove','CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A PYXN- DERIVED TRIPEPTIDE','X-RAY DIFFRACTION',1.820,'SIGNALING PROTEIN/ANTAGONIST',1,1,1),(3432,'3ovv','HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',1.580,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3433,'3ow3','DISCOVERY OF DIHYDROTHIENO- AND DIHYDROFUROPYRIMIDINES AS POTENT PAN AKT INHIBITORS','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3434,'3owp','HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',1.880,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3435,'3owt','CRYSTAL STRUCTURE OF S. CEREVISIAE RAP1-SIR3 COMPLEX','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',1,2,1),(3436,'3ox7','THE CRYSTAL STRUCTURE OF UPA COMPLEX WITH PEPTIDE INHIBITOR MH027 AT PH4.6','X-RAY DIFFRACTION',1.580,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3437,'3ox8','CRYSTAL STRUCTURE OF HLA A*02:03 BOUND TO HBV CORE 18-27','X-RAY DIFFRACTION',2.160,'IMMUNE SYSTEM',2,2,1),(3438,'3oxi','DESIGN AND SYNTHESIS OF DISUBSTITUTED THIOPHENE AND THIAZOLE BASED INHIBITORS OF JNK FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3439,'3oxr','CRYSTAL STRUCTURE OF HLA A*02:06 BOUND TO HBV CORE 18-27','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(3440,'3oxs','CRYSTAL STRUCTURE OF HLA A*02:07 BOUND TO HBV CORE 18-27','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',1,1,1),(3441,'3oxt','HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(3442,'3oy5','THE CRYSTAL STRUCTURE OF UPA COMPLEX WITH PEPTIDE INHIBITOR MH027 AT PH7.4','X-RAY DIFFRACTION',2.310,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3443,'3oy6','THE CRYSTAL STRUCTURE OF UPA COMPLEX WITH PEPTIDE INHIBITOR MH036 AT PH4.6','X-RAY DIFFRACTION',2.310,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3444,'3ozj','CRYSTAL STRUCTURE OF HUMAN RETINOIC X RECEPTOR ALPHA COMPLEXED WITH BIGELOVIN AND COACTIVATOR SRC-1','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(3445,'3p0m','HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',2.030,'TRANSFERASE',1,1,1),(3446,'3p17','THROMBIN INHIBITION BY PYRIDIN DERIVATIVES','X-RAY DIFFRACTION',1.430,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3447,'3p1n','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH TASK-3 PEPTIDE','X-RAY DIFFRACTION',1.400,'PEPTIDE BINDING PROTEIN',1,1,1),(3448,'3p1o','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH TASK-3 PEPTIDE AND STABILISATOR FUSICOCCIN A','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN',1,1,1),(3449,'3p1p','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38N/N166H IN COMPLEX WITH TASK-3 PEPTIDE','X-RAY DIFFRACTION',1.950,'PEPTIDE BINDING PROTEIN',1,1,1),(3450,'3p1q','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38N/N166H IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER FUSICOCCIN A','X-RAY DIFFRACTION',1.700,'PEPTIDE BINDING PROTEIN',1,1,1),(3451,'3p1r','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38V/N166H IN COMPLEX WITH TASK-3 PEPTIDE','X-RAY DIFFRACTION',1.700,'PEPTIDE BINDING PROTEIN',1,1,1),(3452,'3p1s','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38N/N166H IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER FUSICOCCIN A','X-RAY DIFFRACTION',1.650,'PEPTIDE BINDING PROTEIN',1,1,1),(3453,'3p2z','POLO-LIKE KINASE I POLO-BOX DOMAIN IN COMPLEX WITH PLHSPTA PHOSPHOPEPTIDE FROM PBIP1','X-RAY DIFFRACTION',1.790,'TRANSFERASE',1,1,1),(3454,'3p34','POLO-LIKE KINASE I POLO-BOX DOMAIN IN COMPLEX WITH MQSPTPL PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.400,'TRANSFERASE',1,1,1),(3455,'3p35','POLO-LIKE KINASE I POLO-BOX DOMAIN IN COMPLEX WITH MQSPSPL PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.090,'TRANSFERASE',2,3,1),(3456,'3p36','POLO-LIKE KINASE I POLO-BOX DOMAIN IN COMPLEX WITH DPPLHSPTA PHOSPHOPEPTIDE FROM PBIP1','X-RAY DIFFRACTION',1.590,'TRANSFERASE',1,1,1),(3457,'3p37','POLO-LIKE KINASE I POLO-BOX DOMAIN IN COMPLEX WITH FDPPLHSPTA PHOSPHOPEPTIDE FROM PBIP1','X-RAY DIFFRACTION',2.380,'TRANSFERASE',3,3,1),(3458,'3p3n','FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH NOTCH 1 FRAGMENT MOUSE NOTCH (1930-1949) PEPTIDE','X-RAY DIFFRACTION',2.400,'OXIDOREDUCTASE/TRANSCRIPTION',1,1,1),(3459,'3p4f','STRUCTURAL AND BIOCHEMICAL INSIGHTS INTO MLL1 CORE COMPLEX ASSEMBLY AND REGULATION.','X-RAY DIFFRACTION',2.350,'TRANSCRIPTION',2,1,1),(3460,'3p4k','THE THIRD CONFORMATION OF P38A MAP KINASE OBSERVED IN PHOSPHORYLATED P38A AND IN SOLUTION','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(3461,'3p4m','CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-LCMV EPITOPE YTVKYPNL, AN 8-MER PEPTIDE FROM THE LCMV','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,2,1),(3462,'3p4n','CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE NP205-PV EPITOPE YTVKFPNM, AN 8-MER PEPTIDE FROM PV','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,2,1),(3463,'3p4o','CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE MUTANT NP205-LCMV-V3A EPITOPE YTAKYPNL, AN 8-MER MODIFIED PEPTIDE FROM THE LCMV','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(3464,'3p4u','CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 IN COMPLEX WITH AC-VEID-CHO INHIBITOR','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(3465,'3p6z','STRUCTURAL BASIS OF THROMBIN MEDIATED FACTOR V ACTIVATION: ESSENTIAL ROLE OF THE HIRUDIN-LIKE SEQUENCE GLU666-GLU672 FOR PROCESSING AT THE HEAVY CHAIN-B DOMAIN JUNCTION','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',4,2,1),(3466,'3p72','STRUCTURE OF PLATELET GLYCOPROTEIN 1B ALPHA WITH A BOUND PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.900,'BLOOD CLOTTING/INHIBITOR',1,1,1),(3467,'3p89','FXR BOUND TO A QUINOLINECARBOXYLIC ACID','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION/INHIBITOR',1,1,1),(3468,'3p8f','CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH SFTI-1','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3469,'3p8n','CRYSTAL STRUCTURE OF HCV NS3/NS4A PROTEASE COMPLEXED WITH BI 201335','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3470,'3p8o','CRYSTAL STRUCTURE OF HCV NS3/NS4A PROTEASE COMPLEXED WITH DES-BROMINE ANALOGUE OF BI 201335','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3471,'3p9g','CRYSTAL STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH FA459 PEPTIDE','X-RAY DIFFRACTION',1.800,'PROTEIN TRANSPORT',1,1,1),(3472,'3p9h','CRYSTAL STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH FA258 PEPTIDE','X-RAY DIFFRACTION',1.800,'PROTEIN TRANSPORT',1,1,1),(3473,'3p9l','CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH THE CHICKEN OVALBUMIN EPITOPE OVA','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(3474,'3p9m','CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-G4','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(3475,'3p9y','CRYSTAL STRUCTURE OF THE DROSOPHILA MELANOGASTER SSU72-PCTD COMPLEX','X-RAY DIFFRACTION',2.100,'HYDROLASE',4,4,1),(3476,'3pab','CRYSTAL STRUCTURE OF H2-KB IN COMPLEX WITH A MUTANT OF THE CHICKEN OVALBUMIN EPITOPE OVA-E1','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,2,1),(3477,'3pcu','CRYSTAL STRUCTURE OF HUMAN RETINOIC X RECEPTOR ALPHA LIGAND-BINDING DOMAIN COMPLEXED WITH LX0278 AND SRC1 PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION/TRANSCRIPTION REGULATOR',1,1,1),(3478,'3pcx','CASPASE-3 E246A, K242A DOUBLE MUTANT','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3479,'3pd0','CASPASE-3 E246A','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3480,'3pd1','CASPASE-3 K242A','X-RAY DIFFRACTION',1.620,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3481,'3pdh','STRUCTURE OF SIR2TM BOUND TO A PROPIONYLATED PEPTIDE','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(3482,'3pdo','CRYSTAL STRUCTURE OF HLA-DR1 WITH CLIP102-120','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,2,1),(3483,'3pe4','STRUCTURE OF HUMAN O-GLCNAC TRANSFERASE AND ITS COMPLEX WITH A PEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.950,'TRANSFERASE',2,2,1),(3484,'3pfv','CRYSTAL STRUCTURE OF CBL-B TKB DOMAIN IN COMPLEX WITH EGFR PY1069 PEPTIDE','X-RAY DIFFRACTION',2.270,'LIGASE/PROTEIN BINDING',2,2,1),(3485,'3pk1','CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH THE BAXBH3 DOMAIN','X-RAY DIFFRACTION',2.490,'APOPTOSIS/APOPTOSIS REGULATOR',2,2,1),(3486,'3pkn','CRYSTAL STRUCTURE OF MLLE DOMAIN OF POLY(A) BINDING PROTEIN IN COMPLEX WITH PAM2 MOTIF OF LA-RELATED PROTEIN 4 (LARP4)','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',1,1,1),(3487,'3plf','REVERSE BINDING MODE OF METRD PEPTIDE COMPLEXED WITH C-CBL TKB DOMAIN','X-RAY DIFFRACTION',1.920,'PROTEIN BINDING/LIGASE',2,2,1),(3488,'3plu','STRUCTURE OF HUB-1 PROTEIN IN COMPLEX WITH SNU66 PEPTIDE (HINDI)','X-RAY DIFFRACTION',1.400,'PEPTIDE BINDING PROTEIN',2,2,1),(3489,'3plv','STRUCTURE OF HUB-1 PROTEIN IN COMPLEX WITH SNU66 PEPTIDE (HINDII)','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN',1,1,1),(3490,'3plx','THE CRYSTAL STRUCTURE OF ASPARTATE ALPHA-DECARBOXYLASE FROM CAMPYLOBACTER JEJUNI SUBSP. JEJUNI NCTC 11168','X-RAY DIFFRACTION',1.750,'LYASE',1,1,1),(3491,'3plz','HUMAN LRH1 LBD BOUND TO GR470','X-RAY DIFFRACTION',1.750,'TRANSCRIPTION/RECEPTOR/AGONIST',2,2,1),(3492,'3pma','2.2 ANGSTROM CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN BOVINE THROMBIN AND SUCROSE OCTASULFATE','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3493,'3pmp','CRYSTAL STRUCTURE OF CYCLOPHILIN A FROM MONILIOPHTHORA PERNICIOSA IN COMPLEX WITH CYCLOSPORIN A','X-RAY DIFFRACTION',1.470,'ISOMERASE/IMMUNOSUPPRESSANT',2,2,1),(3494,'3po1','THROMBIN IN COMPLEX WITH BENZOTHIAZOLE GUANIDINE','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3495,'3poa','STRUCTURAL AND FUNCTIONAL ANALYSIS OF PHOSPHOTHREONINE-DEPENDENT FHA DOMAIN INTERACTIONS','X-RAY DIFFRACTION',2.010,'PEPTIDE BINDING PROTEIN',1,1,1),(3496,'3pob','CRYSTAL STRUCTURE OF MASP-1 CUB2 DOMAIN IN COMPLEX WITH THE COLLAGEN- LIKE DOMAIN OF MBL','X-RAY DIFFRACTION',1.800,'HYDROLASE',2,1,1),(3497,'3poo','HUMAN CAMP-DEPENDENT PROTEIN KINASE IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',1.600,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3498,'3pqz','GRB7 SH2 WITH PEPTIDE','X-RAY DIFFRACTION',2.410,'PROTEIN BINDING',2,4,1),(3499,'3prk','INHIBITION OF PROTEINASE K BY METHOXYSUCCINYL-ALA-ALA-PRO-ALA- CHLOROMETHYL KETONE. AN X-RAY STUDY AT 2.2-ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3500,'3psl','FINE-TUNING THE STIMULATION OF MLL1 METHYLTRANSFERASE ACTIVITY BY A HISTONE H3 BASED PEPTIDE MIMETIC','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',2,2,1),(3501,'3ptg','DESIGN AND SYNTHESIS OF A NOVEL, ORALLY EFFICACIOUS TRI-SUBSTITUTED THIOPHENE BASED JNK INHIBITOR','X-RAY DIFFRACTION',2.430,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3502,'3pth','THE PABC1 MLLE DOMAIN BOUND TO THE VARIANT PAM2 MOTIF OF LARP4B','X-RAY DIFFRACTION',1.700,'RNA BINDING PROTEIN',1,1,1),(3503,'3ptl','CRYSTAL STRUCTURE OF PROTEINASE K INHIBITED BY A LACTOFERRIN NONAPEPTIDE, LYS-GLY-GLU-ALA-ASP-ALA-LEU-SER-LEU-ASP AT 1.3 A RESOLUTION.','X-RAY DIFFRACTION',1.300,'HYDROLASE/INHIBITOR',1,1,1),(3504,'3pwj','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L,I9V) PEPTIDE VARIANT','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING',2,2,1),(3505,'3pwl','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD PEPTIDE','X-RAY DIFFRACTION',1.650,'PROTEIN BINDING',2,2,1),(3506,'3pwn','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH THE HUD (G2L) PEPTIDE VARIANT','X-RAY DIFFRACTION',1.600,'PROTEIN BINDING',2,2,1),(3507,'3pwu','AN IMMMUNODOMINANT CTL EPITOPE FROM RINDERPEST VIRUS PRESENTED BY CATTLE MHC CLASS I MOLECULE N*01801(BOLA-A11)','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(3508,'3pzd','STRUCTURE OF THE MYOSIN X MYTH4-FERM/DCC COMPLEX','X-RAY DIFFRACTION',2.500,'MOTOR PROTEIN/APOPTOSIS',1,1,1),(3509,'3q1i','POLO-LIKE KINASE I POLO-BOX DOMAIN IN COMPLEX WITH FMPPPMSPSM PHOSPHOPEPTIDE FROM TCERG1','X-RAY DIFFRACTION',1.400,'TRANSFERASE',1,1,1),(3510,'3q47','CRYSTAL STRUCTURE OF TPR DOMAIN OF CHIP COMPLEXED WITH PSEUDOPHOSPHORYLATED SMAD1 PEPTIDE','X-RAY DIFFRACTION',1.710,'LIGASE/TRANSCRIPTION',1,1,1),(3511,'3q49','CRYSTAL STRUCTURE OF THE TPR DOMAIN OF CHIP COMPLEXED WITH HSP70-C PEPTIDE','X-RAY DIFFRACTION',1.540,'LIGASE/CHAPERONE',1,1,1),(3512,'3q4a','CRYSTAL STRUCTURE OF THE TPR DOMAIN OF CHIP COMPLEXED WITH PHOSPHORYLATED SMAD1 PEPTIDE','X-RAY DIFFRACTION',1.540,'LIGASE/TRANSCRIPTION',1,1,1),(3513,'3q4j','STRUCTURE OF A SMALL PEPTIDE LIGAND BOUND TO E.COLI DNA SLIDING CLAMP','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE INHIBITOR',5,5,1),(3514,'3q4l','STRUCTURE OF A SMALL PEPTIDE LIGAND BOUND TO E.COLI DNA SLIDING CLAMP','X-RAY DIFFRACTION',1.950,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(3515,'3q5u','A MINIMAL NLS FROM HUMAN SCRAMBLASE 4 COMPLEXED WITH IMPORTIN ALPHA','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT/MEMBRANE PROTEIN',1,1,1),(3516,'3q6s','THE CRYSTAL STRUCTURE OF THE HETEROCHROMATIN PROTEIN 1 BETA CHROMOSHADOW DOMAIN COMPLEXED WITH A PEPTIDE FROM SHUGOSHIN 1','X-RAY DIFFRACTION',1.930,'CELL CYCLE',2,4,1),(3517,'3q75','CRYPTOCOCCUS NEOFORMANS PROTEIN FARNESYLTRANSFERASE IN COMPLEX WITH FPT-II AND TKCVVM PEPTIDE','X-RAY DIFFRACTION',2.140,'TRANSFERASE',1,2,1),(3518,'3q78','CRYPTOCOCCUS NEOFORMANS PROTEIN FARNESYLTRANSFERASE IN COMPLEX WITH FSPP AND DDPTASACNIQ PEPTIDE','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,2,1),(3519,'3q8d','E. COLI RECO COMPLEX WITH SSB C-TERMINUS','X-RAY DIFFRACTION',2.300,'DNA BINDING PROTEIN',2,2,1),(3520,'3q95','CRYSTAL STRUCTURE OF HUMAN ESTROGEN RECEPTOR ALPHA LBD IN COMPLEX WITH GRIP PEPTIDE AND ESTRIOL','X-RAY DIFFRACTION',2.050,'TRANSCRIPTION REGULATOR',2,2,1),(3521,'3qal','CRYSTAL STRUCTURE OF ARG280ALA MUTANT OF CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE','X-RAY DIFFRACTION',1.700,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3522,'3qam','CRYSTAL STRUCTURE OF GLU208ALA MUTANT OF CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE','X-RAY DIFFRACTION',1.920,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3523,'3qby','CRYSTAL STRUCTURE OF THE PWWP DOMAIN OF HUMAN HEPATOMA-DERIVED GROWTH FACTOR 2','X-RAY DIFFRACTION',1.950,'PROTEIN BINDING',1,2,1),(3524,'3qdj','THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,3,1),(3525,'3qf7','THE MRE11:RAD50 COMPLEX FORMS AN ATP DEPENDENT MOLECULAR CLAMP IN DNA DOUBLE-STRAND BREAK REPAIR','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,2,1),(3526,'3qf9','CRYSTAL STRUCTURE OF HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND A FURAN- THIAZOLIDINEDIONE LIGAND','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3527,'3qfd','HUMAN CLASS I MHC HLA-A2 IN COMPLEX WITH MART-1(27-35) NONAMERIC PEPTIDE','X-RAY DIFFRACTION',1.680,'IMMUNE SYSTEM',2,2,1),(3528,'3qfj','THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE','X-RAY DIFFRACTION',2.290,'IMMUNE SYSTEM',1,3,1),(3529,'3qg6','STRUCTURAL BASIS FOR LIGAND RECOGNITION AND DISCRIMINATION OF A QUORUM QUENCHING ANTIBODY','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM/INHIBITOR',2,4,1),(3530,'3qgj','1.3A STRUCTURE OF ALPHA-LYTIC PROTEASE BOUND TO AC-ALAALAPRO-ALANAL','X-RAY DIFFRACTION',1.300,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3531,'3qgn','THE ALLOSTERIC E*-E EQUILIBRIUM IS A KEY PROPERTY OF THE TRYPSIN FOLD','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(3532,'3qhe','CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE ARMADILLO REPEAT DOMAIN OF ADENOMATOUS POLYPOSIS COLI AND THE TYROSINE-RICH DOMAIN OF SAM68','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN/SPLICING',2,2,1),(3533,'3qhr','STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC','X-RAY DIFFRACTION',2.170,'TRANSFERASE/PROTEIN BINDING',4,4,1),(3534,'3qhw','STRUCTURE OF A PCDK2/CYCLINA TRANSITION-STATE MIMIC','X-RAY DIFFRACTION',1.910,'TRANSFERASE/PROTEIN BINDING',4,4,1),(3535,'3qis','RECOGNITION OF THE F&H MOTIF BY THE LOWE SYNDROME PROTEIN OCRL','X-RAY DIFFRACTION',2.300,'HYDROLASE/PROTEIN BINDING',1,1,1),(3536,'3qj6','THE CRYSTAL STRUCTURE OF PWWP DOMAIN OF HUMAN HEPATOMA-DERIVED GROWTH FACTOR 2 IN COMPLEX WITH H3K79ME3 PEPTIDE','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING/ NUCLEAR PROTEIN',1,1,1),(3537,'3qjm','STRUCTURAL FLEXIBILITY OF SHANK PDZ DOMAIN IS IMPORTANT FOR ITS BINDING TO DIFFERENT LIGANDS','X-RAY DIFFRACTION',2.310,'PROTEIN BINDING',2,2,1),(3538,'3qkk','SPIROCHROMANE AKT INHIBITORS','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3539,'3qkl','SPIROCHROMANE AKT INHIBITORS','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3540,'3qks','MRE11 RAD50 BINDING DOMAIN BOUND TO RAD50','X-RAY DIFFRACTION',2.100,'REPLICATION',1,2,1),(3541,'3ql9','MONOCLINIC COMPLEX STRUCTURE OF ATRX ADD BOUND TO HISTONE H3K9ME3 PEPTIDE','X-RAY DIFFRACTION',0.930,'TRANSCRIPTION/STRUCTURAL PROTEIN',1,1,1),(3542,'3qla','HEXAGONAL COMPLEX STRUCTURE OF ATRX ADD BOUND TO H3K9ME3 PEPTIDE','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION/STRUCTURAL PROTEIN',2,2,1),(3543,'3qlc','COMPLEX STRUCTURE OF ATRX ADD DOMAIN BOUND TO UNMODIFIED H3 1-15 PEPTIDE','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/STRUCTURAL PROTEIN',2,2,1),(3544,'3qlp','X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND A MODIFIED THROMBIN BINDING APTAMER (MTBA)','X-RAY DIFFRACTION',2.140,'HYDROLASE/HYDROLASE INHIBITOR/DNA',1,1,1),(3545,'3qn7','POTENT AND SELECTIVE BICYCLIC PEPTIDE INHIBITOR (UK18) OF HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR(UPA)','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3546,'3qnj','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH THE ANTIMICROBIAL PEPTIDE ONCOCIN','X-RAY DIFFRACTION',2.280,'CHAPERONE/ANTIMICROBIAL PROTEIN',2,2,1),(3547,'3qnz','ORTHORHOMBIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC TUBULIN PEPTIDE) SHARING SAME FV AS IGA','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,2,1),(3548,'3qo0','MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(3549,'3qo2','STRUCTURAL INSIGHTS FOR MPP8 CHROMODOMAIN INTERACTION WITH HISTONE H3 LYSINE 9','X-RAY DIFFRACTION',2.490,'DNA BINDING PROTEIN/GENE REGULATION',2,1,1),(3550,'3qq4','CRYSTAL STRUCTURE OF SWINE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I SLA-1 0401 AND IDENTIFICATION OF 2009 PANDEMIC SWINE-ORIGIN INFLUENZA A H1N1 VIRUS CYTOTOXIC T LYMPHOCYTE EPITOPE PEPTIDES','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(3551,'3qrx','CHLAMYDOMONAS REINHARDTII CENTRIN BOUND TO MELITTIN','X-RAY DIFFRACTION',2.200,'METAL BINDING PROTEIN/TOXIN',1,1,1),(3552,'3qt0','REVEALING A STEROID RECEPTOR LIGAND AS A UNIQUE PPARGAMMA AGONIST','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',1,1,1),(3553,'3qto','THROMBIN INHIBITION BY PYRIDIN DERIVATIVES','X-RAY DIFFRACTION',1.520,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3554,'3qtv','THROMBIN INHIBITION BY PYRIDIN DERIVATIVES','X-RAY DIFFRACTION',1.630,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3555,'3quk','CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4A)','X-RAY DIFFRACTION',2.410,'IMMUNE SYSTEM',2,2,1),(3556,'3qul','CRYSTAL STRUCTURES OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (Y4S)','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',4,4,1),(3557,'3qv1','CRYSTAL STRUCTURE OF THE BINARY COMPLEX OF PHOTOSYNTETIC A4 GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (GAPDH) WITH CP12-2, BOTH FROM ARABIDOPSIS THALIANA.','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE/PROTEIN BINDING',3,5,1),(3558,'3qw5','CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR RRGF','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3559,'3qw6','CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR RYGC','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3560,'3qw7','CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR RRFC','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3561,'3qw8','CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A PEPTIDE INHIBITOR CRGC','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3562,'3qwc','THROMBIN INHIBITION BY PYRIDIN DERIVATIVES','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3563,'3qx5','THROMBIN INHIBITION BY PYRIDIN DERIVATIVES','X-RAY DIFFRACTION',1.350,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3564,'3qxd','F54C HLA-DR1 BOUND WITH CLIP PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,4,1),(3565,'3qzs','CRYSTAL STRUCTURE OF BPTF BROMO IN COMPLEX WITH HISTONE H4K16AC - FORM I','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION/NUCLEAR PROTEIN',2,2,1),(3566,'3qzt','CRYSTAL STRUCTURE OF BPTF BROMO IN COMPLEX WITH HISTONE H4K16AC - FORM II','X-RAY DIFFRACTION',1.500,'TRANSCRIPTION/NUCLEAR PROTEIN',1,1,1),(3567,'3qzv','CRYSTAL STRUCTURE OF BPTF PHD-LINKER-BROMO IN COMPLEX WITH HISTONE H4K12AC PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION/NUCLEAR PROTEIN',1,1,1),(3568,'3r0l','CRYSTAL STRUCTURE OF CROTOXIN','X-RAY DIFFRACTION',1.350,'TOXIN/HYDROLASE',2,1,1),(3569,'3r3g','STRUCTURE OF HUMAN THROMBIN WITH RESIDUES 145-150 OF MURINE THROMBIN.','X-RAY DIFFRACTION',1.750,'HYDROLASE',1,1,1),(3570,'3r42','CRYSTAL STRUCTURE OF THE YEAST VPS23 UEV DOMAIN IN COMPLEX WITH A VPS27 PSDP PEPTIDE','X-RAY DIFFRACTION',1.870,'PROTEIN TRANSPORT',1,1,1),(3571,'3r5j','CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-ADVAD-CHO','X-RAY DIFFRACTION',1.770,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(3572,'3r6g','CRYSTAL STRUCTURE OF ACTIVE CASPASE-2 BOUND WITH AC-VDVAD-CHO','X-RAY DIFFRACTION',2.070,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(3573,'3r6l','CASPASE-2 T380A BOUND WITH AC-VDVAD-CHO','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(3574,'3r7b','CASPASE-2 BOUND TO ONE COPY OF AC-DVAD-CHO','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(3575,'3r7g','CRYSTAL STRUCTURE OF SPIRE KIND DOMAIN IN COMPLEX WITH THE TAIL OF FMN2','X-RAY DIFFRACTION',2.200,'PROTEIN BINDING',1,1,1),(3576,'3r7n','CASPASE-2 BOUND WITH TWO COPIES OF AC-DVAD-CHO','X-RAY DIFFRACTION',2.330,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(3577,'3r85','CRYSTAL STRUCTURE OF HUMAN SOUL BH3 DOMAIN IN COMPLEX WITH BCL-XL','X-RAY DIFFRACTION',1.950,'APOPTOSIS',4,4,1),(3578,'3r93','CRYSTAL STRUCTURE OF THE CHROMO DOMAIN OF M-PHASE PHOSPHOPROTEIN 8 BOUND TO H3K9ME3 PEPTIDE','X-RAY DIFFRACTION',2.060,'CELL CYCLE',3,1,1),(3579,'3rbq','CO-CRYSTAL STRUCTURE OF HUMAN UNC119 (RETINA GENE 4) AND AN N-TERMINAL TRANSDUCIN-ALPHA MIMICKING PEPTIDE','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT/LIPID BINDING PROTE',6,6,1),(3580,'3rc0','HUMAN SETD6 IN COMPLEX WITH RELA LYS310 PEPTIDE','X-RAY DIFFRACTION',2.190,'TRANSFERASE',1,1,1),(3581,'3rc4','MOLECULAR MECHANISMS OF VIRAL AND HOST-CELL SUBSTRATE RECOGNITION BY HCV NS3/4A PROTEASE','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3582,'3rc5','MOLECULAR MECHANISMS OF VIRAL AND HOST-CELL SUBSTRATE RECOGNITION BY HCV NS3/4A PROTEASE','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3583,'3rdv','STRUCTURE OF THE SLAIN2C-CLIPCG1 COMPLEX','X-RAY DIFFRACTION',1.750,'STRUCTURAL PROTEIN',4,4,1),(3584,'3rew','CRYSTAL STRUCTURE OF AN LMP2A-DERIVED PEPTIDE BOUND TO HUMAN CLASS I MHC HLA-A2','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(3585,'3rf3','SHIGELLA IPAA-VBS3 IN COMPLEX WITH HUMAN VINCULIN','X-RAY DIFFRACTION',1.610,'PROTEIN BINDING/TOXIN',2,2,1),(3586,'3rig','SIRT5 IS AN NAD-DEPENDENT PROTEIN LYSINE DEMALONYLASE AND DESUCCINYLASE','X-RAY DIFFRACTION',2.000,'HYDROLASE',2,2,1),(3587,'3riy','SIRT5 IS AN NAD-DEPENDENT PROTEIN LYSINE DEMALONYLASE AND DESUCCINYLASE','X-RAY DIFFRACTION',1.550,'HYDROLASE',2,2,1),(3588,'3rk2','TRUNCATED SNARE COMPLEX','X-RAY DIFFRACTION',2.200,'MEMBRANE PROTEIN/EXOCYTOSIS',2,5,1),(3589,'3rl1','HIV RT DERIVED PEPTIDE COMPLEXED TO HLA-A*0301','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(3590,'3rl2','HIV NEF DERIVED PEPTIDE NEF73 COMPLEXED TO HLA-A*0301','X-RAY DIFFRACTION',2.390,'IMMUNE SYSTEM',1,1,1),(3591,'3rl7','CRYSTAL STRUCTURE OF HDLG1-PDZ1 COMPLEXED WITH APC','X-RAY DIFFRACTION',2.300,'MEMBRANE PROTEIN/SIGNALING PROTEIN',6,6,1),(3592,'3rl8','CRYSTAL STRUCTURE OF HDLG1-PDZ2 COMPLEXED WITH APC','X-RAY DIFFRACTION',2.200,'MEMBRANE PROTEIN/SIGNALING PROTEIN',1,1,1),(3593,'3rlw','HUMAN THROMBIN IN COMPLEX WITH MI328','X-RAY DIFFRACTION',1.690,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3594,'3rly','HUMAN THROMBIN IN COMPLEX WITH MI329','X-RAY DIFFRACTION',1.510,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3595,'3rm0','HUMAN THROMBIN IN COMPLEX WITH MI354','X-RAY DIFFRACTION',1.340,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3596,'3rm1','1.24 ANGSTROM X-RAY STRUCTURE OF BOVINE TRTK12-CA(2+)-S100B D63N','X-RAY DIFFRACTION',1.240,'METAL BINDING PROTEIN/PROTEIN BINDING',1,1,1),(3597,'3rm2','HUMAN THROMBIN IN COMPLEX WITH MI003','X-RAY DIFFRACTION',1.230,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3598,'3rml','HUMAN THROMBIN IN COMPLEX WITH MI331','X-RAY DIFFRACTION',1.530,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3599,'3rmm','HUMAN THROMBIN IN COMPLEX WITH MI332','X-RAY DIFFRACTION',1.580,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3600,'3rmn','HUMAN THROMBIN IN COMPLEX WITH MI341','X-RAY DIFFRACTION',1.780,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3601,'3rmo','HUMAN THROMBIN IN COMPLEX WITH MI004','X-RAY DIFFRACTION',1.400,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3602,'3rnm','THE CRYSTAL STRUCTURE OF THE SUBUNIT BINDING OF HUMAN DIHYDROLIPOAMIDE TRANSACYLASE (E2B) BOUND TO HUMAN DIHYDROLIPOAMIDE DEHYDROGENASE (E3)','X-RAY DIFFRACTION',2.400,'OXIDOREDUCTASE/PROTEIN BINDING',1,2,1),(3603,'3ro2','STRUCTURES OF THE LGN/NUMA COMPLEX','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING',1,1,1),(3604,'3ro3','CRYSTAL STRUCTURE OF LGN/MINSCUTEABLE COMPLEX','X-RAY DIFFRACTION',1.100,'PROTEIN BINDING',1,1,1),(3605,'3rof','CRYSTAL STRUCTURE OF THE S. AUREUS PROTEIN TYROSINE PHOSPHATASE PTPA','X-RAY DIFFRACTION',1.030,'HYDROLASE',1,1,1),(3606,'3roo','MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2KB IN COMPLEX WITH IMMUNODOMINANT LCMV-DERIVED GP34-41 PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(3607,'3rq7','POLO-LIKE KINASE 1 POLO BOX DOMAIN IN COMPLEX WITH A C6H5(CH2)8- DERIVATIZED PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.550,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3608,'3rqd','IDEAL THIOLATE-ZINC COORDINATION GEOMETRY IN DEPSIPEPTIDE BINDING TO HISTONE DEACETYLASE 8','X-RAY DIFFRACTION',2.140,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3609,'3rqg','CEREBRAL CAVERNOUS MALFORMATION 3 (CCM3) IN COMPLEX WITH PAXILLIN LD4','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING',1,1,1),(3610,'3rrb','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH AMP','X-RAY DIFFRACTION',2.400,'LYASE',1,1,1),(3611,'3rre','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH ADP','X-RAY DIFFRACTION',2.150,'LYASE',1,1,1),(3612,'3rrf','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH ATP','X-RAY DIFFRACTION',2.100,'LYASE',1,1,1),(3613,'3rrj','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH P1,P5-DI(ADENOSINE-5\') PENTAPHOSPHATE','X-RAY DIFFRACTION',2.500,'LYASE',1,1,1),(3614,'3rs8','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH ADP-RIBOSE','X-RAY DIFFRACTION',2.100,'LYASE',1,1,1),(3615,'3rs9','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH P1,P3-DI(ADENOSINE-5\') TRIPHOSPHATE','X-RAY DIFFRACTION',2.100,'LYASE',1,1,1),(3616,'3rsf','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH P1,P4-DI(ADENOSINE-5\') TETRAPHOSPHATE','X-RAY DIFFRACTION',2.300,'LYASE',1,1,1),(3617,'3rsg','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH NAD.','X-RAY DIFFRACTION',2.100,'LYASE',1,1,1),(3618,'3rsq','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH NADH','X-RAY DIFFRACTION',2.050,'LYASE',1,1,1),(3619,'3rss','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH NADP','X-RAY DIFFRACTION',1.950,'LYASE',1,1,1),(3620,'3rt7','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA IN COMPLEX WITH ADP-GLUCOSE','X-RAY DIFFRACTION',2.100,'LYASE',1,1,1),(3621,'3rt9','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH COENZYME A','X-RAY DIFFRACTION',1.950,'LYASE',1,1,1),(3622,'3rta','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH ACETYL COENZYME A','X-RAY DIFFRACTION',1.950,'LYASE',1,1,1),(3623,'3rtb','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH ADENOSINE-3\'-5\'-DIPHOSPHATE','X-RAY DIFFRACTION',2.100,'LYASE',1,1,1),(3624,'3rtc','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH NAD AND ATP.','X-RAY DIFFRACTION',2.100,'LYASE',1,1,1),(3625,'3rtd','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH NADH AND ADP.','X-RAY DIFFRACTION',2.300,'LYASE',1,1,1),(3626,'3rte','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH NADP AND ATP.','X-RAY DIFFRACTION',2.100,'LYASE',1,1,1),(3627,'3rtg','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH COENZYME A AND ATP','X-RAY DIFFRACTION',2.050,'LYASE',1,1,1),(3628,'3ru2','CRYSTAL STRUCTURE OF TM0922, A FUSION OF A DOMAIN OF UNKNOWN FUNCTION AND ADP/ATP-DEPENDENT NAD(P)H-HYDRATE DEHYDRATASE FROM THERMOTOGA MARITIMA SOAKED WITH NADPH.','X-RAY DIFFRACTION',2.200,'LYASE',1,1,1),(3629,'3ru4','CRYSTAL STRUCTURE OF THE BOWMAN-BIRK SERINE PROTEASE INHIBITOR BTCI IN COMPLEX WITH TRYPSIN AND CHYMOTRYPSIN','X-RAY DIFFRACTION',1.680,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(3630,'3run','NEW STRATEGY TO ANALYZE STRUCTURES OF GLYCOPEPTIDE ANTIBIOTIC-TARGET COMPLEXES','X-RAY DIFFRACTION',1.400,'HYDROLASE/ANTIBIOTIC',1,1,1),(3631,'3ruu','FXR WITH SRC1 AND GSK237','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION REGULATOR',1,1,1),(3632,'3rwc','CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-IW9','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,2,1),(3633,'3rwe','RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-FW9','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(3634,'3rwg','RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-MW9','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(3635,'3rwi','RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*17-GW10','X-RAY DIFFRACTION',2.010,'IMMUNE SYSTEM',1,1,1),(3636,'3ryb','LACTOCOCCAL OPPA COMPLEXED WITH SLSQSLSQS','X-RAY DIFFRACTION',1.500,'PEPTIDE BINDING PROTEIN',1,1,1),(3637,'3rz9','MOUSE IMPORTIN ALPHA-KU80 NLS PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.290,'PROTEIN TRANSPORT',1,1,1),(3638,'3s04','CRYSTAL STRUCTURE OF ESCHERICHIA COLI TYPE I SIGNAL PEPTIDASE IN COMPLEX WITH AN ARYLOMYCIN LIPOGLYCOPEPTIDE ANTIBIOTIC','X-RAY DIFFRACTION',2.440,'HYDROLASE/ANTIBIOTIC',2,2,1),(3639,'3s3j','TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR','X-RAY DIFFRACTION',2.250,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3640,'3s3p','TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR','X-RAY DIFFRACTION',2.500,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3641,'3s3s','TRANSGLUTAMINASE 2 IN COMPLEX WITH A NOVEL INHIBITOR','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3642,'3s4s','CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,4,1),(3643,'3s5l','CRYSTAL STRUCTURE OF CD4 MUTANT BOUND TO HLA-DR1','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,4,1),(3644,'3s6p','CRYSTAL STRUCTURE OF HELICOVERPA ARMIGERA STUNT VIRUS','X-RAY DIFFRACTION',2.500,'VIRUS',2,3,1),(3645,'3s70','CRYSTAL STRUCTURE OF ACTIVE CASPASE-6 BOUND WITH AC-VEID-CHO SOLVED BY AS-SAD','X-RAY DIFFRACTION',1.620,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3646,'3s7d','STRUCTURAL BASIS OF SUBSTRATE METHYLATION AND INHIBITION OF SMYD2','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(3647,'3s7h','STRUCTURE OF THROMBIN MUTANT Y225P IN THE E* FORM','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(3648,'3s7k','STRUCTURE OF THROMBIN MUTANT Y225P IN THE E FORM','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,2,1),(3649,'3s8f','1.8 A STRUCTURE OF BA3 CYTOCHROME C OXIDASE FROM THERMUS THERMOPHILUS IN LIPID ENVIRONMENT','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE',1,2,1),(3650,'3s8g','1.8 A STRUCTURE OF BA3 CYTOCHROME C OXIDASE MUTANT (A120F) FROM THERMUS THERMOPHILUS IN LIPID ENVIRONMENT','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE',1,2,1),(3651,'3s8l','PROTEIN-LIGAND INTERACTIONS: THERMODYNAMIC EFFECTS ASSOCIATED WITH INCREASING HYDROPHOBIC SURFACE AREA','X-RAY DIFFRACTION',1.710,'SIGNALING PROTEIN/ANTAGONIST',1,1,1),(3652,'3s8n','CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A PYXN- DERIVED TRIPEPTIDE','X-RAY DIFFRACTION',1.710,'SIGNALING PROTEIN/ANTAGONIST',1,1,1),(3653,'3s8o','CRYSTAL STRUCTURE OF THE GRB2 SH2 DOMAIN IN COMPLEX WITH A PYXN- DERIVED TRIPEPTIDE','X-RAY DIFFRACTION',1.850,'SIGNALING PROTEIN/ANTAGONIST',1,1,1),(3654,'3s90','HUMAN VINCULIN HEAD DOMAIN VH1 (RESIDUES 1-252) IN COMPLEX WITH MURINE TALIN (VBS33; RESIDUES 1512-1546)','X-RAY DIFFRACTION',1.970,'CELL ADHESION',2,2,1),(3655,'3s9c','RUSSELL\'S VIPER VENOM SERINE PROTEINASE, RVV-V IN COMPLEX WITH THE FRAGMENT (RESIDUES 1533-1546) OF HUMAN FACTOR V','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(3656,'3sfj','CRYSTAL STRUCTURE OF TAX-INTERACTING PROTEIN-1 (TIP-1) PDZ DOMAIN BOUND TO ICAL36 INHIBITOR PEPTIDE','X-RAY DIFFRACTION',1.240,'SIGNALING PROTEIN/INHIBITOR',2,2,1),(3657,'3sga','STRUCTURES OF PRODUCT AND INHIBITOR COMPLEXES OF STREPTOMYCES GRISEUS PROTEASE A AT 1.8 ANGSTROMS RESOLUTION. A MODEL FOR SERINE PROTEASE CATALYSIS','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3658,'3sgb','STRUCTURE OF THE COMPLEX OF STREPTOMYCES GRISEUS PROTEASE B AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR AT 1.8 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.800,'COMPLEX(SERINE PROTEINASE-INHIBITOR)',1,1,1),(3659,'3sge','CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE','X-RAY DIFFRACTION',1.890,'IMMUNE SYSTEM',2,4,1),(3660,'3sha','HUMAN THROMBIN IN COMPLEX WITH UBTHR97','X-RAY DIFFRACTION',1.520,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3661,'3shb','CRYSTAL STRUCTURE OF PHD DOMAIN OF UHRF1','X-RAY DIFFRACTION',1.800,'LIGASE/NUCLEAR PROTEIN',1,1,1),(3662,'3shc','HUMAN THROMBIN IN COMPLEX WITH UBTHR101','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3663,'3shv','CRYSTAL STRUCTURE OF HUMAN MCPH1 TANDEM BRCT DOMAINS-GAMMA H2AX COMPLEX','X-RAY DIFFRACTION',2.100,'CELL CYCLE',2,2,1),(3664,'3si3','HUMAN THROMBIN IN COMPLEX WITH UBTHR103','X-RAY DIFFRACTION',1.550,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3665,'3si4','HUMAN THROMBIN IN COMPLEX WITH UBTHR104','X-RAY DIFFRACTION',1.270,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3666,'3si5','KINETOCHORE-BUBR1 KINASE COMPLEX','X-RAY DIFFRACTION',2.200,'CELL CYCLE',2,2,1),(3667,'3sj9','CRYSTAL STRUCTURE OF THE C147A MUTANT 3C OF CVA16 IN COMPLEX WITH FAGLRQAVTQ PEPTIDE','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,1,1),(3668,'3sjh','CRYSTAL STRUCTURE OF A CHIMERA CONTAINING THE N-TERMINAL DOMAIN (RESIDUES 8-29) OF DROSOPHILA CIBOULOT AND THE C-TERMINAL DOMAIN (RESIDUES 18-44) OF BOVINE THYMOSIN-BETA4, BOUND TO G-ACTIN-ATP- LATRUNCULIN A','X-RAY DIFFRACTION',1.750,'CONTRACTILE PROTEIN, PROTEIN BINDING',1,1,1),(3669,'3sjk','CRYSTAL STRUCTURE OF THE C147A MUTANT 3C FROM ENTEROVIRUS 71','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(3670,'3skm','CRYSTAL STRUCTURE OF THE HLA-B8FLRGRAYVL, MUTANT G8V OF THE FLR PEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(3671,'3sko','CRYSTAL STRUCTURE OF THE HLA-B8-A66-FLR, MUTANT A66 OF THE HLA B8','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(3672,'3sl9','X-RAY STRUCTURE OF BETA CATENIN IN COMPLEX WITH BCL9','X-RAY DIFFRACTION',2.200,'SIGNALING PROTEIN, PROTEIN BINDING',4,4,1),(3673,'3sm1','THE CRYSTAL STRUCTURE OF XMRV PROTEASE COMPLEXED WITH PEPSTATIN A','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3674,'3smk','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38V/N166H IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER COTYLENIN A','X-RAY DIFFRACTION',2.100,'PEPTIDE BINDING PROTEIN',1,1,1),(3675,'3sml','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38N/N166H IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER FUSICOCCIN A AGLYCONE','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN',1,1,1),(3676,'3smm','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38N/N166H IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER FUSICOCCIN J AGLYCONE','X-RAY DIFFRACTION',2.000,'PEPTIDE BINDING PROTEIN',1,1,1),(3677,'3smn','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38N/N166H IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER FUSICOCCIN A-THF','X-RAY DIFFRACTION',2.000,'PEPTIDE BINDING PROTEIN',1,1,1),(3678,'3smo','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38V/N166H IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER FUSICOCCIN J AGLYCONE','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(3679,'3snb','CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC- DSFDQ-H (SOAKING)','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3680,'3snd','CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC- ESTLQ-H (COCRYSTALLIZATION)','X-RAY DIFFRACTION',1.890,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3681,'3so6','CRYSTAL STRUCTURE OF THE LDL RECEPTOR TAIL IN COMPLEX WITH AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA PTB DOMAIN','X-RAY DIFFRACTION',1.370,'PROTEIN BINDING/PROTEIN TRANSPORT',1,1,1),(3682,'3soq','THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A DKK1 PEPTIDE','X-RAY DIFFRACTION',1.900,'PROTEIN BINDING/ANTAGONIST',1,1,1),(3683,'3sou','STRUCTURE OF UHRF1 PHD FINGER IN COMPLEX WITH HISTONE H3 1-9 PEPTIDE','X-RAY DIFFRACTION',1.800,'LIGASE',2,2,1),(3684,'3sov','THE STRUCTURE OF A BETA PROPELLER DOMAIN IN COMPLEX WITH PEPTIDE S','X-RAY DIFFRACTION',1.270,'PROTEIN BINDING/ANTAGONIST',1,1,1),(3685,'3sow','STRUCTURE OF UHRF1 PHD FINGER IN COMPLEX WITH HISTONE H3K4ME3 1-9 PEPTIDE','X-RAY DIFFRACTION',1.950,'LIGASE',2,2,1),(3686,'3sp5','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38V/N166H IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER COTYLENOL','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(3687,'3sp6','STRUCTURAL BASIS FOR ILOPROST AS A DUAL PPARALPHA/DELTA AGONIST','X-RAY DIFFRACTION',2.210,'TRANSCRIPTION',1,1,1),(3688,'3spr','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA C38V/N166H IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER FC-THF','X-RAY DIFFRACTION',1.990,'PEPTIDE BINDING PROTEIN',1,1,1),(3689,'3spv','CRYSTAL STRUCTURE OF A PEPTIDE-HLA COMPLEX','X-RAY DIFFRACTION',1.300,'IMMUNE SYSTEM',1,1,1),(3690,'3sqd','CRYSTAL STRUCTURE OF HUMAN PTIP BRCT5/6-GAMMA H2AX COMPLEX','X-RAY DIFFRACTION',2.150,'CELL CYCLE',2,2,1),(3691,'3sri','CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 29AA PFRON2 PEPTIDE','X-RAY DIFFRACTION',1.600,'CELL INVASION',1,1,1),(3692,'3srj','PFAMA1 IN COMPLEX WITH INVASION-INHIBITORY PEPTIDE R1','X-RAY DIFFRACTION',2.150,'CELL INVASION/INHIBITOR',4,2,1),(3693,'3srn','STRUCTURAL CHANGES THAT ACCOMPANY THE REDUCED CATALYTIC EFFICIENCY OF TWO SEMISYNTHETIC RIBONUCLEASE ANALOGS','X-RAY DIFFRACTION',2.000,'HYDROLASE(NUCLEIC ACID,RNA)',1,1,1),(3694,'3ssb','STRUCTURE OF INSECT METALLOPROTEINASE INHIBITOR IN COMPLEX WITH THERMOLYSIN','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',4,2,1),(3695,'3sui','CRYSTAL STRUCTURE OF CA2+-CALMODULIN IN COMPLEX WITH A TRPV1 C- TERMINAL PEPTIDE','X-RAY DIFFRACTION',1.950,'CALCIUM-BINDING PROTEIN',1,1,1),(3696,'3sv2','HUMAN THROMBIN IN COMPLEX WITH UBTHR105','X-RAY DIFFRACTION',1.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3697,'3svm','HUMAN MPP8 - HUMAN DNMT3AK47ME2 PEPTIDE','X-RAY DIFFRACTION',2.310,'TRANSFERASE',1,1,1),(3698,'3swc','GLP (G9A-LIKE PROTEIN) SET DOMAIN IN COMPLEX WITH DNMT3AK44ME2 PEPTIDE','X-RAY DIFFRACTION',2.330,'TRANSFERASE',2,2,1),(3699,'3sxu','STRUCTURE OF THE E. COLI SSB-DNA POLYMERASE III INTERFACE','X-RAY DIFFRACTION',1.850,'TRANSFERASE',1,1,1),(3700,'3szs','CRYSTAL STRUCTURE ANALYSIS OF HELLETHIONIN D','X-RAY DIFFRACTION',1.950,'TOXIN',3,1,1),(3701,'3t03','CRYSTAL STRUCTURE OF PPAR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A NOVEL PARTIAL AGONIST GQ-16','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION/TRANSCRIPTION REGULATOR',2,2,1),(3702,'3t0y','STRUCTURE OF THE PHYR ANTI-ANTI-SIGMA DOMAIN BOUND TO THE ANTI-SIGMA FACTOR, NEPR','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION REGULATOR/PROTEIN BINDI',2,2,1),(3703,'3t1u','CRYSTAL STRUCTURE OF THE COMPLEX OF CYCLOPHILIN-A ENZYME FROM AZOTOBACTER VINELANDII WITH SUCAFPFPNA PEPTIDE','X-RAY DIFFRACTION',2.000,'ISOMERASE',1,1,1),(3704,'3t4p','CRYSTAL STRUCTURE OF O-ACETYL SERINE SULFHYDRYLASE FROM LEISHMANIA DONOVANI IN COMPLEX WITH DESIGNED TETRAPEPTIDE','X-RAY DIFFRACTION',1.770,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3705,'3t5f','HUMAN THROMBIN IN COMPLEX WITH MI340','X-RAY DIFFRACTION',1.450,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3706,'3t5i','STRUCTURE OF FULLY MODIFIED FARNESYLATED RHEB PEPTIDE IN COMPLEX WITH PDE6D','X-RAY DIFFRACTION',2.100,'LIPID BINDING PROTEIN',2,2,1),(3707,'3t5x','PCID2:DSS1 STRUCTURE','X-RAY DIFFRACTION',2.120,'TRANSCRIPTION',1,1,1),(3708,'3t64','5\'-DIPHENYL NUCLEOSIDE INHIBITORS OF PLASMODIUM FALCIPARUM DUTPASE','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(3709,'3t6b','STRUCTURE OF HUMAN DPPIII IN COMPLEX WITH THE OPIOID PEPTIDE TYNORPHIN, AT 2.4 ANGSTROMS','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3710,'3t6r','STRUCTURE OF UHRF1 IN COMPLEX WITH UNMODIFIED H3 N-TERMINAL TAIL','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',1,2,1),(3711,'3t70','5\'-DIPHENYL NUCLEOSIDE INHIBITORS OF PLASMODIUM FALCIPARUM DUTPASE','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(3712,'3t7g','ATG8 TRANSFER FROM ATG7 TO ATG3: A DISTINCTIVE E1-E2 ARCHITECTURE AND MECHANISM IN THE AUTOPHAGY PATHWAY','X-RAY DIFFRACTION',2.080,'LIGASE',2,2,1),(3713,'3t7k','COMPLEX STRUCTURE OF RTT107P AND PHOSPHORYLATED HISTONE H2A','X-RAY DIFFRACTION',2.030,'PROTEIN BINDING',2,2,1),(3714,'3t98','MOLECULAR ARCHITECTURE OF THE TRANSPORT CHANNEL OF THE NUCLEAR PORE COMPLEX: NUP54/NUP58','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT',2,1,1),(3715,'3tax','A NEUTRAL DIPHOSPHATE MIMIC CROSSLINKS THE ACTIVE SITE OF HUMAN O- GLCNAC TRANSFERASE','X-RAY DIFFRACTION',1.880,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(3716,'3tbh','CRYSTAL STRUCTURE OF O-ACETYL SERINE SULFHYDRYLASE IN COMPLEX WITH OCTAPEPTIDE DERIVED FROM SERINE ACETYL TRANSFERASE OF LEISHMANIA DONOVANI','X-RAY DIFFRACTION',1.680,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3717,'3tbs','CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX THE WITH LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P,Y4A)','X-RAY DIFFRACTION',2.490,'IMMUNE SYSTEM/AGONIST',2,2,1),(3718,'3tbt','CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4S)','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM/AGONIST',4,4,1),(3719,'3tbv','CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G,V3P,Y4A)','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM/AGONIST',4,4,1),(3720,'3tbw','CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (A2G, V3P, Y4S)','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM/AGONIST',4,4,1),(3721,'3tby','CRYSTAL STRUCTURE OF THE MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP33 ALTERED PEPTIDE LIGAND (V3P, Y4F)','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM/AGONIST',4,4,1),(3722,'3tcg','CRYSTAL STRUCTURE OF E. COLI OPPA COMPLEXED WITH THE TRIPEPTIDE KGE','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT',8,8,1),(3723,'3tcj','CCDB DIMER FROM V. FISHERI IN COMPLEX WITH ONE C-TERMINAL DOMAIN OF F- PLASMID CCDA','X-RAY DIFFRACTION',1.930,'TOXIN/ANTITOXIN',1,2,1),(3724,'3td5','CRYSTAL STRUCTURE OF OMPA-LIKE DOMAIN FROM ACINETOBACTER BAUMANNII IN COMPLEX WITH L-ALA-GAMMA-D-GLU-M-DAP-D-ALA-D-ALA','X-RAY DIFFRACTION',2.000,'MEMBRANE PROTEIN/PEPTIDE BINDING PROT',8,8,1),(3725,'3tdi','YEAST CUL1WHB-DCN1P ACETYLATED UBC12N COMPLEX','X-RAY DIFFRACTION',2.300,'LIGASE/PROTEIN BINDING',2,2,1),(3726,'3tdu','N-TERMINAL ACETYLATION ACTS AS AN AVIDITY ENHANCER WITHIN AN INTERCONNECTED MULTIPROTEIN COMPLEX: STRUCTURE OF A HUMAN CUL1WHB- DCN1P-ACETYLATED UBC12N COMPLEX','X-RAY DIFFRACTION',1.500,'LIGASE/PROTEIN BINDING',2,2,1),(3727,'3tdz','N-TERMINAL ACETYLATION ACTS AS AN AVIDITY ENHANCER WITHIN AN INTERCONNECTED MULTIPROTEIN COMPLEX: STRUCTURE OF A HUMAN CUL1WHB- DCN1P-STAPLED ACETYLATED UBC12N COMPLEX','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING/INHIBITOR',2,2,1),(3728,'3tei','CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSFERASE',1,1,1),(3729,'3tg5','STRUCTURE OF SMYD2 IN COMPLEX WITH P53 AND SAH','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(3730,'3tid','CRYSTAL STRUCTURE OF THE LCMV DERIVED PEPTIDE GP34 IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',1,1,1),(3731,'3tie','CRYSTAL STRUCTURE OF THE VACCINIA DERIVED PEPTIDE A11R IN COMPLEX WITH THE MURINE MHC CLASS I H-2 KB','X-RAY DIFFRACTION',2.250,'IMMUNE SYSTEM',2,2,1),(3732,'3tiw','CRYSTAL STRUCTURE OF P97N IN COMPLEX WITH THE C-TERMINUS OF GP78','X-RAY DIFFRACTION',1.800,'PROTEIN TRANSPORT/LIGASE',2,2,1),(3733,'3tj5','HUMAN VINCULIN HEAD DOMAIN (VH1, RESIDUES 1-258) IN COMPLEX WITH THE VINCULIN BINDING SITE OF THE SURFACE CELL ANTIGEN 4 (SCA4-VBS-N; RESIDUES 412-434) FROM RICKETTSIA RICKETTSII','X-RAY DIFFRACTION',1.990,'PROTEIN BINDING/TOXIN',1,1,1),(3734,'3tjh','42F3-P3A1/H2-LD COMPLEX','X-RAY DIFFRACTION',2.120,'IMMUNE SYSTEM',1,3,1),(3735,'3tjv','CRYSTAL STRUCTURE OF HUMAN GRANZYME H WITH A PEPTIDYL SUBSTRATE','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,1,1),(3736,'3tkz','STRUCTURE OF THE SHP-2 N-SH2 DOMAIN IN A 1:2 COMPLEX WITH RVIPYFVPLNR PEPTIDE','X-RAY DIFFRACTION',1.800,'HYDROLASE/PEPTIDE',2,1,1),(3737,'3tl0','STRUCTURE OF SHP2 N-SH2 DOMAIN IN COMPLEX WITH RLNPYAQLWHR PEPTIDE','X-RAY DIFFRACTION',2.050,'HYDROLASE/PEPTIDE',1,1,1),(3738,'3tm7','PROCESSED ASPARTATE DECARBOXYLASE MUTANT WITH ASN72 MUTATED TO ALA','X-RAY DIFFRACTION',1.700,'LYASE',2,2,1),(3739,'3to6','CRYSTAL STRUCTURE OF YEAST ESA1 HAT DOMAIN COMPLEXED WITH H4K16COA BISUBSTRATE INHIBITOR','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3740,'3tod','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH 1- BUTYL-1H-PYRAZOLE-5-CARBOXYLIC ACID AT 1.38 A RESOLUTION','X-RAY DIFFRACTION',1.380,'HYDROLASE',1,1,1),(3741,'3tpm','CRYSTAL STRUCTURE OF MAL RPEL DOMAIN IN COMPLEX WITH IMPORTIN-ALPHA','X-RAY DIFFRACTION',2.100,'PROTEIN TRANSPORT/TRANSCRIPTION',1,1,1),(3742,'3trs','THE CRYSTAL STRUCTURE OF ASPERGILLOGLUTAMIC PEPTIDASE FROM ASPERGILLUS NIGER','X-RAY DIFFRACTION',1.600,'HYDROLASE',2,2,1),(3743,'3tsz','CRYSTAL STRUCTURE OF PDZ3-SH3-GUK CORE MODULE FROM HUMAN ZO-1 IN COMPLEX WITH 12MER PEPTIDE FROM HUMAN JAM-A CYTOPLASMIC TAIL','X-RAY DIFFRACTION',2.500,'CELL ADHESION',1,1,1),(3744,'3tu7','HUMAN ALPHA-THROMBIN COMPLEXED WITH N-(METHYLSULFONYL)-D-PHENYLALANYL- N-((1-CARBAMIMIDOYL-4-PIPERIDINYL)METHYL)-L-PROLINAMIDE (BMS-189664)','X-RAY DIFFRACTION',2.490,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3745,'3tvj','CATALYTIC FRAGMENT OF MASP-2 IN COMPLEX WITH ITS SPECIFIC INHIBITOR DEVELOPED BY DIRECTED EVOLUTION ON SGCI SCAFFOLD','X-RAY DIFFRACTION',1.280,'HYDROLASE',1,1,1),(3746,'3tvt','STRUCTURAL BASIS FOR DISCS LARGE INTERACTION WITH PINS','X-RAY DIFFRACTION',1.600,'ANTITUMOR PROTEIN/PROTEIN BINDING',1,1,1),(3747,'3twr','CRYSTAL STRUCTURE OF ARC4 FROM HUMAN TANKYRASE 2 IN COMPLEX WITH PEPTIDE FROM HUMAN 3BP2','X-RAY DIFFRACTION',1.550,'SIGNALING PROTEIN/PEPTIDE',4,4,1),(3748,'3tws','CRYSTAL STRUCTURE OF ARC4 FROM HUMAN TANKYRASE 2 IN COMPLEX WITH PEPTIDE FROM HUMAN TERF1 (CHIMERIC PEPTIDE)','X-RAY DIFFRACTION',1.700,'SIGNALING PROTEIN/PEPTIDE',4,4,1),(3749,'3twt','CRYSTAL STRUCTURE OF ARC4 FROM HUMAN TANKYRASE 2 IN COMPLEX WITH PEPTIDE FROM HUMAN MCL1 (CHIMERIC PEPTIDE)','X-RAY DIFFRACTION',1.850,'SIGNALING PROTEIN/PEPTIDE',4,4,1),(3750,'3twu','CRYSTAL STRUCTURE OF ARC4 FROM HUMAN TANKYRASE 2 IN COMPLEX WITH PEPTIDE FROM HUMAN MCL1','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN/PEPTIDE',1,1,1),(3751,'3twv','CRYSTAL STRUCTURE OF ARC4 FROM HUMAN TANKYRASE 2 IN COMPLEX WITH PEPTIDE FROM HUMAN NUMA1 (CHIMERIC PEPTIDE)','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN/PEPTIDE',4,4,1),(3752,'3tww','CRYSTAL STRUCTURE OF ARC4 FROM HUMAN TANKYRASE 2 IN COMPLEX WITH PEPTIDE FROM HUMAN LNPEP (CHIMERIC PEPTIDE)','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN/PEPTIDE',2,2,1),(3753,'3twx','CRYSTAL STRUCTURE OF ARC4 FROM HUMAN TANKYRASE 2 IN COMPLEX WITH PEPTIDE FROM HUMAN FNBP1 (CHIMERIC PEPTIDE)','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN/PEPTIDE',2,2,1),(3754,'3tz1','CRYSTAL STRUCTURE OF THE CA2+-SATURATED C-TERMINAL DOMAIN OF AKAZARA SCALLOP TROPONIN C IN COMPLEX WITH A TROPONIN I FRAGMENT','X-RAY DIFFRACTION',1.800,'CONTRACTILE PROTEIN',1,1,1),(3755,'3tzx','CRYSTAL STRUCTURE OF A FRAGMENT CONTAINING THE ACYLTRANSFERASE DOMAIN OF PKS13 FROM MYCOBACTERIUM TUBERCULOSIS IN TETRAGONAL APO FORM AT 2.3 A','X-RAY DIFFRACTION',2.300,'TRANSFERASE',2,2,1),(3756,'3tzy','CRYSTAL STRUCTURE OF A FRAGMENT CONTAINING THE ACYLTRANSFERASE DOMAIN OF PKS13 FROM MYCOBACTERIUM TUBERCULOSIS IN THE PALMITOYLATED FORM AT 2.2 A','X-RAY DIFFRACTION',2.200,'TRANSFERASE',2,2,1),(3757,'3tzz','CRYSTAL STRUCTURE OF A FRAGMENT CONTAINING THE ACYLTRANSFERASE DOMAIN OF PKS13 FROM MYCOBACTERIUM TUBERCULOSIS IN THE CARBOXYPALMITOYLATED FORM AT 2.5 A','X-RAY DIFFRACTION',2.490,'TRANSFERASE',1,1,1),(3758,'3u0t','FAB-ANTIBODY COMPLEX','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(3759,'3u1i','DENGUE VIRUS PROTEASE COVALENTLY BOUND TO A PEPTIDE','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',4,2,1),(3760,'3u1j','APROTININ BOUND TO DENGUE VIRUS PROTEASE','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3761,'3u28','CRYSTAL STRUCTURE OF A CBF5-NOP10-GAR1 COMPLEX FROM SACCHAROMYCES CEREVISIAE','X-RAY DIFFRACTION',1.900,'ISOMERASE/PROTEIN BINDING',1,1,1),(3762,'3u31','PLASMODIUM FALCIPARUM SIR2A PREFERENTIALLY HYDROLYZES MEDIUM AND LONG CHAIN FATTY ACYL LYSINE','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(3763,'3u3d','PLASMODIUM FALCIPARUM SIR2A PREFERENTIALLY HYDROLYZES MEDIUM AND LONG CHAIN FATTY ACYL LYSINE','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,1,1),(3764,'3u3w','CRYSTAL STRUCTURE OF BACILLUS THURINGIENSIS PLCR IN COMPLEX WITH THE PEPTIDE PAPR7 AND DNA','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION ACTIVATOR/DNA',2,2,1),(3765,'3u3z','STRUCTURE OF HUMAN MICROCEPHALIN (MCPH1) TANDEM BRCT DOMAINS IN COMPLEX WITH AN H2A.X PEPTIDE PHOSPHORYLATED AT SER139 AND TYR142','X-RAY DIFFRACTION',1.500,'CELL CYCLE',1,1,1),(3766,'3u4s','HISTONE LYSINE DEMETHYLASE JMJD2A IN COMPLEX WITH T11C PEPTIDE SUBSTRATE CROSSLINKED TO N-OXALYL-D-CYSTEINE','X-RAY DIFFRACTION',2.150,'OXIDOREDUCTASE/OXIDOREDUCTASE SUBSTRA',2,2,1),(3767,'3u5n','CRYSTAL STRUCTURE OF THE COMPLEX OF TRIM33 PHD-BROMO AND H3(1-20) K9ME3K14AC HISTONE PEPTIDE','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',2,2,1),(3768,'3u69','UNLIGANDED WILD-TYPE HUMAN THROMBIN','X-RAY DIFFRACTION',1.550,'HYDROLASE',1,1,1),(3769,'3u6b','EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDI028','X-RAY DIFFRACTION',2.120,'TRANSLATION FACTOR/ANTIBIOTIC',2,2,1),(3770,'3u6k','EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH NVP-LDK733','X-RAY DIFFRACTION',2.450,'TRANSLATION FACTOR/ANTIBIOTIC',2,2,1),(3771,'3u72','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH ISONIAZID AT 2.2 A RESOLUTION','X-RAY DIFFRACTION',2.200,'METAL BINDING PROTEIN',1,1,1),(3772,'3u7d','CRYSTAL STRUCTURE OF THE KRIT1/CCM1 FERM DOMAIN IN COMPLEX WITH THE HEART OF GLASS (HEG1) CYTOPLASMIC TAIL','X-RAY DIFFRACTION',2.490,'PROTEIN BINDING',2,2,1),(3773,'3u7x','CRYSTAL STRUCTURE OF THE HUMAN EIF4E-4EBP1 PEPTIDE COMPLEX WITHOUT CAP','X-RAY DIFFRACTION',2.100,'TRANSLATION',2,2,1),(3774,'3u8o','HUMAN THROMBIN COMPLEXED WITH D-PHE-PRO-D-ARG-D-THR','X-RAY DIFFRACTION',1.280,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3775,'3u8q','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH PHENYL-PROPANOLAMINE AT 1.97 A RESOLUTION','X-RAY DIFFRACTION',1.970,'METAL BINDING PROTEIN',1,1,1),(3776,'3u8r','HUMAN THROMBIN COMPLEXED WITH D-PHE-PRO-D-ARG-ILE','X-RAY DIFFRACTION',1.470,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3777,'3u8t','HUMAN THROMBIN COMPLEXED WITH D-PHE-PRO-D-ARG-CYS','X-RAY DIFFRACTION',1.860,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3778,'3u8x','CRYSTAL STRUCTURE OF A CHIMERA CONTAINING THE N-TERMINAL DOMAIN (RESIDUES 8-29) OF DROSOPHILA CIBOULOT AND THE C-TERMINAL DOMAIN (RESIDUES 18-44) OF BOVINE THYMOSIN-BETA4, BOUND TO G-ACTIN-ATP','X-RAY DIFFRACTION',2.000,'CONTRACTILE PROTEIN, PROTEIN BINDING',2,2,1),(3779,'3u98','HUMAN THROMBIN IN COMPLEX WITH MI001','X-RAY DIFFRACTION',1.450,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3780,'3u9a','HUMAN THROMBIN IN COMPLEX WITH MI330','X-RAY DIFFRACTION',1.580,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3781,'3u9d','CRYSTAL STRUCTURE OF A CHIMERA CONTAINING THE N-TERMINAL DOMAIN (RESIDUES 8-24) OF DROSOPHILA CIBOULOT AND THE C-TERMINAL DOMAIN (RESIDUES 13-44) OF BOVINE THYMOSIN-BETA4, BOUND TO G-ACTIN-ATP','X-RAY DIFFRACTION',2.500,'CONTRACTILE PROTEIN, PROTEIN BINDING',2,2,1),(3782,'3u9q','LIGAND BINDING DOMAIN OF PPARGAMMA COMPLEXED WITH DECANOIC ACID AND PGC-1A PEPTIDE','X-RAY DIFFRACTION',1.520,'TRANSCRIPTION',1,1,1),(3783,'3u9z','CRYSTAL STRUCTURE BETWEEN ACTIN AND A PROTEIN CONSTRUCT CONTAINING THE FIRST BETA-THYMOSIN DOMAIN OF DROSOPHILA CIBOULOT (RESIDUES 2-58) WITH THE THREE MUTATIONS N26D/Q27K/D28S','X-RAY DIFFRACTION',2.090,'CONTRACTILE PROTEIN, PROTEIN BINDING',1,1,1),(3784,'3ua7','CRYSTAL STRUCTURE OF THE HUMAN FYN SH3 DOMAIN IN COMPLEX WITH A PEPTIDE FROM THE HEPATITIS C VIRUS NS5A-PROTEIN','X-RAY DIFFRACTION',1.500,'TRANSFERASE/VIRAL PROTEIN',2,3,1),(3785,'3ual','CRYSTAL STRUCTURE OF 14-3-3 EPSILON WITH MLF1 PEPTIDE','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN/PROTEIN BINDING',1,1,1),(3786,'3ubw','COMPLEX OF 14-3-3 ISOFORM EPSILON, A MLF1 PHOSPHOPEPTIDE AND A SMALL FRAGMENT HIT FROM A FBDD SCREEN','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN/PROTEIN BINDING',1,1,1),(3787,'3uec','CRYSTAL STRUCTURE OF HUMAN SURVIVIN BOUND TO HISTONE H3 PHOSPHORYLATED ON THREONINE-3.','X-RAY DIFFRACTION',2.180,'CELL CYCLE',1,1,1),(3788,'3uef','CRYSTAL STRUCTURE OF HUMAN SURVIVIN BOUND TO HISTONE H3 (C2 SPACE GROUP).','X-RAY DIFFRACTION',2.450,'CELL CYCLE',2,2,1),(3789,'3uf7','CO-CRYSTAL STRUCTURE OF ESCHERICHIA COLI URACIL-DNA GLYCOSYLASE AND A C-TERMINAL FRAGEMENT OF THE SINGLE-STRANDED DNA-BINDING PROTEIN','X-RAY DIFFRACTION',1.200,'HYDROLASE',2,1,1),(3790,'3ufm','CO-CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS URACIL-DNA GLYCOSYLASE AND THE C-TERMINUS OF THE SINGLE-STRANDED DNA-BINDING PROTEIN','X-RAY DIFFRACTION',1.950,'HYDROLASE',1,1,1),(3791,'3ugw','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH DEOXYCYTIDINE AT 1.87 A RESOLUTION','X-RAY DIFFRACTION',1.870,'HYDROLASE',1,1,1),(3792,'3uig','CRYSTAL STRUCTURE OF HUMAN SURVIVIN IN COMPLEX WITH T3 PHOSPHORYLATED H3(1-15) PEPTIDE','X-RAY DIFFRACTION',2.400,'APOPTOSIS/APOPTOSIS INHIBITOR',2,2,1),(3793,'3uih','CRYSTAL STRUCTURE OF HUMAN SURVIVIN IN COMPLEX WITH SMAC/DIABLO(1-15) PEPTIDE','X-RAY DIFFRACTION',2.400,'APOPTOSIS/APOPTOSIS INHIBITOR',2,2,1),(3794,'3uji','CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2558 IN COMPLEX WITH MN PEPTIDE','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,2,1),(3795,'3ujj','CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(3796,'3uk4','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH 1,2, 5-PENTANETRIOL AT 1.98 A RESOLUTION','X-RAY DIFFRACTION',1.980,'HYDROLASE',1,1,1),(3797,'3ukw','MOUSE IMPORTIN ALPHA: BIMAX1 PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.100,'PROTEIN TRANSPORT/INHIBITOR',1,1,1),(3798,'3ukx','MOUSE IMPORTIN ALPHA: BIMAX2 PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT/INHIBITOR',1,1,1),(3799,'3uky','MOUSE IMPORTIN ALPHA: YEAST CBP80 CNLS COMPLEX','X-RAY DIFFRACTION',2.350,'PROTEIN TRANSPORT/PROTEIN BINDING',1,1,1),(3800,'3ukz','MOUSE IMPORTIN ALPHA: MOUSE CBP80 CNLS COMPLEX','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT/PROTEIN BINDING',1,1,1),(3801,'3ul0','MOUSE IMPORTIN ALPHA: MOUSE CBP80Y8D CNLS COMPLEX','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT/PROTEIN BINDING',1,1,1),(3802,'3ul1','MOUSE IMPORTIN ALPHA: NUCLEOPLASMIN CNLS PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.900,'PROTEIN TRANSPORT/NUCLEAR PROTEIN',1,1,1),(3803,'3ulr','LYSOZYME CONTAMINATION FACILITATES CRYSTALLIZATION OF A HETERO- TRIMERICCORTACTIN:ARG:LYSOZYME COMPLEX','X-RAY DIFFRACTION',1.650,'HYDROLASE, PROTEIN BINDING',1,2,1),(3804,'3unn','MONOMERIC STRUCTURE OF THE HUMAN MDC1 FHA DOMAIN IN COMPLEX WITH AN MDC1 PHOSPHO-T4 PEPTIDE','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING',1,1,1),(3805,'3uo1','STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN','X-RAY DIFFRACTION',1.640,'IMMUNE SYSTEM',1,2,1),(3806,'3uo8','CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P1 FORM)','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3807,'3uoa','CRYSTAL STRUCTURE OF THE MALT1 PARACASPASE (P21 FORM)','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3808,'3uot','CRYSTAL STRUCTURE OF MDC1 FHA DOMAIN IN COMPLEX WITH A PHOSPHORYLATED PEPTIDE FROM THE MDC1 N-TERMINUS','X-RAY DIFFRACTION',1.800,'CELL CYCLE',2,2,1),(3809,'3up0','NUCLEAR RECEPTOR DAF-12 FROM HOOKWORM ANCYLOSTOMA CEYLANICUM IN COMPLEX WITH (25S)-DELTA7-DAFACHRONIC ACID','X-RAY DIFFRACTION',1.600,'STEROID BINDING PROTEIN/TRANSCRIPTION',2,2,1),(3810,'3up3','NUCLEAR RECEPTOR DAF-12 FROM HOOKWORM ANCYLOSTOMA CEYLANICUM IN COMPLEX WITH (25S)-CHOLESTENOIC ACID','X-RAY DIFFRACTION',1.250,'STEROID BINDING PROTEIN/TRANSCRIPTION',1,1,1),(3811,'3upr','HLA-B*57:01 COMPLEXED TO PEP-V AND ABACAVIR','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(3812,'3upv','TPR2B-DOMAIN:PHSP70-COMPLEX OF YEAST STI1','X-RAY DIFFRACTION',1.600,'PEPTIDE BINDING PROTEIN',1,1,1),(3813,'3uqp','CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR','X-RAY DIFFRACTION',1.770,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3814,'3uri','ENDOTHIAPEPSIN-DB5 COMPLEX.','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3815,'3url','ENDOTHIAPEPSIN-DB6 COMPLEX.','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(3816,'3usd','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH IMIDAZOL (1,2 A) PYRIDINE3-YL-ACITIC ACID AT 2.4 A RESOLUTION','X-RAY DIFFRACTION',2.400,'METAL BINDING PROTEIN',1,1,1),(3817,'3utm','CRYSTAL STRUCTURE OF A MOUSE TANKYRASE-AXIN COMPLEX','X-RAY DIFFRACTION',2.000,'TRANSFERASE/SIGNALING PROTEIN',1,2,1),(3818,'3utq','HUMAN HLA-A*0201-ALWGPDPAAA','X-RAY DIFFRACTION',1.670,'IMMUNE SYSTEM',1,1,1),(3819,'3utu','HIGH AFFINITY INHIBITOR OF HUMAN THROMBIN','X-RAY DIFFRACTION',1.550,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3820,'3uu7','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BISPHENOL-A','X-RAY DIFFRACTION',2.200,'HORMONE RECEPTOR',2,2,1),(3821,'3uua','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BISPHENOL-AF','X-RAY DIFFRACTION',2.050,'HORMONE RECEPTOR',2,2,1),(3822,'3uud','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ESTRADIOL','X-RAY DIFFRACTION',1.600,'HORMONE RECEPTOR',2,2,1),(3823,'3uvk','CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF MLL2','X-RAY DIFFRACTION',1.400,'TRANSCRIPTION',1,1,1),(3824,'3uvl','CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF MLL3','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(3825,'3uvm','CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF MLL4','X-RAY DIFFRACTION',1.570,'TRANSCRIPTION',1,1,1),(3826,'3uvn','CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF SET1A','X-RAY DIFFRACTION',1.790,'TRANSCRIPTION',2,2,1),(3827,'3uvo','CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH THE WDR5-INTERACTING MOTIF OF SET1B','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(3828,'3uvu','STRUCTURAL BASIS OF NUCLEAR IMPORT OF FLAP ENDONUCLEASE 1 (FEN1)','X-RAY DIFFRACTION',2.380,'PROTEIN BINDING/PEPTIDE',1,1,1),(3829,'3uvw','CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H4K5ACK8AC)','X-RAY DIFFRACTION',1.370,'TRANSCRIPTION/PROTEIN BINDING',1,1,1),(3830,'3uvx','CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H4K12ACK16AC)','X-RAY DIFFRACTION',1.910,'TRANSCRIPTION/PROTEIN BINDING',1,1,1),(3831,'3uvy','CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H4K16ACK20AC)','X-RAY DIFFRACTION',2.020,'TRANSCRIPTION/PROTEIN BINDING',1,1,1),(3832,'3uw4','CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO GDC0152','X-RAY DIFFRACTION',1.790,'APOPTOSIS INHIBITOR',1,1,1),(3833,'3uw5','CRYSTAL STRUCTURE OF THE BIR DOMAIN OF MLIAP BOUND TO GDC0152','X-RAY DIFFRACTION',1.710,'APOPTOSIS INHIBITOR',2,2,1),(3834,'3uw9','CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H4K8ACK12AC)','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING',2,4,1),(3835,'3uwj','HUMAN THROMBIN IN COMPLEX WITH MI353','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(3836,'3ux0','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER FUSICOCCIN H','X-RAY DIFFRACTION',1.750,'PEPTIDE BINDING PROTEIN',1,1,1),(3837,'3uxg','CRYSTAL STRUCTURE OF RFXANK','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',1,1,1),(3838,'3uyr','STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,2,1),(3839,'3uzd','CRYSTAL STRUCTURE OF 14-3-3 GAMMA','X-RAY DIFFRACTION',1.860,'PROTEIN BINDING/HYDROLASE',1,1,1),(3840,'3v2o','CRYSTAL STRUCTURE OF THE PEPTIDE BOUND COMPLEX OF THE ANKYRIN REPEAT DOMAINS OF HUMAN ANKRA2','X-RAY DIFFRACTION',1.890,'PROTEIN BINDING',1,1,1),(3841,'3v2x','CRYSTAL STRUCTURE OF THE PEPTIDE BOUND COMPLEX OF THE ANKYRIN REPEAT DOMAINS OF HUMAN ANKRA2','X-RAY DIFFRACTION',1.850,'PROTEIN BINDING',1,1,1),(3842,'3v30','CRYSTAL STRUCTURE OF THE PEPTIDE BOUND COMPLEX OF THE ANKYRIN REPEAT DOMAINS OF HUMAN RFXANK','X-RAY DIFFRACTION',1.570,'PROTEIN BINDING',1,1,1),(3843,'3v31','CRYSTAL STRUCTURE OF THE PEPTIDE BOUND COMPLEX OF THE ANKYRIN REPEAT DOMAINS OF HUMAN ANKRA2','X-RAY DIFFRACTION',1.570,'PROTEIN BINDING',1,1,1),(3844,'3v3b','STRUCTURE OF THE STAPLED P53 PEPTIDE BOUND TO MDM2','X-RAY DIFFRACTION',2.000,'LIGASE/LIGASE INHIBITOR',2,2,1),(3845,'3v43','CRYSTAL STRUCTURE OF MOZ','X-RAY DIFFRACTION',1.470,'TRANSFERASE/STRUCTURAL PROTEIN',1,1,1),(3846,'3v49','STRUCTURE OF AR LBD WITH ACTIVATOR PEPTIDE AND SARM INHIBITOR 1','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION',1,1,1),(3847,'3v4a','STRUCTURE OF AR LBD WITH ACTIVATOR PEPTIDE AND SARM INHIBITOR 2','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',1,1,1),(3848,'3v4o','HUMAN MALT1 (CASPASE DOMAIN) IN COMPLEX WITH AN IRREVERSIBLE PEPTIDIC INHIBITOR','X-RAY DIFFRACTION',2.100,'HYDROLASE/INHIBITOR',1,1,1),(3849,'3v4u','STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN','X-RAY DIFFRACTION',1.640,'IMMUNE SYSTEM',1,2,1),(3850,'3v4y','CRYSTAL STRUCTURE OF THE FIRST NUCLEAR PP1 HOLOENZYME','X-RAY DIFFRACTION',2.100,'HYDROLASE',4,4,1),(3851,'3v52','STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,2,1),(3852,'3v5a','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH GAMMA AMINO BUTYRIC ACID AT 1.44 A RESOLUTION','X-RAY DIFFRACTION',1.440,'METAL BINDING PROTEIN',1,1,1),(3853,'3v5d','HLA-A2.1 KVAELVHFL','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,3,1),(3854,'3v5h','HLA-A2.1 KVAEIVHFL','X-RAY DIFFRACTION',1.630,'IMMUNE SYSTEM',2,3,1),(3855,'3v5k','HLA2.1 KVAELVWFL','X-RAY DIFFRACTION',2.310,'IMMUNE SYSTEM',2,2,1),(3856,'3v7d','CRYSTAL STRUCTURE OF SCSKP1-SCCDC4-PSIC1 PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.310,'CELL CYCLE',1,1,1),(3857,'3v9t','CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR','X-RAY DIFFRACTION',1.650,'TRANSCRIPTION/TRANSCRIPTION REGULATOR',1,1,1),(3858,'3v9v','CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION/TRANSCRIPTION REGULATOR',1,1,1),(3859,'3v9y','CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION/TRANSCRIPTION REGULATOR',1,1,1),(3860,'3va4','CRYSTAL STRUCTURE OF THE MAMMALIAN MDC1 FHA DOMAIN COMPLEXED WITH CHK2 PTHR68 PEPTIDE','X-RAY DIFFRACTION',1.540,'CELL CYCLE',1,1,1),(3861,'3vb4','CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH B4Z','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3862,'3vb5','CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH C4Z','X-RAY DIFFRACTION',1.950,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3863,'3vb6','CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH C6Z','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3864,'3vb7','CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH M4Z','X-RAY DIFFRACTION',1.950,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(3865,'3vcl','CRYSTAL STRUCTURE OF HLA-B7 WITH THE HCMV PP65 PEPTIDE RPHERNGFTVL','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(3866,'3vdf','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH DIAMINOPIMELIC ACID AT 1.46 A RESOLUTION','X-RAY DIFFRACTION',1.460,'METAL BINDING PROTEIN',1,1,1),(3867,'3vep','CRYSTAL STRUCTURE OF SIGD4 IN COMPLEX WITH ITS NEGATIVE REGULATOR RSDA','X-RAY DIFFRACTION',2.500,'MEMBRANE PROTEIN/TRANSCRIPTION',4,4,1),(3868,'3vfm','CRYSTAL STRUCTURE OF HLA B*3508 LPEP155A, HLA MUTANT ALA155','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(3869,'3vfn','CRYSTAL STRUCTURE OF HLA B*3508LPEP151A, HLA MUTANT ALA151','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,1,1),(3870,'3vfo','CRYSTAL STRUCTURE OF HLA B*3508 LPEP157A, HLA MUTANT ALA157','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(3871,'3vfp','CRYSTAL STRUCTURE OF HLA B*3508 LPEP158G, HLA MUTANT GLY158','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(3872,'3vfr','CRYSTAL STRUCTURE OF HLA B*3508LPEP-P4ALA, PEPTIDE MUTANT P4-ALA','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(3873,'3vfs','CRYSTAL STRUCTURE OF HLA B*3508LPEP-P5ALA , PEPTIDE MUTANT P5-ALA','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(3874,'3vft','CRYSTAL STRUCTURE OF HLA B*3508LPEP-P6ALA, PEPTIDE MUTANT P6-ALA','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,1,1),(3875,'3vfu','CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P7ALA, PEPTIDE MUTANT P7-ALA','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',1,1,1),(3876,'3vfv','CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P9ALA, PEPTIDE MUTANT P9-ALA','X-RAY DIFFRACTION',1.550,'IMMUNE SYSTEM',1,1,1),(3877,'3vfw','CRYSTAL STRUCTURE OF HLA B*3508 LPEP-P10ALA, PEPTIDE MUTANT P10-ALA','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(3878,'3vgc','GAMMA-CHYMOTRYPSIN L-NAPHTHYL-1-ACETAMIDO BORONIC ACID ACID INHIBITOR COMPLEX','X-RAY DIFFRACTION',1.670,'SERINE PROTEASE',1,2,1),(3879,'3vh8','KIR3DL1 IN COMPLEX WITH HLA-B*5701','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,4,1),(3880,'3vi1','CRYSTAL STRUCTURE OF PSEUDOMONAS AERGINOSA ALKALINE PROTEASE COMPLEXED WITH SUBSTANCE P(1-6)','X-RAY DIFFRACTION',2.000,'HYDROLASE',2,2,1),(3881,'3viv','1510-N MEMBRANE-BOUND STOMATIN-SPECIFIC PROTEASE K138A MUTANT IN COMPLEX WITH A SUBSTRATE PEPTIDE','X-RAY DIFFRACTION',2.250,'HYDROLASE/PROTEIN BINDING',1,2,1),(3882,'3vj6','STRUCTURE OF THE MHC CLASS IB MOLECULE QA-1B','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(3883,'3vjs','VITAMIN D RECEPTOR COMPLEX WITH A CARBORANE COMPOUND','X-RAY DIFFRACTION',1.930,'TRANSCRIPTION',1,1,1),(3884,'3vjt','VITAMIN D RECEPTOR COMPLEX WITH A CARBORANE COMPOUND','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(3885,'3vn2','CRYSTAL STRUCTURE OF PPARGAMMA COMPLEXED WITH TELMISARTAN','X-RAY DIFFRACTION',2.180,'SIGNALING PROTEIN',1,1,1),(3886,'3vqg','CRYSTAL STRUCTURE ANALYSIS OF THE PDZ DOMAIN DERIVED FROM THE TIGHT JUNCTION REGULATING PROTEIN','X-RAY DIFFRACTION',1.350,'PEPTIDE BINDING PROTEIN',1,1,1),(3887,'3vqh','BROMINE SAD PARTIALLY RESOLVES MULTIPLE BINDING MODES FOR PKA INHIBITOR H-89','X-RAY DIFFRACTION',1.950,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(3888,'3vri','HLA-B*57:01-RVAQLENVYI IN COMPLEX WITH ABACAVIR','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(3889,'3vrj','HLA-B*57:01-LTTKLTNTNI IN COMPLEX WITH ABACAVIR','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(3890,'3vro','CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C IN COMPLEX WITH PHOSPHO-SRC PEPTIDE','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING/TRANSFERASE',1,1,1),(3891,'3vrp','CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C IN COMPLEX WITH PHOSPHO-EGFR PEPTIDE','X-RAY DIFFRACTION',1.520,'PROTEIN BINDING/TRANSFERASE',1,1,1),(3892,'3vrr','CRYSTAL STRUCTURE OF THE TYROSINE KINASE BINDING DOMAIN OF CBL-C (PL MUTANT) IN COMPLEX WITH PHOSPHO-EGFR PEPTIDE','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING/TRANSFERASE',1,1,1),(3893,'3vrt','VDR LIGAND BINDING DOMAIN IN COMPLEX WITH 2-MEHYLIDENE-19,25,26,27- TETRANOR-1ALPHA,24-DIHYDROXYVITAMIND3','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(3894,'3vru','VDR LIGAND BINDING DOMAIN IN COMPLEX WITH 2-METHYLIDENE-19,24-DINOR- 1ALPHA,25-DIHYDROXY VITAMIND3','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(3895,'3vrv','VDR LIGAND BINDING DOMAIN IN COMPLEX WITH 2-METHYLIDENE-26,27- DIMETHYL-19,24-DINOR-1ALPHA,25-DIHYDROXYVITAMIN D3','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(3896,'3vrw','VDR LIGAND BINDING DOMAIN IN COMPLEX WITH 22S-BUTYL-2-METHYLIDENE-26, 27-DIMETHYL-19,24-DINOR-1ALPHA,25-DIHYDROXYVITAMIN D3','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(3897,'3vt3','CRYSTAL STRUCTURES OF RAT VDR-LBD WITH R270L MUTATION','X-RAY DIFFRACTION',1.700,'HORMONE RECEPTOR',1,1,1),(3898,'3vt4','CRYSTAL STRUCTURES OF RAT VDR-LBD WITH R270L MUTATION','X-RAY DIFFRACTION',1.900,'HORMONE RECEPTOR',1,1,1),(3899,'3vt5','CRYSTAL STRUCTURES OF RAT VDR-LBD WITH R270L MUTATION','X-RAY DIFFRACTION',2.110,'HORMONE RECEPTOR',1,1,1),(3900,'3vt6','CRYSTAL STRUCTURE OF RAT VDR-LBD WITH 2-SUBSTITUTED-16-ENE-22-THIA- 1ALPHA,25-DIHYDROXY-26,27-DIMETHYL-19-NORVITAMIN D3','X-RAY DIFFRACTION',2.300,'HORMONE RECEPTOR',1,1,1),(3901,'3vt7','CRYSTAL STRUCTURES OF RAT VDR-LBD WITH W282R MUTATION','X-RAY DIFFRACTION',1.650,'HORMONE RECEPTOR',1,1,1),(3902,'3vt8','CRYSTAL STRUCTURES OF RAT VDR-LBD WITH W282R MUTATION','X-RAY DIFFRACTION',2.100,'HORMONE RECEPTOR',1,1,1),(3903,'3vt9','CRYSTAL STRUCTURES OF RAT VDR-LBD WITH W282R MUTATION','X-RAY DIFFRACTION',2.350,'HORMONE RECEPTOR',1,1,1),(3904,'3vtb','CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO A PARTIAL AGONIST 25-ADAMANTYL-23-YNE-19-NORVITAMMIN D ADTK1','X-RAY DIFFRACTION',2.000,'HORMONE RECEPTOR',1,1,1),(3905,'3vtc','CRYSTAL STRUCTURE OF RAT VITAMIN D RECEPTOR BOUND TO A PARTIAL AGONIST 26-ADAMANTYL-23-YNE-19-NORVITAMMIN D ADTK3','X-RAY DIFFRACTION',1.500,'HORMONE RECEPTOR',1,1,1),(3906,'3vuw','CRYSTAL STRUCTURE OF A20 ZF7 IN COMPLEX WITH LINEAR UBIQUITIN, FORM I','X-RAY DIFFRACTION',1.950,'PROTEIN BINDING/METAL BINDING PROTEIN',3,3,1),(3907,'3vux','CRYSTAL STRUCTURE OF A20 ZF7 IN COMPLEX WITH LINEAR UBIQUITIN, FORM II','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING/METAL BINDING PROTEIN',3,3,1),(3908,'3vuy','CRYSTAL STRUCTURE OF A20 ZF7 IN COMPLEX WITH LINEAR TETRAUBIQUITIN','X-RAY DIFFRACTION',1.980,'PROTEIN BINDING/METAL BINDING PROTEIN',3,3,1),(3909,'3vxe','HUMAN ALPHA-THROMBIN-BIVALIRUDIN COMPLEX AT PD5.0','X-RAY DIFFRACTION',1.250,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(3910,'3vxm','THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,3,1),(3911,'3vxn','HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(WT)','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,1,1),(3912,'3vxp','HLA-A24 IN COMPLEX WITH HIV-1 NEF134-10(6L)','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,2,1),(3913,'3vxr','THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,3,1),(3914,'3vxs','THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,3,1),(3915,'3vza','CRYSTAL STRUCTURE OF THE CHICKEN SPC24-SPC25 GLOBULAR DOMAIN IN COMPLEX WITH CENP-T PEPTIDE','X-RAY DIFFRACTION',1.900,'CELL CYCLE',2,4,1),(3916,'3w0g','CRYSTAL STRUCTURE OF RAT VDR LIGAND BINDING DOMAIN IN COMPLEX WITH NOVEL NONSECOSTEROIDAL LIGANDS','X-RAY DIFFRACTION',1.940,'TRANSCRIPTION',1,1,1),(3917,'3w0h','CRYSTAL STRUCTURE OF RAT VDR LIGAND BINDING DOMAIN IN COMPLEX WITH NOVEL NONSECOSTEROIDAL LIGANDS','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',1,1,1),(3918,'3w0i','CRYSTAL STRUCTURE OF RAT VDR LIGAND BINDING DOMAIN IN COMPLEX WITH NOVEL NONSECOSTEROIDAL LIGANDS','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(3919,'3w0j','CRYSTAL STRUCTURE OF RAT VDR LIGAND BINDING DOMAIN IN COMPLEX WITH NOVEL NONSECOSTEROIDAL LIGANDS','X-RAY DIFFRACTION',1.840,'TRANSCRIPTION',1,1,1),(3920,'3w1b','CRYSTAL STRUCTURE OF HUMAN DNA LIGASE IV-ARTEMIS COMPLEX (MERCURY DERIVATIVE)','X-RAY DIFFRACTION',2.400,'LIGASE',1,1,1),(3921,'3w3w','CRYSTAL STRUCTURE OF KAP121P BOUND TO STE12P','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT/DNA BINDING PROTEIN',1,1,1),(3922,'3w5p','CRYSTAL STRUCTURE OF COMPLEXES OF VITAMIN D RECEPTOR LIGAND BINDING DOMAIN WITH LITHOCHOLIC ACID DERIVATIVES','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(3923,'3w5q','CRYSTAL STRUCTURE OF COMPLEXES OF VITAMIN D RECEPTOR LIGAND BINDING DOMAIN WITH LITHOCHOLIC ACID DERIVATIVES','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(3924,'3w5r','CRYSTAL STRUCTURE OF COMPLEXES OF VITAMIN D RECEPTOR LIGAND BINDING DOMAIN WITH LITHOCHOLIC ACID DERIVATIVES','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(3925,'3w5t','CRYSTAL STRUCTURE OF COMPLEXES OF VITAMIN D RECEPTOR LIGAND BINDING DOMAIN WITH LITHOCHOLIC ACID DERIVATIVES','X-RAY DIFFRACTION',2.290,'TRANSCRIPTION',1,1,1),(3926,'3w6k','CRYSTAL STRUCTURE OF DIMER OF SCPB N-TERMINAL DOMAIN COMPLEXED WITH SCPA PEPTIDE','X-RAY DIFFRACTION',2.370,'CELL CYCLE',2,4,1),(3927,'3w8j','CRYSTAL STRUCTURE OF P5 A0 IN A COMPLEX WITH PRX4 C-TERM','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE/ISOMERASE',2,2,1),(3928,'3wa0','CRYSTAL STRUCTURE OF MERLIN COMPLEXED WITH DCAF1/VPRBP','X-RAY DIFFRACTION',2.310,'CELL ADHESION',2,2,1),(3929,'3wa4','GRB2 SH2 DOMAIN/CD28-DERIVED PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.350,'SIGNALING PROTEIN',1,1,1),(3930,'3wbn','CRYSTAL STRUCTURE OF MATE IN COMPLEX WITH MAL6','X-RAY DIFFRACTION',2.450,'TRANSPORT PROTEIN/INHIBITOR',1,1,1),(3931,'3wdc','N-TERMINAL DOMAIN OF MYCOBACTERIUM TUBERCULOSIS CLPC1 BOUND TO CYCLOMARIN A','X-RAY DIFFRACTION',1.180,'CHAPERONE/ANTIMICROBIAL PROTEIN',1,1,1),(3932,'3wdd','MUTANT N-TERMINAL DOMAIN OF MYCOBACTERIUM TUBERCULOSIS CLPC1, F2Y, BOUND TO CYCLOMARIN A','X-RAY DIFFRACTION',1.180,'CHAPERONE/ANTIMICROBIAL PROTEIN',1,1,1),(3933,'3wde','MUTANT N-TERMINAL DOMAIN OF MYCOBACTERIUM TUBERCULOSIS CLPC1, F80Y, BOUND TO CYCLOMARIN A','X-RAY DIFFRACTION',1.440,'CHAPERONE/ANTIMICROBIAL PROTEIN',1,1,1),(3934,'3wg5','1510-N MEMBRANE-BOUND STOMATIN-SPECIFIC PROTEASE K138A MUTANT IN COMPLEX WITH A SUBSTRATE PEPTIDE UNDER HEAT TREATMENT','X-RAY DIFFRACTION',2.400,'HYDROLASE/PROTEIN BINDING',1,2,1),(3935,'3wg7','A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY','X-RAY DIFFRACTION',1.900,'OXIDOREDUCTASE',6,10,1),(3936,'3wgx','CRYSTAL STRUCTURE OF ERP46 TRX2 IN A COMPLEX WITH PRX4 C-TERM','X-RAY DIFFRACTION',0.920,'ISOMERASE',2,2,1),(3937,'3wl9','HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8I10F)','X-RAY DIFFRACTION',1.660,'IMMUNE SYSTEM',1,1,1),(3938,'3wlb','HLA-A24 IN COMPLEX WITH HIV-1 NEF126-10(8T10F)','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(3939,'3wmg','CRYSTAL STRUCTURE OF AN INWARD-FACING EUKARYOTIC ABC MULTIDRUG TRANSPORTER G277V/A278V/A279V MUTANT IN COMPLEX WITH AN CYCLIC PEPTIDE INHIBITOR, ACAP','X-RAY DIFFRACTION',2.400,'TRANSPORT PROTEIN/INHIBITOR',1,1,1),(3940,'3wn7','CRYSTAL STRUCTURE OF KEAP1 IN COMPLEX WITH THE N-TERMINAL REGION OF THE NRF2 TRANSCRIPTION FACTOR','X-RAY DIFFRACTION',1.570,'TRANSCRIPTION',2,2,1),(3941,'3wne','CYCLIC HEXAPEPTIDE PKIDNG IN COMPLEX WITH HIV-1 INTEGRASE','X-RAY DIFFRACTION',1.700,'VIRAL PROTEIN/PEPTIDE',2,2,1),(3942,'3wnf','CYCLIC HEXAPEPTIDE CKIDNC IN COMPLEX WITH HIV-1 INTEGRASE','X-RAY DIFFRACTION',1.450,'VIRAL PROTEIN/PEPTIDE',2,2,1),(3943,'3wng','CYCLIC HEXAPEPTIDE PKIDNP IN COMPLEX WITH HIV-1 INTEGRASE','X-RAY DIFFRACTION',1.750,'VIRAL PROTEIN/PEPTIDE',2,2,1),(3944,'3wnh','CYCLIC HEXAPEPTIDE PKZDNV IN COMPLEX WITH HIV-1 INTEGRASE','X-RAY DIFFRACTION',1.500,'VIRAL PROTEIN/PEPTIDE',2,2,1),(3945,'3woo','CRYSTAL STRUCTURE OF THE DAP BII HEXAPEPTIDE COMPLEX I','X-RAY DIFFRACTION',1.800,'HYDROLASE/HORMONE',2,2,1),(3946,'3wop','CRYSTAL STRUCTURE OF THE DAP BII HEXAPEPTIDE COMPLEX II','X-RAY DIFFRACTION',1.950,'HYDROLASE/HORMONE',2,2,1),(3947,'3woq','CRYSTAL STRUCTURE OF THE DAP BII HEXAPEPTIDE COMPLEX III','X-RAY DIFFRACTION',1.820,'HYDROLASE/HORMONE',2,2,1),(3948,'3wor','CRYSTAL STRUCTURE OF THE DAP BII OCTAPEPTIDE COMPLEX','X-RAY DIFFRACTION',2.100,'HYDROLASE/HORMONE',2,2,1),(3949,'3wp0','CRYSTAL STRUCTURE OF DLG GK IN COMPLEX WITH A PHOSPHOR-LGL2 PEPTIDE','X-RAY DIFFRACTION',2.040,'PEPTIDE BINDING PROTEIN',1,1,1),(3950,'3ws3','CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH AN INSULIN DERIVED PEPTIDE','X-RAY DIFFRACTION',2.340,'IMMUNE SYSTEM',2,2,1),(3951,'3ws6','CRYSTAL STRUCTURE OF H-2D IN COMPLEX WITH A MIMOTOPIC PEPTIDE','X-RAY DIFFRACTION',1.980,'IMMUNE SYSTEM',2,2,1),(3952,'3wsr','CRYSTAL STRUCTURE OF CLEC-2 IN COMPLEX WITH O-GLYCOSYLATED PODOPLANIN','X-RAY DIFFRACTION',1.910,'SUGAR BINDING PROTEIN',2,2,1),(3953,'3wt5','A MIXED POPULATION OF ANTAGONIST AND AGONIST BINDING CONFORMERS IN A SINGLE CRYSTAL EXPLAINS PARTIAL AGONISM AGAINST VITAMIN D RECEPTOR: ACTIVE VITAMIN D ANALOGUES WITH 22R-ALKYL GROUP','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(3954,'3wt6','A MIXED POPULATION OF ANTAGONIST AND AGONIST BINDING CONFORMERS IN A SINGLE CRYSTAL EXPLAINS PARTIAL AGONISM AGAINST VITAMIN D RECEPTOR: ACTIVE VITAMIN D ANALOGUES WITH 22R-ALKYL GROUP','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(3955,'3wt7','CRYSTAL STRUCTURE OF VDR-LBD COMPLEXED WITH 22R-BUTYL-2-METHYLIDENE- 26,27-DIMETHYL-19,24-DINOR-1 ,25-DIHYDROXYVITAMIN D3','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(3956,'3wtq','CRYSTAL STRUCTURE OF VDR-LBD COMPLEXED WITH 22S-BUTYL-2-METHYLIDENE- 19-NOR-1A,25-DIHYDROXYVITAMIN D3','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(3957,'3wu2','CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX','X-RAY DIFFRACTION',1.900,'ELECTRON TRANSPORT, PHOTOSYNTHESIS',18,16,1),(3958,'3wuw','KIR3DL1 IN COMPLEX WITH HLA-B*57:01.I80T','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',1,2,1),(3959,'3wv0','O-GLYCAN ATTACHED TO HERPES SIMPLEX VIRUS TYPE 1 GLYCOPROTEIN GB IS RECOGNIZED BY THE IG V-SET DOMAIN OF HUMAN PAIRED IMMUNOGLOBULIN-LIKE TYPE 2 RECEPTOR ALPHA','X-RAY DIFFRACTION',2.300,'MEMBRANE PROTEIN',2,2,1),(3960,'3wwq','CRYSTAL STRUCTURE OF FAAP20 UBZ DOMAIN IN COMPLEX WITH LYS63-LINKED DIUBIQUITIN','X-RAY DIFFRACTION',1.900,'PROTEIN BINDING/METAL BINDING PROTEIN',4,8,1),(3961,'3wxa','X-RAY CRYSTAL STRUCTURAL ANALYSIS OF THE COMPLEX BETWEEN ALG-2 AND SEC31A PEPTIDE','X-RAY DIFFRACTION',2.360,'APOPTOSIS/TRANSPORT PROTEIN',2,2,1),(3962,'3wy9','CRYSTAL STRUCTURE OF A COMPLEX OF THE ARCHAEAL RIBOSOMAL STALK PROTEIN AP1 AND THE GDP-BOUND ARCHAEAL ELONGATION FACTOR AEF1ALPHA','X-RAY DIFFRACTION',2.300,'TRANSLATION/RIBOSOMAL PROTEIN',2,2,1),(3963,'3wyg','CRYSTAL STRUCTURE OF XPO1P-PKI-GSP1P-GTP COMPLEX','X-RAY DIFFRACTION',2.150,'GTP-BINDING PROTEIN/GTP-BINDING PROTE',1,1,1),(3964,'3x11','CRYSTAL STRUCTURE OF HLA-B*57:01.I80N.L82R.R83G','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM',1,1,1),(3965,'3x12','CRYSTAL STRUCTURE OF HLA-B*57:01.I80N','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(3966,'3x13','CRYSTAL STRUCTURE OF HLA-B*0801.N80I','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(3967,'3x14','CRYSTAL STRUCTURE OF HLA-B*0801.N80I.R82L.G83R','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(3968,'3x23','RADIXIN COMPLEX','X-RAY DIFFRACTION',2.400,'CELL INVASION',1,1,1),(3969,'3x2q','X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE',6,10,1),(3970,'3x2u','MICHAELIS-LIKE INITIAL COMPLEX OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT.','X-RAY DIFFRACTION',2.400,'TRANSFERASE/PEPTIDE',1,1,1),(3971,'3x2v','MICHAELIS-LIKE COMPLEX OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT','X-RAY DIFFRACTION',1.770,'TRANSFERASE/PEPTIDE',1,1,1),(3972,'3x2w','MICHAELIS COMPLEX OF CAMP-DEPENDENT PROTEIN KINASE CATALYTIC SUBUNIT','X-RAY DIFFRACTION',1.700,'TRANSFERASE/PEPTIDE',1,1,1),(3973,'3zdf','STRUCTURE OF GAPDH WITH CP12 PEPTIDE FROM THERMOSYNECHOCOCCUS ELONGATUS','X-RAY DIFFRACTION',2.340,'OXIDOREDUCTASE',2,2,1),(3974,'3zdl','VINCULIN HEAD (1-258) IN COMPLEX WITH A RIAM FRAGMENT','X-RAY DIFFRACTION',2.300,'CELL ADHESION',1,1,1),(3975,'3zdm','CRYSTAL STRUCTURE OF THE SGT2 N DOMAIN AND THE GET5 UBL DOMAIN COMPLEX','X-RAY DIFFRACTION',1.800,'CHAPERONE/SIGNALING PROTEIN',2,4,1),(3976,'3zdy','INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.450,'CELL ADHESION/IMMUNE SYSTEM/PEPTIDE',2,4,1),(3977,'3ze2','INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.350,'CELL ADHESION/IMMUNE SYSTEM/PEPTIDE',2,4,1),(3978,'3zed','X-RAY STRUCTURE OF THE BIRNAVIRUS VP1-VP3 COMPLEX','X-RAY DIFFRACTION',2.200,'VIRAL PROTEIN',3,3,1),(3979,'3zg6','THE NOVEL DE-LONG CHAIN FATTY ACID FUNCTION OF HUMAN SIRT6','X-RAY DIFFRACTION',2.200,'HYDROLASE/INHIBITOR',1,1,1),(3980,'3zg7','CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 4 FROM LISTERIA MONOCYTOGENES IN THE APO FORM','X-RAY DIFFRACTION',1.990,'PENICILLIN-BINDING PROTEIN',1,1,1),(3981,'3zg8','CRYSTAL STRUCTURE OF PENICILLIN BINDING PROTEIN 4 FROM LISTERIA MONOCYTOGENES IN THE AMPICILLIN BOUND FORM','X-RAY DIFFRACTION',2.090,'PENICILLIN-BINDING PROTEIN',1,1,1),(3982,'3zg9','CRYSTAL STRUCTURE OF PENICILLIN-BINDING PROTEIN 4 FROM LISTERIA MONOCYTOGENES IN THE CEFUROXIME BOUND FORM','X-RAY DIFFRACTION',1.800,'PENICILLIN-BINDING PROTEIN',1,1,1),(3983,'3zga','CRYSTAL STRUCTURE OF PENISCILLIN-BINDING PROTEIN 4 FROM LISTERIA MONOCYTOGENES IN THE CARBENICILLIN BOUND FORM','X-RAY DIFFRACTION',2.000,'PENICILLIN-BINDING PROTEIN',1,1,1),(3984,'3zgc','CRYSTAL STRUCTURE OF THE KEAP1-NEH2 COMPLEX','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,2,1),(3985,'3zhf','GAMMA 2 ADAPTIN EAR DOMAIN CRYSTAL STRUCTURE WITH PRES1 SITE1 PEPTIDE NPDWDFN','X-RAY DIFFRACTION',1.700,'PROTEIN TRANSPORT/VIRAL PROTEIN',1,1,1),(3986,'3zia','THE STRUCTURE OF F1-ATPASE FROM SACCHAROMYCES CEREVISIAE INHIBITED BY ITS REGULATORY PROTEIN IF1','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,10,1),(3987,'3zil','STRUCTURE OF THE WPL1 PROTEIN','X-RAY DIFFRACTION',2.010,'CELL CYCLE',1,1,1),(3988,'3zin','GU_ALPHA_HELICASE','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN/HYDROLASE',2,1,1),(3989,'3zio','MINOR-SITE SPECIFIC NLS (A28)','X-RAY DIFFRACTION',2.100,'TRANSPORT PROTEIN',2,1,1),(3990,'3zip','MINOR-SITE SPECIFIC NLS (A58)','X-RAY DIFFRACTION',2.400,'TRANSPORT PROTEIN',2,1,1),(3991,'3ziq','MINOR-SITE SPECIFIC NLS (B6)','X-RAY DIFFRACTION',2.100,'TRANSPORT PROTEIN',2,1,1),(3992,'3zir','MINOR-SITE SPECIFIC NLS (B141)','X-RAY DIFFRACTION',2.300,'TRANSPORT PROTEIN',2,1,1),(3993,'3zke','STRUCTURE OF LC8 IN COMPLEX WITH NEK9 PEPTIDE','X-RAY DIFFRACTION',2.200,'CONTRACTILE PROTEIN/PEPTIDE',6,6,1),(3994,'3zni','STRUCTURE OF PHOSPHOTYR363-CBL-B - UBCH5B-UB - ZAP-70 PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.210,'LIGASE',4,4,1),(3995,'3zo1','THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS','X-RAY DIFFRACTION',2.000,'TRANSFERASE/INHIBITOR',1,1,1),(3996,'3zo2','THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS','X-RAY DIFFRACTION',1.980,'TRANSFERASE/INHIBITOR',1,1,1),(3997,'3zo3','THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS','X-RAY DIFFRACTION',2.100,'TRANSFERASE/INHIBITOR',1,1,1),(3998,'3zo4','THE SYNTHESIS AND EVALUATION OF DIAZASPIROCYCLIC PROTEIN KINASE INHIBITORS','X-RAY DIFFRACTION',1.650,'TRANSFERASE/INHIBITOR',1,1,1),(3999,'3zoq','STRUCTURE OF BSUDG-P56 COMPLEX','X-RAY DIFFRACTION',1.450,'HYDROLASE/VIRAL PROTEIN',1,1,1),(4000,'3zqg','STRUCTURE OF TETRACYCLINE REPRESSOR IN COMPLEX WITH ANTIINDUCER PEPTIDE-TAP2','X-RAY DIFFRACTION',2.450,'TRANSCRIPTION',1,1,1),(4001,'3zqh','STRUCTURE OF TETRACYCLINE REPRESSOR IN COMPLEX WITH INDUCER PEPTIDE- TIP3','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',1,1,1),(4002,'3zqi','STRUCTURE OF TETRACYCLINE REPRESSOR IN COMPLEX WITH INDUCER PEPTIDE- TIP2','X-RAY DIFFRACTION',1.500,'TRANSCRIPTION',2,2,1),(4003,'3zrj','COMPLEX OF CLPV N-DOMAIN WITH VIPB PEPTIDE','X-RAY DIFFRACTION',1.940,'CHAPERONE/PEPTIDE',2,2,1),(4004,'3zrk','IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS','X-RAY DIFFRACTION',2.370,'TRANSFERASE/PEPTIDE',2,2,1),(4005,'3zrl','IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK-3BETA INHIBITORS','X-RAY DIFFRACTION',2.480,'TRANSFERASE/PEPTIDE',2,2,1),(4006,'3zrm','IDENTIFICATION OF 2-(4-PYRIDYL)THIENOPYRIDINONES AS GSK- 3BETA INHIBITORS','X-RAY DIFFRACTION',2.490,'TRANSFERASE/PEPTIDE',2,2,1),(4007,'3zrz','CRYSTAL STRUCTURE OF THE SECOND AND THIRD FIBRONECTIN F1 MODULES IN COMPLEX WITH A FRAGMENT OF STREPTOCOCCUS PYOGENES SFBI-5','X-RAY DIFFRACTION',1.700,'CELL ADHESION',2,2,1),(4008,'3zs6','THE STRUCTURAL CHARACTERIZATION OF BURKHOLDERIA PSEUDOMALLEI OPPA.','X-RAY DIFFRACTION',2.100,'PEPTIDE BINDING PROTEIN',1,1,1),(4009,'3zs9','S. CEREVISIAE GET3-ADP-ALF4- COMPLEX WITH A CYTOSOLIC GET2 FRAGMENT','X-RAY DIFFRACTION',2.100,'HYDROLASE/TRANSPORT PROTEIN',2,2,1),(4010,'3ztx','AURORA KINASE SELECTIVE INHIBITORS IDENTIFIED USING A TAXOL- INDUCED CHECKPOINT SENSITIVITY SCREEN.','X-RAY DIFFRACTION',1.950,'TRANSFERASE/CELL CYCLE',2,2,1),(4011,'3zvy','PHD FINGER OF HUMAN UHRF1 IN COMPLEX WITH UNMODIFIED HISTONE H3 N- TERMINAL TAIL','X-RAY DIFFRACTION',1.950,'LIGASE/PEPTIDE',2,2,1),(4012,'3zwh','CA2+-BOUND S100A4 C3S, C81S, C86S AND F45W MUTANT COMPLEXED WITH MYOSIN IIA','X-RAY DIFFRACTION',1.940,'CA-BINDING PROTEIN/MOTOR PROTEIN',1,2,1),(4013,'3zwl','STRUCTURE OF EUKARYOTIC TRANSLATION INITIATION FACTOR EIF3I COMPLEX WITH EIF3B C-TERMINUS (655-700)','X-RAY DIFFRACTION',2.200,'TRANSLATION',2,2,1),(4014,'3zwz','CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 39AA PFRON2 PEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(4015,'3zyb','CRYSTAL STRUCTURE OF PA-IL LECTIN COMPLEXED WITH GALAG0 AT 2.3 A RESOLUTION','X-RAY DIFFRACTION',2.290,'SUGAR BINDING PROTEIN',3,5,1),(4016,'4a1s','CRYSTALLOGRAPHIC STRUCTURE OF THE PINS:INSC COMPLEX','X-RAY DIFFRACTION',2.100,'CELL CYCLE',2,2,1),(4017,'4a1t','CO-COMPLEX OF THE OF NS3-4A PROTEASE WITH THE INHIBITORY PEPTIDE CP5- 46-A (IN-HOUSE DATA)','X-RAY DIFFRACTION',2.050,'HYDROLASE/PEPTIDE',2,2,1),(4018,'4a1u','CRYSTAL STRUCTURE OF ALPHA-BETA-FOLDAMER 2C IN COMPLEX WITH BCL-XL','X-RAY DIFFRACTION',1.540,'APOPTOSIS',1,1,1),(4019,'4a1v','CO-COMPLEX STRUCTURE OF NS3-4A PROTEASE WITH THE OPTIMIZED INHIBITORY PEPTIDE CP5-46A-4D5E','X-RAY DIFFRACTION',2.200,'HYDROLASE/PEPTIDE',2,2,1),(4020,'4a1w','CRYSTAL STRUCTURE OF ALPHA-BETA FOLDAMER 4C IN COMPLEX WITH BCL-XL','X-RAY DIFFRACTION',2.500,'APOPTOSIS/INHIBITOR',4,4,1),(4021,'4a1x','CO-COMPLEX STRUCTURE OF NS3-4A PROTEASE WITH THE INHIBITORY PEPTIDE CP5-46-A (SYNCHROTRON DATA)','X-RAY DIFFRACTION',1.900,'HYDROLASE/PEPTIDE',2,2,1),(4022,'4a2a','THERMOTOGA MARITIMA FTSA:FTSZ(336-351)','X-RAY DIFFRACTION',1.800,'CELL CYCLE',2,2,1),(4023,'4a5x','STRUCTURES OF MITD1','X-RAY DIFFRACTION',1.910,'PROTEIN TRANSPORT',2,2,1),(4024,'4a62','PARM FROM R1 PLASMID IN COMPLEX WITH PEPTIDE FROM C-TERMINUS OF PARR','X-RAY DIFFRACTION',2.200,'TRANSPORT PROTEIN',2,2,1),(4025,'4a7j','SYMMETRIC DIMETHYLATION OF H3 ARGININE 2 IS A NOVEL HISTONE MARK THAT SUPPORTS EUCHROMATIN MAINTENANCE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(4026,'4a8x','STRUCTURE OF THE CORE ASAP COMPLEX','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,2,1),(4027,'4aa1','CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH ANGIOTENSIN-II','X-RAY DIFFRACTION',1.990,'HYDROLASE/HORMONE',1,1,1),(4028,'4aa2','CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ POTENTIATING PEPTIDE B','X-RAY DIFFRACTION',1.990,'HYDROLASE/PEPTIDE',1,1,1),(4029,'4abi','CO-COMPLEX STRUCTURE OF BOVINE TRYPSIN WITH A MODIFIED BOWMAN-BIRK INHIBITOR (PTA)SFTI-1(1,14), THAT WAS 1,4-DISUBSTITUTED WITH A 1,2,3- TRIZOL TO MIMIC A TRANS AMIDE BOND','X-RAY DIFFRACTION',1.550,'HYDROLASE/INHIBITOR',1,1,1),(4030,'4abj','CO-COMPLEX STRUCTURE OF BOVINE TRYPSIN WITH A MODIFIED BOWMAN-BIRK INHIBITOR (ICA)SFTI-1(1,14), THAT WAS 1,5- DISUBSTITUTED WITH 1,2,3-TRIZOL TO MIMIC A CIS AMIDE BOND','X-RAY DIFFRACTION',1.450,'HYDROLASE/INHIBITOR',1,1,1),(4031,'4aen','HLA-DR1 WITH COVALENTLY LINKED CLIP106-120 IN REVERSED ORIENTATION','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,2,1),(4032,'4afj','5-ARYL-4-CARBOXAMIDE-1,3-OXAZOLES: POTENT AND SELECTIVE GSK-3 INHIBITORS','X-RAY DIFFRACTION',1.980,'TRANSFERASE/PEPTIDE',2,2,1),(4033,'4afx','CRYSTAL STRUCTURE OF THE REACTIVE LOOP CLEAVED ZPI IN I2 SPACE GROUP','X-RAY DIFFRACTION',2.090,'HYDROLASE INHIBITOR',1,1,1),(4034,'4aif','AIP TPR DOMAIN IN COMPLEX WITH HUMAN HSP90 PEPTIDE','X-RAY DIFFRACTION',2.010,'SIGNALING PROTEIN/PEPTIDE',2,2,1),(4035,'4ajy','VON HIPPEL-LINDAU PROTEIN-ELONGINB-ELONGINC COMPLEX, BOUND TO HIF1- ALPHA PEPTIDE','X-RAY DIFFRACTION',1.730,'TRANSCRIPTION',1,1,1),(4036,'4ak4','HIGH RESOLUTION STRUCTURE OF GALACTOSE BINDING LECTIN FROM CHAMPEDAK (CGB)','X-RAY DIFFRACTION',1.650,'SUGAR BINDING PROTEIN',8,8,1),(4037,'4akb','STRUCTURE OF GALACTOSE BINDING LECTIN FROM CHAMPEDAK (CGB) WITH GALACTOSE','X-RAY DIFFRACTION',1.950,'SUGAR BINDING PROTEIN',4,4,1),(4038,'4akc','STRUCTURE OF GALACTOSE BINDING LECTIN FROM CHAMPEDAK (CGB) WITH GAL(BETA)1,3-GALNAC','X-RAY DIFFRACTION',2.300,'SUGAR BINDING PROTEIN',4,4,1),(4039,'4am9','CRYSTAL STRUCTURE OF THE YERSINIA ENTEROCOLITICA TYPE III SECRETION CHAPERONE SYCD IN COMPLEX WITH A PEPTIDE OF THE TRANSLOCATOR YOPD','X-RAY DIFFRACTION',2.500,'CHAPERONE',1,1,1),(4040,'4aok','CONFORMATIONAL DYNAMICS OF ASPARTATE ALPHA-DECARBOXYLASE ACTIVE SITE REVEALED BY PROTEIN-LIGAND COMPLEXES: 1-METHYL- L-ASPARTATE COMPLEX','X-RAY DIFFRACTION',1.500,'HYDROLASE',2,2,1),(4041,'4aom','MTIP AND MYOA COMPLEX','X-RAY DIFFRACTION',1.940,'MEMBRANE PROTEIN/MOTOR PROTEIN',1,1,1),(4042,'4aon','CONFORMATIONAL DYNAMICS OF ASPARTATE ALPHA-DECARBOXYLASE ACTIVE SITE REVEALED BY PROTEIN-LIGAND COMPLEXES: 1-METHYL- L-ASPARTATE COMPLEX','X-RAY DIFFRACTION',1.500,'HYDROLASE',2,2,1),(4043,'4aoq','CATIONIC TRYPSIN IN COMPLEX WITH MUTATED SPINACIA OLERACEA TRYPSIN INHIBITOR III (SOTI-III) (F14A)','X-RAY DIFFRACTION',2.000,'HYDROLASE/INHIBITOR',3,3,1),(4044,'4aor','CATIONIC TRYPSIN IN COMPLEX WITH THE SPINACIA OLERACEA TRYPSIN INHIBITOR III (SOTI-III)','X-RAY DIFFRACTION',1.700,'HYDROLASE/INHIBITOR',3,3,1),(4045,'4aph','HUMAN ANGIOTENSIN-CONVERTING ENZYME IN COMPLEX WITH ANGIOTENSIN-II','X-RAY DIFFRACTION',1.990,'HYDROLASE/HORMONE',1,1,1),(4046,'4apo','AIP TPR DOMAIN IN COMPLEX WITH HUMAN TOMM20 PEPTIDE','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN/PEPTIDE',2,2,1),(4047,'4apr','STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4048,'4ar8','CRYSTAL STRUCTURE OF THE PEPTIDASE DOMAIN OF COLLAGENASE T FROM CLOSTRIDIUM TETANI COMPLEXED WITH THE PEPTIDIC INHIBITOR ISOAMYL- PHOSPHONYL-GLY-PRO-ALA AT 2.05 ANGSTROM RESOLUTION.','X-RAY DIFFRACTION',2.050,'HYDROLASE/INHIBITOR',2,2,1),(4049,'4arf','CRYSTAL STRUCTURE OF THE PEPTIDASE DOMAIN OF COLLAGENASE H FROM CLOSTRIDIUM HISTOLYTICUM IN COMPLEX WITH THE PEPTIDIC INHIBITOR ISOAMYLPHOSPHONYL-GLY-PRO-ALA AT 1.77 ANGSTROM RESOLUTION.','X-RAY DIFFRACTION',1.770,'HYDROLASE/INHIBITOR',1,1,1),(4050,'4asq','CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH BRADYKININ','X-RAY DIFFRACTION',1.990,'HYDROLASE',1,1,1),(4051,'4asr','CRYSTAL STRUCTURE OF ANCE IN COMPLEX WITH THR6-BRADYKININ','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(4052,'4au2','CRYSTAL STRUCTURE OF A HSP47-COLLAGEN COMPLEX','X-RAY DIFFRACTION',2.300,'CHAPERONE/PEPTIDE',6,4,1),(4053,'4au7','THE STRUCTURE OF THE SUV4-20H2 TERNARY COMPLEX WITH HISTONE H4','X-RAY DIFFRACTION',2.070,'TRANSFERASE',1,2,1),(4054,'4auc','BOVINE CHYMOSIN IN COMPLEX WITH PEPSTATIN A','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4055,'4aw9','CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH YVAD-CMK','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4056,'4awa','CRYSTAL STRUCTURE OF ACTIVE LEGUMAIN IN COMPLEX WITH YVAD-CMK AT PH 5.0','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4057,'4ax9','HUMAN THROMBIN COMPLEXED WITH NAPSAGATRAN, RO0466240','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(4058,'4axa','STRUCTURE OF PKA-PKB CHIMERA COMPLEXED WITH (1S)-2-AMINO-1-( 4-CHLOROPHENYL)-1-(4-(1H-PYRAZOL-4-YL)PHENYL)ETHAN-1-OL','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4059,'4aya','CRYSTAL STRUCTURE OF ID2 HLH HOMODIMER AT 2.1A RESOLUTION','X-RAY DIFFRACTION',2.100,'CELL CYCLE',1,1,1),(4060,'4aza','IMPROVED EIF4E BINDING PEPTIDES BY PHAGE DISPLAY GUIDED DESIGN.','X-RAY DIFFRACTION',2.160,'TRANSLATION',2,2,1),(4061,'4b1u','STRUCTURE OF THE PHACTR1 RPEL DOMAIN AND RPEL MOTIF DIRECTED ASSEMBLIES WITH G-ACTIN REVEAL THE MOLECULAR BASIS FOR ACTIN BINDING COOPERATIVITY.','X-RAY DIFFRACTION',2.000,'STRUCTURAL PROTEIN',1,1,1),(4062,'4b1v','STRUCTURE OF THE PHACTR1 RPEL-N DOMAIN BOUND TO G-ACTIN','X-RAY DIFFRACTION',1.750,'STRUCTURAL PROTEIN',2,2,1),(4063,'4b1w','STRUCTURE OF THE PHACTR1 RPEL-2 DOMAIN BOUND TO ACTIN','X-RAY DIFFRACTION',1.950,'STRUCTURAL PROTEIN',1,1,1),(4064,'4b1x','STRUCTURE OF THE PHACTR1 RPEL-2 BOUND TO G-ACTIN','X-RAY DIFFRACTION',1.800,'STRUCTURAL PROTEIN',1,1,1),(4065,'4b1y','STRUCTURE OF THE PHACTR1 RPEL-3 BOUND TO G-ACTIN','X-RAY DIFFRACTION',1.290,'STRUCTURAL PROTEIN',1,1,1),(4066,'4b3b','HUMANISED MONOMERIC RADA IN COMPLEX WITH FHTA TETRAPEPTIDE','X-RAY DIFFRACTION',1.190,'HYDROLASE/PEPTIDE',1,1,1),(4067,'4b45','CETZ2 FROM HALOFERAX VOLCANII - GTPGS BOUND PROTOFILAMENT','X-RAY DIFFRACTION',2.100,'STRUCTURAL PROTEIN',1,1,1),(4068,'4b4n','CPSF6 DEFINES A CONSERVED CAPSID INTERFACE THAT MODULATES HIV-1 REPLICATION','X-RAY DIFFRACTION',1.810,'VIRAL PROTEIN/RNA BINDING PROTEIN',1,1,1),(4069,'4b4s','CRYSTAL STRUCTURE OF A PRO-SURVIVAL BCL-2:BIM BH3 COMPLEX','X-RAY DIFFRACTION',1.900,'APOPTOSIS',1,1,1),(4070,'4b60','STRUCTURE OF RFNBPA(189-505) IN COMPLEX WITH FIBRINOGEN GAMMA CHAIN C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',1.830,'CELL ADHESION',2,2,1),(4071,'4b7e','FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT DOMAIN-LEU PEPTIDE (20-MER)','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE/PEPTIDE',1,1,1),(4072,'4b7k','FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT DOMAIN-SER PEPTIDE (20-MER)','X-RAY DIFFRACTION',2.390,'OXIDOREDUCTASE',1,1,1),(4073,'4b8m','AURORA B KINASE IN COMPLEX WITH VX-680','X-RAY DIFFRACTION',1.850,'CELL CYCLE',2,2,1),(4074,'4b8o','RIMP_ALPHA_SV40TAGNLS','X-RAY DIFFRACTION',2.080,'TRANSPORT PROTEIN',2,1,1),(4075,'4b8p','RIMP_ALPHA_A89NLS','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT',2,2,1),(4076,'4b8y','FERRICHROME-BOUND FHUD2','X-RAY DIFFRACTION',1.900,'TRANSPORT PROTEIN/SIDEROPHORE',1,1,1),(4077,'4b9w','STRUCTURE OF EXTENDED TUDOR DOMAIN TD3 FROM MOUSE TDRD1 IN COMPLEX WITH MILI PEPTIDE CONTAINING DIMETHYLARGININE 45.','X-RAY DIFFRACTION',2.100,'REPLICATION',2,2,1),(4078,'4ba3','MIMP_ALPHADIBB_A89NLS','X-RAY DIFFRACTION',2.100,'PROTEIN TRANSPORT/PEPTIDE',1,1,1),(4079,'4bah','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.940,'HYDROLASE',2,1,1),(4080,'4bak','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.940,'HYDROLASE',2,1,1),(4081,'4bam','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.880,'HYDROLASE',2,1,1),(4082,'4ban','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.870,'HYDROLASE',2,1,1),(4083,'4bao','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.870,'HYDROLASE',2,1,1),(4084,'4baq','THROMBIN IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.890,'HYDROLASE',2,1,1),(4085,'4bb2','CRYSTAL STRUCTURE OF CLEAVED CORTICOSTEROID-BINDING GLOBULIN IN COMPLEX WITH PROGESTERONE','X-RAY DIFFRACTION',2.480,'TRANSPORT PROTEIN',1,1,1),(4086,'4bd2','BAX DOMAIN SWAPPED DIMER IN COMPLEX WITH BIDBH3','X-RAY DIFFRACTION',2.210,'APOPTOSIS',1,1,1),(4087,'4bd6','BAX DOMAIN SWAPPED DIMER IN COMPLEX WITH BAXBH3','X-RAY DIFFRACTION',2.490,'APOPTOSIS',1,1,1),(4088,'4bg6','14-3-3 INTERACTION WITH RND3 PRENYL-PHOSPHORYLATION MOTIF','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',2,2,1),(4089,'4bh8','CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE GDPRPSYISHLL','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,2,1),(4090,'4bjt','CRYSTAL STRUCTURE OF THE RAP1 C-TERMINAL DOMAIN (RAP1-RCT) IN COMPLEX WITH THE RAP1 BINDING MODULE OF RIF1 (RIF1-RBM)','X-RAY DIFFRACTION',1.610,'TRANSCRIPTION',3,3,1),(4091,'4bl0','CRYSTAL STRUCTURE OF YEAST BUB3-BUB1 BOUND TO PHOSPHO-SPC105','X-RAY DIFFRACTION',1.950,'CELL CYCLE',4,2,1),(4092,'4bos','STRUCTURE OF OTUD2 OTU DOMAIN IN COMPLEX WITH UBIQUITIN K11-LINKED PEPTIDE','X-RAY DIFFRACTION',2.350,'HYDROLASE',1,3,1),(4093,'4bpi','MCL-1 BOUND TO ALPHA BETA PUMA BH3 PEPTIDE 2','X-RAY DIFFRACTION',1.980,'APOPTOSIS',1,1,1),(4094,'4bpj','MCL-1 BOUND TO ALPHA BETA PUMA BH3 PEPTIDE 3','X-RAY DIFFRACTION',1.600,'APOPTOSIS',1,1,1),(4095,'4bpk','BCL-XL BOUND TO ALPHA BETA PUMA BH3 PEPTIDE 5','X-RAY DIFFRACTION',1.760,'APOPTOSIS',2,2,1),(4096,'4bpl','RICE IMPORTIN_ALPHA IN COMPLEX WITH NUCLEOPLASMIN NLS','X-RAY DIFFRACTION',2.300,'TRANSPORT PROTEIN',1,1,1),(4097,'4bq6','CRYSTAL STRUCTURE OF THE RGMB-NEO1 COMPLEX FORM 1','X-RAY DIFFRACTION',2.300,'CELL ADHESION',2,2,1),(4098,'4bqd','KD1 OF HUMAN TFPI IN COMPLEX WITH A SYNTHETIC PEPTIDE','X-RAY DIFFRACTION',2.480,'BLOOD CLOTTING',2,2,1),(4099,'4bqk','RICE IMPORTIN_ALPHA : VIRD2NLS COMPLEX','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN',2,2,1),(4100,'4bt9','CRYSTAL STRUCTURE OF THE PEPTIDE(PRO-PRO-GLY)3 BOUND COMPLEX OF N- TERMINAL DOMAIN AND PEPTIDE SUBSTRATE BINDING DOMAIN OF PROLYL-4 HYDROXYLASE (RESIDUES 1-238) TYPE I FROM HUMAN','X-RAY DIFFRACTION',1.900,'OXIDOREDUCTASE',1,1,1),(4101,'4btb','CRYSTAL STRUCTURE OF THE PEPTIDE(PRO)9 BOUND COMPLEX OF N-TERMINAL DOMAIN AND PEPTIDE SUBSTRATE BINDING DOMAIN OF PROLYL-4 HYDROXYLASE (RESIDUES 1-238) TYPE I FROM HUMAN','X-RAY DIFFRACTION',1.900,'OXIDOREDUCTASE',1,1,1),(4102,'4bu0','CRYSTAL STRUCTURE OF RAD4 BRCT1,2 IN COMPLEX WITH A CRB2 PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.500,'REPLICATION',2,1,1),(4103,'4bu1','CRYSTAL STRUCTURE OF RAD4 BRCT1,2 IN COMPLEX WITH A CRB2 PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.100,'REPLICATION',2,2,1),(4104,'4buz','SIR2 COMPLEX STRUCTURE MIXTURE OF EX-527 INHIBITOR AND REACTION PRODUCTS OR OF REACTION SUBSTRATES P53 PEPTIDE AND NAD','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(4105,'4bve','CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH THIOALKYLIMIDATE FORMED FROM THIO-ACETYL-LYSINE ACS2- PEPTIDE','X-RAY DIFFRACTION',2.050,'HYDROLASE/LIGASE',1,1,1),(4106,'4bvg','CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH NATIVE ALKYLIMIDATE FORMED FROM ACETYL-LYSINE ACS2-PEPTIDE CRYSTALLIZED IN PRESENCE OF THE INHIBITOR EX-527','X-RAY DIFFRACTION',2.500,'HYDROLASE/LIGASE',1,1,1),(4107,'4bwq','CRYSTAL STRUCTURE OF U5-15KD IN A COMPLEX WITH PQBP1','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',4,4,1),(4108,'4bws','CRYSTAL STRUCTURE OF THE HETEROTRIMER OF PQBP1, U5-15KD AND U5-52KD.','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,2,1),(4109,'4bxf','60S RIBOSOMAL PROTEIN L27A HISTIDINE HYDROXYLASE (MINA53 Y209C) IN COMPLEX WITH MN(II), 2-OXOGLUTARATE (2OG) AND 60S RIBOSOMAL PROTEIN L27A (RPL27A G37C) PEPTIDE FRAGMENT','X-RAY DIFFRACTION',2.050,'OXIDOREDUCTASE/TRANSLATION',2,2,1),(4110,'4bxr','STRUCTURE OF THE WILD-TYPE TCP10 DOMAIN OF DANIO RERIO CPAP IN COMPLEX WITH A PEPTIDE OF DANIO RERIO STIL','X-RAY DIFFRACTION',2.200,'CELL CYCLE',2,2,1),(4111,'4bxu','STRUCTURE OF PEX14 IN COMPLEX WITH PEX5 LVXEF MOTIF','SOLUTION NMR',NULL,'PROTEIN TRANSPORT',1,1,1),(4112,'4c1q','CRYSTAL STRUCTURE OF THE PRDM9 SET DOMAIN IN COMPLEX WITH H3K4ME2 AND ADOHCY.','X-RAY DIFFRACTION',2.300,'TRANSFERASE/PEPTIDE',1,1,1),(4113,'4c2c','CRYSTAL STRUCTURE OF THE PROTEASE CTPB IN AN ACTIVE STATE','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,1,1),(4114,'4c2f','CRYSTAL STRUCTURE OF THE CTPB R168A MUTANT PRESENT IN AN ACTIVE CONFORMATION','X-RAY DIFFRACTION',2.400,'HYDROLASE',2,1,1),(4115,'4c2g','CRYSTAL STRUCTURE OF CTPB(S309A) IN COMPLEX WITH A PEPTIDE HAVING A VAL-PRO-ALA C-TERMINUS','X-RAY DIFFRACTION',1.900,'HYDROLASE/PEPTIDE',2,1,1),(4116,'4c2v','AURORA B KINASE IN COMPLEX WITH THE SPECIFIC INHIBITOR BARASERTIB','X-RAY DIFFRACTION',1.490,'TRANSFERASE/CELL CYCLE',2,2,1),(4117,'4c2w','CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH AMP-PNP','X-RAY DIFFRACTION',1.700,'TRANSFERASE',2,2,1),(4118,'4c33','PKA-S6K1 CHIMERA APO','X-RAY DIFFRACTION',1.700,'TRANSFERASE/INHIBITOR',1,1,1),(4119,'4c34','PKA-S6K1 CHIMERA WITH STAUROSPORINE BOUND','X-RAY DIFFRACTION',1.780,'TRANSFERASE/INHIBITOR',1,1,1),(4120,'4c35','PKA-S6K1 CHIMERA WITH COMPOUND 1 (NU1085) BOUND','X-RAY DIFFRACTION',2.190,'TRANSFERASE/INHIBITOR',1,1,1),(4121,'4c36','PKA-S6K1 CHIMERA WITH COMPOUND 15E (CCT147581) BOUND','X-RAY DIFFRACTION',1.980,'TRANSFERASE/INHIBITOR',1,1,1),(4122,'4c37','PKA-S6K1 CHIMERA WITH COMPOUND 21A (CCT196539) BOUND','X-RAY DIFFRACTION',1.700,'TRANSFERASE/INHIBITOR',1,1,1),(4123,'4c38','PKA-S6K1 CHIMERA WITH COMPOUND 21E (CCT239066) BOUND','X-RAY DIFFRACTION',1.580,'TRANSFERASE/INHIBITOR',1,1,1),(4124,'4c5a','THE X-RAY CRYSTAL STRUCTURES OF D-ALANYL-D-ALANINE LIGASE IN COMPLEX ADP AND D-CYCLOSERINE PHOSPHATE','X-RAY DIFFRACTION',1.650,'LIGASE',1,1,1),(4125,'4c5e','CRYSTAL STRUCTURE OF THE MINIMAL PHO-SFMBT COMPLEX (P21 SPACEGROUP)','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',4,4,1),(4126,'4c5g','CRYSTAL STRUCTURE OF THE MINIMAL PHO-SFMBT COMPLEX (P6122 SPACEGROUP)','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(4127,'4c5i','CRYSTAL STRUCTURE OF MBTD1 YY1 COMPLEX','X-RAY DIFFRACTION',2.490,'TRANSCRIPTION',1,1,1),(4128,'4c78','COMPLEX OF HUMAN SIRT3 WITH BROMO-RESVERATROL AND ACS2 PEPTIDE','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(4129,'4c7b','COMPLEX OF HUMAN SIRT3 WITH BROMO-RESVERATROL AND FLUOR-DE-LYS PEPTIDE','X-RAY DIFFRACTION',2.200,'HYDROLASE/PEPTIDE',1,1,1),(4130,'4cay','CRYSTAL STRUCTURE OF A HUMAN ANP32E-H2A.Z-H2B COMPLEX','X-RAY DIFFRACTION',1.480,'TRANSCRIPTION',1,2,1),(4131,'4cc2','COMPLEX OF HUMAN TUBA C-TERMINAL SH3 DOMAIN WITH HUMAN N- WASP PROLINE-RICH PEPTIDE - P212121','X-RAY DIFFRACTION',1.550,'STRUCTURAL PROTEIN',2,2,1),(4132,'4cc3','COMPLEX OF HUMAN TUBA C-TERMINAL SH3 DOMAIN AND MENA PROLINE-RICH PEPTIDE - H3','X-RAY DIFFRACTION',1.970,'STRUCTURAL PROTEIN',4,4,1),(4133,'4cc7','CRYSTAL STRUCTURE OF THE SIXTH OR C-TERMINAL SH3 DOMAIN OF HUMAN TUBA IN COMPLEX WITH PROLINE-RICH PEPTIDES OF N-WASP. SPACE GROUP P41','X-RAY DIFFRACTION',1.970,'STRUCTURAL PROTEIN',7,7,1),(4134,'4cc9','CRYSTAL STRUCTURE OF HUMAN SAMHD1 (AMINO ACID RESIDUES 582-626) BOUND TO VPX ISOLATED FROM SOOTY MANGABEY AND HUMAN DCAF1 (AMINO ACID RESIDUES 1058-1396)','X-RAY DIFFRACTION',2.470,'PROTEIN BINDING',1,2,1),(4135,'4ccn','60S RIBOSOMAL PROTEIN L8 HISTIDINE HYDROXYLASE (NO66 L299C/C300S) IN COMPLEX WITH MN(II), N-OXALYLGLYCINE (NOG) AND 60S RIBOSOMAL PROTEIN L8 (RPL8 G220C) PEPTIDE FRAGMENT (COMPLEX-2)','X-RAY DIFFRACTION',2.230,'OXIDOREDUCTASE',2,2,1),(4136,'4cco','60S RIBOSOMAL PROTEIN L8 HISTIDINE HYDROXYLASE (NO66 S373C) IN COMPLEX WITH MN(II), N-OXALYLGLYCINE (NOG) AND 60S RIBOSOMAL PROTEIN L8 (RPL8 G214C) PEPTIDE FRAGMENT (COMPLEX-3)','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',2,2,1),(4137,'4cfq','CA-BOUND TRUNCATED (DELTA13C) AND C3S, C81S AND C86S MUTATED S100A4 COMPLEXED WITH NON-MUSCLE MYOSIN IIA','X-RAY DIFFRACTION',1.370,'CA-BINDING PROTEIN/MOTOR PROTEIN',2,4,1),(4138,'4cfr','CA-BOUND S100A4 C3S, C81S, C86S AND F45W MUTANT COMPLEXED WITH NON- MUSCLE MYOSIN IIA','X-RAY DIFFRACTION',1.400,'CA-BINDING PROTEIN/MOTOR PROTEIN',1,2,1),(4139,'4cgq','FULL LENGTH TAH1 BOUND TO HSP90 PEPTIDE SRMEEVD','X-RAY DIFFRACTION',2.000,'CHAPERONE/PEPTIDE',1,1,1),(4140,'4cgu','FULL LENGTH TAH1 BOUND TO YEAST PIH1 AND HSP90 PEPTIDE SRMEEVD','X-RAY DIFFRACTION',2.110,'CHAPERONE/PEPTIDE',1,1,1),(4141,'4ch2','LOW-SALT CRYSTAL STRUCTURE OF A THROMBIN-GPIBALPHA PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.600,'HYDROLASE/PEPTIDE',4,2,1),(4142,'4ch8','HIGH-SALT CRYSTAL STRUCTURE OF A THROMBIN-GPIBALPHA PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.750,'HYDROLASE/PEPTIDE',8,4,1),(4143,'4ch9','CRYSTAL STRUCTURE OF THE HUMAN KLHL3 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE','X-RAY DIFFRACTION',1.840,'SIGNALING PROTEIN/TRANSFERASE',2,2,1),(4144,'4cha','STRUCTURE OF ALPHA-*CHYMOTRYPSIN REFINED AT 1.68 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.680,'HYDROLASE (SERINE PROTEINASE)',2,4,1),(4145,'4chb','CRYSTAL STRUCTURE OF THE HUMAN KLHL2 KELCH DOMAIN IN COMPLEX WITH A WNK4 PEPTIDE','X-RAY DIFFRACTION',1.560,'SIGNALING PROTEIN/TRANSFERASE',2,2,1),(4146,'4chg','CRYSTAL STRUCTURE OF VAPBC15 COMPLEX FROM MYCOBACTERIUM TUBERCULOSIS','X-RAY DIFFRACTION',2.100,'TOXIN/ANTITOXIN',4,6,1),(4147,'4chx','CRYSTAL STRUCTURE OF MLTC IN COMPLEX WITH DISACCHARIDE PENTAPEPTIDE DHL89','X-RAY DIFFRACTION',2.450,'LYASE',1,1,1),(4148,'4cic','T. POTENS ISCR','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',1,2,1),(4149,'4cim','COMPLEX OF A BCL-W BH3 MUTANT WITH A BH3 DOMAIN','X-RAY DIFFRACTION',1.500,'APOPTOSIS',2,2,1),(4150,'4ckq','X-RAY STRUCTURE OF GLUCURONOXYLAN-XYLANOHYDROLASE (XYN30A) FROM CLOSTRIDIUM THERMOCELLUM','X-RAY DIFFRACTION',1.400,'HYDROLASE',1,1,1),(4151,'4co6','CRYSTAL STRUCTURE OF THE NIPAH VIRUS RNA FREE NUCLEOPROTEIN-PHOSPHOPROTEIN COMPLEX','X-RAY DIFFRACTION',2.500,'CHAPERONE',3,3,1),(4152,'4cpa','REFINED CRYSTAL STRUCTURE OF THE POTATO INHIBITOR COMPLEX OF CARBOXYPEPTIDASE A AT 2.5 ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.500,'HYDROLASE (C-TERMINAL PEPTIDASE)',2,2,1),(4153,'4cri','CRYSTAL STRUCTURE OF 53BP1 TANDEM TUDOR DOMAINS IN COMPLEX WITH METHYLATED K810 RB PEPTIDE','X-RAY DIFFRACTION',2.350,'PEPTIDE BINDING PROTEIN',2,2,1),(4154,'4cry','DIRECT VISUALISATION OF STRAIN-INDUCED PROTEIN POST- TRANSLATIONAL MODIFICATION','X-RAY DIFFRACTION',1.610,'LYASE',1,2,1),(4155,'4csj','THE DISCOVERY OF POTENT SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS, SUITABLE FOR INHALATION','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',1,1,1),(4156,'4cu4','FHUA FROM E. COLI IN COMPLEX WITH THE LASSO PEPTIDE MICROCIN J25 (MCCJ25)','X-RAY DIFFRACTION',2.300,'TRANSPORT PROTEIN/ANTIBIOTIC',1,1,1),(4157,'4cvz','COMPLEX OF A B21 CHICKEN MHC CLASS I MOLECULE AND A 10MER CHICKEN PEPTIDE','X-RAY DIFFRACTION',2.390,'IMMUNE SYSTEM',1,1,1),(4158,'4cxf','STRUCTURE OF CNRH IN COMPLEX WITH THE CYTOSOLIC DOMAIN OF CNRY','X-RAY DIFFRACTION',1.750,'TRANSCRIPTION',1,1,1),(4159,'4cy1','CRYSTAL STRUCTURE OF THE KANSL1-WDR5 COMPLEX.','X-RAY DIFFRACTION',1.500,'TRANSCRIPTION',2,2,1),(4160,'4cy2','CRYSTAL STRUCTURE OF THE KANSL1-WDR5-KANSL2 COMPLEX.','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,1,1),(4161,'4cy3','CRYSTAL STRUCTURE OF THE NSL1-WDS COMPLEX.','X-RAY DIFFRACTION',1.400,'TRANSCRIPTION',1,1,1),(4162,'4cy5','CRYSTAL STRUCTURE OF THE NSL1-WDS-NSL2 COMPLEX.','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,1,1),(4163,'4cyd','GLXR BOUND TO CAMP','X-RAY DIFFRACTION',1.820,'TRANSCRIPTION',2,4,1),(4164,'4czs','DISCOVERY OF GLYCOMIMETIC LIGANDS VIA GENETICALLY-ENCODED LIBRARY OF PHAGE DISPLAYING MANNOSE-PEPTIDES','X-RAY DIFFRACTION',1.730,'SUGAR BINDING PROTEIN',4,4,1),(4165,'4d07','DYNLL2 DYNEIN LIGHT CHAIN BINDS TO AN EXTENDED, UNSTRUCTURED LINEAR MOTIF OF MYOSIN 5A TAIL','X-RAY DIFFRACTION',1.850,'MOTOR PROTEIN',1,1,1),(4166,'4d0g','STRUCTURE OF RAB14 IN COMPLEX WITH RAB-COUPLING PROTEIN (RCP)','X-RAY DIFFRACTION',2.500,'HYDROLASE',1,1,1),(4167,'4d0t','GALNAC-T2 CRYSTAL SOAKED WITH UDP-GALNAC,  EA2 PEPTIDE AND MANGANESE','X-RAY DIFFRACTION',2.450,'TRANSFERASE',2,4,1),(4168,'4d0z','GALNAC-T2 CRYSTAL SOAKED WITH UDP-5SGALNAC, MEA2 AND MANGANESE (HIGHER RESOLUTION DATASET)','X-RAY DIFFRACTION',2.200,'TRANSFERASE/PEPTIDE',2,2,1),(4169,'4d2m','VACCINIA VIRUS F1L BOUND TO BIM BH3','X-RAY DIFFRACTION',2.100,'APOPTOSIS',2,2,1),(4170,'4d49','CRYSTAL STRUCTURE OF COMPUTATIONALLY DESIGNED ARMADILLO REPEAT PROTEINS FOR MODULAR PEPTIDE RECOGNITION.','X-RAY DIFFRACTION',2.090,'DE NOVO PROTEIN/PEPTIDE',4,4,1),(4171,'4d7z','E. COLI L-ASPARTATE-ALPHA-DECARBOXYLASE MUTANT N72Q TO A RESOLUTION OF 1.9 ANGSTROMS','X-RAY DIFFRACTION',1.900,'LYASE',1,1,1),(4172,'4d8i','HIGH RESOLUTION STRUCTURES OF MONOMERIC S. PYOGENES SPEB REVEALS ROLE OF GLYCINE-RICH ACTIVE SITE LOOP','X-RAY DIFFRACTION',1.380,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4173,'4dat','STRUCTURE OF 14-3-3 SIGMA IN COMPLEX WITH PADI6 14-3-3 BINDING MOTIF II','X-RAY DIFFRACTION',1.400,'SIGNALING PROTEIN/PROTEIN BINDING',1,1,1),(4174,'4dau','STRUCTURE OF 14-3-3 SIGMA IN COMPLEX WITH PADI6 14-3-3 BINDING MOTIF I','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN/PROTEIN BINDING',1,1,1),(4175,'4dc2','STRUCTURE OF PKC IN COMPLEX WITH A SUBSTRATE PEPTIDE FROM PAR-3','X-RAY DIFFRACTION',2.400,'TRANSFERASE/TRANSFERASE SUBSTRATE',1,1,1),(4176,'4dcb','Y. PESTIS PLASMINOGEN ACTIVATOR PLA IN COMPLEX WITH HUMAN PLASMINOGEN ACTIVATION LOOP PEPTIDE ALP11','X-RAY DIFFRACTION',2.030,'HYDROLASE',1,1,1),(4177,'4dcj','CRYSTAL STRUCTURE OF CASPASE 3, L168D MUTANT','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(4178,'4dco','CRYSTAL STRUCTURE OF CASPASE 3, L168Y MUTANT','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(4179,'4dcp','CRYSTAL STRUCTURE OF CASPASE 3, L168F MUTANT','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(4180,'4dex','CRYSTAL STRUCTURE OF THE VOLTAGE DEPENDENT CALCIUM CHANNEL BETA-2 SUBUNIT IN COMPLEX WITH THE CAV2.2 I-II LINKER.','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN',1,1,1),(4181,'4dey','CRYSTAL STRUCTURE OF THE VOLTAGE DEPENDENT CALCIUM CHANNEL BETA-2 SUBUNIT IN COMPLEX WITH THE CAV1.2 I-II LINKER.','X-RAY DIFFRACTION',1.950,'TRANSPORT PROTEIN',1,1,1),(4182,'4dfw','OXIME-BASED POST SOLID-PHASE PEPTIDE DIVERSIFICATION: IDENTIFICATION OF HIGH AFFINITY POLO-LIKE KINASE 1 (PLK1) POLO-BOX DOMAIN BINDING PEPTIDES','X-RAY DIFFRACTION',1.550,'TRANSCRIPTION/ANTAGONIST',1,1,1),(4183,'4dfx','CRYSTAL STRUCTURE OF MYRISTOYLATED K7C CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20 AND AMP-PNP','X-RAY DIFFRACTION',1.350,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4184,'4dfz','CRYSTAL STRUCTURE OF MYRISTOYLATED K7C CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4185,'4dg0','CRYSTAL STRUCTURE OF MYRISTOYLATED WT CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20 AND AMP-PNP','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4186,'4dg2','CRYSTAL STRUCTURE OF MYRISTOYLATED WT CATALYTIC SUBUNIT OF CAMP- DEPENDENT PROTEIN KINASE IN COMPLEX WITH SP20','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4187,'4dg3','CRYSTAL STRUCTURE OF R336A MUTANT OF CAMP-DEPENDENT PROTEIN KINASE WITH UNPHOSPHORYLATED TURN MOTIF.','X-RAY DIFFRACTION',1.800,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4188,'4dgb','TRIMCYP CYCLOPHILIN DOMAIN FROM MACACA MULATTA: HIV-2 CA CYCLOPHILIN- BINDING LOOP COMPLEX','X-RAY DIFFRACTION',1.700,'ISOMERASE/VIRAL PROTEIN',1,1,1),(4189,'4dgv','STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, P2(1) FORM','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM/VIRAL PROTEIN',1,2,1),(4190,'4dgy','STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, C2 FORM','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM/VIRAL PROTEIN',1,2,1),(4191,'4dh1','LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH LOW MG2+, ATP AND IP20','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4192,'4dh3','LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+, ATP AND IP20','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4193,'4dh5','ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+, ADP, PHOSPHATE, AND IP20','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4194,'4dh7','LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+, AMP-PNP AND IP20\'','X-RAY DIFFRACTION',1.800,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4195,'4dh8','ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A CATALYTIC SUBUNIT WITH HIGH MG2+, AMP-PNP AND IP20','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4196,'4dig','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH N- ACETYLMURAMYL L-ALANYL D-ISOGLUTAMINE AT 1.8 A RESOLUTION','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(4197,'4dih','X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND THROMBIN BINDING APTAMER IN THE PRESENCE OF SODIUM IONS','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR/DNA',1,1,1),(4198,'4dii','X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN ALPHA THROMBIN AND THROMBIN BINDING APTAMER IN THE PRESENCE OF POTASSIUM IONS','X-RAY DIFFRACTION',2.050,'HYDROLASE/HYDROLASE INHIBITOR/DNA',1,1,1),(4199,'4dj9','HUMAN VINCULIN HEAD DOMAIN VH1 (RESIDUES 1-258) IN COMPLEX WITH THE TALIN VINCULIN BINDING SITE 50 (VBS50, RESIDUES 2078-2099)','X-RAY DIFFRACTION',2.250,'CELL ADHESION',1,1,1),(4200,'4djc','1.35 A CRYSTAL STRUCTURE OF THE NAV1.5 DIII-IV-CA/CAM COMPLEX','X-RAY DIFFRACTION',1.350,'CALCIUM-BINDING PROTEIN',1,1,1),(4201,'4dk7','CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN IN COMPLEX WITH FULL AGONIST 1','X-RAY DIFFRACTION',2.450,'TRANSCRIPTION/PEPTIDE/AGONIST',2,2,1),(4202,'4dlq','CRYSTAL STRUCTURE OF THE GAIN AND HORMR DOMAINS OF CIRL 1/LATROPHILIN 1 (CL1)','X-RAY DIFFRACTION',1.850,'SIGNALING PROTEIN',1,1,1),(4203,'4dm6','CRYSTAL STRUCTURE OF RARB LBD HOMODIMER IN COMPLEX WITH TTNPB','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION/PROTEIN BINDING',2,2,1),(4204,'4dm8','CRYSTAL STRUCTURE OF RARB LBD IN COMPLEX WITH 9CIS RETINOIC ACID','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION/PROTEIN BINDING',2,2,1),(4205,'4dm9','THE CRYSTAL STRUCTURE OF UBIQUITIN CARBOXY-TERMINAL HYDROLASE L1 (UCHL1) BOUND TO A TRIPEPTIDE FLUOROMETHYL KETONE Z-VAE(OME)-FMK','X-RAY DIFFRACTION',2.350,'HYDROLASE, LIGASE/INHIBITOR',2,2,1),(4206,'4dma','CRYSTAL STRUCTURE OF ERA LBD IN COMPLEX WITH RU100132','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION/PROTEIN BINDING/AGONIST',2,2,1),(4207,'4dnc','CRYSTAL STRUCTURE OF HUMAN MOF IN COMPLEX WITH MSL1','X-RAY DIFFRACTION',2.050,'TRANSCRIPTION',2,2,1),(4208,'4doq','CRYSTAL STRUCTURE OF THE COMPLEX OF PORCINE PANCREATIC TRYPSIN WITH 1/2SLPI','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,3,1),(4209,'4dor','HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, IN ITS APO STATE BOUND TO A FRAGMENT OF HUMAN SHP BOX1','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(4210,'4dos','HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO DLPC AND A FRAGMENT OF TIF-2','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,1,1),(4211,'4dow','STRUCTURE OF MOUSE ORC1 BAH DOMAIN BOUND TO H4K20ME2','X-RAY DIFFRACTION',1.950,'REPLICATION',2,2,1),(4212,'4ds1','THE STRUCTURE OF A YEAST DYN2-NUP159 COMPLEX AND THE MOLECULAR BASIS FOR THE DYNEIN LIGHT CHAIN - NUCLEAR PORE INTERACTION','X-RAY DIFFRACTION',1.850,'STRUCTURAL PROTEIN/TRANSPORT PROTEIN',2,2,1),(4213,'4ds7','CRYSTAL STRUCTURE OF YEAST CALMODULIN BOUND TO THE C-TERMINAL FRAGMENT OF SPINDLE POLE BODY PROTEIN SPC110','X-RAY DIFFRACTION',2.150,'PROTEIN BINDING',4,4,1),(4214,'4dt7','CRYSTAL STRUCTURE OF THROMBIN BOUND TO THE ACTIVATION DOMAIN QEDQVDPRLIDGKMTRRGDS OF PROTEIN C','X-RAY DIFFRACTION',1.900,'HYDROLASE',4,2,1),(4215,'4dv9','CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR','X-RAY DIFFRACTION',2.080,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4216,'4dvf','CRYSTAL STRUCTURE OF BACE1 WITH ITS INHIBITOR','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4217,'4dxr','HUMAN SUN2-KASH1 COMPLEX','X-RAY DIFFRACTION',2.320,'STRUCTURAL PROTEIN',1,1,1),(4218,'4dxu','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH AMINOCAPROIC ACID AT 1.46 A RESOLUTION','X-RAY DIFFRACTION',1.460,'METAL BINDING PROTEIN',1,1,1),(4219,'4dzu','COMPLEX OF 3-ALPHA BOUND TO GP41-5','X-RAY DIFFRACTION',2.100,'DE NOVO PROTEIN',1,1,1),(4220,'4dzv','COMPLEX OF 4-ALPHA/BETA BOUND TO GP41-5','X-RAY DIFFRACTION',2.100,'DE NOVO PROTEIN',1,1,1),(4221,'4e05','ANOPHELIN FROM THE MALARIA VECTOR INHIBITS THROMBIN THROUGH A NOVEL REVERSE-BINDING MECHANISM','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(4222,'4e0r','STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401','X-RAY DIFFRACTION',2.260,'IMMUNE SYSTEM',2,2,1),(4223,'4e17','ALPHA-E-CATENIN IS AN AUTOINHIBITED MOLECULE THAT CO-ACTIVATES VINCULIN','X-RAY DIFFRACTION',2.300,'CELL ADHESION',1,1,1),(4224,'4e18','ALPHA-E-CATENIN IS AN AUTOINHIBITED MOLECULE THAT CO-ACTIVATES VINCULIN','X-RAY DIFFRACTION',2.400,'CELL ADHESION',1,1,1),(4225,'4e2j','X-RAY CRYSTAL STRUCTURE OF THE ANCESTRAL GLUCOCORTICOID RECEPTOR 2 LIGAND BINDING DOMAIN IN COMPLEX WITH MOMETASONE FUROATE AND TIF-2 COACTIVATOR FRAGMENT','X-RAY DIFFRACTION',2.500,'HORMONE/HORMONE ACTIVATOR',2,2,1),(4226,'4e34','CRYSTAL STRUCTURE OF CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO ICAL36 (ANSRWPTSII) PEPTIDE','X-RAY DIFFRACTION',1.400,'PROTEIN TRANSPORT/INHIBITOR',2,2,1),(4227,'4e35','CRYSTAL STRUCTURE OF CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO ICAL36-L (ANSRWPTSIL) PEPTIDE','X-RAY DIFFRACTION',1.400,'PROTEIN TRANSPORT/PROTEIN BINDING',2,2,1),(4228,'4e3b','CRYSTAL STRUCTURE OF TAX-INTERACTING PROTEIN-1 (TIP-1) PDZ DOMAIN BOUND TO ICAL36-L (ANSRWPTSIL) PEPTIDE','X-RAY DIFFRACTION',1.500,'SIGNALING PROTEIN/PROTEIN BINDING',2,2,1),(4229,'4e43','HIV PROTEASE (PR) DIMER WITH ACETATE IN EXO SITE AND PEPTIDE IN ACTIVE SITE','X-RAY DIFFRACTION',1.540,'HYDROLASE',1,2,1),(4230,'4e5x','CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE HUMAN ADENOVIRUS TYPE 2 E3- 19K PROTEIN AND MHC CLASS I MOLECULE HLA-A2/TAX','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM/TRANSCRIPTION',2,2,1),(4231,'4e67','THE STRUCTURE OF THE POLO-BOX DOMAIN (PBD) OF POLO-LIKE KINASE 1 (PLK1) IN COMPLEX WITH HYDROCINNAMOYL-DERIVATIZED PLHSPTA PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4232,'4e6k','2.0 A RESOLUTION STRUCTURE OF PSEUDOMONAS AERUGINOSA BACTERIOFERRITIN (BFRB) IN COMPLEX WITH BACTERIOFERRITIN ASSOCIATED FERREDOXIN (BFD)','X-RAY DIFFRACTION',2.000,'METAL BINDING PROTEIN/ELECTRON TRANSP',1,2,1),(4233,'4e73','CRYSTAL STRUCTURE OF JNK1BETA-JIP IN COMPLEX WITH AN AZAQUINOLONE INHBITOR','X-RAY DIFFRACTION',2.270,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4234,'4e7r','THROMBIN IN COMPLEX WITH 3-AMIDINOPHENYLALANINE INHIBITOR','X-RAY DIFFRACTION',2.250,'HYDROLASE/HYDROLASE INHIBITOR',4,2,1),(4235,'4e81','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH A SHORT APIDAECIN PEPTIDE','X-RAY DIFFRACTION',1.900,'CHAPERONE',2,2,1),(4236,'4e9c','THE STRUCTURE OF THE POLO-BOX DOMAIN (PBD) OF POLO-LIKE KINASE 1 (PLK1) IN COMPLEX WITH LDPPLHSPTA PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.700,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4237,'4eak','CO-CRYSTAL STRUCTURE OF AN AMPK CORE WITH ATP','X-RAY DIFFRACTION',2.500,'TRANSFERASE',1,2,1),(4238,'4efh','ACANTHAMOEBA ACTIN COMPLEX WITH SPIR DOMAIN D','X-RAY DIFFRACTION',2.480,'CONTRACTILE PROTEIN/TRANSPORT PROTEIN',1,1,1),(4239,'4eha','ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4240,'4ehd','ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS','X-RAY DIFFRACTION',1.580,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4241,'4ehf','ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS','X-RAY DIFFRACTION',1.660,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4242,'4ehh','ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS','X-RAY DIFFRACTION',1.780,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4243,'4ehk','ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS','X-RAY DIFFRACTION',1.670,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4244,'4ehl','ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4245,'4ehn','ALLOSTERIC MODULATION OF CASPASE-3 THROUGH MUTAGENESIS','X-RAY DIFFRACTION',1.690,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4246,'4ehq','CRYSTAL STRUCTURE OF CALMODULIN BINDING DOMAIN OF ORAI1 IN COMPLEX WITH CA2+/CALMODULIN DISPLAYS A UNIQUE BINDING MODE','X-RAY DIFFRACTION',1.900,'PROTEIN BINDING',1,1,1),(4247,'4ejd','HIV PROTEASE (PR) DIMER IN CLOSED FORM WITH PEPSTATIN IN ACTIVE SITE AND FRAGMENT 1F1 IN THE OUTSIDE/TOP OF FLAP','X-RAY DIFFRACTION',1.100,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(4248,'4eje','STRUCTURE OF THE TSG101 UEV DOMAIN IN COMPLEX WITH AN EBOLA PTAP LATE DOMAIN PEPTIDE','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT',2,2,1),(4249,'4ejk','HIV PROTEASE (PR) DIMER IN CLOSED FORM WITH PEPSTATIN IN ACTIVE SITE AND FRAGMENT 1F1-N IN THE OUTSIDE/TOP OF FLAP','X-RAY DIFFRACTION',1.790,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(4250,'4eoy','PLASMODIUM FALCIPARUM ATG8 IN COMPLEX WITH PLASMODIUM FALCIPARUM ATG3 PEPTIDE','X-RAY DIFFRACTION',2.220,'TRANSPORT PROTEIN',3,3,1),(4251,'4ep2','CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE RT-RH','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(4252,'4ep3','CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE CA-P2','X-RAY DIFFRACTION',1.810,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(4253,'4epj','CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN WILD-TYPE HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE P2-NC','X-RAY DIFFRACTION',1.690,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(4254,'4eq0','CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN VARIANT OF HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE P2-NC','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(4255,'4eqj','CRYSTAL STRUCTURE OF INACTIVE SINGLE CHAIN VARIANT OF HIV-1 PROTEASE IN COMPLEX WITH THE SUBSTRATE RT-RH','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(4256,'4eqy','CRYSTAL STRUCTURE OF ACYL-[ACYL-CARRIER-PROTEIN]--UDP-N- ACETYLGLUCOSAMINE O-ACYLTRANSFERASE FROM BURKHOLDERIA THAILANDENSIS','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(4257,'4er2','THE ACTIVE SITE OF ASPARTIC PROTEINASES','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4258,'4er4','HIGH-RESOLUTION X-RAY ANALYSES OF RENIN INHIBITOR-ASPARTIC PROTEINASE COMPLEXES','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4259,'4erq','X-RAY STRUCTURE OF WDR5-MLL2 WIN MOTIF PEPTIDE BINARY COMPLEX','X-RAY DIFFRACTION',1.910,'TRANSCRIPTION/TRANSFERASE',3,3,1),(4260,'4ery','X-RAY STRUCTURE OF WDR5-MLL3 WIN MOTIF PEPTIDE BINARY COMPLEX','X-RAY DIFFRACTION',1.300,'TRANSCRIPTION/TRANSFERASE',1,1,1),(4261,'4erz','X-RAY STRUCTURE OF WDR5-MLL4 WIN MOTIF PEPTIDE BINARY COMPLEX','X-RAY DIFFRACTION',1.750,'TRANSCRIPTION/TRANSFERASE',3,3,1),(4262,'4es0','X-RAY STRUCTURE OF WDR5-SETD1B WIN MOTIF PEPTIDE BINARY COMPLEX','X-RAY DIFFRACTION',1.820,'TRANSCRIPTION/TRANSFERASE',1,1,1),(4263,'4esg','X-RAY STRUCTURE OF WDR5-MLL1 WIN MOTIF PEPTIDE BINARY COMPLEX','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION/TRANSFERASE',2,2,1),(4264,'4est','CRYSTAL STRUCTURE OF THE COVALENT COMPLEX FORMED BY A PEPTIDYL ALPHA, ALPHA-DIFLUORO-BETA-KETO AMIDE WITH PORCINE PANCREATIC ELASTASE AT 1.78-ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.780,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4265,'4eto','STRUCTURE OF S100A4 IN COMPLEX WITH NON-MUSCLE MYOSIN-IIA PEPTIDE','X-RAY DIFFRACTION',1.540,'METAL BINDING PROTEIN',1,2,1),(4266,'4ewr','X-RAY STRUCTURE OF WDR5-SETD1A WIN MOTIF PEPTIDE BINARY COMPLEX','X-RAY DIFFRACTION',1.500,'TRANSCRIPTION/TRANSFERASE',1,1,1),(4267,'4exh','THE CRYSTAL STRUCTURE OF XMRV PROTEASE COMPLEXED WITH ACETYL-PEPSTATIN','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',3,2,1),(4268,'4ext','STRUCTURE OF POLYMERASE-INTERACTING DOMAIN OF HUMAN REV1 IN COMPLEX WITH TRANSLESIONAL SYNTHESIS POLYMERASE ZETA','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSCRIPTION',1,1,1),(4269,'4ez1','CRYSTAL STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) FROM APLYSIA CALIFORNICA IN COMPLEX WITH ALPHA-CONOTOXIN BUIA','X-RAY DIFFRACTION',2.490,'CHOLINE BINDING PROTEIN/TOXIN',5,5,1),(4270,'4ezn','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH PYRRHOCORICIN','X-RAY DIFFRACTION',1.800,'CHAPERONE/PEPTIDE BINDING PROTEIN',2,2,1),(4271,'4ezo','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH PR-39 (RESIDUES 1 TO 15)','X-RAY DIFFRACTION',1.900,'CHAPERONE/PEPTIDE BINDING PROTEIN',2,2,1),(4272,'4ezp','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH A3-APO(RESIDUES 1 TO 20)','X-RAY DIFFRACTION',1.650,'CHAPERONE/PEPTIDE BINDING PROTEIN',2,2,1),(4273,'4ezq','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH THE C-TERMINAL PART OF PYRRHOCORICIN (RESIDUES 12 TO 20)','X-RAY DIFFRACTION',2.000,'CHAPERONE/PEPTIDE BINDING PROTEIN',1,1,1),(4274,'4ezr','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH THE C-TERMINAL PART OF DROSOCIN (RESIDUES 12 TO 19)','X-RAY DIFFRACTION',1.900,'CHAPERONE/PEPTIDE BINDING PROTEIN',1,1,1),(4275,'4ezs','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH METCHNIKOWIN (RESIDUES 20 TO 26)','X-RAY DIFFRACTION',1.900,'CHAPERONE/PEPTIDE BINDING PROTEIN',1,1,1),(4276,'4ezt','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH HELIOCIN (RESIDUES 14 TO 21)','X-RAY DIFFRACTION',2.000,'CHAPERONE/PEPTIDE BINDING PROTEIN',1,1,1),(4277,'4ezu','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH PR-BOMBESIN IN SPACE GROUP I222','X-RAY DIFFRACTION',1.900,'CHAPERONE/PEPTIDE BINDING PROTEIN',1,1,1),(4278,'4ezv','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH PR-BOMBESIN IN SPACE GROUP P21212','X-RAY DIFFRACTION',2.100,'CHAPERONE/PEPTIDE BINDING PROTEIN',2,2,1),(4279,'4ezw','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH THE DESIGNER PEPTIDE NRLLLTG','X-RAY DIFFRACTION',1.800,'CHAPERONE/PEPTIDE BINDING PROTEIN',4,4,1),(4280,'4ezx','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH THE DESIGNER PEPTIDE NRLMLTG','X-RAY DIFFRACTION',1.700,'CHAPERONE/PEPTIDE BINDING PROTEIN',2,2,1),(4281,'4ezy','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH THE DESIGNER PEPTIDE NRLILTG','X-RAY DIFFRACTION',1.850,'CHAPERONE',1,1,1),(4282,'4ezz','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH THE DESIGNER PEPTIDE ELPLVKI','X-RAY DIFFRACTION',2.050,'CHAPERONE',1,1,1),(4283,'4f00','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH AN APIDAECIN FRAGMENT FROM THE BUMBLEBEE (RESIDUES 3 TO 11)','X-RAY DIFFRACTION',1.950,'CHAPERONE/IMMUNE SYSTEM',1,1,1),(4284,'4f02','CRYSTAL STRUCTURE OF THE PABP-BINDING SITE OF EIF4G IN COMPLEX WITH RRM1-2 OF PABP AND POLY(A)','X-RAY DIFFRACTION',2.000,'TRANSLATION/RNA',2,2,1),(4285,'4f0z','CRYSTAL STRUCTURE OF CALCINEURIN IN COMPLEX WITH THE CALCINEURIN- INHIBITING DOMAIN OF THE AFRICAN SWINE FEVER VIRUS PROTEIN A238L','X-RAY DIFFRACTION',1.700,'HYDROLASE/PROTEIN BINDING',1,2,1),(4286,'4f1z','CRYSTAL STRUCTURES REVEAL THE MULTI-LIGAND BINDING MECHANISM OF THE STAPHYLOCOCCUS AUREUS CLFB','X-RAY DIFFRACTION',2.300,'CELL ADHESION',1,1,1),(4287,'4f20','CRYSTAL STRUCTURES REVEAL THE MULTI-LIGAND BINDING MECHANISM OF THE STAPHYLOCOCCUS AUREUS CLFB','X-RAY DIFFRACTION',2.500,'CELL ADHESION/CYTOKINE',1,1,1),(4288,'4f27','CRYSTAL STRUCTURES REVEAL THE MULTI-LIGAND BINDING MECHANISM OF THE STAPHYLOCOCCUS AUREUS CLFB','X-RAY DIFFRACTION',1.920,'CELL ADHESION/BLOOD CLOTTING',1,1,1),(4289,'4f4u','THE BICYCLIC INTERMEDIATE STRUCTURE PROVIDES INSIGHTS INTO THE DESUCCINYLATION MECHANISM OF SIRT5','X-RAY DIFFRACTION',2.000,'HYDROLASE',2,2,1),(4290,'4f56','THE BICYCLIC INTERMEDIATE STRUCTURE PROVIDES INSIGHTS INTO THE DESUCCINYLATION MECHANISM OF SIRT5','X-RAY DIFFRACTION',1.700,'HYDROLASE',2,2,1),(4291,'4f73','CRYSTAL STRUCTURE OF ACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE N TERMINAL PRODUCT OF CA-P2 CLEAVAGE SITE','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE PRODUCT',2,2,1),(4292,'4f74','CRYSTAL STRUCTURE OF ACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE N TERMINAL PRODUCT OF THE SUBSTRATE MA-CA.','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE PRODUCT',1,2,1),(4293,'4f75','CRYSTAL STRUCTURE OF ACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE N TERMINAL PRODUCT OF THE SUBSTRATE RH-IN','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE PRODUCT',2,2,1),(4294,'4f76','CRYSTAL STRUCTURE OF THE ACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE PRODUCTS OF P1-P6 SUBSTRATE','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE PRODUCT',2,2,1),(4295,'4f7m','CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PA (649-658)','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,2,1),(4296,'4f7p','CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009H1N1 PB1 (496-505)','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(4297,'4f7t','CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED WITH A NEWLY IDENTIFIED PEPTIDE FROM 2009 H1N1 PB1 (498-505)','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',2,2,1),(4298,'4f9m','CRYSTAL STRUCTURE OF THE PPARGAMMA-LBD COMPLEXED WITH A CERCOSPORAMIDE DERIVATIVE MODULATOR','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION/TRANSCRIPTION REGULATOR',1,1,1),(4299,'4fa7','STRUCTURE OF RECOMBINANT CYTOCHROME BA3 OXIDASE MUTANT A204F FROM THERMUS THERMOPHILUS','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE',1,2,1),(4300,'4fae','SUBSTRATE P2/NC IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE VARIANT','X-RAY DIFFRACTION',2.300,'VIRAL PROTEIN',1,2,1),(4301,'4faf','SUBSTRATE CA/P2 IN COMPLEX WITH A HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE VARIANT','X-RAY DIFFRACTION',2.100,'VIRAL PROTEIN',1,2,1),(4302,'4faj','STRUCTURE AND MODE OF PEPTIDE BINDING OF PHEROMONE RECEPTOR PRGZ','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN',1,1,1),(4303,'4fas','COMPLEX CRYSTAL STRUCTURE OF HYDROXYLAMINE OXIDOREDUCTASE AND NE1300 FROM NITROSOMONAS EUROPAEA','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',3,3,1),(4304,'4fbw','CRYSTAL STRUCTURE OF AN UNFUSED MRE11-NBS1 COMPLEX WITH TWO MANGANESE IONS PER ACTIVE SITE','X-RAY DIFFRACTION',2.200,'HYDROLASE/PROTEIN BINDING',2,2,1),(4305,'4fdd','CRYSTAL STRUCTURE OF KAP BETA2-PY-NLS','X-RAY DIFFRACTION',2.300,'TRANSPORT PROTEIN',1,1,1),(4306,'4fga','DESIGN OF PEPTIDE INHIBITORS OF GROUP II PHOSPHOLIPASE A2: CRYSTAL STRUCTURE OF THE COMPLEX OF PHOSPHOLIPSAE A2 WITH A DESIGNED TRIPEPTIDE, ALA- TYR- LYS AT 2.3 A RESOLUTION','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4307,'4fgt','ALLOSTERIC PEPTIDIC INHIBITOR OF HUMAN THYMIDYLATE SYNTHASE THAT STABILIZES INACTIVE CONFORMATION OF THE ENZYME.','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4308,'4fgx','CRYSTAL STRUCTURE OF BACE1 WITH NOVEL INHIBITOR','X-RAY DIFFRACTION',1.590,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4309,'4fhh','DEVELOPMENT OF SYNTHETICALLY ACCESSIBLE NON-SECOSTEROIDAL HYBRID MOLECULES COMBINING VITAMIN D RECEPTOR AGONISM AND HISTONE DEACETYLASE INHIBITION','X-RAY DIFFRACTION',2.330,'TRANSCRIPTION/PROTEIN BINDING/INHIBIT',1,1,1),(4310,'4fhi','DEVELOPMENT OF SYNTHETICALLY ACCESSIBLE NON-SECOSTEROIDAL HYBRID MOLECULES COMBINING VITAMIN D RECEPTOR AGONISM AND HISTONE DEACETYLASE INHIBITION','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION/PROTEIN BINDING/INHIBIT',1,1,1),(4311,'4fii','CATALYTIC DOMAIN OF HUMAN PAK4 WITH RPKPLVDP PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSFERASE/PEPTIDE',1,1,1),(4312,'4fim','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH CELECOXIB ACID AT 1.80 A RESOLUTION','X-RAY DIFFRACTION',1.800,'HYDROLASE',1,1,1),(4313,'4fj3','14-3-3 ISOFORM ZETA IN COMPLEX WITH A DIPHOYPHORYLATED C-RAF PEPTIDE','X-RAY DIFFRACTION',1.950,'PROTEIN BINDING/TRANSFERASE',1,2,1),(4314,'4fjp','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH NAPROXEN AT 1.68 A RESOLUTION','X-RAY DIFFRACTION',1.680,'HYDROLASE',1,1,1),(4315,'4fl5','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH A TAU-PROTEIN PEPTIDE SURROUNDING PS214','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN',2,2,1),(4316,'4fl8','HIV-1 PROTEASE COMPLEXED WITH GEM-DIOL-AMINE TETRAHEDRAL INTERMEDIATE','X-RAY DIFFRACTION',1.200,'HYDROLASE',2,2,1),(4317,'4flg','HIV-1 PROTEASE MUTANT I47V COMPLEXED WITH REACTION INTERMEDIATE','X-RAY DIFFRACTION',1.310,'HYDROLASE',3,2,1),(4318,'4fm6','HIV-1 PROTEASE MUTANT V32I COMPLEXED WITH REACTION INTERMEDIATE','X-RAY DIFFRACTION',1.400,'HYDROLASE',1,2,1),(4319,'4fmq','CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/SIGNALING PROTEIN',1,1,1),(4320,'4for','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH FLURBIPROFEN AT 1.58 A RESOLUTION','X-RAY DIFFRACTION',1.580,'HYDROLASE',1,1,1),(4321,'4fr3','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH TASK-3 PEPTIDE AND STABILIZER 16-O-ME-FC-H','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN/TOXIN',1,1,1),(4322,'4fvd','CRYSTAL STRUCTURE OF EV71 2A PROTEINASE C110A MUTANT IN COMPLEX WITH SUBSTRATE','X-RAY DIFFRACTION',1.660,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(4323,'4fvl','HUMAN COLLAGENASE 3 (MMP-13) FULL FORM WITH PEPTIDES FROM PRO-DOMAIN','X-RAY DIFFRACTION',2.440,'HYDROLASE',2,2,1),(4324,'4fvt','HUMAN SIRT3 BOUND TO AC-ACS PEPTIDE AND CARBA-NAD','X-RAY DIFFRACTION',2.470,'HYDROLASE',1,1,1),(4325,'4fys','HUMAN AMINOPEPTIDASE N (CD13) IN COMPLEX WITH ANGIOTENSIN IV','X-RAY DIFFRACTION',2.010,'HYDROLASE/HORMONE',1,1,1),(4326,'4fyt','HUMAN AMINOPEPTIDASE N (CD13) IN COMPLEX WITH AMASTATIN','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4327,'4fz3','CRYSTAL STRUCTURE OF SIRT3 IN COMPLEX WITH ACETYL P53 PEPTIDE COUPLED WITH 4-AMINO-7-METHYLCOUMARIN','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(4328,'4g1c','HUMAN SIRT5 BOUND TO SUCC-IDH2 AND CARBA-NAD','X-RAY DIFFRACTION',1.940,'HYDROLASE',2,2,1),(4329,'4g1w','CRYSTAL STRUCTURE OF JNK1 IN COMPLEX WITH JIP1 PEPTIDE AND 7-FLUORO-3- [4-(2-HYDROXY-ETHANESULFONYL)-BENZYL]-4-OXO-1-PHENYL-1,4-DIHYDRO- QUINOLINE-2-CARBOXYLIC ACID METHYL ESTER','X-RAY DIFFRACTION',2.450,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4330,'4g1z','STRUCTURAL BASIS FOR THE ACCOMMODATION OF BIS- AND TRIS-AROMATIC DERIVATIVES IN VITAMIN D NUCLEAR RECEPTOR','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',1,1,1),(4331,'4g2h','STRUCTURAL BASIS FOR THE ACCOMMODATION OF BIS- AND TRIS-AROMATIC DERIVATIVES IN VITAMIN D NUCLEAR RECEPTOR','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',1,1,1),(4332,'4g2v','STRUCTURE COMPLEX OF LGN BINDING WITH FRMPD1','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING',1,1,1),(4333,'4g2z','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH MEFENAMIC ACID AT 1.90 A RESOLUTION','X-RAY DIFFRACTION',1.900,'METAL BINDING PROTEIN',1,1,1),(4334,'4g35','MCL-1 IN COMPLEX WITH A BIPHENYL CROSS-LINKED NOXA PEPTIDE.','X-RAY DIFFRACTION',2.000,'APOPTOSIS/INHIBITOR',1,1,1),(4335,'4g42','STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO PEPITDE P8D','X-RAY DIFFRACTION',2.290,'IMMUNE SYSTEM',2,2,1),(4336,'4g43','STRUCTURE OF THE CHICKEN MHC CLASS I MOLECULE BF2*0401 COMPLEXED TO P5E','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,2,1),(4337,'4g5g','EF-TU (ESCHERICHIA COLI) COMPLEXED WITH NVP-LDU796','X-RAY DIFFRACTION',2.300,'TRANSLATION/ANTIBIOTIC',1,1,1),(4338,'4g69','STRUCTURE OF THE HUMAN DISCS LARGE 1 PDZ2 - ADENOMATOUS POLYPOSIS COLI CYTOSKELETAL POLARITY COMPLEX','X-RAY DIFFRACTION',2.000,'MEMBRANE PROTEIN/SIGNALING PROTEIN',1,1,1),(4339,'4g6a','STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(4340,'4g6f','CRYSTAL STRUCTURE OF 10E8 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,4,1),(4341,'4g7s','STRUCTURE OF RECOMBINANT CYTOCHROME BA3 OXIDASE MUTANT V236I FROM THERMUS THERMOPHILUS','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE',1,2,1),(4342,'4g8g','CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,3,1),(4343,'4g8i','CRYSTAL STRUCTURE OF HLA B2705-KK10-L6M','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(4344,'4g91','CCAAT-BINDING COMPLEX FROM ASPERGILLUS NIDULANS','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,2,1),(4345,'4g9d','CRYSTAL STRUCTURE OF HLA B2705-KK10','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(4346,'4g9f','CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,3,1),(4347,'4gag','STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,2,1),(4348,'4gba','DCNL COMPLEX WITH N-TERMINALLY ACETYLATED NEDD8 E2 PEPTIDE','X-RAY DIFFRACTION',2.400,'LIGASE/PEPTIDE',2,2,1),(4349,'4gch','STRUCTURE AND ACTIVITY OF TWO PHOTOREVERSIBLE CINNAMATES BOUND TO CHYMOTRYPSIN','X-RAY DIFFRACTION',1.900,'HYDROLASE (SERINE PROTEINASE)',1,2,1),(4350,'4geq','CRYSTAL STRUCTURE OF THE SPC24-SPC25/CNN1 BINDING INTERFACE','X-RAY DIFFRACTION',2.010,'CELL CYCLE',2,2,1),(4351,'4gf3','STRUCTURE OF A SYCH-YOPH CHAPERONE-EFFECTOR COMPLEX','X-RAY DIFFRACTION',1.900,'CHAPERONE/CHAPERONE EFFECTOR',1,1,1),(4352,'4gfu','PTPN18 IN COMPLEX WITH HER2-PY1248 PHOSPHOR-PEPTIDES','X-RAY DIFFRACTION',2.000,'HYDROLASE/PEPTIDE',1,1,1),(4353,'4gfv','PTPN18 IN COMPLEX WITH HER2-PY1196 PHOSPHOR-PEPTIDES','X-RAY DIFFRACTION',2.100,'HYDROLASE/PEPTIDE',2,2,1),(4354,'4ggd','STRUCTURAL ANALYSIS OF HUMAN CDC20 SUPPORTS MULTISITE DEGRON RECOGNITION BY APC/C.','X-RAY DIFFRACTION',2.440,'CELL CYCLE',2,2,1),(4355,'4ggn','MALARIA INVASION MACHINERY PROTEIN COMPLEX','X-RAY DIFFRACTION',2.290,'PROTEIN BINDING',3,3,1),(4356,'4ghu','CRYSTAL STRUCTURE OF TRAF3/CARDIF','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(4357,'4gks','A2-MHC COMPLEX CARRYING FLTGIGIITV','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',2,2,1),(4358,'4gkv','STRUCTURE OF ESCHERICHIA COLI ADHP (ETHANOL-INDUCIBLE DEHYDROGENASE) WITH BOUND NAD','X-RAY DIFFRACTION',2.010,'OXIDOREDUCTASE',1,2,1),(4359,'4gld','CRYSTAL STRUCTURE OF THE COMPLEX OF TYPE II PHOSPHOLIPASE A2 WITH A DESIGNED PEPTIDE INHIBITOR PHE - LEU - ALA - TYR - LYS AT 1.69 A RESOLUTION','X-RAY DIFFRACTION',1.690,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4360,'4glr','STRUCTURE OF THE ANTI-PTAU FAB (PT231/PS235_1) IN COMPLEX WITH PHOSPHOEPITOPE PT231/PS235','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,4,1),(4361,'4gly','HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR UPA IN COMPLEX WITH THE TWO-DISULFIDE BRIDGE PEPTIDE UK504','X-RAY DIFFRACTION',1.520,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4362,'4gm9','CRYSTAL STRUCTURE OF HUMAN WD REPEAT DOMAIN 5 WITH COMPOUND MM-401','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',2,2,1),(4363,'4gne','CRYSTAL STRUCTURE OF NSD3 TANDEM PHD5-C5HCH DOMAINS COMPLEXED WITH H3 PEPTIDE 1-7','X-RAY DIFFRACTION',1.470,'TRANSFERASE/NUCLEAR PROTEIN',1,1,1),(4364,'4gnf','CRYSTAL STRUCTURE OF NSD3 TANDEM PHD5-C5HCH DOMAINS COMPLEXED WITH H3 PEPTIDE 1-15','X-RAY DIFFRACTION',1.550,'TRANSFERASE/NUCLEAR PROTEIN',1,1,1),(4365,'4gng','CRYSTAL STRUCTURE OF NSD3 TANDEM PHD5-C5HCH DOMAINS COMPLEXED WITH H3K9ME3 PEPTIDE','X-RAY DIFFRACTION',1.730,'TRANSFERASE/NUCLEAR PROTEIN',2,2,1),(4366,'4gnt','COMPLEX OF CHREBP AND 14-3-3BETA','X-RAY DIFFRACTION',2.410,'PROTEIN BINDING',1,1,1),(4367,'4gq6','HUMAN MENIN IN COMPLEX WITH MLL PEPTIDE','X-RAY DIFFRACTION',1.550,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',1,1,1),(4368,'4gqb','CRYSTAL STRUCTURE OF THE HUMAN PRMT5:MEP50 COMPLEX','X-RAY DIFFRACTION',2.060,'TRANSFERASE/PROTEIN BINDING',1,1,1),(4369,'4grk','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH KETOROLAC AT 1.68 A RESOLUTION','X-RAY DIFFRACTION',1.680,'HYDROLASE',1,1,1),(4370,'4gus','CRYSTAL STRUCTURE OF LSD2-NPAC WITH H3 IN SPACE GROUP P3221','X-RAY DIFFRACTION',2.230,'OXIDOREDUCTASE',2,1,1),(4371,'4gut','CRYSTAL STRUCTURE OF LSD2-NPAC','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE',1,1,1),(4372,'4guu','CRYSTAL STRUCTURE OF LSD2-NPAC WITH TRANYLCYPROMINE','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',1,1,1),(4373,'4gux','CRYSTAL STRUCTURE OF TRYPSIN:MCOTI-II COMPLEX','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',3,3,1),(4374,'4gvc','CRYSTAL STRUCTURE OF T-CELL LYMPHOMA INVASION AND METASTASIS-1 PDZ IN COMPLEX WITH PHOSPHORYLATED SYNDECAN1 PEPTIDE','X-RAY DIFFRACTION',1.540,'SIGNALING PROTEIN',1,1,1),(4375,'4gvd','CRYSTAL STRUCTURE OF T-CELL LYMPHOMA INVASION AND METASTASIS-1 PDZ IN COMPLEX WITH SYNDECAN1 PEPTIDE','X-RAY DIFFRACTION',1.850,'SIGNALING PROTEIN',2,2,1),(4376,'4gvu','LYNGBYASTATIN 7-PORCINE PANCREATIC ELASTASE CO-CRYSTAL STRUCTURE','X-RAY DIFFRACTION',1.550,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4377,'4gw1','CQFD MEDITOPE','X-RAY DIFFRACTION',2.240,'IMMUNE SYSTEM',2,4,1),(4378,'4gw5','CQYN MEDITOPE - CETUXIMAB FAB','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,4,1),(4379,'4gw8','HUMAN PROTO-ONCOGENE SERINE THREONINE KINASE (PIM1) IN COMPLEX WITH A CONSENSUS PEPTIDE AND LEUCETTINE L41','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(4380,'4gxb','STRUCTURE OF THE SNX17 ATYPICAL FERM DOMAIN BOUND TO THE NPXY MOTIF OF P-SELECTIN','X-RAY DIFFRACTION',1.800,'PROTEIN TRANSPORT/CELL ADHESION',1,1,1),(4381,'4gxl','THE CRYSTAL STRUCTURE OF GALECTIN-8 C-CRD IN COMPLEX WITH NDP52','X-RAY DIFFRACTION',2.020,'PROTEIN BINDING',1,1,1),(4382,'4gye','MDR 769 HIV-1 PROTEASE IN COMPLEX WITH REDUCED P1F','X-RAY DIFFRACTION',2.270,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(4383,'4gyo','CRYSTAL STRUCTURE OF RAP PROTEIN COMPLEXED WITH COMPETENCE AND SPORULATION FACTOR','X-RAY DIFFRACTION',2.160,'HYDROLASE',2,2,1),(4384,'4gyw','CRYSTAL STRUCTURE OF HUMAN O-GLCNAC TRANSFERASE IN COMPLEX WITH UDP AND A GLYCOPEPTIDE','X-RAY DIFFRACTION',1.700,'TRANSFERASE/PEPTIDE',2,2,1),(4385,'4gyy','CRYSTAL STRUCTURE OF HUMAN O-GLCNAC TRANSFERASE WITH UDP-5SGLCNAC AND A PEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.850,'TRANSFERASE/PEPTIDE',2,2,1),(4386,'4gz3','CRYSTAL STRUCTURE OF HUMAN O-GLCNAC TRANSFERASE WITH UDP AND A THIOGLYCOPEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSFERASE/PEPTIDE',2,2,1),(4387,'4gzf','MULTI-DRUG RESISTANT HIV-1 PROTEASE 769 VARIANT WITH REDUCED LRF PEPTIDE','X-RAY DIFFRACTION',2.050,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(4388,'4h0h','CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING 2D10 SCFV WITH PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(4389,'4h25','TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHTS TO NICKEL CONTACT ALLERGY','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,4,1),(4390,'4h26','TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURE INSIGHT TO NICKEL CONTACT ALLERGY','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(4391,'4h2s','CRYSTAL STRUCTURE OF BRADYRHIZOBIUM JAPONICUM GLYCINE:[CARRIER PROTEIN] LIGASE COMPLEXED WITH COGNATE CARRIER PROTEIN AND AMP','X-RAY DIFFRACTION',2.150,'LIGASE',1,1,1),(4392,'4h2t','CRYSTAL STRUCTURE OF BRADYRHIZOBIUM JAPONICUM GLYCINE:[CARRIER PROTEIN] LIGASE COMPLEXED WITH COGNATE CARRIER PROTEIN AND AN ANALOGUE OF GLYCYL ADENYLATE','X-RAY DIFFRACTION',2.440,'LIGASE',1,1,1),(4393,'4h2u','CRYSTAL STRUCTURE OF BRADYRHIZOBIUM JAPONICUM GLYCINE:[CARRIER PROTEIN] LIGASE COMPLEXED WITH COGNATE CARRIER PROTEIN AND ATP','X-RAY DIFFRACTION',2.100,'LIGASE',1,1,1),(4394,'4h2v','CRYSTAL STRUCTURE OF BRADYRHIZOBIUM JAPONICUM GLYCINE:[CARRIER PROTEIN] LIGASE COMPLEXED WITH GLYCYLATED CARRIER PROTEIN','X-RAY DIFFRACTION',2.000,'LIGASE',1,1,1),(4395,'4h39','CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH JIP1 PEPTIDE','X-RAY DIFFRACTION',1.990,'TRANSFERASE',1,1,1),(4396,'4h3b','CRYSTAL STRUCTURE OF JNK3 IN COMPLEX WITH SAB PEPTIDE','X-RAY DIFFRACTION',2.080,'TRANSFERASE',2,2,1),(4397,'4h3h','CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF HUMAN SYMPLEKIN NTD, HUMAN SSU72 AND A RNA POYMERASE II CTD PEPTIDE PHOSPHORYLATED AT SER-7','X-RAY DIFFRACTION',2.200,'HYDROLASE',1,1,1),(4398,'4h3k','CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF HUMAN SYMPLEKIN NTD, HUMAN SSU72 AND A RNA POLYMERASE II CTD PEPTIDE PHOSPHORYLATED AT SER-2, SER-5 AND SER-7','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(4399,'4h3p','CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSFERASE',2,2,1),(4400,'4h3q','CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A MAPK DOCKING PEPTIDE','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(4401,'4h4f','CRYSTAL STRUCTURE OF HUMAN CHYMOTRYPSIN C (CTRC) BOUND TO INHIBITOR EGLIN C FROM HIRUDO MEDICINALIS','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4402,'4h6s','CRYSTAL STRUCTURE OF THROMBIN MUTANT E14EA/D14LA/E18A/S195A','X-RAY DIFFRACTION',2.190,'HYDROLASE/PEPTIDE',1,1,1),(4403,'4h75','CRYSTAL STRUCTURE OF HUMAN SPINDLIN1 IN COMPLEX WITH A HISTONE H3K4(ME3) PEPTIDE','X-RAY DIFFRACTION',2.100,'GENE REGULATION',1,1,1),(4404,'4hd8','CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH FLUOR-DE-LYS PEPTIDE AND PICEATANNOL','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4405,'4hdq','CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF KRIT1 BOUND TO BOTH THE RAP1 GTPASE AND THE HEART OF GLASS (HEG1) CYTOPLASMIC TAIL','X-RAY DIFFRACTION',1.950,'SIGNALING PROTEIN',1,1,1),(4406,'4hee','CRYSTAL STRUCTURE OF PPARGAMMA IN COMPLEX WITH COMPOUND 13','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',1,1,1),(4407,'4hfp','STRUCTURE OF THROMBIN MUTANT S195A BOUND TO THE ACTIVE SITE INHIBITOR ARGATROBAN','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4408,'4hgc','CRYSTAL STRUCTURE OF BOVINE TRYPSIN COMPLEXED WITH SFTI-1 ANALOG CONTAINING A PEPTOID RESIDUE AT POSITION P1','X-RAY DIFFRACTION',1.290,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4409,'4hh6','PEPTIDE FROM EAEC T6SS SCI1 SCII PROTEIN','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING',1,1,1),(4410,'4hha','ANTI-HUMAN CYTOMEGALOVIRUS (HCMV) FAB KE5 WITH EPITOPE PEPTIDE AD-2S1','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,2,1),(4411,'4hix','CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE','X-RAY DIFFRACTION',2.200,'PROTEIN FIBRIL/IMMUNE SYSTEM',1,2,1),(4412,'4hkc','14-3-3-ZETA IN COMPLEX WITH S1011 PHOSPHORYLATED INTEGRIN ALPHA-4 PEPTIDE','X-RAY DIFFRACTION',2.200,'SIGNALING PROTEIN/PEPTIDE',1,1,1),(4413,'4hki','TANKYRASE 2 IN COMPLEX WITH FLAVONE','X-RAY DIFFRACTION',2.150,'TRANSFERASE',2,2,1),(4414,'4hkk','COMPLEX STRUCTURE OF HUMAN TANKYRASE 2 WITH APIGENIN','X-RAY DIFFRACTION',1.950,'TRANSFERASE',2,2,1),(4415,'4hkn','COMPLEX STRUCTURE OF HUMAN TANKYRASE 2 WITH LUTEOLIN','X-RAY DIFFRACTION',2.050,'TRANSFERASE',1,1,1),(4416,'4hl5','COMPLEX STRUCTURE OF HUMAN TANKYRASE 2 WITH 7-HYDROXY -4\'- METHOXYFLAVONE','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(4417,'4hlf','CRYSTAL STRUCTURE OF TANKYRASE 2 IN COMPLEX WITH 7,3\',4\'- TRIHYDROXYFLAVONE','X-RAY DIFFRACTION',2.150,'TRANSFERASE',2,2,1),(4418,'4hlg','CRYSTAL STRUCTURE OF TANKYRASE 2 IN COMPLEX WITH 3\'-HYDROXYFLAVONE','X-RAY DIFFRACTION',2.000,'TRANSFERASE',2,2,1),(4419,'4hlh','CRYSTAL STRUCTURE OF TANKYRASE 2 IN COMPLEX WITH 4\'-FLUOROFLAVONE','X-RAY DIFFRACTION',1.750,'TRANSFERASE',2,2,1),(4420,'4hlk','CRYSTAL STRUCTURE OF TANKYRASE 2 IN COMPLEX WITH 4\'-METHYLFLAVONE','X-RAY DIFFRACTION',2.000,'TRANSFERASE',2,2,1),(4421,'4hlm','CRYSTAL STRUCTURE OF TANKYRASE 2 IN COMPLEX WITH 3\',4\'- DIHYDROXYFLAVONE','X-RAY DIFFRACTION',1.950,'TRANSFERASE',2,2,1),(4422,'4hmh','CRYSTAL STRUCTURE OF TANKYRASE 2 IN COMPLEX WITH 7,3-DIHYDROXYFLAVONE','X-RAY DIFFRACTION',2.300,'TRANSFERASE',1,1,1),(4423,'4hom','CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N COMPLEXED WITH SUBSTANCE P','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(4424,'4hon','CRYSTAL STRUCTURE OF HUMAN JMJD2D/KDM4D IN COMPLEX WITH AN H3K9ME3 PEPTIDE AND 2-OXOGLUTARATE','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE',2,2,1),(4425,'4hpo','CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58 IN COMPLEX WITH V2 PEPTIDE','X-RAY DIFFRACTION',1.690,'IMMUNE SYSTEM/VIRAL PROTEIN',1,2,1),(4426,'4hpt','CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE DISPLAYING COMPLETE PHOSPHORYL TRANSFER OF AMP-PNP ONTO A SUBSTRATE PEPTIDE','X-RAY DIFFRACTION',2.150,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4427,'4hpu','CRYSTAL STRUCTURE OF THE CATALYTIC SUBUNIT OF CAMP-DEPENDENT PROTEIN KINASE DISPLAYING PARTIAL PHOSPHORYL TRANSFER OF AMP-PNP ONTO A SUBSTRATE PEPTIDE','X-RAY DIFFRACTION',1.550,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4428,'4hpy','CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH59 IN COMPLEX WITH V2 PEPTIDE','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM/VIRAL PROTEIN',1,2,1),(4429,'4hr6','CRYSTAL STRUCTURE OF SNAKE GOURD (TRICHOSANTHES ANGUINA) SEED LECTIN, A THREE CHAIN HOMOLOGUE OF TYPE II RIPS','X-RAY DIFFRACTION',2.250,'SUGAR BINDING PROTEIN',1,2,1),(4430,'4hrg','CRYSTAL STRUCTURE OF P11-ANNEXIN A2(N-TERMINAL) FUSION PROTEIN IN COMPLEX WITH AHNAK1 PEPTIDE','X-RAY DIFFRACTION',2.000,'CALCIUM-BINDING PROTEIN',2,2,1),(4431,'4hs3','CRYSTAL STRUCTURE OF H-2KB WITH A DISULFIDE STABILIZED F POCKET IN COMPLEX WITH THE LCMV DERIVED PEPTIDE GP34','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(4432,'4hs6','HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362','X-RAY DIFFRACTION',1.530,'IMMUNE SYSTEM',2,4,1),(4433,'4hsu','CRYSTAL STRUCTURE OF LSD2-NPAC WITH H3(1-26)IN SPACE GROUP P21','X-RAY DIFFRACTION',1.990,'OXIDOREDUCTASE',2,1,1),(4434,'4ht6','THE STRUCTURE OF A YEAST DYNEIN DYN2-PAC11 COMPLEX AND EFFECT ON SINGLE MOLECULE DYNEIN MOTOR ACTIVITY','X-RAY DIFFRACTION',1.900,'MOTOR PROTEIN',3,3,1),(4435,'4htc','THE REFINED STRUCTURE OF THE HIRUDIN-THROMBIN COMPLEX','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4436,'4htp','CRYSTAL STRUCTURE OF THE DBD DOMAIN OF HUMAN DNA LIGASE IV BOUND TO ARTEMIS PEPTIDE','X-RAY DIFFRACTION',2.250,'LIGASE/HYDROLASE',2,2,1),(4437,'4huu','CRYSTAL STRUCTURE OF H2DB-NPM6I','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(4438,'4huv','CRYSTAL STRUCTURE OF H2DB-NPM6W','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,2,1),(4439,'4hux','CRYSTAL STRUCTURE OF H2DB-H155A-NP','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(4440,'4hv8','CRYSTAL STRUCTURE OF H2DB-H155A-NPM6I','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(4441,'4hva','MECHANISTIC AND STRUCTURAL UNDERSTANDING OF UNCOMPETITIVE INHIBITORS OF CASPASE-6','X-RAY DIFFRACTION',2.070,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4442,'4hvw','CRYSTAL STRUCTURE OF THE T98E C-SRC-SH3 DOMAIN MUTANT IN COMPLEX WITH THE HIGH AFFINITY PEPTIDE VSL12','X-RAY DIFFRACTION',0.980,'SIGNALING PROTEIN/PEPTIDE',1,1,1),(4443,'4hw4','DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN','X-RAY DIFFRACTION',1.530,'APOPTOSIS',2,2,1),(4444,'4hwz','STRUCTURE OF HLA-A68 COMPLEXED WITH AN HIV DERIVED PEPTIDE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(4445,'4hx1','STRUCTURE OF HLA-A68 COMPLEXED WITH A TUMOR ANTIGEN DERIVED PEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(4446,'4hxj','CRYSTAL STRUCTURE OF SH3:RGT COMPLEX','X-RAY DIFFRACTION',2.000,'BLOOD CLOTTING, SIGNALING PROTEIN',1,1,1),(4447,'4hy2','CRYSTAL STRUCTURE OF PLK1 POLO-BOX DOMAIN IN COMPLEX WITH PL-42','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4448,'4hy7','STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF A CYTOSOLIC WHEAT CYCLOPHILIN TACYPA-1','X-RAY DIFFRACTION',1.200,'ISOMERASE/INHIBITOR',1,1,1),(4449,'4hy9','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH PYRRHOCORICIN_LYZZ (RESIDUES 1 TO 11)','X-RAY DIFFRACTION',1.550,'CHAPERONE, PEPTIDE BINDING PROTEIN',2,2,1),(4450,'4hyb','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH PYRRHOCORICIN_LYZI (RESIDUES 1 TO 10)','X-RAY DIFFRACTION',1.700,'CHAPERONE, PEPTIDE BINDING PROTEIN',2,2,1),(4451,'4hys','CRYSTAL STRUCTURE OF JNK1 IN COMPLEX WITH JIP1 PEPTIDE AND 4-(4- INDAZOL-1-YL-PYRIMIDIN-2-YLAMINO)-CYCLOHEXAN','X-RAY DIFFRACTION',2.420,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4452,'4hyu','CRYSTAL STRUCTURE OF JNK1 IN COMPLEX WITH JIP1 PEPTIDE AND 4-{4-[4-(3- METHANESULFONYL-PROPOXY)-INDAZOL-1-YL]-PYRIMIDIN-2-YLAMINO}- CYCLOHEXAN','X-RAY DIFFRACTION',2.150,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4453,'4i1p','HUMAN MALT1 (CASPASE-IG3) IN COMPLEX WITH ACTIVITY BASED-PROBE','X-RAY DIFFRACTION',2.400,'HYDROLASE',2,2,1),(4454,'4i31','CRYSTAL STRUCTURE OF HCV NS3/NS4A PROTEASE COMPLEXED WITH COMPOUND 4','X-RAY DIFFRACTION',1.930,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4455,'4i32','CRYSTAL STRUCTURE OF HCV NS3/4A D168V PROTEASE COMPLEXED WITH COMPOUND 4','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4456,'4i33','CRYSTAL STRUCTURE OF HCV NS3/4A R155K PROTEASE COMPLEXED WITH COMPOUND 4','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4457,'4i4w','PEPTIDE LENGTH DETERMINES THE OUTCOME OF T CELL RECEPTOR/PEPTIDE-MHCI ENGAGEMENT','X-RAY DIFFRACTION',1.770,'IMMUNE SYSTEM',1,1,1),(4458,'4i51','METHYLTRANSFERASE DOMAIN OF HUMAN EUCHROMATIC HISTONE METHYLTRANSFERASE 1, MUTANT Y1211A','X-RAY DIFFRACTION',1.900,'TRANSFERASE/PEPTIDE',2,2,1),(4459,'4i5b','STRUCTURE OF HUMAN MHC CLASS II PROTEIN HLA-DR1 CARRYING AN INFLUENZA HEMAGGLUTININ PEPTIDE PARTIALLY FILLING THE BINDING GROOVE','X-RAY DIFFRACTION',2.120,'IMMUNE SYSTEM',2,4,1),(4460,'4i5l','STRUCTURAL MECHANISM OF TRIMERIC PP2A HOLOENZYME INVOLVING PR70: INSIGHT FOR CDC6 DEPHOSPHORYLATION','X-RAY DIFFRACTION',2.430,'HYDROLASE/TOXIN',2,2,1),(4461,'4i7d','SIAH1 BOUND TO SYNTHETIC PEPTIDE (ACE)KLRPVAMVRP(PRK)VR','X-RAY DIFFRACTION',2.400,'LIGASE/LIGASE INHIBITOR',2,2,1),(4462,'4i7y','CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH A 27-MER APTAMER BOUND TO EXOSITE II','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR/DNA',1,1,1),(4463,'4ia1','DIASTEREOTOPIC AND DEUTERIUM EFFECTS IN GEMINI','X-RAY DIFFRACTION',2.440,'TRANSCRIPTION/TRANSCRIPTION ACTIVATOR',1,1,1),(4464,'4iac','X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH MG2+ CONCENTRATION, AMP-PCP AND PSEUDO-SUBSTRATE PEPTIDE SP20','X-RAY DIFFRACTION',2.150,'TRANSFERASE/PEPTIDE',1,1,1),(4465,'4iad','LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH MG2+ CONCENTRATION, ADP AND PHOSPHORYLATED PEPTIDE PSP20','X-RAY DIFFRACTION',1.900,'TRANSFERASE/PEPTIDE',1,1,1),(4466,'4iaf','ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH MG2+ CONCENTRATION, ADP AND PHOSPHORYLATED PEPTIDE PSP20','X-RAY DIFFRACTION',2.200,'TRANSFERASE/PEPTIDE',1,1,1),(4467,'4iai','X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH CA2+ CONCENTRATION, ADP AND PHOSPHORYLATED PEPTIDE PSP20','X-RAY DIFFRACTION',1.550,'TRANSFERASE/PEPTIDE',1,1,1),(4468,'4iak','LOW TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH SR2+ CONCENTRATION, ADP AND PHOSPHORYLATED PEPTIDE PSP20','X-RAY DIFFRACTION',1.600,'TRANSFERASE/PEPTIDE',1,1,1),(4469,'4iay','ROOM TEMPERATURE X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH SR2+ CONCENTRATION, ADP AND PHOSPHORYLATED PEPTIDE PSP20','X-RAY DIFFRACTION',2.000,'TRANSFERASE/PEPTIDE',1,1,1),(4470,'4iaz','STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH BA2+ CONCENTRATION, ADP AND PHOSPHORYLATED PEPTIDE PSP20','X-RAY DIFFRACTION',1.850,'TRANSFERASE/PEPTIDE',1,1,1),(4471,'4ib0','X-RAY STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH NA+ CONCENTRATION, ADP AND PHOSPHORYLATED PEPTIDE PSP20','X-RAY DIFFRACTION',1.870,'TRANSFERASE/PEPTIDE',1,1,1),(4472,'4ib1','STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH HIGH K+ CONCENTRATION, ADP AND PHOSPHORYLATED PEPTIDE PSP20','X-RAY DIFFRACTION',1.630,'TRANSFERASE/PEPTIDE',1,1,1),(4473,'4ib3','STRUCTURE OF CAMP DEPENDENT PROTEIN KINASE A IN COMPLEX WITH ADP, PHOSPHORYLATED PEPTIDE PSP20, AND NO METAL','X-RAY DIFFRACTION',2.200,'TRANSFERASE/PEPTIDE',1,1,1),(4474,'4ib5','STRUCTURE OF HUMAN PROTEIN KINASE CK2 CATALYTIC SUBUNIT IN COMPLEX WITH A CK2BETA-COMPETITIVE CYCLIC PEPTIDE','X-RAY DIFFRACTION',2.200,'TRANSFERASE',4,3,1),(4475,'4icz','HER2 1221/1222 PHOSPHORYLATION REGULATED BY PTPN9','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(4476,'4ie9','BOVINE PKA C-ALPHA IN COMPLEX WITH 3-PYRIDYLMETHYL-5-METHYL-1H- PYRAZOLE-3-CARBOXYLATE','X-RAY DIFFRACTION',1.920,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4477,'4iea','14-3-3 ISOFORM SIGMA IN COMPLEX WITH A PHOSPHORYLATED C-RAF PEPTIDE','X-RAY DIFFRACTION',1.700,'PEPTIDE BINDING PROTEIN',1,1,1),(4478,'4if6','STRUCTURE OF NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-1 (CLOSED STATE, 2.25 A)','X-RAY DIFFRACTION',2.250,'HYDROLASE',1,1,1),(4479,'4ifi','STRUCTURE OF HUMAN BRCA1 BRCT IN COMPLEX WITH BAAT PEPTIDE','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(4480,'4ifl','CRYSTAL STRUCTURES OF APO KEAP1, KEAP1-PEPTIDE, AND KEAP1-COMPOUND COMPLEXES','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',1,1,1),(4481,'4iga','THE CRYSTAL STRUCTURE OF AN ACTIVATED THERMOTOGA MARITIMA CHEY WITH N- TERMINAL REGION OF FLIM','X-RAY DIFFRACTION',1.730,'SIGNALING PROTEIN/MOTOR PROTEIN',1,1,1),(4482,'4igk','STRUCTURE OF HUMAN BRCA1 BRCT IN COMPLEX WITH ATRIP PEPTIDE','X-RAY DIFFRACTION',1.750,'TRANSCRIPTION',2,2,1),(4483,'4igq','HISTONE H3 LYSINE 4 DEMETHYLATING RICE JMJ703 IN COMPLEX WITH METHYLATED H3K4 SUBSTRATE','X-RAY DIFFRACTION',2.350,'STRUCTURAL PROTEIN/TRANSCRIPTION',1,1,1),(4484,'4ihh','CHASING ACYL CARRIER PROTEIN THROUGH A CATALYTIC CYCLE OF LIPID A PRODUCTION','X-RAY DIFFRACTION',2.130,'TRANSFERASE/LIPID BINDING PROTEIN',2,3,1),(4485,'4ihl','HUMAN 14-3-3 ISOFORM ZETA IN COMPLEX WITH A DIPHOYPHORYLATED C-RAF PEPTIDE AND COTYLENIN A','X-RAY DIFFRACTION',2.200,'PEPTIDE BINDING PROTEIN',1,2,1),(4486,'4ii9','CRYSTAL STRUCTURE OF WEISSELLA VIRIDESCENS FEMXVV NON-RIBOSOMAL AMINO ACID TRANSFERASE IN COMPLEX WITH A PEPTIDYL-RNA CONJUGATE','X-RAY DIFFRACTION',1.660,'TRANSFERASE/PEPTIDE/RNA',1,1,1),(4487,'4iim','CRYSTAL STRUCTURE OF THE SECOND SH3 DOMAIN OF ITSN1 BOUND WITH A SYNTHETIC PEPTIDE','X-RAY DIFFRACTION',1.800,'ENDOCYTOSIS',2,1,1),(4488,'4iio','CRYSTAL STRUCTURE OF THE SECOND SH3 DOMAIN OF ITSN2 BOUND WITH A SYNTHETIC PEPTIDE','X-RAY DIFFRACTION',1.700,'ENDOCYTOSIS',1,1,1),(4489,'4ikn','CRYSTAL STRUCTURE OF ADAPTOR PROTEIN COMPLEX 3 (AP-3) MU3A SUBUNIT C- TERMINAL DOMAIN, IN COMPLEX WITH A SORTING PEPTIDE FROM TGN38','X-RAY DIFFRACTION',1.850,'PROTEIN TRANSPORT',1,1,1),(4490,'4il6','STRUCTURE OF SR-SUBSTITUTED PHOTOSYSTEM II','X-RAY DIFFRACTION',2.100,'ELECTRON TRANSPORT',19,16,1),(4491,'4imi','NOVEL MODIFICATIONS ON C-TERMINAL DOMAIN OF RNA POLYMERASE II CAN FINE- TUNE THE PHOSPHATASE ACTIVITY OF SSU72.','X-RAY DIFFRACTION',2.350,'HYDROLASE',1,1,1),(4492,'4imq','STRUCTURAL BASIS OF SUBSTRATE SPECIFICITY AND PROTEASE INHIBITION IN NORWALK VIRUS','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4493,'4imz','STRUCTURAL BASIS OF SUBSTRATE SPECIFICITY AND PROTEASE INHIBITION IN NORWALK VIRUS','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4494,'4in9','STRUCTURE OF KARILYSIN MMP-LIKE CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORY TETRAPEPTIDE SWFP','X-RAY DIFFRACTION',1.550,'HYDROLASE',1,1,1),(4495,'4inh','STRUCTURAL BASIS OF SUBSTRATE SPECIFICITY AND PROTEASE INHIBITION IN NORWALK VIRUS','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',8,8,1),(4496,'4ioi','MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,3,1),(4497,'4ipz','SMBZ BOUND TO CYCLOPHILIN A','X-RAY DIFFRACTION',1.670,'ISOMERASE/ISOMERASE INHIBITOR',1,1,1),(4498,'4irv','STRUCTURE OF THE HELICOBACTER PYLORI CAGA ONCOGENE BOUND TO THE HUMAN TUMOR SUPPRESSOR APOPTOSIS-STIMULATING PROTEIN OF P53-2','X-RAY DIFFRACTION',2.040,'PROTEIN BINDING',4,4,1),(4499,'4is6','CRYSTAL STRUCTURE OF HLA-DR4 BOUND TO GP100 PEPTIDE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(4500,'4itz','CRYSTAL STRUCTURE OF THE FK506 BINDING DOMAIN OF PLASMODIUM VIVAX FKBP35 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.650,'ISOMERASE/SUBSTRATE',1,2,1),(4501,'4iu7','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 2B','X-RAY DIFFRACTION',2.290,'TRANSCRIPTION',2,2,1),(4502,'4iui','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY DERIVATIVE, 4A','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(4503,'4iur','CRYSTAL STRUCTURE OF SHH1 SAWADEE DOMAIN IN COMPLEX WITH H3K9ME3 PEPTIDE','X-RAY DIFFRACTION',2.500,'GENE REGULATION',1,1,1),(4504,'4iv1','CRYSTAL STRUCTURE OF RECOMBINANT FOOT-AND-MOUTH-DISEASE VIRUS A22 EMPTY CAPSID','X-RAY DIFFRACTION',2.100,'VIRUS',1,3,1),(4505,'4iv2','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY-DERIVATIVE, 5A','X-RAY DIFFRACTION',2.140,'TRANSCRIPTION',2,2,1),(4506,'4iv4','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 5B','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(4507,'4ivw','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 6B','X-RAY DIFFRACTION',2.060,'TRANSCRIPTION',2,2,1),(4508,'4ivy','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY-DERIVATIVE, 7A','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',2,2,1),(4509,'4iw6','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH CONSTRAINED WAY-DERIVATIVE, 7B','X-RAY DIFFRACTION',1.980,'TRANSCRIPTION',2,2,1),(4510,'4iw8','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH DYNAMIC WAY-DERIVATIVE, 9A','X-RAY DIFFRACTION',2.040,'TRANSCRIPTION',2,2,1),(4511,'4iwc','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DYNAMIC THIOPHENE-DERIVATIVE','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(4512,'4iwf','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DYNAMIC OXIME-DERIVATIVE','X-RAY DIFFRACTION',1.930,'TRANSCRIPTION',2,2,1),(4513,'4izy','CRYSTAL STRUCTURE OF JNK1 IN COMPLEX WITH JIP1 PEPTIDE AND 4-{4-[4-(4- METHANESULFONYL-PIPERIDIN-1-YL)-INDOL-1-YL]-PYRIMIDIN-2-YLAMINO}- CYCLOHEXAN','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4514,'4j09','CRYSTAL STRUCTURE OF LPXA BOUND TO RJPXD33','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(4515,'4j1v','FUNCTIONAL AND STRUCTURAL STUDIES OF MOBKL1B, A SALVADOR/WARTS/HIPPO TUMOR SUPPRESSOR PATHWAY, IN HCV REPLICATION','X-RAY DIFFRACTION',1.950,'PEPTIDE BINDING PROTEIN/VIRAL PROTEIN',4,2,1),(4516,'4j24','ESTROGEN RECEPTOR IN COMPLEX WITH PROLINE-FLANKED LXXLL PEPTIDES','X-RAY DIFFRACTION',2.100,'HORMONE RECEPTOR/PEPTIDE',4,4,1),(4517,'4j26','ESTROGEN RECEPTOR IN COMPLEX WITH PROLINE-FLANKED LXXLL PEPTIDES','X-RAY DIFFRACTION',2.300,'HORMONE RECEPTOR/PEPTIDE',2,2,1),(4518,'4j2c','GARP-SNARE INTERACTION','X-RAY DIFFRACTION',1.800,'PROTEIN TRANSPORT',2,2,1),(4519,'4j2j','CRYSTAL STRUCTURE OF AXH DOMAIN COMPLEX WITH CAPICUA','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION REGULATOR',3,3,1),(4520,'4j44','CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH AIAV BOUND','X-RAY DIFFRACTION',1.300,'APOPTOSIS',1,1,1),(4521,'4j45','CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH ATAA BOUND','X-RAY DIFFRACTION',1.480,'APOPTOSIS',1,1,1),(4522,'4j46','CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH AVPI BOUND','X-RAY DIFFRACTION',1.420,'APOPTOSIS',1,1,1),(4523,'4j47','CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH SVPI BOUND','X-RAY DIFFRACTION',1.350,'APOPTOSIS',1,1,1),(4524,'4j48','CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN WITH AMRV BOUND','X-RAY DIFFRACTION',2.100,'APOPTOSIS',1,1,1),(4525,'4j73','CRYSTAL STRUCTURE OF BETA\'-COP/P25 COMPLEX','X-RAY DIFFRACTION',1.440,'PROTEIN TRANSPORT',1,1,1),(4526,'4j77','CRYSTAL STRUCTURE OF BETA\'-COP/HWBP1 COMPLEX','X-RAY DIFFRACTION',1.760,'PROTEIN TRANSPORT',2,2,1),(4527,'4j78','CRYSTAL STRUCTURE OF BETA\'-COP/EMP47P COMPLEX','X-RAY DIFFRACTION',1.480,'PROTEIN TRANSPORT',1,1,1),(4528,'4j79','CRYSTAL STRUCTURE OF BETA\'-COP/PEDVSPIKE COMPLEX','X-RAY DIFFRACTION',1.560,'PROTEIN TRANSPORT',1,1,1),(4529,'4j7b','CRYSTAL STRUCTURE OF POLO-LIKE KINASE 1','X-RAY DIFFRACTION',2.300,'TRANSFERASE',2,2,1),(4530,'4j7f','SET7/9Y335PAF IN COMPLEX WITH TAF10 PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.590,'TRANSFERASE/PEPTIDE',1,1,1),(4531,'4j81','CRYSTAL STRUCTURE OF BETA\'-COP/INSIG-1 COMPLEX','X-RAY DIFFRACTION',1.750,'PROTEIN TRANSPORT',2,2,1),(4532,'4j82','CRYSTAL STRUCTURE OF BETA\'-COP/INSIG-2 COMPLEX','X-RAY DIFFRACTION',1.460,'PROTEIN TRANSPORT',2,2,1),(4533,'4j83','SET7/9 IN COMPLEX WITH TAF10K189A PEPTIDE AND ADOMET','X-RAY DIFFRACTION',1.700,'TRANSFERASE/PEPTIDE',1,1,1),(4534,'4j84','CRYSTAL STRUCTURE OF BETA\'-COP/SCYL1 COMPLEX','X-RAY DIFFRACTION',1.470,'PROTEIN TRANSPORT',2,2,1),(4535,'4j86','CRYSTAL STRUCTURE OF BETA\'-COP/YWBP1 COMPLEX','X-RAY DIFFRACTION',1.480,'PROTEIN TRANSPORT',2,2,1),(4536,'4j8b','CRYSTAL STRUCTURE OF ALPHA-COP/EMP47P COMPLEX','X-RAY DIFFRACTION',1.880,'PROTEIN TRANSPORT',1,1,1),(4537,'4j8g','CRYSTAL STRUCTURE OF ALPHA-COP/E19 COMPLEX','X-RAY DIFFRACTION',1.900,'PROTEIN TRANSPORT',2,2,1),(4538,'4j8o','SET7/9 IN COMPLEX WITH TAF10K189A PEPTIDE AND ADOHCY','X-RAY DIFFRACTION',1.630,'TRANSFERASE/PEPTIDE',1,1,1),(4539,'4j8r','STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,4,1),(4540,'4j8s','CRYSTAL STRUCTURE OF HUMAN CNOT1 MIF4G DOMAIN IN COMPLEX WITH A TTP PEPTIDE','X-RAY DIFFRACTION',1.550,'PROTEIN BINDING',1,1,1),(4541,'4j9c','CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN H59Q-N96T MUTANT COMPLEXED WITH THE DESIGNED HIGH-AFFINITY PEPTIDE LIGAND P17','X-RAY DIFFRACTION',1.050,'TRANSFERASE/UNKNOWN FUNCTION',1,1,1),(4542,'4j9f','CRYSTAL STRUCTURE OF THE ABL-SH3 DOMAIN COMPLEXED WITH THE HIGH AFFINITY PEPTIDE P0','X-RAY DIFFRACTION',1.090,'TRANSFERASE/UNKNOWN FUNCTION',3,2,1),(4543,'4jaa','FACTOR INHIBITING HIF-1 ALPHA IN COMPLEX WITH CONSENSUS ANKYRIN REPEAT DOMAIN-(D)LEU PEPTIDE','X-RAY DIFFRACTION',2.390,'OXIDOREDUCTASE/PEPTIDE',1,1,1),(4544,'4jbn','CRYSTAL STRUCTURE OF O-ACETYL SERINE SULFHYDRYLASE FROM ENTAMOEBA HISTOLYTICA IN COMPLEX WITH SERINE ACETYL TRANSFERASE DERIVED TETRAPEPTIDE, SPSI','X-RAY DIFFRACTION',1.870,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4545,'4jc3','14-3-3 PROTEIN INTERACTION WITH ESTROGEN RECEPTOR ALPHA PROVIDES A NOVEL DRUG TARGET INTERFACE','X-RAY DIFFRACTION',2.050,'SIGNALING PROTEIN/PEPTIDE',1,1,1),(4546,'4jdd','14-3-3 PROTEIN INTERACTION WITH ESTROGEN RECEPTOR ALPHA PROVIDES A NOVEL DRUG TARGET INTERFACE','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN/PEPTIDE',1,1,1),(4547,'4jdh','CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE','X-RAY DIFFRACTION',2.000,'TRANSFERASE/PEPTIDE',1,1,1),(4548,'4jdi','CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.850,'TRANSFERASE/PEPTIDE',1,1,1),(4549,'4jdj','CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE T PEPTIDE SUBSTRATE','X-RAY DIFFRACTION',2.300,'TRANSFERASE/PEPTIDE',1,1,1),(4550,'4jdk','CRYSTAL STRUCTURE OF SERINE/THREONINE-PROTEIN KINASE PAK 4 F461V MUTANT IN COMPLEX WITH PAKTIDE S PEPTIDE SUBSTRATE','X-RAY DIFFRACTION',2.400,'TRANSFERASE/PEPTIDE',1,1,1),(4551,'4je8','CRYSTAL STRUCTURE OF A HUMAN-LIKE MITOCHONDRIAL PEPTIDE DEFORMYLASE IN COMPLEX WITH MET-ALA-SER','X-RAY DIFFRACTION',2.400,'HYDROLASE/PEPTIDE',2,2,1),(4552,'4jfd','PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR','X-RAY DIFFRACTION',2.460,'IMMUNE SYSTEM',1,3,1),(4553,'4jff','PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR','X-RAY DIFFRACTION',2.430,'IMMUNE SYSTEM',1,3,1),(4554,'4jfo','A2 HLA COMPLEX WITH E1A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE','X-RAY DIFFRACTION',2.110,'IMMUNE SYSTEM',2,2,1),(4555,'4jfp','A2 HLA COMPLEX WITH G4A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE','X-RAY DIFFRACTION',1.910,'IMMUNE SYSTEM',2,2,1),(4556,'4jfq','A2 HLA COMPLEX WITH L8A HETEROCLITIC VARIANT OF MELANOMA PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(4557,'4jfx','STRUCTURE OF PHOSPHOTYROSINE (PTYR) SCAFFOLD BOUND TO PTYR PEPTIDE','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,2,1),(4558,'4jfz','STRUCTURE OF PHOSPHOSERINE (PSAB) SCAFFOLD BOUND TO PSER PEPTIDE','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',1,2,1),(4559,'4jg0','STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PSER PEPTIDE','X-RAY DIFFRACTION',1.810,'IMMUNE SYSTEM',1,2,1),(4560,'4jg1','STRUCTURE OF PHOSPHOSERINE/THREONINE (PSTAB) SCAFFOLD BOUND TO PTHR PEPTIDE','X-RAY DIFFRACTION',1.550,'IMMUNE SYSTEM',1,2,1),(4561,'4jif','CO-CRYSTAL STRUCTURE OF ICAP1 PTB DOMAIN IN COMPLEX WITH A KRIT1 PEPTIDE','X-RAY DIFFRACTION',1.700,'SIGNALING PROTEIN',1,1,1),(4562,'4jij','CRYSTAL STRUCTURE OF AN INACTIVE MUTANT OF MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A FLUOROGENIC SYNTHETIC PEPTIDIC SUBSTRATE','X-RAY DIFFRACTION',1.700,'HYDROLASE/SUBSTRATE',2,2,1),(4563,'4jiz','HUMAN MOB1-PHOSPHOPEPTIDE COMPLEX','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN',1,1,1),(4564,'4jj7','CASPASE-3 SPECIFIC UNNATURAL AMINO ACID-BASED PEPTIDES','X-RAY DIFFRACTION',1.180,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4565,'4jje','CASPASE-3 SPECIFIC UNNATURAL AMINO ACID PEPTIDES','X-RAY DIFFRACTION',1.480,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4566,'4jjm','STRUCTURE OF A CYCLOPHILIN FROM CITRUS SINENSIS (CSCYP) IN COMPLEX WITH CYCLOSPORIN A','X-RAY DIFFRACTION',2.090,'ISOMERASE/IMMUNOSUPPRESSANT',2,2,1),(4567,'4jjq','CRYSTAL STRUCTURE OF USP7-NTD WITH AN E2 ENZYME','X-RAY DIFFRACTION',1.950,'HYDROLASE',1,1,1),(4568,'4jk5','HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) IN COMPLEX WITH A BICYCLIC PEPTIDE INHIBITOR (UK18-D-SER)','X-RAY DIFFRACTION',1.550,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4569,'4jk6','HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) IN COMPLEX WITH A BICYCLIC PEPTIDE INHIBITOR (UK18-D-ABA)','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4570,'4jl0','CRYSTAL STRUCTURE OF PCRH IN COMPLEX WITH THE CHAPERONE BINDING REGION OF POPB','X-RAY DIFFRACTION',2.220,'CHAPERONE',2,2,1),(4571,'4jmf','CRYSTAL STRUCTURE OF EXOT (RESIDUES 28 -77)- SPCS COMPLEX FROM PSEUDOMONAS AERUGINOSA AT 2.1 ANGSTROM','X-RAY DIFFRACTION',2.100,'TOXIN/CHAPERONE',1,2,1),(4572,'4jmg','CRYSTAL STRUCTURE OF THE SYNTHETIC PROTEIN IN COMPLEX WITH PY PEPTIDE','X-RAY DIFFRACTION',1.400,'DE NOVO PROTEIN',1,1,1),(4573,'4jmh','CRYSTAL STRUCTURE OF SYNTHETIC PROTEIN IN COMPLEX WITH DOUBLE PY PEPTIDE','X-RAY DIFFRACTION',2.410,'DE NOVO PROTEIN',1,1,1),(4574,'4jml','CRYSTAL STRUCTURE OF THE TOLB(P201C)-COLICINE9 TBE PEPTIDE(A33C) COMPLEX.','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT/TOXIN',1,1,1),(4575,'4jmy','CRYSTAL STRUCTURE OF HCV NS3/NS4A PROTEASE COMPLEXED WITH DDIVPC PEPTIDE','X-RAY DIFFRACTION',1.950,'HYDROLASE/PROTEIN BINDING',4,2,1),(4576,'4jna','CRYSTAL STRUCTURE OF THE DEPH COMPLEX WITH DIMETHYL-FK228','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE/OXIDOREDUCTASE INHIBIT',2,2,1),(4577,'4jo1','CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120','X-RAY DIFFRACTION',2.030,'IMMUNE SYSTEM/VIRAL PROTEIN',2,4,1),(4578,'4jo2','CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM/VIRAL PROTEIN',2,4,1),(4579,'4jo6','STREPTAVIDIN COMPLEX WITH SBP-TAG','X-RAY DIFFRACTION',1.750,'UNKNOWN FUNCTION',2,4,1),(4580,'4jo7','CRYSTAL STRUCTURE OF THE HUMAN NUP49CCS2+3* NUP57CCS3* COMPLEX WITH 2:2 STOICHIOMETRY','X-RAY DIFFRACTION',1.750,'TRANSPORT PROTEIN',4,4,1),(4581,'4jo9','CRYSTAL STRUCTURE OF THE HUMAN NUP49CCS2+3* NUP57CCS3* COMPLEX 1:2 STOICHIOMETRY','X-RAY DIFFRACTION',2.500,'TRANSPORT PROTEIN',2,1,1),(4582,'4joe','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE A-ICAL36 (ANSRAPTSII)','X-RAY DIFFRACTION',1.140,'PEPTIDE BINDING PROTEIN',2,2,1),(4583,'4jof','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE L-ICAL36 (ANSRLPTSII)','X-RAY DIFFRACTION',1.200,'PEPTIDE BINDING PROTEIN',2,2,1),(4584,'4jog','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE V-ICAL36 (ANSRVPTSII)','X-RAY DIFFRACTION',1.470,'PEPTIDE BINDING PROTEIN',2,2,1),(4585,'4joh','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE H-ICAL36 (ANSRHPTSII)','X-RAY DIFFRACTION',1.470,'PEPTIDE BINDING PROTEIN',2,2,1),(4586,'4joj','CFTR ASSOCIATED LIGAND (CAL) DOMAIN BOUND TO PEPTIDE F-ICAL36 (ANSRFPTSII)','X-RAY DIFFRACTION',1.200,'PEPTIDE BINDING PROTEIN',2,2,1),(4587,'4jok','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE Y-ICAL36 (ANSRYPTSII)','X-RAY DIFFRACTION',1.090,'PEPTIDE BINDING PROTEIN',2,2,1),(4588,'4jop','CFTR ASSOCIATED LIGAND (CAL) PDZ BOUND TO HPV16 E6 ONCOPROTEIN C- TERMINAL PEPTIDE (TRRETQL)','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',2,2,1),(4589,'4jor','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO HPV18 E6 ONCOPROTEIN C-TERMINAL PEPTIDE (RLQRRRETQV)','X-RAY DIFFRACTION',1.340,'PEPTIDE BINDING PROTEIN',2,2,1),(4590,'4jqg','CRYSTAL STRUCTURE OF AN INACTIVE MUTANT OF MMP-9 CATALYTIC DOMAIN IN COMPLEX WITH A FLUOROGENIC SYNTHETIC PEPTIDIC SUBSTRATE WITH A FLUORINE ATOM.','X-RAY DIFFRACTION',1.850,'HYDROLASE/SUBSTRATE',2,2,1),(4591,'4jqv','HLA-B*18:01 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 173-180)','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,1,1),(4592,'4jqx','HLA-B*44:03 IN COMPLEX WITH EPSTEIN-BARR VIRUS BZLF1-DERIVED PEPTIDE (RESIDUES 169-180)','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(4593,'4jr0','HUMAN PROCASPASE-3 BOUND TO AC-DEVD-CMK','X-RAY DIFFRACTION',1.800,'APOPTOSIS, HYDROLASE/HYDROLASE INHIBI',2,2,1),(4594,'4jr1','HUMAN PROCASPASE-7 BOUND TO AC-DEVD-CMK','X-RAY DIFFRACTION',2.150,'APOPTOSIS, HYDROLASE/HYDROLASE INHIBI',2,2,1),(4595,'4jr2','HUMAN PROCASPASE-7/CASPASE-7 HETERODIMER BOUND TO AC-DEVD-CMK','X-RAY DIFFRACTION',1.650,'APOPTOSIS, HYDROLASE/HYDROLASE INHIBI',2,2,1),(4596,'4jrx','CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,3,1),(4597,'4js0','COMPLEX OF CDC42 WITH THE CRIB-PR DOMAIN OF IRSP53','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN/SIGNALING PROTEIN',1,1,1),(4598,'4jta','CRYSTAL STRUCTURE OF KV1.2-2.1 PADDLE CHIMERA CHANNEL IN COMPLEX WITH CHARYBDOTOXIN','X-RAY DIFFRACTION',2.500,'TRANSPORT PROTEIN/TOXIN',1,1,1),(4599,'4jwc','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH BOVINE BAC7(1-16)','X-RAY DIFFRACTION',1.800,'CHAPERONE/ANTIBIOTIC',2,2,1),(4600,'4jwd','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH BOVINE BAC7(15-28)','X-RAY DIFFRACTION',1.950,'CHAPERONE/ANTIBIOTIC',2,2,1),(4601,'4jwe','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH SHEEP BAC7(1-21)','X-RAY DIFFRACTION',1.950,'CHAPERONE/ANTIBIOTIC',2,2,1),(4602,'4jwi','CRYSTAL STRUCTURE OF THE SUBSTRATE BINDING DOMAIN OF E.COLI DNAK IN COMPLEX WITH SHEEP BAC7(35-43)','X-RAY DIFFRACTION',1.900,'CHAPERONE/ANTIBIOTIC',2,2,1),(4603,'4jx7','CRYSTAL STRUCTURE OF PIM1 KINASE IN COMPLEX WITH INHIBITOR 2-[(TRANS- 4-AMINOCYCLOHEXYL)AMINO]-4-{[3-(TRIFLUOROMETHYL) PHENYL]AMINO}PYRIDO[4,3-D]PYRIMIDIN-5(6H)-ONE','X-RAY DIFFRACTION',2.400,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4604,'4jxt','CID OF HUMAN RPRD1A IN COMPLEX WITH A PHOSPHORYLATED PEPTIDE FROM RPB1-CTD','X-RAY DIFFRACTION',1.900,'PROTEIN BINDING',1,1,1),(4605,'4jyg','CRYSTAL STRUCTURE OF RARBETA LBD IN COMPLEX WITH AGONIST BMS411 [4- {[(5,5-DIMETHYL-8-PHENYL-5,6-DIHYDRONAPHTHALEN-2-YL) CARBONYL]AMINO}BENZOIC ACID]','X-RAY DIFFRACTION',2.350,'TRANSCRIPTION/AGONIST',2,2,1),(4606,'4jyi','CRYSTAL STRUCTURE OF RARBETA LBD IN COMPLEX WITH SELECTIVE PARTIAL AGONIST BMS641 [3-CHLORO-4-[(E)-2-(5,5-DIMETHYL-8-PHENYL-5,6- DIHYDRONAPHTHALEN-2-YL)ETHENYL]BENZOIC ACID]','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION/AGONIST',2,2,1),(4607,'4jzn','THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-1','X-RAY DIFFRACTION',2.050,'IMMUNE SYSTEM/VIRAL PROTEIN',1,2,1),(4608,'4jzo','THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC84-27','X-RAY DIFFRACTION',2.220,'IMMUNE SYSTEM/VIRAL PROTEIN',4,8,1),(4609,'4jzw','CRYSTAL STRUCTURE OF CD4-MIMETIC MINIPROTEIN M48U1 IN COMPLEX WITH HIV-1 YU2 GP120 IN P212121 SPACE GROUP','X-RAY DIFFRACTION',1.780,'VIRAL PROTEIN/INHIBITOR',2,2,1),(4610,'4jzz','CRYSTAL STRUCTURE OF CD4-MIMETIC MINIPROTEIN M48U1 IN COMPLEX WITH HIV-1 YU2 GP120 IN C2221 SPACE GROUP','X-RAY DIFFRACTION',1.490,'VIRAL PROTEIN/INHIBITOR',1,1,1),(4611,'4k0a','CRYSTAL STRUCTURE OF CD4-MIMETIC MINIPROTEIN M48U7 IN COMPLEX WITH HIV-1 YU2 GP120','X-RAY DIFFRACTION',2.130,'VIRAL PROTEIN/INHIBITOR',1,1,1),(4612,'4k0u','PILOTIN/SECRETIN PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.150,'PROTEIN TRANSPORT',1,1,1),(4613,'4k1e','ATOMIC RESOLUTION CRYSTAL STRUCTURES OF KALLIKREIN-RELATED PEPTIDASE 4 COMPLEXED WITH A MODIFIED SFTI INHIBITOR FCQR','X-RAY DIFFRACTION',1.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4614,'4k38','NATIVE ANSMECPE WITH BOUND ADOMET AND KP18CYS PEPTIDE','X-RAY DIFFRACTION',1.830,'OXIDOREDUCTASE',2,2,1),(4615,'4k39','NATIVE ANSMECPE WITH BOUND ADOMET AND CP18CYS PEPTIDE','X-RAY DIFFRACTION',1.780,'OXIDOREDUCTASE',2,2,1),(4616,'4k3m','E.COLI SLIDING CLAMP IN COMPLEX WITH ACALDLF PEPTIDE','X-RAY DIFFRACTION',1.850,'TRANSFERASE',1,1,1),(4617,'4k3o','E. COLI SLIDING CLAMP IN COMPLEX WITH ACQADLF','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(4618,'4k3p','E. COLI SLIDING CLAMP IN COMPLEX WITH ACQLALF','X-RAY DIFFRACTION',2.150,'TRANSFERASE',1,1,1),(4619,'4k3q','E. COLI SLIDING CLAMP IN COMPLEX WITH ACQLDAF','X-RAY DIFFRACTION',1.850,'TRANSFERASE',1,1,1),(4620,'4k3r','E. COLI SLIDING CLAMP IN COMPLEX WITH ACQLDLA','X-RAY DIFFRACTION',1.860,'TRANSFERASE',1,1,1),(4621,'4k45','AUTO-INHIBITION AND PHOSPHORYLATION-INDUCED ACTIVATION OF PLC-GAMMA ISOZYMES','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4622,'4k4j','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 9CUAB30 AND THE COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(4623,'4k6i','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH TARGRETIN AND THE COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(4624,'4k6y','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36-Q (ANSRWQTSII)','X-RAY DIFFRACTION',1.480,'PEPTIDE BINDING PROTEIN/PROTEIN BINDI',2,2,1),(4625,'4k72','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36-VQD (ANSRVQDSII)','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN/PROTEIN BINDI',2,2,1),(4626,'4k74','THE UMUC SUBUNIT OF THE E. COLI DNA POLYMERASE V SHOWS A UNIQUE INTERACTION WITH THE BETA-CLAMP PROCESSIVITY FACTOR.','X-RAY DIFFRACTION',2.500,'DNA BINDING PROTEIN/TRANSFERASE',2,2,1),(4627,'4k75','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36-QDTRL (ANSRWQDTRL)','X-RAY DIFFRACTION',1.500,'PEPTIDE BINDING PROTEIN/PROTEIN BINDI',1,1,1),(4628,'4k76','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36-TRL (ANSRWPTTRL)','X-RAY DIFFRACTION',1.750,'PEPTIDE BINDING PROTEIN/PROTEIN BINDI',4,4,1),(4629,'4k78','CFTR ASSOCIATED LIGAND (CAL) E317A PDZ DOMAIN BOUND TO PEPTIDE ICAL36- QDTRL (ANSRWQDTRL)','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN/PROTEIN BINDI',1,1,1),(4630,'4k7f','NEWLY IDENTIFIED EPITOPE V60 FROM HBV CORE PROTEIN COMPLEXED WITH HLA- A*0201','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(4631,'4k7l','CRYSTAL STRUCTURE OF RNASE S VARIANT (K7C/Q11C)','X-RAY DIFFRACTION',1.380,'HYDROLASE',1,1,1),(4632,'4k8y','ATOMIC RESOLUTION CRYSTAL STRUCTURES OF KALLIKREIN-RELATED PEPTIDASE 4 COMPLEXED WITH SUNFLOWER TRYPSIN INHIBITOR (SFTI-1)','X-RAY DIFFRACTION',1.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4633,'4ka2','CRYSTAL STRUCTURE OF CD4-MIMETIC MINIPROTEIN M48U12 IN COMPLEX WITH HIV-1 YU2 GP120','X-RAY DIFFRACTION',1.790,'VIRAL PROTEIN/INHIBITOR',1,1,1),(4634,'4ka7','STRUCTURE OF ORGANELLAR OLIGOPEPTIDASE (E572Q) IN COMPLEX WITH AN ENDOGENOUS SUBSTRATE','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(4635,'4kbb','STRUCTURE OF BOTULINUM NEUROTOXIN B BINDING DOMAIN IN COMPLEX WITH BOTH SYNAPTOTAGMIN II AND GD1A','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN/TOXIN',2,2,1),(4636,'4kel','ATOMIC RESOLUTION CRYSTAL STRUCTURE OF KALLIKREIN-RELATED PEPTIDASE 4 COMPLEXED WITH A MODIFIED SFTI INHIBITOR FCQR(N)','X-RAY DIFFRACTION',1.150,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4637,'4kg9','CRYSTAL STRUCTURE OF USP7-NTD WITH MCM-BP','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(4638,'4kmd','CRYSTAL STRUCTURE OF SUFUD60-GLI1P','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING/TRANSCRIPTION',1,1,1),(4639,'4knl','CRYSTAL STRUCTURE OF STAPHYLOCOCCUS AUREUS HYDROLASE AMIA IN COMPLEX WITH ITS LIGAND','X-RAY DIFFRACTION',1.550,'HYDROLASE/SUBSTRATE',2,2,1),(4640,'4kp3','CRYSTAL STRUCTURE OF MYOVA-GTD IN COMPLEX WITH TWO CARGOS','X-RAY DIFFRACTION',2.410,'MOTOR PROTEIN/PROTEIN TRANSPORT',2,2,1),(4641,'4ks6','CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN BONT/A C134S MUTANT WITH COVALENT INHIBITOR THAT MODIFIES CYS-165 CAUSING DISORDER IN 166-174 STRETCH','X-RAY DIFFRACTION',1.930,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4642,'4ktc','NS3/NS4A PROTEASE WITH INHIBITOR','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4643,'4kts','BOVINE TRYPSIN IN COMPLEX WITH MICROVIRIDIN J AT PH 8.5','X-RAY DIFFRACTION',1.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4644,'4ktu','BOVINE TRYPSIN IN COMPLEX WITH MICROVIRIDIN J AT PH 6.5','X-RAY DIFFRACTION',1.350,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4645,'4kty','FIBRIN-STABILIZING FACTOR WITH A BOUND LIGAND','X-RAY DIFFRACTION',1.980,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4646,'4kv1','CRYSTAL STRUCTURE OF BRD4 BROMODOMAIN 1 IN COMPLEX WITH ACETYLATED REL PEPTIDE','X-RAY DIFFRACTION',1.500,'TRANSCRIPTION',2,2,1),(4647,'4kv4','BRD4 BROMODOMAIN 2 IN COMPLEX WITH ACETYLATED REL PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(4648,'4kx8','CRYSTAL STRUCTURE OF HUMAN AMINOPEPTIDASE A COMPLEXED WITH AMASTATIN','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4649,'4kxq','STRUCTURE OF NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-1 (CLOSED STATE, 1.85 A)','X-RAY DIFFRACTION',1.850,'HYDROLASE',1,1,1),(4650,'4kzl','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 4\'-FLUORO FLAVONE','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4651,'4kzq','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 4\' -HYDROXY FLAVONE','X-RAY DIFFRACTION',2.250,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4652,'4kzu','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 4\' -BROMO FLAVONE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4653,'4l09','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 4-(4-OXO-4H- CHROMEN-2-YL)BENZOIC ACID','X-RAY DIFFRACTION',2.050,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4654,'4l0b','TANKYRASE 2 IN COMPLEX WITH 4\'-DIMETHYLAMINO FLAVONE','X-RAY DIFFRACTION',1.800,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4655,'4l0i','TANKYRASE 2 CATALYTIC DOMAIN IN COMPLEX WITH ETHYL 4-(4-OXO-4H- CHROMEN-2-YL)BENZOATE','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4656,'4l0s','TANKYRASE 2 IN COMPLEX WITH 4\'-CYANO FLAVONE','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4657,'4l0t','TANKYRASE 2 IN COMPLEX WITH 4\'-NITRO FLAVONE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4658,'4l0v','TANKYRASE 2 IN COMPLEX WITH 4\'-CHLORO FLAVONE','X-RAY DIFFRACTION',1.700,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4659,'4l10','TANKYRASE 2 IN COMPLEX WITH 4\'-METHOXY FLAVONE','X-RAY DIFFRACTION',1.700,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4660,'4l1u','CRYSTAL STRUCTURE OF HUMAN RTF1 PLUS3 DOMAIN IN COMPLEX WITH SPT5 CTR PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.420,'TRANSCRIPTION/PEPTIDE',4,6,1),(4661,'4l2f','TANKYRASE 2 IN COMPLEX WITH 6-CHLORO FLAVONE','X-RAY DIFFRACTION',2.050,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4662,'4l2g','TANKYRASE 2 IN COMPLEX WITH 6- FLUORO FLAVONE','X-RAY DIFFRACTION',2.050,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4663,'4l2k','TANKYRASE 2 IN COMPLEX WITH 2-(1,3-BENZODIOXOL-5-YL)-4H-CHROMEN-4-ONE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4664,'4l31','TANKYRASE 2 IN COMPLEX WITH METHYL 4-(4-OXOCHROMEN-2-YL)BENZOATE','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4665,'4l32','TANKYRASE 2 IN COMPLEX WITH 2-[4-(4-METHYLPIPERAZINE-1-CARBONYL) PHENYL]CHROMEN-4-ONE','X-RAY DIFFRACTION',1.850,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4666,'4l33','TANKYRASE 2 IN COMPLEX WITH CYANOMETHYL 4-(4-OXO-4H-CHROMEN-2-YL) BENZOATE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4667,'4l34','TANKYRASE 2 IN COMPLEX WITH 4\'-TETRAZOLE FLAVONE','X-RAY DIFFRACTION',1.800,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4668,'4l58','CRYSTAL STRUCTURE OF THE MLL5 PHD FINGER IN COMPLEX WITH H3K4ME3','X-RAY DIFFRACTION',1.480,'TRANSFERASE',1,1,1),(4669,'4l5n','CRYSTALLOGRAPHIC STRUCTURE OF HHV-1 URACIL-DNA GLYCOSYLASE COMPLEXED WITH THE BACILLUS PHAGE PZA INHIBITOR PROTEIN P56','X-RAY DIFFRACTION',2.160,'HYDROLASE/HYDROLASE INHIBITOR',4,2,1),(4670,'4l7x','CRYSTAL STRUCTURE OF THE DIDO PHD FINGER IN COMPLEX WITH H3K4ME3','X-RAY DIFFRACTION',1.350,'CELL CYCLE, GENE REGULATION',1,1,1),(4671,'4l8b','CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5H PEPTIDE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(4672,'4l8d','CRYSTAL STRUCTURE OF THE H2DB IN COMPLEX WITH THE NP-N5D PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(4673,'4l9p','CRYSTAL STRUCTURE OF ASPERGILLUS FUMIGATUS PROTEIN FARNESYLTRANSFERASE COMPLEXED WITH THE FII ANALOG, FPT-II, AND THE KCVVM PEPTIDE','X-RAY DIFFRACTION',1.450,'TRANSFERASE',1,2,1),(4674,'4laj','CRYSTAL STRUCTURE OF HIV-1 YU2 ENVELOPE GP120 GLYCOPROTEIN IN COMPLEX WITH CD4-MIMETIC MINIPROTEIN, M48U1, AND LLAMA SINGLE-DOMAIN, BROADLY NEUTRALIZING, CO-RECEPTOR BINDING SITE ANTIBODY, JM4','X-RAY DIFFRACTION',2.140,'VIRAL PROTEIN/INHIBITOR',4,8,1),(4675,'4lcy','CRYSTAL STRUCTURE OF HLA-B46 AT 1.6 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',1.600,'MEMBRANE PROTEIN',2,2,1),(4676,'4ld3','STRUCTURAL ANALYSIS OF THE MICROCEPHALY PROTEIN CPAP G-BOX DOMAIN SUGGESTS A ROLE IN CENTRIOLE ELONGATION.','X-RAY DIFFRACTION',2.440,'STRUCTURAL PROTEIN, PROTEIN BINDING',1,1,1),(4677,'4leb','STRUCTURE OF THE ALS3 ADHESIN FROM CANDIDA ALBICANS, RESIDUES 1-299 (MATURE SEQUENCE) IN COMPLEX WITH HEPTA-THREONINE','X-RAY DIFFRACTION',1.400,'CELL ADHESION',1,1,1),(4678,'4lfd','STAPHYLOCOCCUS AUREUS SORTASE B-SUBSTRATE COMPLEX','X-RAY DIFFRACTION',2.490,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(4679,'4lg6','CRYSTAL STRUCTURE OF ANKRA2-CCDC8 COMPLEX','X-RAY DIFFRACTION',1.800,'STRUCTURAL PROTEIN',1,1,1),(4680,'4lk9','CRYSTAL STRUCTURE OF MOZ DOUBLE PHD FINGER HISTONE H3 TAIL COMPLEX','X-RAY DIFFRACTION',1.600,'TRANSFERASE',1,1,1),(4681,'4lka','CRYSTAL STRUCTURE OF MOZ DOUBLE PHD FINGER HISTONE H3K9AC COMPLEX','X-RAY DIFFRACTION',1.610,'TRANSFERASE',1,1,1),(4682,'4lkd','CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN LECA COMPLEXED WITH GALA-QRS AT 2.31 A RESOLUTION','X-RAY DIFFRACTION',2.310,'SUGAR BINDING PROTEIN/INHIBITOR',8,8,1),(4683,'4lke','CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN LECA COMPLEXED WITH GALA-WRI AT 1.65 A RESOLUTION','X-RAY DIFFRACTION',1.650,'SUGAR BINDING PROTEIN/INHIBITOR',4,4,1),(4684,'4lkf','CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA LECTIN LECA COMPLEXED WITH GALA-WKY AT 1.64 A RESOLUTION','X-RAY DIFFRACTION',1.640,'SUGAR BINDING PROTEIN/INHIBITOR',2,2,1),(4685,'4lkl','CRYSTAL STRUCTURE OF PLK1 POLO-BOX DOMAIN IN COMPLEX WITH PL-55','X-RAY DIFFRACTION',1.580,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4686,'4lkm','CRYSTAL STRUCTURE OF PLK1 POLO-BOX DOMAIN IN COMPLEX WITH PL-74','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(4687,'4lkx','HUMANIZED ANTIBODY 4B12 FAB COMPLEXED WITH A CEMX SEGMENT','X-RAY DIFFRACTION',1.920,'IMMUNE SYSTEM',1,2,1),(4688,'4llb','CRYSTAL STRUCTURE OF MOZ DOUBLE PHD FINGER HISTONE H3K14AC COMPLEX','X-RAY DIFFRACTION',2.500,'TRANSFERASE',2,2,1),(4689,'4ln2','THE SECOND SH3 DOMAIN FROM CAP/PONSIN IN COMPLEX WITH PROLINE RICH PEPTIDE FROM VINCULIN','X-RAY DIFFRACTION',1.000,'SIGNALING PROTEIN',1,1,1),(4690,'4lnp','THE FIRST SH3 DOMAIN FROM CAP/PONSIN IN COMPLEX WITH PROLINE RICH PEPTIDE FROM VINCULIN','X-RAY DIFFRACTION',1.410,'SIGNALING PROTEIN',1,1,1),(4691,'4lnr','THE STRUCTURE OF HLA-B*35:01 IN COMPLEX WITH THE PEPTIDE (RPQVPLRPMTY)','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(4692,'4loo','STRUCTURAL BASIS OF AUTOACTIVATION OF P38 ALPHA INDUCED BY TAB1 (MONOCLINIC CRYSTAL FORM)','X-RAY DIFFRACTION',1.950,'TRANSFERASE',1,1,1),(4693,'4lop','STRUCTURAL BASIS OF AUTOACTIVATION OF P38 ALPHA INDUCED BY TAB1 (TETRAGONAL CRYSTAL FORM)','X-RAY DIFFRACTION',2.050,'TRANSFERASE',4,4,1),(4694,'4loq','STRUCTURAL BASIS OF AUTOACTIVATION OF P38 ALPHA INDUCED BY TAB1 (TETRAGONAL CRYSTAL FORM WITH BOUND SULPHATE)','X-RAY DIFFRACTION',2.320,'TRANSFERASE',4,4,1),(4695,'4lor','C1S CUB1-EGF-CUB2 IN COMPLEX WITH A COLLAGEN-LIKE PEPTIDE FROM C1Q','X-RAY DIFFRACTION',2.500,'HYDROLASE/PROTEIN BINDING',3,1,1),(4696,'4loy','CRYSTAL STRUCTURE ANALYSIS OF THROMBIN IN COMPLEX WITH COMPOUND D57, 5-CHLOROTHIOPHENE-2-CARBOXYLIC ACID [(S)-2-[2-METHYL-3-(2- OXOPYRROLIDIN-1-YL)BENZENESULFONYLAMINO]-3-(4-METHYLPIPERAZIN-1- YL)- 3-OXOPROPYL]AMIDE (SAR107375)','X-RAY DIFFRACTION',1.770,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(4697,'4lp9','ENDOTHIAPEPSIN COMPLEXED WITH PHE-REDUCED-TYR PEPTIDE.','X-RAY DIFFRACTION',1.350,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4698,'4lrs','CRYSTAL AND SOLUTION STRUCTURES OF THE BIFUNCTIONAL ENZYME (ALDOLASE/ALDEHYDE DEHYDROGENASE) FROM THERMOMONOSPORA CURVATA, REVEAL A COFACTOR-BINDING DOMAIN MOTION DURING NAD+ AND COA ACCOMMODATION WHITHIN THE SHARED COFACTOR-BINDING SITE','X-RAY DIFFRACTION',1.550,'OXIDOREDUCTASE',1,2,1),(4699,'4lsj','CRYSTAL STRUCTURE OF THE GLUCOCORTICOID RECEPTOR LIGAND BINDING DOMAIN BOUND TO A DIBENZOXAPINE SULFONAMIDE','X-RAY DIFFRACTION',2.350,'TRANSCRIPTION',1,1,1),(4700,'4lx2','CRYSTAL STRUCTURE OF MYO5A GLOBULAR TAIL DOMAIN IN COMPLEX WITH MELANOPHILIN GTBD','X-RAY DIFFRACTION',1.500,'CONTRACTILE PROTEIN/PROTEIN TRANSPORT',1,1,1),(4701,'4lx3','CONSERVED RESIDUES THAT MODULATE PROTEIN TRANS-SPLICING OF NPU DNAE SPLIT INTEIN','X-RAY DIFFRACTION',1.500,'TRANSFERASE',1,1,1),(4702,'4lxb','CRYSTAL STRUCTURE ANALYSIS OF THROMBIN IN COMPLEX WITH COMPOUND D58','X-RAY DIFFRACTION',1.610,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(4703,'4lxl','CRYSTAL STRUCTURE OF JMJD2B COMPLEXED WITH PYRIDINE-2,4-DICARBOXYLIC ACID AND H3K9ME3','X-RAY DIFFRACTION',1.870,'OXIDOREDUCTASE/PEPTIDE',1,1,1),(4704,'4lz1','X-RAY STRUCTURE OF THE COMPLEX BETWEEN HUMAN THROMBIN AND THE TBA DELETION MUTANT LACKING THYMINE 12 NUCLEOBASE','X-RAY DIFFRACTION',1.650,'HYDROLASE/HYDROLASE INHIBITOR/DNA',1,1,1),(4705,'4lzf','A NOVEL DOMAIN IN THE MICROCEPHALY PROTEIN CPAP SUGGESTS A ROLE IN CENTRIOLE ARCHITECTURE','X-RAY DIFFRACTION',1.720,'STRUCTURAL PROTEIN, PROTEIN BINDING',1,1,1),(4706,'4lzx','COMPLEX OF IQCG AND CA2+-FREE CAM','X-RAY DIFFRACTION',1.500,'METAL BINDING PROTEIN',1,1,1),(4707,'4m1d','CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,4,1),(4708,'4m1l','COMPLEX OF IQCG AND CA2+-BOUND CAM','X-RAY DIFFRACTION',2.100,'METAL BINDING PROTEIN',1,1,1),(4709,'4m1z','CRYSTAL STRUCTURE OF MYCP1 WITH THE N-TERMINAL PROPEPTIDE REMOVED','X-RAY DIFFRACTION',2.250,'HYDROLASE',2,2,1),(4710,'4m38','CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI PROTEIN ARGININE METHYLTRANSFERASE 7 COMPLEX WITH ADOHCY AND HISTONE H4 PEPTIDE','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE SUBSTRATE',2,2,1),(4711,'4m5s','HUMAN ALPHAB CRYSTALLIN CORE DOMAIN IN COMPLEX WITH C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',1.370,'CHAPERONE',1,1,1),(4712,'4m5t','DISULFIDE TRAPPED HUMAN ALPHAB CRYSTALLIN CORE DOMAIN IN COMPLEX WITH C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',2.000,'CHAPERONE',4,4,1),(4713,'4m6b','CRYSTAL STRUCTURE OF YEAST SWR1-Z DOMAIN IN COMPLEX WITH H2A.Z-H2B DIMER','X-RAY DIFFRACTION',1.780,'STRUCTURAL PROTEIN/HYDROLASE',2,2,1),(4714,'4m7c','CRYSTAL STRUCTURE OF THE TRF2-BINDING MOTIF OF SLX4 IN COMPLEX WITH THE TRFH DOMAIN OF TRF2','X-RAY DIFFRACTION',2.050,'HYDROLASE REGULATOR',2,2,1),(4715,'4m8e','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (S) 4-METHYL 9CUAB30 COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(4716,'4m8h','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH (R)4-METHYL 9CUAB30 AND COACTIVATOR PEPTIDE GRIP- 1','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(4717,'4m91','CRYSTAL STRUCTURE OF HN33/TUSC3-PEPTIDE 1','X-RAY DIFFRACTION',1.100,'OXIDOREDUCTASE',1,1,1),(4718,'4m92','CRYSTAL STRUCTURE OF HN33/TUSC3-PEPTIDE 2','X-RAY DIFFRACTION',1.600,'OXIDOREDUCTASE',1,1,1),(4719,'4mcy','IMMUNE RECEPTOR','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(4720,'4mcz','IMMUNE RECEPTOR','X-RAY DIFFRACTION',2.410,'IMMUNE SYSTEM',1,2,1),(4721,'4md0','IMMUNE RECEPTOR','X-RAY DIFFRACTION',2.190,'IMMUNE SYSTEM',1,2,1),(4722,'4md4','IMMUNE RECEPTOR','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,2,1),(4723,'4md5','IMMUNE RECEPTOR','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',1,2,1),(4724,'4mdd','CRYSTAL STRUCTURE OF THE GLUCOCORTICOID RECEPTOR BOUND TO A NON- STEROIDAL ANTAGONIST REVEALS REPOSITIONING AND PARTIAL DISORDERING OF ACTIVATION FUNCTION HELIX 12','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING',2,2,1),(4725,'4mdi','IMMUNE RECEPTOR','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(4726,'4mdj','IMMUNE RECEPTOR','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,2,1),(4727,'4mdr','CRYSTAL STRUCTURE OF ADAPTOR PROTEIN COMPLEX 4 (AP-4) MU4 SUBUNIT C- TERMINAL DOMAIN D190A MUTANT, IN COMPLEX WITH A SORTING PEPTIDE FROM THE AMYLOID PRECURSOR PROTEIN (APP)','X-RAY DIFFRACTION',1.850,'PROTEIN TRANSPORT/PROTEIN BINDING',1,1,1),(4728,'4mg5','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH CHLORDECONE','X-RAY DIFFRACTION',2.050,'HORMONE RECEPTOR',2,2,1),(4729,'4mg6','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BENZYLBUTYLPHTALATE','X-RAY DIFFRACTION',2.100,'HORMONE RECEPTOR',2,2,1),(4730,'4mg7','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH FERUTININE','X-RAY DIFFRACTION',2.150,'HORMONE RECEPTOR',2,2,1),(4731,'4mg8','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ALPHA-ZEARALANOL','X-RAY DIFFRACTION',1.850,'HORMONE RECEPTOR',2,2,1),(4732,'4mg9','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BUTYLPARABEN','X-RAY DIFFRACTION',2.000,'HORMONE RECEPTOR',2,2,1),(4733,'4mga','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH 4-TERT- OCTYLPHENOL','X-RAY DIFFRACTION',1.800,'HORMONE RECEPTOR',2,2,1),(4734,'4mgb','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH TCBPA','X-RAY DIFFRACTION',1.850,'HORMONE RECEPTOR',2,2,1),(4735,'4mgc','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BENZOPHENONE-2','X-RAY DIFFRACTION',2.150,'HORMONE RECEPTOR',2,2,1),(4736,'4mgd','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH HPTE','X-RAY DIFFRACTION',1.900,'HORMONE RECEPTOR',2,2,1),(4737,'4mi8','CRYSTAL STRUCTURE OF THE COMPLEX OF MURINE GAMMA-HERPESVIRUS 68 BCL-2 HOMOLOG M11 AND A BECLIN 1 BH3 DOMAIN-DERIVED PEPTIDE','X-RAY DIFFRACTION',2.100,'VIRAL PROTEIN/APOPTOSIS',2,2,1),(4738,'4mit','CRYSTAL STRUCTURE OF E. HISTOLYTICA RACC BOUND TO THE EHPAK4 PBD','X-RAY DIFFRACTION',2.350,'SIGNALING PROTEIN',4,4,1),(4739,'4mj5','CRYSTAL STRUCTURE OF HLA-A*1101 IN COMPLEX WITH H1-22, AN INFLUENZA A(H1N1) VIRUS EPITOPE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(4740,'4mlf','CRYSTAL STRUCTURE FOR THE COMPLEX OF THROMBIN MUTANT D102N AND HIRUDIN','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4741,'4mli','CRYSTAL STRUCTURE OF THE SPYTAG/SPYCATCHER COMPLEX','X-RAY DIFFRACTION',2.100,'PEPTIDE BINDING PROTEIN',2,2,1),(4742,'4mls','CRYSTAL STRUCTURE OF THE SPYTAG AND SPYCATCHER-DELTAN1 COMPLEX','X-RAY DIFFRACTION',1.980,'PEPTIDE BINDING PROTEIN',1,1,1),(4743,'4mnv','CRYSTAL STRUCTURE OF BICYCLIC PEPTIDE UK729 BOUND AS AN ACYL-ENZYME INTERMEDIATE TO UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA)','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(4744,'4mnw','CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK749','X-RAY DIFFRACTION',1.490,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4745,'4mnx','CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK811','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4746,'4mny','CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK903','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4747,'4moy','STRUCTURE OF A SECOND NUCLEAR PP1 HOLOENZYME, CRYSTAL FORM 1','X-RAY DIFFRACTION',2.200,'HYDROLASE/NUCLEAR PROTEIN',1,1,1),(4748,'4mp0','STRUCTURE OF A SECOND NUCLEAR PP1 HOLOENZYME, CRYSTAL FORM 2','X-RAY DIFFRACTION',2.100,'HYDROLASE',2,2,1),(4749,'4mqv','CRYSTAL COMPLEX OF RPA32C AND SMARCAL1 N-TERMINUS','X-RAY DIFFRACTION',1.950,'PROTEIN BINDING',2,2,1),(4750,'4ms8','42F3 TCR PCPB9/H-2LD COMPLEX','X-RAY DIFFRACTION',1.920,'IMMUNE SYSTEM',1,3,1),(4751,'4mvi','CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN US7) IN COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE ABETA(1-40)','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING/PROTEIN FIBRIL',1,1,1),(4752,'4mvk','CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN US7) IN COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE FRAGMENT VFFAED','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING/PROTEIN FIBRIL',1,1,1),(4753,'4mvl','CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN H1GA) IN COMPLEX WITH THE ALZHEIMER AMYLOID PEPTIDE ABETA1-40','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING/PROTEIN FIBRIL',4,4,1),(4754,'4mz5','STRUCTURE OF IMPORTIN-ALPHA: DUTPASE NLS COMPLEX','X-RAY DIFFRACTION',2.100,'PROTEIN TRANSPORT',2,1,1),(4755,'4mz6','STRUCTURE OF IMPORTIN-ALPHA: DUTPASE S11E NLS MUTANT COMPLEX','X-RAY DIFFRACTION',1.880,'PROTEIN TRANSPORT',2,1,1),(4756,'4mzf','CRYSTAL STRUCTURE OF HUMAN SPINDLIN1 BOUND TO HISTONE H3(K4ME3-R8ME2A) PEPTIDE','X-RAY DIFFRACTION',2.100,'GENE REGULATION',1,1,1),(4757,'4mzg','CRYSTAL STRUCTURE OF HUMAN SPINDLIN1 BOUND TO HISTONE H3K4ME3 PEPTIDE','X-RAY DIFFRACTION',1.700,'GENE REGULATION',2,2,1),(4758,'4mzh','CRYSTAL STRUCTURE OF HUMAN SPINDLIN1 BOUND TO HISTONE H3(K4ME3-R8ME2S) PEPTIDE','X-RAY DIFFRACTION',2.200,'GENE REGULATION',1,1,1),(4759,'4mzj','CRYSTAL STRUCTURE OF MTIP FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH PGLY[801,805], A STAPLED MYOA TAIL PEPTIDE','X-RAY DIFFRACTION',1.470,'PROTEIN BINDING/INHIBITOR',1,1,1),(4760,'4mzk','CRYSTAL STRUCTURE OF MTIP FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH PGLY[807,811], A STAPLED MYOA TAIL PEPTIDE','X-RAY DIFFRACTION',1.820,'PROTEIN BINDING/INHIBITOR',1,1,1),(4761,'4mzl','CRYSTAL STRUCTURE OF MTIP FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH HBS MYOA, A HYDROGEN BOND SURROGATE MYOA HELIX MIMETIC','X-RAY DIFFRACTION',2.010,'PROTEIN BINDING/INHIBITOR',2,2,1),(4762,'4n0y','STRUCTURE OF THE HEPATITIS C ENVELOPE GLYCOPROTEIN E1 ANTIGENIC REGION 314-324 BOUND TO THE CROSS-NEUTRALIZING ANTIBODY IGH526','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',1,2,1),(4763,'4n39','CRYSTAL STRUCTURE OF HUMAN O-GLCNAC TRANSFERASE BOUND TO A PEPTIDE FROM HCF-1 PRO-REPEAT 2 (11-26)','X-RAY DIFFRACTION',1.760,'TRANSFERASE/SUBSTRATE',1,1,1),(4764,'4n3a','CRYSTAL STRUCTURE OF HUMAN O-GLCNAC TRANSFERASE BOUND TO A PEPTIDE FROM HCF-1 PRO-REPEAT 2 (1-26)E10A','X-RAY DIFFRACTION',1.880,'TRANSFERASE/SUBSTRATE',1,1,1),(4765,'4n3b','CRYSTAL STRUCTURE OF HUMAN O-GLCNAC TRANSFERASE BOUND TO A PEPTIDE FROM HCF-1 PRO-REPEAT2(1-26)E10Q AND UDP-5SGLCNAC','X-RAY DIFFRACTION',2.170,'TRANSFERASE/SUBSTRATE',1,1,1),(4766,'4n3w','CRYSTAL STRUCTURE OF THE BROMODOMAIN-PHD FINGER MODULE OF HUMAN TRANSCRIPTIONAL CO-ACTIVATOR CBP IN COMPLEX WITH ACETYLATED HISTONE 4 PEPTIDE (H4K20AC).','X-RAY DIFFRACTION',1.900,'TRANSFERASE/NUCLEAR PROTEIN',1,1,1),(4767,'4n3y','CRYSTAL STRUCTURE OF RABEX-5CC AND RABAPTIN-5C21 COMPLEX','X-RAY DIFFRACTION',2.200,'ENDOCYTOSIS',1,2,1),(4768,'4n4f','CRYSTAL STRUCTURE OF THE BROMODOMAIN-PHD FINGER MODULE OF HUMAN TRANSCRIPTIONAL CO-ACTIVATOR CBP IN COMPLEX WITH DI-ACETYLATED HISTONE 4 PEPTIDE (H412ACK16AC).','X-RAY DIFFRACTION',1.830,'TRANSCRIPTION/PROTEIN BINDING',1,1,1),(4769,'4n4h','CRYSTAL STRUCTURE OF THE BROMO-PWWP OF THE MOUSE ZINC FINGER MYND-TYPE CONTAINING 11 ISOFORM ALPHA IN COMPLEX WITH HISTONE H3.1K36ME3','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(4770,'4n4i','CRYSTAL STRUCTURE OF THE BROMO-PWWP OF THE MOUSE ZINC FINGER MYND-TYPE CONTAINING 11 ISOFORM ALPHA IN COMPLEX WITH HISTONE H3.3K36ME3','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(4771,'4n5t','THE 1.7A CRYSTAL STRUCTURE OF MDMX WITH A STAPLED PEPTIDE, ATSP-7041','X-RAY DIFFRACTION',1.700,'CELL CYCLE/CELL CYCLE INHIBITOR',1,1,1),(4772,'4n6p','CRYSTAL STRUCTURE OF C-LOBE OF BOVINE LACTOFERRIN COMPLEXED WITH MECLOFENAMIC ACID AT 1.4 A RESOLUTION','X-RAY DIFFRACTION',1.400,'HYDROLASE',1,1,1),(4773,'4n78','THE WAVE REGULATORY COMPLEX LINKS DIVERSE RECEPTORS TO THE ACTIN CYTOSKELETON','X-RAY DIFFRACTION',2.430,'PROTEIN BINDING',1,3,1),(4774,'4n7g','CRYSTAL STRUCTURE OF 14-3-3ZETA IN COMPLEX WITH A PEPTIDE DERIVED FROM EXOS','X-RAY DIFFRACTION',2.250,'SIGNALING PROTEIN',1,1,1),(4775,'4n7y','CRYSTAL STRUCTURE OF 14-3-3ZETA IN COMPLEX WITH A 8-CARBON-LINKER CYCLIC PEPTIDE DERIVED FROM EXOS','X-RAY DIFFRACTION',2.160,'SIGNALING PROTEIN',2,2,1),(4776,'4n84','CRYSTAL STRUCTURE OF 14-3-3ZETA IN COMPLEX WITH A 12-CARBON-LINKER CYCLIC PEPTIDE DERIVED FROM EXOS','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',2,2,1),(4777,'4n8c','THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',2,4,1),(4778,'4n8v','CRYSTAL STRUCTURE OF KILLER CELL IMMUNOGLOBULIN-LIKE RECEPTOR KIR2DS2 IN COMPLEX WITH HLA-A','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(4779,'4n9g','CRYSTAL STRUCTURE OF A COMPUTATIONALLY DESIGNED RSV-PRESENTING EPITOPE SCAFFOLD AND ITS ELICITED ANTIBODY 17HD9','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',4,8,1),(4780,'4naq','CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N COMPLEXED WITH POLY- ALANINE','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(4781,'4naw','CRYSTAL STRUCTURE OF HUMAN ATG12~ATG5-ATG16N IN COMPLEX WITH A FRAGMENT OF ATG3','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT/LIGASE',8,8,1),(4782,'4nb3','CRYSTAL STRUCTURE OF RPA70N IN COMPLEX WITH A 3,4 DICHLOROPHENYLALANINE ATRIP DERIVED PEPTIDE','X-RAY DIFFRACTION',1.350,'PEPTIDE BINDING PROTEIN',2,2,1),(4783,'4nec','CONVERSION OF A DISULFIDE BOND INTO A THIOACETAL GROUP DURING ECHINOMYCIN BIOSYNTHESIS','X-RAY DIFFRACTION',1.500,'TRANSFERASE/ANTIBIOTIC',4,4,1),(4784,'4nie','CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR ROR(GAMMA)T LIGAND- BINDING DOMAIN IN COMPLEX WITH SMALL MOLECULE LIGAND','X-RAY DIFFRACTION',2.010,'TRANSCRIPTION/AGONIST',2,2,1),(4785,'4niq','CRYSTAL STRUCTURE OF VPS4 MIT-VFA1 MIM2','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT',2,2,1),(4786,'4nm0','CRYSTAL STRUCTURE OF PEPTIDE INHIBITOR-FREE GSK-3/AXIN COMPLEX','X-RAY DIFFRACTION',2.500,'TRANSFERASE/PEPTIDE',1,1,1),(4787,'4nm3','CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED N- TERMINAL AUTO-INHIBITORY PS9 PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSFERASE/PEPTIDE',1,1,1),(4788,'4nm5','CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED WNT RECEPTOR LRP6 C-MOTIF','X-RAY DIFFRACTION',2.300,'TRANSFERASE/PEPTIDE',2,1,1),(4789,'4nm7','CRYSTAL STRUCTURE OF GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED WNT RECEPTOR LRP6 E-MOTIF','X-RAY DIFFRACTION',2.300,'TRANSFERASE/PEPTIDE',2,1,1),(4790,'4nmo','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36(AC-K- 1)(ANSRWPTS[AC-K]I)','X-RAY DIFFRACTION',1.400,'PROTEIN TRANSPORT/INHIBITOR',2,2,1),(4791,'4nmp','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36(AC-K- 3) (ANSRWP[AC-K]SII)','X-RAY DIFFRACTION',1.300,'PROTEIN TRANSPORT/INHIBITOR',2,2,1),(4792,'4nmq','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36(AC-K- 4) (ANSRW[AC-K]TSII)','X-RAY DIFFRACTION',1.400,'PROTEIN TRANSPORT/INHIBITOR',2,2,1),(4793,'4nmr','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36(AC-K- 5) (ANSR[AC-K]PTSII)','X-RAY DIFFRACTION',1.550,'PROTEIN TRANSPORT/INHIBITOR',2,2,1),(4794,'4nms','CFTR ASSOCIATED LIGAND (CAL)PDZ DOMAIN BOUND TO PEPTIDE ICAL36(FLB-K- 1) (ANSRWPTS[4-FLUOROBENZOIC-ACYL-K]I)','X-RAY DIFFRACTION',1.700,'PROTEIN TRANSPORT/INHIBITOR',2,2,1),(4795,'4nmt','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36(TFA-K- 1) (ANSRWPTS[TFA-ACYL-K]I)','X-RAY DIFFRACTION',1.400,'PROTEIN TRANSPORT/INHIBITOR',2,2,1),(4796,'4nmv','CFTR ASSOCIATED LIGAND (CAL) PDZ DOMAIN BOUND TO PEPTIDE ICAL36(BRB-K- 1) (ANSRWPTS[4-BROMOBENZOIC-ACYL-K]I)','X-RAY DIFFRACTION',1.400,'PROTEIN TRANSPORT/INHIBITOR',2,2,1),(4797,'4nmx','PCSK9(DELTACRD) IN COMPLEX WITH PHAGE-DERIVED INHIBITORY PEPTIDE 2-8','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4798,'4nnd','STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES','X-RAY DIFFRACTION',2.500,'HYDROLASE',4,4,1),(4799,'4nnl','TAX-INTERACTING PROTEIN-1 (TIP-1) PDZ DOMAIN BOUND TO F-ICAL36 (ANSRFPTSII) PEPTIDE','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING',2,2,1),(4800,'4nnm','TAX-INTERACTING PROTEIN-1 (TIP-1) PDZ DOMAIN BOUND TO Y-ICAL36 (YPTSII) PEPTIDE','X-RAY DIFFRACTION',1.600,'PROTEIN BINDING',2,2,1),(4801,'4nnx','CRYSTAL STRUCTURE OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM/ANTIGEN',1,1,1),(4802,'4nny','CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF PKD2 PHOSPHOPEPTIDE BOUND TO HLA-A2','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM/ANTIGEN',1,1,1),(4803,'4no2','CRYSTAL STRUCTURE OF RQA_V PHOSPHOPEPTIDE BOUND TO HLA-A2','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM/ANTIGEN',1,1,1),(4804,'4no3','CRYSTAL STRUCTURE OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM/ANTIGEN',1,1,1),(4805,'4no5','CRYSTAL STRUCTURE OF NON-PHOSPHORYLATED FORM OF AMPD2 PHOSPHOPEPTIDE BOUND TO HLA-A2','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM/ANTIGEN',1,1,1),(4806,'4nql','THE CRYSTAL STRUCTURE OF THE DUB DOMAIN OF AMSH ORTHOLOGUE, SST2 FROM S. POMBE, IN COMPLEX WITH LYSINE 63-LINKED DIUBIQUITIN','X-RAY DIFFRACTION',2.300,'HYDROLASE/PROTEIN BINDING',1,2,1),(4807,'4nqv','CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44, AN 9-MER INFLUENZA EPITOPE','X-RAY DIFFRACTION',2.390,'IMMUNE SYSTEM/VIRAL PROTEIN',6,6,1),(4808,'4nqx','CRYSTAL STRUCTURE OF HLA A*0101 IN COMPLEX WITH NP44-S7N, AN 9-MER INFLUENZA EPITOPE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM/VIRAL PROTEIN',6,6,1),(4809,'4nrx','CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE','X-RAY DIFFRACTION',2.210,'IMMUNE SYSTEM',2,4,1),(4810,'4nt6','HLA-C*0801 CRYSTAL STRUCTURE','X-RAY DIFFRACTION',1.840,'IMMUNE SYSTEM',1,1,1),(4811,'4nu1','CRYSTAL STRUCTURE OF A TRANSITION STATE MIMIC OF THE GSK-3/AXIN COMPLEX BOUND TO PHOSPHORYLATED N-TERMINAL AUTO-INHIBITORY PS9 PEPTIDE','X-RAY DIFFRACTION',2.500,'TRANSFERASE/PEPTIDE',1,1,1),(4812,'4nu8','CRYSTAL STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH HIGH AFFINITY INHIBITORY PEPTIDE FROM SERINE ACETYL TRANSFERASE OF SALMONELLA TYPHIMURIUM AT 2.0 A','X-RAY DIFFRACTION',2.070,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4813,'4nut','CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN SNU13P AND THE PEP DOMAIN OF RSA1','X-RAY DIFFRACTION',1.550,'RNA BINDING PROTEIN',1,1,1),(4814,'4nuu','HETEROTRIMER STRUCTURE OF REGION II FROM PLASMODIUM VIVAX DUFFY BINDING PROTEIN (PVDBP) BOUND TO THE ECTODOMAIN OF THE DUFFY ANTIGEN RECEPTOR FOR CHEMOKINES (DARC)','X-RAY DIFFRACTION',1.950,'MEMBRANE PROTEIN, CELL INVASION',1,2,1),(4815,'4nw2','TANDEM CHROMODOMAINS OF HUMAN CHD1 IN COMPLEX WITH INFLUENZA VIRUS NS1 C-TERMINAL TAIL TRIMETHYLATED AT K229','X-RAY DIFFRACTION',1.900,'PEPTIDE BINDING PROTEIN/VIRAL PROTEIN',2,2,1),(4816,'4nxq','CRYSTAL STRUCTURE OF T-CELL LYMPHOMA INVASION AND METASTASIS-1 PDZ DOMAIN QUADRUPLE MUTANT (QM) IN COMPLEX WITH CASPR4 PEPTIDE','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN/PEPTIDE',3,3,1),(4817,'4nxr','CRYSTAL STRUCTURE OF T-CELL LYMPHOMA INVASION AND METASTASIS-1 PDZ DOMAIN QUADRUPLE MUTANT (QM) IN COMPLEX WITH NEUREXIN-1 PEPTIDE','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN/PEPTIDE',1,1,1),(4818,'4ny3','HUMAN PTPA IN COMPLEX WITH PEPTIDE','X-RAY DIFFRACTION',1.800,'HYDROLASE ACTIVATOR',2,2,1),(4819,'4nz8','CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE-N COMPLEXED WITH CLEAVED POLY-ALANINE','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(4820,'4o1v','SPOP PROMOTES TUMORIGENESIS BY ACTING AS A KEY REGULATORY HUB IN KIDNEY CANCER','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',1,1,1),(4821,'4o21','PRODUCT COMPLEX OF METAL-FREE PKAC, ATP-GAMMA-S AND SP20.','X-RAY DIFFRACTION',1.950,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4822,'4o22','BINARY COMPLEX OF METAL-FREE PKAC WITH SP20.','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4823,'4o2c','AN NT-ACETYLATED PEPTIDE COMPLEXED WITH HLA-B*3901','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(4824,'4o2e','A PEPTIDE COMPLEXED WITH HLA-B*3901','X-RAY DIFFRACTION',1.980,'IMMUNE SYSTEM',2,2,1),(4825,'4o2f','A PEPTIDE COMPLEXED WITH HLA-B*3901','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(4826,'4o30','CRYSTAL STRUCTURE OF ATXR5 IN COMPLEX WITH HISTONE H3.1 AND ADOHCY','X-RAY DIFFRACTION',2.100,'TRANSFERASE',2,2,1),(4827,'4o36','SEMISYNTHETIC RNASE S1-15-H7/11-Q10','X-RAY DIFFRACTION',1.220,'HYDROLASE',1,1,1),(4828,'4o37','SEMINSYNTHETIC RNASE S1-15-3PL-7/11','X-RAY DIFFRACTION',1.400,'HYDROLASE',1,1,1),(4829,'4o42','TANDEM CHROMODOMAINS OF HUMAN CHD1 IN COMPLEX WITH INFLUENZA NS1 C- TERMINAL TAIL DIMETHYLATED AT K229','X-RAY DIFFRACTION',1.870,'DNA BINDING PROTEIN/VIRAL PROTEIN',1,1,1),(4830,'4o45','WDR5 IN COMPLEX WITH INFLUENZA NS1 C-TERMINAL TAIL','X-RAY DIFFRACTION',1.870,'TRANSCRIPTION/RNA BINDING PROTEIN',1,1,1),(4831,'4o4y','CRYSTAL STRUCTURE OF THE ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,2,1),(4832,'4o51','CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',4,8,1),(4833,'4o56','STRUCTURE OF PLK1 IN COMPLEX WITH PEPTIDE','X-RAY DIFFRACTION',1.800,'TRANSFERASE/PEPTIDE',1,1,1),(4834,'4o62','CW-TYPE ZINC FINGER OF ZCWPW2 IN COMPLEX WITH THE AMINO TERMINUS OF HISTONE H3','X-RAY DIFFRACTION',1.780,'METAL/DNA BINDING PROTEIN',1,1,1),(4835,'4o6w','PEPTIDE-BASED INHIBITORS OF PLK1 POLO-BOX DOMAIN','X-RAY DIFFRACTION',1.450,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4836,'4o97','CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4837,'4o9v','CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4838,'4o9w','CRYSTAL STRUCTURE OF POLO-LIKE KINASE(PLK1)PBD IN COMPLEX WITH PHOSPHO PEPTIDE','X-RAY DIFFRACTION',1.690,'TRANSFERASE/PEPTIDE',1,1,1),(4839,'4oaj','CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN SAP97 PDZ2 AND 5HT2A RECEPTOR PEPTIDE','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING',1,1,1),(4840,'4oar','PROGESTERONE RECEPTOR WITH BOUND ULIPRISTAL ACETATE AND A PEPTIDE FROM THE CO-REPRESSOR SMRT','X-RAY DIFFRACTION',2.410,'TRANSCRIPTION/PEPTIDE',1,1,1),(4841,'4obd','CRYSTAL STRUCTURE OF NELFINAVIR-RESISTANT, INACTIVE HIV-1 PROTEASE (D30N/N88D) IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (L449F/S451N)','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,4,1),(4842,'4obf','CRYSTAL STRUCTURE OF NELFINAVIR-RESISTANT, INACTIVE HIV-1 PROTEASE VARIANT (D30N/N88D) IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (S451N)','X-RAY DIFFRACTION',1.680,'HYDROLASE',2,4,1),(4843,'4obg','CRYSTAL STRUCTURE OF NELFINAVIR-RESISTANT, INACTIVE HIV-1 PROTEASE (D30N/N88D) IN COMPLEX WITH THE P1-P6 SUBSTRATE.','X-RAY DIFFRACTION',1.780,'HYDROLASE',2,4,1),(4844,'4obh','CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (L449F)','X-RAY DIFFRACTION',1.850,'HYDROLASE',2,4,1),(4845,'4obj','CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (S451N)','X-RAY DIFFRACTION',1.750,'HYDROLASE',1,2,1),(4846,'4obk','CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH THE P1-P6 SUBSTRATE VARIANT (L449F/S451N)','X-RAY DIFFRACTION',1.650,'HYDROLASE',1,2,1),(4847,'4oc7','RETINOIC ACID RECEPTOR ALPHA IN COMPLEX WITH (E)-3-(3\'-ALLYL-6- HYDROXY-[1,1\'-BIPHENYL]-3-YL)ACRYLIC ACID AND A FRAGMENT OF THE COACTIVATOR TIF2','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',1,1,1),(4848,'4od7','COMPLEX STRUCTURE OF PROTEUS MIRABLIS DSBA (C30S) WITH A NON- COVALENTLY BOUND PEPTIDE PWATCDS','X-RAY DIFFRACTION',1.600,'OXIDOREDUCTASE/PEPTIDE',3,3,1),(4849,'4od8','CRYSTAL STRUCTURE OF THE VACCINIA VIRUS DNA POLYMERASE HOLOENZYME SUBUNIT D4 IN COMPLEX WITH THE A20 N-TERMINUS','X-RAY DIFFRACTION',1.850,'HYDROLASE/REPLICATION',1,1,1),(4850,'4odk','STRUCTURE OF SLYD FROM THERMUS THERMOPHILUS IN COMPLEX WITH T1 PEPTIDE','X-RAY DIFFRACTION',1.400,'ISOMERASE, CHAPERONE',2,1,1),(4851,'4odm','STRUCTURE OF SLYD FROM THERMUS THERMOPHILUS IN COMPLEX WITH S2-W23A PEPTIDE','X-RAY DIFFRACTION',1.750,'ISOMERASE, CHAPERONE',9,4,1),(4852,'4odn','STRUCTURE OF SLYD FROM THERMUS THERMOPHILUS IN COMPLEX WITH S2-PLUS PEPTIDE','X-RAY DIFFRACTION',1.600,'ISOMERASE, CHAPERONE',1,1,1),(4853,'4odp','STRUCTURE OF SLYD DELTA-IF FROM THERMUS THERMOPHILUS IN COMPLEX WITH S2-W23A PEPTIDE','X-RAY DIFFRACTION',1.750,'ISOMERASE, CHAPERONE',1,1,1),(4854,'4odq','STRUCTURE OF SLYD DELTA-IF FROM THERMUS THERMOPHILUS IN COMPLEX WITH S3 PEPTIDE','X-RAY DIFFRACTION',2.000,'ISOMERASE, CHAPERONE',1,1,1),(4855,'4oey','CRYSTAL STRUCTURE OF AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',1.830,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4856,'4oez','CRYSTAL STRUCTURE OF AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',1.800,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4857,'4ofr','CRYSTAL STRUCTURE OF AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',2.260,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4858,'4ofu','CRYSTAL STRUCTURE OF AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',2.120,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4859,'4ogq','INTERNAL LIPID ARCHITECTURE OF THE HETERO-OLIGOMERIC CYTOCHROME B6F COMPLEX','X-RAY DIFFRACTION',2.500,'ELECTRON TRANSPORT',4,4,1),(4860,'4oh4','CRYSTAL STRUCTURE OF BRI1 IN COMPLEX WITH BKI1','X-RAY DIFFRACTION',2.250,'TRANSFERASE/SIGNALING PROTEIN',2,2,1),(4861,'4oh5','CRYSTAL STRUCTURE OF T877A-AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',2.000,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4862,'4oha','CRYSTAL STRUCTURE OF T877A-AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',1.420,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4863,'4oi4','PROTEIN COMPLEX OF CLP1 BOUND TO ATP AND MG2+ WITH PCF11DELTAN454DELTAC563 OF S. CEREVISIAE','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',3,2,1),(4864,'4oih','IMPORTIN ALPHA IN COMPLEX WITH THE BIPARTITE NLS OF PRP20','X-RAY DIFFRACTION',2.100,'PROTEIN TRANSPORT/NUCLEAR PROTEIN',1,1,1),(4865,'4ojf','HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(4866,'4ok1','CRYSTAL STRUCTURE OF W741L-AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',2.090,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4867,'4okf','RNASE S IN COMPLEX WITH AN ARTIFICIAL PEPTIDE','X-RAY DIFFRACTION',1.540,'HYDROLASE',1,1,1),(4868,'4okt','CRYSTAL STRUCTURE OF W741L-AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',2.500,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4869,'4okw','CRYSTAL STRUCTURE OF W741L-AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',2.000,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4870,'4okx','CRYSTAL STRUCTURE OF W741L-AR-LBD BOUND WITH CO-REGULATOR PEPTIDE','X-RAY DIFFRACTION',2.100,'HORMONE RECEPTOR/PEPTIDE',1,1,1),(4871,'4omc','X-RAY STRUCTURE OF HUMAN FURIN IN COMPLEX WITH THE COMPETITIVE INHIBITOR META-GUANIDINOMETHYL-PHAC-RVR-AMBA','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',6,6,1),(4872,'4onf','FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(4873,'4ong','FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-40','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,2,1),(4874,'4oni','STRUCTURE OF HUMAN ORPHAN RECEPTOR LRH1 BOUND TO TWO BACTERIAL PHOSPHOLIPIDS','X-RAY DIFFRACTION',1.800,'NUCLEAR PROTEIN',2,2,1),(4875,'4ore','CYRSTAL STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE TERNARY COMPLEX FROM HAEMOPHILUS INFLUENZAE AT 2.2 A','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(4876,'4os1','CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK601 (BICYCLIC 1)','X-RAY DIFFRACTION',2.200,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4877,'4os2','CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK602 (BICYCLIC 1)','X-RAY DIFFRACTION',1.790,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4878,'4os4','CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK603 (BICYCLIC 1)','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4879,'4os5','CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK603 (BICYCLIC 2)','X-RAY DIFFRACTION',2.260,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4880,'4os6','CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK604 (BICYCLIC 2)','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4881,'4os7','CRYSTAL STRUCTURE OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (UPA) COMPLEXED WITH BICYCLIC PEPTIDE UK607 (BICYCLIC)','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4882,'4ou3','CRYSTAL STRUCTURE OF PORCINE AMINOPEPTIDASE N COMPLEXED WITH CNGRCG TUMOR-HOMING PEPTIDE','X-RAY DIFFRACTION',1.950,'HYDROLASE/PROTEIN BINDING',1,1,1),(4883,'4ouc','STRUCTURE OF HUMAN HASPIN IN COMPLEX WITH HISTONE H3 SUBSTRATE','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(4884,'4ov5','STRUCTURE OF HLA-DR1 WITH A BOUND PEPTIDE WITH NON-OPTIMAL ALANINE IN THE P1 POCKET','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',6,12,1),(4885,'4owf','CRYSTAL STRUCTURE OF THE NEMO COZI IN COMPLEX WITH HOIP NZF1 DOMAIN','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION/PROTEIN BINDING',1,2,1),(4886,'4owt','STRUCTURAL BASIS OF SOSS1 COMPLEX ASSEMBLY','X-RAY DIFFRACTION',2.000,'DNA BINDING PROTEIN',1,1,1),(4887,'4oww','STRUCTURAL BASIS OF SOSS1 IN COMPLEX WITH A 35NT SSDNA','X-RAY DIFFRACTION',2.300,'DNA BINDING PROTEIN',1,1,1),(4888,'4oyk','STRUCTURE OF HOIP PUB DOMAIN BOUND TO OTULIN PIM','X-RAY DIFFRACTION',2.000,'LIGASE',2,2,1),(4889,'4oz1','CRYSTAL STRUCTURE OF HUMAN CAPERALPHA UHM BOUND TO SF3B155 ULM5','X-RAY DIFFRACTION',1.740,'TRANSCRIPTION',1,2,1),(4890,'4p0a','CRYSTAL STRUCTURE OF HOIP PUB DOMAIN IN COMPLEX WITH P97 PIM','X-RAY DIFFRACTION',2.300,'LIGASE',2,2,1),(4891,'4p1n','CRYSTAL STRUCTURE OF ATG1-ATG13 COMPLEX','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT',1,2,1),(4892,'4p3c','MT1-MMP:FAB COMPLEX (FORM I)','X-RAY DIFFRACTION',1.940,'IMMUNE SYSTEM',1,2,1),(4893,'4p3d','MT1-MMP:FAB COMPLEX (FORM II)','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',2,4,1),(4894,'4p3w','CRYSTAL STRUCTURE OF THE HUMAN FILAMIN A IG-LIKE DOMAINS 20-21 IN COMPLEX WITH MIGFILIN PEPTIDE','X-RAY DIFFRACTION',2.000,'CELL ADHESION',6,6,1),(4895,'4p6w','CRYSTAL STRUCTURE OF MOMETASONE FUROATE-BOUND GLUCOCORTICOID RECEPTOR LIGAND BINDING DOMAIN','X-RAY DIFFRACTION',1.950,'HORMONE RECEPTOR/HORMONE ACTIVATOR',1,1,1),(4896,'4p6x','CRYSTAL STRUCTURE OF CORTISOL-BOUND GLUCOCORTICOID RECEPTOR LIGAND BINDING DOMAIN','X-RAY DIFFRACTION',2.500,'HORMONE RECEPTOR/HORMONE ACTIVATOR',6,6,1),(4897,'4p9v','GRB2 SH2 COMPLEXED WITH A PTYR-AC6CN-ASN TRIPEPTIDE','X-RAY DIFFRACTION',1.640,'SIGNALING PROTEIN/ANTAGONIST',1,1,1),(4898,'4p9z','GRB2 SH2 COMPLEXED WITH A PTYR-AC6C-ASN TRIPEPTIDE','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN/ANTAGONIST',1,1,1),(4899,'4pby','STRUCTURE OF THE HUMAN RBAP48-MTA1(656-686) COMPLEX','X-RAY DIFFRACTION',2.500,'CELL CYCLE',2,2,1),(4900,'4pbz','STRUCTURE OF THE HUMAN RBAP48-MTA1(670-695) COMPLEX','X-RAY DIFFRACTION',2.150,'CELL CYCLE',1,1,1),(4901,'4pc0','STRUCTURE OF THE HUMAN RBAP48-MTA1(670-711) COMPLEX','X-RAY DIFFRACTION',2.500,'CELL CYCLE',2,2,1),(4902,'4pd1','STRUCTURE OF GEPHYRIN E DOMAIN WITH GLYCINE-BETA RECEPTOR PEPTIDE','X-RAY DIFFRACTION',1.980,'STRUCTURAL PROTEIN/TRANSPORT PROTEIN',1,1,1),(4903,'4pes','CRYSTAL STRUCTURE OF INSULIN DEGRADING ENZYME COMPLEXED WITH INHIBITOR TERT-BUTYL [(2S)-2-(2,5-DIFLUOROPHENYL)-3-(QUINOLIN-3-YL) PROPYL]CARBAMATE','X-RAY DIFFRACTION',2.210,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4904,'4pg9','MHC CLASS I IN COMPLEX WITH SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAL','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(4905,'4pgc','MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGN(3,5-DIIODOTYROSINE)PAL','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM/PEPTIDE',3,3,1),(4906,'4pge','MHC CLASS I IN COMPLEX WITH MODIFIED SENDAI VIRUS NUCLEOPROTEIN PEPTIDE FAPGNYPAW','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM/PEPTIDE',1,1,1),(4907,'4pid','CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEASE WITH A WEAK PYRIMIDINE NITRILE INHIBITOR','X-RAY DIFFRACTION',1.590,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4908,'4pie','CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEASE A SUBSTRATE BASED NITRILE INHIBITOR','X-RAY DIFFRACTION',1.940,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4909,'4piq','CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 8 PROTEASE WITH A NITRILE INHIBITOR','X-RAY DIFFRACTION',2.070,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4910,'4pis','CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 8 PROTEASE IN COMPLEX WITH A NITRILE INHIBITOR','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4911,'4pj0','STRUCTURE OF T.ELONGATUS PHOTOSYSTEM II, ROWS OF DIMERS CRYSTAL PACKING','X-RAY DIFFRACTION',2.440,'OXIDOREDUCTASE, ELECTRON TRANSPORT',20,16,1),(4912,'4pk2','TUBULIN ACETYLTRANSFERASE COMPLEX WITH BISUBSTRATE ANALOG','X-RAY DIFFRACTION',1.350,'TRANSFERASE/PEPTIDE',1,1,1),(4913,'4pk3','TUBULIN ACETYLTRANSFERASE COMPLEX WITH BISUBSTRATE ANALOG','X-RAY DIFFRACTION',1.350,'TRANSFERASE/PEPTIDE',1,1,1),(4914,'4pkf','BENZYLSUCCINATE SYNTHASE ALPHA-BETA-GAMMA COMPLEX','X-RAY DIFFRACTION',2.000,'LYASE',1,1,1),(4915,'4pl8','STRUCTURE OF RABBIT SKELETAL MUSCLE ACTIN IN COMPLEX WITH A HYBRID PEPTIDE COMPRISING THYMOSIN BETA4 AND THE LYSINE-RICH REGION OF CORDON-BLEU','X-RAY DIFFRACTION',2.000,'CONTRACTILE PROTEIN/STRUCTURAL PROTEI',1,2,1),(4916,'4pld','HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, IN ITS APO STATE BOUND TO A FRAGMENT OF HUMAN TIF-2','X-RAY DIFFRACTION',1.750,'TRANSCRIPTION',1,1,1),(4917,'4ple','HUMAN NUCLEAR RECEPTOR LIVER RECEPTOR HOMOLOGUE-1, LRH-1, BOUND TO AN E. COLI PHOSPHOLIPID AND A FRAGMENT OF TIF-2','X-RAY DIFFRACTION',1.750,'TRANSCRIPTION',4,4,1),(4918,'4po2','CRYSTAL STRUCTURE OF THE STRESS-INDUCIBLE HUMAN HEAT SHOCK PROTEIN HSP70 SUBSTRATE-BINDING DOMAIN IN COMPLEX WITH PEPTIDE SUBSTRATE','X-RAY DIFFRACTION',2.000,'CHAPERONE',2,2,1),(4919,'4po6','CRYSTAL STRUCTURE OF THE HUMAN TYK2 FERM AND SH2 DOMAINS WITH AN IFNAR1 INTRACELLULAR PEPTIDE','X-RAY DIFFRACTION',1.990,'TRANSFERASE',1,1,1),(4920,'4poh','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 8-METHYL UAB30 AND THE COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(4921,'4poj','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 7-METHYL UAB30 AND THE COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(4922,'4pp3','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 6-METHYL UAB30 AND THE COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(4923,'4pp5','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 5-METHYL UAB30 AND THE COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(4924,'4pp6','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH RESVERATROL','X-RAY DIFFRACTION',2.200,'PROTEIN BINDING',2,2,1),(4925,'4pps','CRYSTAL STRUCTURE OF THE ESTROGEN RECEPTOR ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN A-CD RING ESTROGEN DERIVATIVE','X-RAY DIFFRACTION',1.930,'PROTEIN BINDING',2,2,1),(4926,'4pr5','CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-D5','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(4927,'4pra','CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-Q5','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(4928,'4prb','CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-A4','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',1,1,1),(4929,'4prd','CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-D5','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',1,1,1),(4930,'4pre','CRYSTAL STRUCTURE OF A HLA-B*35:08-HPVG-Q5','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',1,1,1),(4931,'4prh','CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG-D5 COMPLEX','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,3,1),(4932,'4pri','CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,3,1),(4933,'4prn','CRYSTAL STRUCTURE OF A HLA-B*35:01-HPVG-A4','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',1,1,1),(4934,'4prp','CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,3,1),(4935,'4pry','CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES','X-RAY DIFFRACTION',1.700,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4936,'4prz','CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES','X-RAY DIFFRACTION',2.120,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4937,'4ps0','CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES','X-RAY DIFFRACTION',1.630,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4938,'4ps1','CASPASE-8 SPECIFIC UNNATURAL AMINO ACID PEPTIDES','X-RAY DIFFRACTION',1.730,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(4939,'4psi','PIH1D1/PHOSPHO-TEL2 COMPLEX','X-RAY DIFFRACTION',2.450,'PROTEIN BINDING',2,2,1),(4940,'4psw','CRYSTAL STRUCTURE OF HISTONE ACETYLTRANSFERASE COMPLEX','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,2,1),(4941,'4pv8','CRYSTAL STRUCTURE OF H2KB-Q600F COMPLEX','X-RAY DIFFRACTION',2.310,'IMMUNE SYSTEM',2,2,1),(4942,'4pv9','CRYSTAL STRUCTURE OF H2KB-Q600V COMPLEX','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(4943,'4pvz','STRUCTURE OF YEAST IMPORTIN A BOUND TO THE MEMBRANE PROTEIN NUCLEAR LOCALIZATION SIGNAL SEQUENCE OF INM PROTEIN HEH2','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING',2,2,1),(4944,'4pxm','THE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN D538G MUTANT IN COMPLEX WITH ESTRADIOL AND A GLUCOCORTICOID RECEPTOR-INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',1.900,'HORMONE/PEPTIDE',2,2,1),(4945,'4pyu','THE CONSERVED UBIQUITIN-LIKE PROTEIN HUB1 PLAYS A CRITICAL ROLE IN SPLICING IN HUMAN CELLS','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING/ALLERGEN',6,6,1),(4946,'4pyw','1.92 ANGSTROM CRYSTAL STRUCTURE OF A1AT:TTAI TERNARY COMPLEX','X-RAY DIFFRACTION',1.910,'HYDROLASE INHIBITOR',2,1,1),(4947,'4pz3','HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE HUMAN CD44 HYALURONAN BINDING DOMAIN COMPLEX WITH UNDEFINED PEPTIDES','X-RAY DIFFRACTION',1.080,'CELL ADHESION',1,1,1),(4948,'4pz5','CRYSTAL STRUCTURE OF THE SECOND AND THIRD FIBRONECTIN F1 MODULES IN COMPLEX WITH A FRAGMENT OF BBK32 FROM BORRELIA BURGDORFERI','X-RAY DIFFRACTION',1.960,'CELL ADHESION',1,1,1),(4949,'4pz6','PCE1 GUANYLYLTRANSFERASE BOUND TO SER2/SER5 PHOSPHORYLATED RNA POL II CTD','X-RAY DIFFRACTION',2.410,'TRANSFERASE/TRANSCRIPTION',2,2,1),(4950,'4q0a','VITAMIN D RECEPTOR COMPLEX WITH LITHOCHOLIC ACID','X-RAY DIFFRACTION',1.900,'GENE REGULATION',1,1,1),(4951,'4q13','APO ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN D538G MUTANT WITH A GLUCOCORTICOID RECEPTOR-INTERACTING PROTEIN 1 NR BOX II PEPTIDE','X-RAY DIFFRACTION',2.240,'HORMONE BINDING PROTEIN/PEPTIDE',2,2,1),(4952,'4q1l','CRYSTAL STRUCTURE OF LEUCUROLYSIN-A COMPLEXED WITH AN ENDOGENOUS TRIPEPTIDE (QSW).','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(4953,'4q4i','CRYSTAL STRUCTURE OF E.COLI AMINOPEPTIDASE N IN COMPLEX WITH AMASTATIN','X-RAY DIFFRACTION',2.310,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4954,'4q5u','STRUCTURE OF CALMODULIN BOUND TO ITS RECOGNITION SITE FROM CALCINEURIN','X-RAY DIFFRACTION',1.950,'CALCIUM BINDING PROTEIN/PROTEIN BINDI',1,1,1),(4955,'4q6h','CFTR ASSOCIATED LIGAND (CAL) BOUND TO LAST 6 RESIDUES OF CFTR (DECAMERIC PEPTIDE: ICAL36VQDTRL)','X-RAY DIFFRACTION',1.900,'TRANSPORT PROTEIN',1,1,1),(4956,'4q6s','CFTR ASSOCIATED LIGAND (CAL) PDZ BOUND TO BIOTINYLATED PEPTIDE BT-L- ICAL36','X-RAY DIFFRACTION',1.450,'TRANSPORT PROTEIN',2,2,1),(4957,'4q94','HUMAN RPRD1B CID IN COMPLEX WITH A RPB1-CTD DERIVED SER2 PHOSPHORYLATED PEPTIDE','X-RAY DIFFRACTION',1.850,'PEPTIDE BINDING PROTEIN',2,2,1),(4958,'4q96','CID OF HUMAN RPRD1B IN COMPLEX WITH AN UNMODIFIED CTD PEPTIDE','X-RAY DIFFRACTION',1.850,'PROTEIN BINDING',2,4,1),(4959,'4qa5','CRYSTAL STRUCTURE OF A188T/Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.760,'HYDROLASE',2,2,1),(4960,'4qa6','CRYSTAL STRUCTURE OF I243N/Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',2.050,'HYDROLASE',2,2,1),(4961,'4qa7','CRYSTAL STRUCTURE OF H334R/Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',2.310,'HYDROLASE',1,1,1),(4962,'4qae','CRYSTAL STRUCTURE OF AN ENGINEERED LIPOCALIN (ANTICALIN) IN COMPLEX WITH HUMAN HEPCIDIN','X-RAY DIFFRACTION',2.100,'TRANSPORT PROTEIN/SIGNALING PROTEIN',6,6,1),(4963,'4qbm','CRYSTAL STRUCTURE OF HUMAN BAZ2A BROMODOMAIN IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H4K16ACK20AC)','X-RAY DIFFRACTION',1.650,'TRANSCRIPTION',2,2,1),(4964,'4qbq','CRYSTAL STRUCTURE OF DNMT3A ADD DOMAIN BOUND TO H3 PEPTIDE','X-RAY DIFFRACTION',2.410,'TRANSFERASE',1,2,1),(4965,'4qbr','CRYSTAL STRUCTURE OF DNMT3A ADD DOMAIN G550D MUTANT BOUND TO H3 PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSFERASE',2,2,1),(4966,'4qbs','CRYSTAL STRUCTURE OF DNMT3A ADD DOMAIN E545R MUTANT BOUND TO H3T3PH PEPTIDE','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(4967,'4qc1','CRYSTAL STRUCTURE OF HUMAN BAZ2B BROMODOMAIN IN COMPLEX WITH AN ACETYLATED HISTONE 3 PEPTIDE (H3K14AC)','X-RAY DIFFRACTION',1.990,'TRANSCRIPTION',2,2,1),(4968,'4qc3','CRYSTAL STRUCTURE OF HUMAN BAZ2B BROMODOMAIN IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H4K8ACK12AC)','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',1,2,1),(4969,'4qe6','FXR WITH CDCA AND NCOA-2 PEPTIDE','X-RAY DIFFRACTION',1.650,'TRANSCRIPTION',1,1,1),(4970,'4qeo','CRYSTAL STRUCTURE OF KRYPTONITE IN COMPLEX WITH MCHH DNA, H3(1-15) PEPTIDE AND SAH','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION/DNA',1,1,1),(4971,'4qfq','CRYSTAL STRUCTURE OF NATVIE NPU DNAE SPLIT INTEIN','X-RAY DIFFRACTION',2.040,'SPLICING',1,1,1),(4972,'4qh7','LC8 - ANA2 (159-168) COMPLEX','X-RAY DIFFRACTION',1.830,'MOTOR PROTEIN',4,4,1),(4973,'4qh8','LC8 - ANA2 (237-246) COMPLEX','X-RAY DIFFRACTION',1.900,'MOTOR PROTEIN',2,2,1),(4974,'4qj2','CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE VARIANT (I50V/A71V) IN COMPLEX WITH WT P1-P6 SUBSTRATE','X-RAY DIFFRACTION',2.130,'HYDROLASE',2,4,1),(4975,'4qj6','CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE VARIANT (I50V/A71V) IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (L449F)','X-RAY DIFFRACTION',1.500,'HYDROLASE',2,4,1),(4976,'4qj7','CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE VARIANT (I50V/A71V) IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (R452S)','X-RAY DIFFRACTION',1.670,'HYDROLASE',2,4,1),(4977,'4qj8','CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE VARIANT (I50V/A71V) IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (P453L)','X-RAY DIFFRACTION',2.000,'HYDROLASE',2,4,1),(4978,'4qj9','CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (R452S)','X-RAY DIFFRACTION',1.830,'HYDROLASE',1,2,1),(4979,'4qja','CRYSTAL STRUCTURE OF INACTIVE HIV-1 PROTEASE IN COMPLEX WITH P1-P6 SUBSTRATE VARIANT (P453L)','X-RAY DIFFRACTION',1.540,'HYDROLASE',1,2,1),(4980,'4qjr','CRYSTAL STRUCTURE OF HUMAN NUCLEAR RECEPTOR SF-1 (NR5A1) BOUND TO ITS HORMONE PIP3 AT 2.4 A RESOLUTION','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION FACTOR/HORMONE',1,1,1),(4981,'4qli','A NOVEL PHOSPHO-SWITCH IN THE LINKER REGION OF THE SNAIL ZINC FINGER PROTEIN WHICH REGULATES 14-3-3 ASSOCIATION, DNA BINDING AND EPITHELIAL-MESENCHYMAL DIFFERENTIATION','X-RAY DIFFRACTION',1.450,'SIGNALING PROTEIN',1,1,1),(4982,'4qo2','CRYSTAL STRUCTURE OF RHOMBOID INTRAMEMBRANE PROTEASE GLPG IN COMPLEX WITH PEPTIDE DERIVED INHIBITOR AC-IATA-CMK','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4983,'4qqi','CRYSTAL STRUCTURE OF ANKRA2-RFX7 COMPLEX','X-RAY DIFFRACTION',2.030,'STRUCTURAL PROTEIN',1,1,1),(4984,'4qrq','CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(4985,'4qrs','CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELK_IYM, ELKRKMIYM','X-RAY DIFFRACTION',1.400,'IMMUNE SYSTEM',1,1,1),(4986,'4qrt','CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELN_YYM, ELNRKMIYM','X-RAY DIFFRACTION',1.400,'IMMUNE SYSTEM',1,1,1),(4987,'4qru','CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH ELR_MYM, ELRRKMMYM','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(4988,'4qsy','SHP2 SH2 DOMAIN IN COMPLEX WITH GAB1 PEPTIDE','X-RAY DIFFRACTION',2.100,'HYDROLASE/PROTEIN BINDING',1,1,1),(4989,'4qt7','CRYSTAL STRUCTURE OF THE C-SRC SH3 DOMAIN IN COMPLEX WITH A PEPTIDE FROM THE HEPATITIS C VIRUS NS5A-PROTEIN','X-RAY DIFFRACTION',1.550,'TRANSFERASE/TRANSFERASE ACTIVATOR',1,1,1),(4990,'4qtx','CASPASE-3 Y195A','X-RAY DIFFRACTION',1.970,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4991,'4qty','CASPASE-3 E190A','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4992,'4qu0','CASPASE-3 Y195AV266H','X-RAY DIFFRACTION',1.950,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4993,'4qu5','CASPASE-3 T140V','X-RAY DIFFRACTION',1.910,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4994,'4qu8','CASPASE-3 M61A V266H','X-RAY DIFFRACTION',1.720,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4995,'4qu9','CASPASE-3 F128A','X-RAY DIFFRACTION',1.560,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4996,'4qua','CASPASE-3 Y195F','X-RAY DIFFRACTION',1.890,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4997,'4qub','CASPASE-3 K137A','X-RAY DIFFRACTION',1.690,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(4998,'4qud','CASPASE-3 T140F','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(4999,'4que','CASPASE-3 Y195FV266H','X-RAY DIFFRACTION',1.840,'HYDROLASE/HYDROLASE INHIBITOR',4,2,1),(5000,'4quf','CRYSTAL STRUCTURE OF CHROMODOMAIN OF RHINO WITH H3K9ME3','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING',3,3,1),(5001,'4qug','CASPASE-3 M61A','X-RAY DIFFRACTION',1.920,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5002,'4quh','CASPASE-3 T140G','X-RAY DIFFRACTION',1.760,'HYDROLASE/HYDROLASE INHIBITOR',3,2,1),(5003,'4qui','CASPASE-3 F128AV266H','X-RAY DIFFRACTION',1.760,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5004,'4quj','CASPASE-3 T140GV266H','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5005,'4qul','CASPASE-3 F55W','X-RAY DIFFRACTION',1.900,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5006,'4qut','STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN- CONTAINING PROTEIN 2 (ATAD2) COMPLEXED WITH HISTONE H4-K(AC)12','X-RAY DIFFRACTION',1.700,'SIGNALING PROTEIN',1,1,1),(5007,'4quu','STRUCTURE OF THE BROMODOMAIN OF HUMAN ATPASE FAMILY AAA DOMAIN- CONTAINING PROTEIN 2 (ATAD2) COMPLEXED WITH HISTONE H4-K(AC)5','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(5008,'4qve','CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH BID BH3 DOMAIN','X-RAY DIFFRACTION',2.050,'APOPTOSIS',1,1,1),(5009,'4qvf','CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH BIM BH3 DOMAIN','X-RAY DIFFRACTION',1.530,'APOPTOSIS',1,1,1),(5010,'4qwn','HISTONE DEMETHYLASE KDM2A-H3K36ME1-ALPHA-KG COMPLEX STRUCTURE','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE/STRUCTURAL PROTEIN',2,2,1),(5011,'4qx7','CRYSTAL STRUCTURE OF HISTONE DEMETHYLASE KDM2A-H3K36ME2 WITH ALPHA-KG','X-RAY DIFFRACTION',2.340,'OXIDOREDUCTASE/STRUCTURAL PROTEIN',2,2,1),(5012,'4qx8','CRYSTAL STRUCTURE OF HISTONE DEMETHYLASE KDM2A-H3K36ME3 COMPLEX WITH ALPHA-KG','X-RAY DIFFRACTION',1.650,'OXIDOREDUCTASE/STRUCTURAL PROTEIN',2,2,1),(5013,'4qxb','CRYSTAL STRUCTURE OF HISTONE DEMETHYLASE KDM2A-H3K36ME3 WITH NOG','X-RAY DIFFRACTION',1.600,'OXIDOREDUCTASE/STRUCTURAL PROTEIN',2,2,1),(5014,'4qxc','CRYSTAL STRUCTURE OF HISTONE DEMETHYLASE KDM2A-H3K36ME2 WITH NOG','X-RAY DIFFRACTION',1.750,'OXIDOREDUCTASE/STRUCTURAL PROTEIN',2,2,1),(5015,'4qxh','CRYSTAL STRUCTURE OF HISTONE DEMETHYLASE KDM2A-H3K36ME1 WITH NOG','X-RAY DIFFRACTION',2.200,'OXIDOREDUCTASE/STRUCTURAL PROTEIN',2,2,1),(5016,'4qxt','CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH FC27-MSP2 14-30','X-RAY DIFFRACTION',1.580,'IMMUNE SYSTEM',1,2,1),(5017,'4qxu','NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(5018,'4qy8','CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8) IN COMPLEX WITH 3D7-MSP2 14-30','X-RAY DIFFRACTION',1.350,'IMMUNE SYSTEM',1,2,1),(5019,'4qyd','CRYSTAL STRUCTURE OF THE HUMAN BRPF1 BROMODOMAIN IN COMPLEX WITH A HISTONE H4K12AC PEPTIDE','X-RAY DIFFRACTION',1.940,'PROTEIN BINDING',1,1,1),(5020,'4qyl','CRYSTAL STRUCTURE OF THE HUMAN BRPF1 BROMODOMAIN IN COMPLEX WITH A HISTONE H2AK5AC PEPTIDE','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',4,4,1),(5021,'4qyo','CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 14-22','X-RAY DIFFRACTION',1.210,'IMMUNE SYSTEM',1,2,1),(5022,'4r0i','CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(5023,'4r10','A CONSERVED PHOSPHORYLATION SWITCH CONTROLS THE INTERACTION BETWEEN CADHERIN AND BETA-CATENIN IN VITRO AND IN VIVO','X-RAY DIFFRACTION',2.300,'CELL ADHESION/PROTEIN BINDING',1,1,1),(5024,'4r1e','CRYSTAL STRUCTURE OF MTIP FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH A PEPTIDE-FRAGMENT CHIMERA','X-RAY DIFFRACTION',1.980,'PROTEIN BINDING/INHIBITOR',1,1,1),(5025,'4r3l','CRYSTAL STRUCTURE OF ARD1 N-TERMINAL ACETYLTRANSFERASE FROM SULFOLOBUS SOLFATARICUS BOUND TO SUBSTRATE PEPTIDE FRAGMENT AND COA','X-RAY DIFFRACTION',1.840,'TRANSFERASE/TRANSFERASE SUBSTRATE',1,1,1),(5026,'4r3s','CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 11-23','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,2,1),(5027,'4r5i','CRYSTAL STRUCTURE OF THE DNAK C-TERMINUS WITH THE SUBSTRATE PEPTIDE NRLLLTG','X-RAY DIFFRACTION',1.970,'CHAPERONE',1,1,1),(5028,'4r6n','JACALIN-CARBOHYDRATE INTERACTIONS. DISTORTION OF THE LIGAND AS A DETERMINANT OF AFFINITY','X-RAY DIFFRACTION',1.670,'SUGAR BINDING PROTEIN',4,4,1),(5029,'4r6o','JACALIN-CARBOHYDRATE INTERACTIONS. DISTORTION OF THE LIGAND AS A DETERMINANT OF AFFINITY.','X-RAY DIFFRACTION',1.600,'SUGAR BINDING PROTEIN',4,4,1),(5030,'4r6p','JACALIN-CARBOHYDRATE INTERACTIONS. DISTORTION OF THE LIGAND AS A DETERMINANT OF AFFINITY.','X-RAY DIFFRACTION',1.700,'SUGAR BINDING PROTEIN',4,4,1),(5031,'4r6q','JACALIN-CARBOHYDRATE INTERACTIONS. DISTORTION OF THE LIGAND AS A DETERMINANT OF AFFINITY.','X-RAY DIFFRACTION',1.600,'SUGAR BINDING PROTEIN',4,4,1),(5032,'4r6r','JACALIN-CARBOHYDRATE INTERACTIONS. DISTORTION OF THE LIGAND AS A DETERMINANT OF AFFINITY.','X-RAY DIFFRACTION',1.380,'SUGAR BINDING PROTEIN',4,4,1),(5033,'4r7a','CRYSTAL STRUCTURE OF RBBP4 BOUND TO PHF6 PEPTIDE','X-RAY DIFFRACTION',1.850,'GENE REGULATION',1,1,1),(5034,'4r8m','HUMAN SIRT2 CRYSTAL STRUCTURE IN COMPLEX WITH BHJH-TM1','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5035,'4r8t','STRUCTURE OF JEV PROTEASE','X-RAY DIFFRACTION',2.130,'HYDROLASE',1,1,1),(5036,'4rav','CRYSTAL STRUCTURE OF SCFVC4 IN COMPLEX WITH THE FIRST 17 AA OF HUNTINGTIN','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM/APOPTOSIS',2,4,1),(5037,'4rcp','CRYSTAL STRUCTURE OF PLK1 POLO-BOX DOMAIN IN COMPLEX WITH PL-2','X-RAY DIFFRACTION',1.600,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5038,'4re1','CRYSTAL STRUCTURE OF HUMAN TEAD1 AND DISULFIDE-ENGINEERED YAP','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION/PROTEIN BINDING',2,2,1),(5039,'4rey','CRYSTAL STRUCTURE OF THE GRASP65-GM130 C-TERMINAL PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.960,'MEMBRANE PROTEIN',1,1,1),(5040,'4rfw','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA-LIGAND BINDING DOMAIN COMPLEX WITH 9CUAB70 AND THE COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(5041,'4rh5','CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH EPS15 PTYR849 PEPTIDE','X-RAY DIFFRACTION',1.600,'HYDROLASE/PROTEIN BINDING',1,1,1),(5042,'4rh9','CRYSTAL STRUCTURE OF PTPN3 (PTPH1) H812F, M883G MUTANT IN COMPLEX WITH EPS15 PTYR849 PEPTIDE','X-RAY DIFFRACTION',1.600,'HYDROLASE/PROTEIN BINDING',1,1,1),(5043,'4rhg','CRYSTAL STRUCTURE OF PTPN3 (PTPH1) D811E, C842S MUTANT IN COMPLEX WITH EPS15 PTYR849 PEPTIDE','X-RAY DIFFRACTION',1.580,'HYDROLASE/PROTEIN BINDING',1,1,1),(5044,'4ris','STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(5045,'4rjf','CRYSTAL STRUCTURE OF THE HUMAN SLIDING CLAMP AT 2.0 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',2.010,'REPLICATION',3,3,1),(5046,'4rkj','CRYSTAL STRUCTURE OF THROMBIN MUTANT S195T (FREE FORM)','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(5047,'4rko','CRYSTAL STRUCTURE OF THROMBIN MUTANT S195T BOUND WITH PPACK','X-RAY DIFFRACTION',1.840,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5048,'4rmd','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEX WITH 9CUAB110 AND COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(5049,'4rme','CRYSTAL STRUCTURE OF HUMAN RETINOID X RECEPTOR ALPHA LIGAND BINDING DOMAIN COMPLEX WITH 9CUAB111 AND COACTIVATOR PEPTIDE GRIP-1','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(5050,'4rmi','HUMAN SIRT2 IN COMPLEX WITH SIRREAL1 AND AC-LYS-OTC PEPTIDE','X-RAY DIFFRACTION',1.450,'HYDROLASE/HYDROLASE INBITITOR',1,1,1),(5051,'4roj','CRYSTAL STRUCTURE OF THE VAV2 SH2 DOMAIN IN COMPLEX WITH TXNIP PHOSPHORYLATED PEPTIDE','X-RAY DIFFRACTION',1.950,'LIGASE',3,3,1),(5052,'4rqi','STRUCTURE OF TRF2/RAP1 SECONDARY INTERACTION BINDING SITE','X-RAY DIFFRACTION',2.440,'CELL CYCLE',4,4,1),(5053,'4rqz','RE-REFINEMENT OF 1SOZ, CRYSTAL STRUCTURE OF DEGS PROTEASE IN COMPLEX WITH AN ACTIVATING PEPTIDE','X-RAY DIFFRACTION',2.400,'HYDROLASE/PEPTIDE',3,3,1),(5054,'4rrv','CRYSTAL STRUCTURE OF PDK1 IN COMPLEX WITH ATP AND PIFTIDE','X-RAY DIFFRACTION',1.410,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5055,'4rs9','STRUCTURE OF MYC3 N-TERMINAL JAZ-BINDING DOMAIN [44-238] IN COMPLEX WITH JAS MOTIF OF JAZ9','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION REGULATOR',1,1,1),(5056,'4rsp','X-RAY STRUCTURE OF MERS-COV NSP5 PROTEASE BOUND WITH A DESIGNED INHIBITOR','X-RAY DIFFRACTION',1.620,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5057,'4rtz','CRYSTAL STRUCTURE OF THE C-SRC-SH3 DOMAIN IN COMPLEX WITH THE HIGH AFFINITY PEPTIDE VSL12','X-RAY DIFFRACTION',0.980,'PROTEIN BINDING',1,1,1),(5058,'4ru2','CRYSTAL STRUCTURE OF A RNA-BINDING PROTEIN 39 (RBM39) IN COMPLEX WITH FRAGMENT OF SPLICING FACTOR (U2AF) FROM MUS MUSCULUS AT 2.20 A RESOLUTION','X-RAY DIFFRACTION',2.200,'RNA BINDING PROTEIN',9,9,1),(5059,'4ruj','CRYSTAL STRUCTURE OF ZVDR L337H MUTANT-VD COMPLEX','X-RAY DIFFRACTION',2.350,'TRANSCRIPTION FACTOR/TRANSCRIPTION RE',1,1,1),(5060,'4rv0','CRYSTAL STRUCTURE OF TN COMPLEX','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING, TRANSPORT PROTEIN',1,3,1),(5061,'4rwf','CRYSTAL STRUCTURE OF THE CLR:RAMP2 EXTRACELLULAR DOMAIN HETERODIMER WITH BOUND ADRENOMEDULLIN','X-RAY DIFFRACTION',1.760,'MEMBRANE PROTEIN/HORMONE',1,1,1),(5062,'4rwg','CRYSTAL STRUCTURE OF THE CLR:RAMP1 EXTRACELLULAR DOMAIN HETERODIMER WITH BOUND HIGH AFFINITY CGRP ANALOG','X-RAY DIFFRACTION',2.440,'MEMBRANE PROTEIN/HORMONE',3,3,1),(5063,'4rwv','CRYSTAL STRUCTURE OF PIP3 BOUND HUMAN NUCLEAR RECEPTOR LRH-1 (LIVER RECEPTOR HOMOLOG 1, NR5A2) IN COMPLEX WITH A CO-REGULATOR DAX-1 (NR0B1) PEPTIDE AT 1.86 A RESOLUTION','X-RAY DIFFRACTION',1.860,'TRANSCRIPTION',1,1,1),(5064,'4rxh','CRYSTAL STRUCTURE OF IMPORTIN-ALPHA FROM NEUROSPORA CRASSA COMPLEXED WITH SV40NLS','X-RAY DIFFRACTION',1.760,'TRANSPORT PROTEIN',2,1,1),(5065,'4rxz','CRYSTAL STRUCTURE OF MDMX PHOSPORYLATED TYR99 IN COMPLEX WITH A 12-MER PEPTIDE','X-RAY DIFFRACTION',1.550,'INHIBITOR',2,2,1),(5066,'4ryd','X-RAY STRUCTURE OF HUMAN FURIN IN COMPLEX WITH THE COMPETITIVE INHIBITOR PARA-GUANIDINOMETHYL-PHAC-R-TLE-R-AMBA','X-RAY DIFFRACTION',2.150,'HYDROLASE/HYDROLASE INHIBITOR',6,6,1),(5067,'4s0g','CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH EPS15 PTYR849 P850V PEPTIDE','X-RAY DIFFRACTION',1.720,'HYDROLASE/PROTEIN BINDING',1,1,1),(5068,'4s15','CRYSTAL STRUCTURE OF THE ORPHAN NUCLEAR RECEPTOR RORALPHA LIGAND- BINDING DOMAIN IN COMPLEX WITH 4ALPHA-CABOXYL, 4BETA-METHYL- ZYMOSTEROL (4ACD8)','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(5069,'4s2t','CRYSTAL STRUCTURE OF X-PROLYL AMINOPEPTIDASE FROM CAENORHABDITIS ELEGANS: A CYTOSOLIC ENZYME WITH A DI-NUCLEAR ACTIVE SITE','X-RAY DIFFRACTION',2.150,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5070,'4sga','STRUCTURES OF PRODUCT AND INHIBITOR COMPLEXES OF STREPTOMYCES GRISEUS PROTEASE A AT 1.8 ANGSTROMS RESOLUTION. A MODEL FOR SERINE PROTEASE CATALYSIS','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5071,'4srn','STRUCTURAL CHANGES THAT ACCOMPANY THE REDUCED CATALYTIC EFFICIENCY OF TWO SEMISYNTHETIC RIBONUCLEASE ANALOGS','X-RAY DIFFRACTION',2.000,'HYDROLASE(NUCLEIC ACID,RNA)',1,1,1),(5072,'4thn','THE CRYSTAL STRUCTURE OF ALPHA-THROMBIN-HIRUNORM IV COMPLEX REVEALS A NOVEL SPECIFICITY SITE RECOGNITION MODE.','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(5073,'4tjx','CRYSTAL STRUCTURE OF PROTEASE-ASSOCIATED DOMAIN OF ARABIDOPSIS VSR1 IN COMPLEX WITH ALEURAIN PEPTIDE','X-RAY DIFFRACTION',1.900,'PROTEIN TRANSPORT',1,1,1),(5074,'4tky','THE COMPLEX STRUCTURE OF E. COLI DSBA BOUND TO A PEPTIDE AT THE DSBA/DSBB INTERFACE','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE/PEPTIDE INHIBITOR',4,4,1),(5075,'4tmp','CRYSTAL STRUCTURE OF AF9 YEATS BOUND TO H3K9AC PEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(5076,'4tn7','CRYSTAL STRUCTURE OF MOUSE KDM2A-H3K36ME-NO COMPLEX','X-RAY DIFFRACTION',2.200,'OXIDOREDUCTASE',2,2,1),(5077,'4tot','CRYSTAL STRUCTURE OF RAT CYCLOPHILIN D IN COMPLEX WITH A POTENT NONIMMUNOSUPPRESSIVE INHIBITOR','X-RAY DIFFRACTION',2.390,'ISOMERASE/ISOMERASE INHIBITOR',4,4,1),(5078,'4tq1','CRYSTAL STRUCTURE OF HUMAN ATG5-TECAIR','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',1,1,1),(5079,'4tqe','STRUCTURE OF TAU PEPTIDE IN COMPLEX WITH TAU5 ANTIBODY FAB FRAGMENT','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,2,1),(5080,'4tr9','TERNARY CO-CRYSTAL STRUCTURE OF FRUCTOSE-BISPHOSPHATE ALDOLASE FROM PLASMODIUM FALCIPARUM IN COMPLEX WITH TRAP AND A SMALL MOLECULE INHIBITOR','X-RAY DIFFRACTION',2.110,'LYASE/LYASE INHIBITOR',6,4,1),(5081,'4tsz','CRYSTAL STRUCTURE OF DNA POLYMERASE SLIDING CLAMP FROM PSEUDOMONAS AERUGINOSA WITH LIGAND','X-RAY DIFFRACTION',2.000,'TRANSFERASE',16,16,1),(5082,'4tt2','CRYSTAL STRUCTURE OF ATAD2A BROMODOMAIN COMPLEXED WITH H4(1-20)K5AC PEPTIDE','X-RAY DIFFRACTION',2.500,'GENE REGULATION',1,1,1),(5083,'4tuj','CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.','X-RAY DIFFRACTION',1.890,'IMMUNE SYSTEM',2,4,1),(5084,'4tuk','CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,2,1),(5085,'4tul','CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY AGAINST NEUROBLASTOMA ASSOCIATED ANTIGEN.','X-RAY DIFFRACTION',1.400,'IMMUNE SYSTEM',1,2,1),(5086,'4tuz','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH ALPHA-ZEARALENOL','X-RAY DIFFRACTION',1.900,'NUCLEAR PROTEIN',2,2,1),(5087,'4tv1','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH PROPYLPARABEN','X-RAY DIFFRACTION',1.850,'HORMONE RECEPTOR',2,2,1),(5088,'4tvg','HIV PROTEASE (PR) DIMER IN CLOSED FORM WITH PEPSTATIN IN ACTIVE SITE AND FRAGMENT AK-2097 IN THE OUTSIDE/TOP OF FLAP','X-RAY DIFFRACTION',2.180,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(5089,'4twi','THE STRUCTURE OF SIR2AF1 BOUND TO A SUCCINYLATED HISTONE PEPTIDE','X-RAY DIFFRACTION',1.790,'HYDROLASE',1,1,1),(5090,'4twj','THE STRUCTURE OF SIR2AF2 BOUND TO A MYRISTOYLATED HISTONE PEPTIDE','X-RAY DIFFRACTION',1.650,'HYDROLASE',1,1,1),(5091,'4txq','CRYSTAL STRUCTURE OF LIP5 N-TERMINAL DOMAIN COMPLEXED WITH CHMP1B MIM','X-RAY DIFFRACTION',2.210,'PROTEIN TRANSPORT',2,2,1),(5092,'4txr','CRYSTAL STRUCTURE OF LIP5 N-TERMINAL DOMAIN COMPLEXED WITH CHMP1B MIM AND CHMP5 MIM','X-RAY DIFFRACTION',1.000,'PROTEIN TRANSPORT',2,1,1),(5093,'4ty6','FACTOR XIA IN COMPLEX WITH THE INHIBITOR 4-{2-[(1S)-1-({[TRANS-4- (AMINOMETHYL)CYCLOHEXYL]CARBONYL}AMINO)-2-PHENYLETHYL]-1H-IMIDAZOL-4- YL}BENZAMIDE','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5094,'4tzm','C. ELEGANS HTP-2 BOUND TO HTP-3 CLOSURE MOTIF 1','X-RAY DIFFRACTION',2.300,'PEPTIDE BINDING PROTEIN',2,2,1),(5095,'4tzo','STRUCTURE OF C. ELEGANS HTP-1 BOUND TO HIM-3 CLOSURE MOTIF','X-RAY DIFFRACTION',2.400,'PEPTIDE BINDING PROTEIN',4,4,1),(5096,'4tzq','STRUCTURE OF C. ELEGANS HTP-1 BOUND TO HTP-3 MOTIF-1','X-RAY DIFFRACTION',2.300,'PEPTIDE BINDING PROTEIN',2,2,1),(5097,'4u0a','HEXAMERIC HIV-1 CA IN COMPLEX WITH CPSF6 PEPTIDE, P6 CRYSTAL FORM','X-RAY DIFFRACTION',2.050,'VIRAL PROTEIN',1,1,1),(5098,'4u0c','HEXAMERIC HIV-1 CA IN COMPLEX WITH NUP153 PEPTIDE, P6 CRYSTAL FORM','X-RAY DIFFRACTION',1.770,'VIRAL PROTEIN',1,1,1),(5099,'4u1e','CRYSTAL STRUCTURE OF THE EIF3B-CTD/EIF3I/EIF3G-NTD TRANSLATION INITIATION COMPLEX','X-RAY DIFFRACTION',2.000,'TRANSLATION',1,2,1),(5100,'4u1h','HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES','X-RAY DIFFRACTION',1.590,'IMMUNE SYSTEM',1,1,1),(5101,'4u1i','HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES','X-RAY DIFFRACTION',1.920,'IMMUNE SYSTEM',1,1,1),(5102,'4u1j','HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES','X-RAY DIFFRACTION',1.380,'IMMUNE SYSTEM',1,1,1),(5103,'4u1k','HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES','X-RAY DIFFRACTION',2.090,'IMMUNE SYSTEM',2,2,1),(5104,'4u1l','HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES','X-RAY DIFFRACTION',2.060,'IMMUNE SYSTEM',2,2,1),(5105,'4u1m','HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES','X-RAY DIFFRACTION',1.180,'IMMUNE SYSTEM',1,1,1),(5106,'4u1n','HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES','X-RAY DIFFRACTION',1.770,'IMMUNE SYSTEM',1,1,1),(5107,'4u1p','HUMAN FYN-SH2 DOMAIN IN COMPLEX WITH A SYNTHETIC HIGH-AFFINITY PHOSPHO-PEPTIDE','X-RAY DIFFRACTION',1.400,'TRANSFERASE',1,1,1),(5108,'4u1s','HLA CLASS I MICROPOLYMORPHISMS DETERMINE PEPTIDE-HLA LANDSCAPE AND DICTATE DIFFERENTIAL HIV-1 ESCAPE THROUGH IDENTICAL EPITOPES','X-RAY DIFFRACTION',1.760,'IMMUNE SYSTEM',1,1,1),(5109,'4u2w','ATOMIC RESOLUTION CRYSTAL STRUCTURE OF HV-BBI PROTEASE INHIBITOR FROM AMPHIBIAN SKIN IN COMPLEX WITH BOVINE TRYPSIN','X-RAY DIFFRACTION',1.000,'HYDROLASE/INHIBITOR',1,1,1),(5110,'4u68','CRYSTAL STRUCTURE OF RHINO CHROMODOMAIN IN COMPLEX WITH H3K9ME3','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',2,2,1),(5111,'4u6x','CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH ALQDA, A 15 MER SELF- PEPTIDE','X-RAY DIFFRACTION',1.680,'IMMUNE SYSTEM',1,1,1),(5112,'4u6y','CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH FLNDK, A 15 MER SELF- PEPTIDE','X-RAY DIFFRACTION',1.470,'IMMUNE SYSTEM',1,1,1),(5113,'4u7e','THE CRYSTAL STRUCTURE OF THE COMPLEX OF LIP5 NTD AND IST1 MIM','X-RAY DIFFRACTION',1.600,'PROTEIN TRANSPORT',1,1,1),(5114,'4u7i','STRUCTURE OF THE COMPLEX OF SPARTIN MIT AND IST1 MIM','X-RAY DIFFRACTION',1.790,'PROTEIN TRANSPORT',1,1,1),(5115,'4u7y','STRUCTURE OF THE COMPLEX OF VPS4B MIT AND IST1 MIM','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT',1,1,1),(5116,'4u90','GEPHE IN COMPLEX WITH PEG CROSSLINKED GABA RECEPTOR ALPHA3 SUBUNIT DERIVED DIMERIC PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSFER PROTEIN / STRUCTURAL PROTEIN',1,1,1),(5117,'4u91','GEPHE IN COMPLEX WITH PARA-PHENYL CROSSLINKED GLYCINE RECEPTOR BETA SUBUNIT DERIVED DIMERIC PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSFER PROTEIN / STRUCTURAL PROTEIN',2,1,1),(5118,'4u9w','CRYSTAL STRUCTURE OF NATD BOUND TO H4/H2A PEPTIDE AND COA','X-RAY DIFFRACTION',2.490,'TRANSFERASE',4,4,1),(5119,'4ub6','NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-1) BY A FEMTOSECOND X-RAY LASER','X-RAY DIFFRACTION',1.950,'ELECTRON TRANSPORT, PHOTOSYNTHESIS',19,16,1),(5120,'4ub8','NATIVE STRUCTURE OF PHOTOSYSTEM II (DATASET-2) BY A FEMTOSECOND X-RAY LASER','X-RAY DIFFRACTION',1.950,'ELECTRON TRANSPORT, PHOTOSYNTHESIS',19,16,1),(5121,'4ud7','STRUCTURE OF THE STAPLED PEPTIDE YS-02 BOUND TO MDM2','X-RAY DIFFRACTION',1.600,'LYASE',4,4,1),(5122,'4ud9','THROMBIN IN COMPLEX WITH 5-CHLOROTHIOPHENE-2-CARBOXAMIDE','X-RAY DIFFRACTION',1.120,'HYDROLASE',2,1,1),(5123,'4uda','MR IN COMPLEX WITH DEXAMETHASONE','X-RAY DIFFRACTION',2.030,'SIGNALING PROTEIN',1,1,1),(5124,'4udb','MR IN COMPLEX WITH DESISOBUTYRYLCICLESONIDE','X-RAY DIFFRACTION',2.360,'SIGNALING PROTEIN',1,1,1),(5125,'4udc','GR IN COMPLEX WITH DEXAMETHASONE','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',1,1,1),(5126,'4udd','GR IN COMPLEX WITH DESISOBUTYRYLCICLESONIDE','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(5127,'4udw','THROMBIN IN COMPLEX WITH 1-(2R)-2-AMINO-3-PHENYL-PROPANOYL-N-(2, 5DICHLOROPHENYL)METHYLPYRROLIDINE-2-CARBOXAMIDE','X-RAY DIFFRACTION',1.160,'HYDROLASE',2,1,1),(5128,'4ue1','STRUCTURE OF THE STAPLED PEPTIDE YS-01 BOUND TO MDM2','X-RAY DIFFRACTION',1.450,'LIGASE/PEPTIDE',4,4,1),(5129,'4ue7','THROMBIN IN COMPLEX WITH 1-AMIDINOPIPERIDINE','X-RAY DIFFRACTION',1.130,'HYDROLASE',2,1,1),(5130,'4ue8','COMPLEX OF D. MELANOGASTER EIF4E WITH THE 4E BINDING PROTEIN THOR','X-RAY DIFFRACTION',1.100,'TRANSLATION',1,1,1),(5131,'4ue9','COMPLEX OF D. MELANOGASTER EIF4E WITH THE 4E-BINDING PROTEIN 4E-T','X-RAY DIFFRACTION',2.150,'TRANSLATION',1,1,1),(5132,'4uec','COMPLEX OF D. MELANOGASTER EIF4E WITH EIF4G AND CAP ANALOG','X-RAY DIFFRACTION',2.400,'TRANSLATION',1,2,1),(5133,'4ued','COMPLEX OF HUMAN EIF4E WITH THE 4E BINDING PROTEIN 4E-BP1','X-RAY DIFFRACTION',1.750,'TRANSLATION',1,1,1),(5134,'4ueh','THROMBIN IN COMPLEX WITH BENZAMIDINE','X-RAY DIFFRACTION',1.160,'HYDROLASE',2,1,1),(5135,'4uf1','DEERPOX VIRUS DPV022 IN COMPLEX WITH BAK BH3','X-RAY DIFFRACTION',2.300,'VIRAL PROTEIN',1,1,1),(5136,'4ufd','THROMBIN IN COMPLEX WITH 4-(((1-((2S)-1-((2R)-2-( BENZYLSULFONYLAMINO)-3-PHENYL-PROPANOYL)PYRROLIDIN-2-YL)-1- OXO-ETHYL)AMINO)METHYL)BENZAMIDINE','X-RAY DIFFRACTION',1.430,'HYDROLASE',2,1,1),(5137,'4ufe','THROMBIN IN COMPLEX WITH (2R)-2-(BENZYLSULFONYLAMINO)-N-(2-( (4-CARBAMIMIDOYLPHENYL)METHYLAMINO)-2-OXO-BUTYL)-3-PHENYL- PROPANAMIDE','X-RAY DIFFRACTION',1.590,'HYDROLASE',2,1,1),(5138,'4uff','THROMBIN IN COMPLEX WITH (2R)-2-(BENZYLSULFONYLAMINO)-N-(2-( (4-CARBAMIMIDOYLPHENYL)METHYLAMINO)-2-OXO-ETHYL)-N-METHYL- 3-PHENYL-PROPANAMIDE','X-RAY DIFFRACTION',1.550,'HYDROLASE',2,1,1),(5139,'4ufg','THROMBIN IN COMPLEX WITH (2R)-2-(BENZYLSULFONYLAMINO)-N-(( 1S)-2-((4-CARBAMIMIDOYLPHENYL)METHYLAMINO)-1-METHYL-2-OXO- ETHYL)-N-METHYL-3-PHENYL-PROPANAMIDE ETHANE','X-RAY DIFFRACTION',1.650,'HYDROLASE',2,1,1),(5140,'4ui3','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH TA-26','X-RAY DIFFRACTION',2.000,'TRANSFERASE',2,2,1),(5141,'4ui4','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH TA-29','X-RAY DIFFRACTION',2.400,'TRANSFERASE',2,2,1),(5142,'4ui5','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH TA-41','X-RAY DIFFRACTION',1.650,'TRANSFERASE',2,2,1),(5143,'4ui6','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH TA-47','X-RAY DIFFRACTION',1.800,'TRANSFERASE',2,2,1),(5144,'4ui7','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH TA-49','X-RAY DIFFRACTION',1.800,'TRANSFERASE',2,2,1),(5145,'4ui8','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH TA-55','X-RAY DIFFRACTION',2.050,'TRANSFERASE',2,2,1),(5146,'4uj1','PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',1.770,'TRANSFERASE/INHIBITOR',1,1,1),(5147,'4uj2','PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',2.020,'TRANSFERASE/INHIBITOR',1,1,1),(5148,'4uj9','PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',1.870,'TRANSFERASE',1,1,1),(5149,'4uja','PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',1.930,'TRANSFERASE',1,1,1),(5150,'4ujb','PROTEIN KINASE A IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',1.950,'TRANSFERASE',1,1,1),(5151,'4um9','CRYSTAL STRUCTURE OF ALPHA V BETA 6 WITH PEPTIDE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(5152,'4umn','STRUCTURE OF A STAPLED PEPTIDE ANTAGONIST BOUND TO NUTLIN-RESISTANT MDM2.','X-RAY DIFFRACTION',1.990,'CELL CYCLE',2,2,1),(5153,'4un2','CRYSTAL STRUCTURE OF THE UBA DOMAIN OF DSK2 IN COMPLEX WITH UBIQUITIN','X-RAY DIFFRACTION',1.510,'PROTEIN BINDING',1,1,1),(5154,'4up0','TERNARY CRYSTAL STRUCTURE OF THE PYGO2 PHD FINGER IN COMPLEX WITH THE B9L HD1 DOMAIN AND A H3K4ME2 PEPTIDE','X-RAY DIFFRACTION',1.280,'TRANSCRIPTION',1,1,1),(5155,'4upu','CRYSTAL STRUCTURE OF IP3 3-K CALMODULIN BINDING REGION IN COMPLEX WITH CALMODULIN','X-RAY DIFFRACTION',2.340,'TRANSFERASE',1,1,1),(5156,'4uq2','CRYSTAL STRUCTURE OF HLA-A1101 IN COMPLEX WITH AN AZOBENZENE-CONTAINING PEPTIDE','X-RAY DIFFRACTION',2.430,'IMMUNE SYSTEM',2,2,1),(5157,'4uq3','CRYSTAL STRUCTURE OF HLA-A0201 IN COMPLEX WITH AN AZOBENZENE- CONTAINING PEPTIDE','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,2,1),(5158,'4uqt','RRM-PEPTIDE STRUCTURE IN RES COMPLEX','SOLUTION NMR',NULL,'TRANSLATION',1,1,1),(5159,'4uqy','COEVOLUTION OF THE ATPASE CLPV, THE TSSB-TSSC SHEATH AND THE ACCESSORY HSIE PROTEIN DISTINGUISHES TWO TYPE VI SECRETION CLASSES','X-RAY DIFFRACTION',1.600,'PROTEIN TRANSPORT',1,1,1),(5160,'4uqz','COEVOLUTION OF THE ATPASE CLPV, THE TSSB-TSSC SHEATH AND THE ACCESSORY HSIE PROTEIN DISTINGUISHES TWO TYPE VI SECRETION CLASSES','X-RAY DIFFRACTION',1.600,'PROTEIN TRANSPORT',1,1,1),(5161,'4usl','THE X-RAY STRUCTURE OF CALCIUM BOUND HUMAN SORCIN','X-RAY DIFFRACTION',1.650,'METAL BINDING PROTEIN',1,1,1),(5162,'4utv','CRYSTAL STRUCTURE OF ZEBRAFISH SIRTUIN 5 IN COMPLEX WITH 3-PHENYL- SUCCINYLATED CPS1-PEPTIDE','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,1,1),(5163,'4uu5','CRYSTAL STRUCTURE OF THE PDZ DOMAIN OF PALS1 IN COMPLEX WITH THE CRB PEPTIDE','X-RAY DIFFRACTION',1.230,'CELL ADHESION',1,1,1),(5164,'4uvp','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH 5-AMINO-3- ETHYL-1,2-DIHYDROISOQUINOLIN-1-ONE','X-RAY DIFFRACTION',1.750,'TRANSFERASE',2,2,1),(5165,'4uwx','STRUCTURE OF LIPRIN-ALPHA3 IN COMPLEX WITH MDIA1 DIAPHANOUS- INHIBITORY DOMAIN','X-RAY DIFFRACTION',1.650,'PEPTIDE-BINDING PROTEIN',2,2,1),(5166,'4ux9','CRYSTAL STRUCTURE OF JNK1 BOUND TO A MKK7 DOCKING MOTIF','X-RAY DIFFRACTION',2.340,'TRANSFERASE',4,4,1),(5167,'4uy4','1.86 A STRUCTURE OF HUMAN SPINDLIN-4 PROTEIN IN COMPLEX WITH HISTONE H3K4ME3 PEPTIDE','X-RAY DIFFRACTION',1.860,'PEPTIDE BINDING PROTEIN',2,2,1),(5168,'4uz3','CRYSTAL STRUCTURE OF THE N-TERMINAL LYSM DOMAINS FROM THE PUTATIVE NLPC/P60 D,L ENDOPEPTIDASE FROM T. THERMOPHILUS BOUND TO N-ACETYL- CHITOHEXAOSE','X-RAY DIFFRACTION',1.750,'HYDROLASE',1,2,1),(5169,'4uzq','STRUCTURE OF THE WNT DEACYLASE NOTUM IN COMPLEX WITH O-PALMITOLEOYL SERINE - CRYSTAL FORM IX - 1.5A','X-RAY DIFFRACTION',1.500,'HYDROLASE',1,1,1),(5170,'4uzy','CRYSTAL STRUCTURE OF THE CHLAMYDOMONAS IFT70 AND IFT52 COMPLEX','X-RAY DIFFRACTION',2.480,'MOTOR PROTEIN',1,1,1),(5171,'4v0v','THE CRYSTAL STRUCTURE OF MOUSE PP1G IN COMPLEX WITH TRUNCATED HUMAN PPP1R15B (631-660)','X-RAY DIFFRACTION',1.610,'HYDROLASE/HYDROLASE REGULATOR',2,2,1),(5172,'4v0w','THE CRYSTAL STRUCTURE OF MOUSE PP1G IN COMPLEX WITH TRUNCATED HUMAN PPP1R15B (631-669)','X-RAY DIFFRACTION',1.550,'HYDROLASE/HYDROLASE REGULATOR',2,2,1),(5173,'4v0x','THE CRYSTAL STRUCTURE OF MOUSE PP1G IN COMPLEX WITH TRUNCATED HUMAN PPP1R15B (631-684)','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE REGULATOR',1,1,1),(5174,'4v11','STRUCTURE OF SYNAPTOTAGMIN-1 WITH SV2A PEPTIDE PHOSPHORYLATED AT THR84','X-RAY DIFFRACTION',1.950,'SIGNALING PROTEIN',1,1,1),(5175,'4v1t','HETEROCYCLASE IN COMPLEX WITH SUBSTRATE AND COFACTOR','X-RAY DIFFRACTION',2.140,'HYDROLASE',2,2,1),(5176,'4v2v','JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27ME3 PEPTIDE (25-29) ARK(ME3)SA','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE',2,2,1),(5177,'4v2w','JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H3K27ME3 PEPTIDE (16-35)','X-RAY DIFFRACTION',1.810,'OXIDOREDUCTASE',1,1,1),(5178,'4v3i','CRYSTAL STRUCTURE OF TSSL FROM VIBRIO CHOLERAE.','X-RAY DIFFRACTION',1.500,'UNKNOWN FUNCTION',1,1,1),(5179,'4vgc','GAMMA-CHYMOTRYPSIN D-NAPHTHYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.100,'SERINE PROTEASE',1,2,1),(5180,'4w4z','STRUCTURE OF THE EPHA4 LBD IN COMPLEX WITH PEPTIDE','X-RAY DIFFRACTION',2.410,'TRANSFERASE/TRANSFERASE INHIBITOR',4,4,1),(5181,'4w50','STRUCTURE OF THE EPHA4 LBD IN COMPLEX WITH PEPTIDE','X-RAY DIFFRACTION',2.420,'TRANSFERASE/TRANSFERASE INHIBITOR',4,4,1),(5182,'4w8h','CRYSTAL STRUCTURE OF THE TIR DOMAIN OF THE TOLL-RELATED RECEPTOR TRR-2 FROM THE LOWER METAZOAN HYDRA MAGNIPAPILLATA (CRYSTAL FORM II)','X-RAY DIFFRACTION',1.140,'SIGNALING PROTEIN',1,1,1),(5183,'4w8p','CRYSTAL STRUCTURE OF RIAM TBS1 IN COMPLEX WITH TALIN R7R8 DOMAINS','X-RAY DIFFRACTION',1.500,'PEPTIDE BINDING PROTEIN',1,1,1),(5184,'4wb5','CRYSTAL STRUCTURE OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)','X-RAY DIFFRACTION',1.640,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5185,'4wb6','CRYSTAL STRUCTURE OF A L205R MUTANT OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(5186,'4wb7','CRYSTAL STRUCTURE OF A CHIMERIC FUSION OF HUMAN DNAJ (HSP40) AND CAMP- DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT)','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(5187,'4wb8','CRYSTAL STRUCTURE OF HUMAN CAMP-DEPENDENT PROTEIN KINASE A (CATALYTIC ALPHA SUBUNIT), EXON 1 DELETION','X-RAY DIFFRACTION',1.550,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5188,'4wci','CRYSTAL STRUCTURE OF THE 1ST SH3 DOMAIN FROM HUMAN CD2AP (CMS) IN COMPLEX WITH A PROLINE-RICH PEPTIDE (AA 378-393) FROM HUMAN RIN3','X-RAY DIFFRACTION',1.650,'SIGNALING PROTEIN',2,2,1),(5189,'4wdi','WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES','X-RAY DIFFRACTION',2.310,'IMMUNE SYSTEM',2,2,1),(5190,'4wfd','STRUCTURE OF THE RRP6-RRP47-MTR4 INTERACTION','X-RAY DIFFRACTION',2.400,'HYDROLASE',3,6,1),(5191,'4whh','A NEW CLASS OF PEPTIDOMIMETICS TARGETING THE POLO-BOX DOMAIN OF POLO- LIKE KINASE 1','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5192,'4whk','A NEW CLASS OF PEPTIDOMIMETICS TARGETING THE POLO-BOX DOMAIN OF POLO- LIKE KINASE 1','X-RAY DIFFRACTION',1.800,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5193,'4wht','STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11, P1 CRYSTAL FORM','X-RAY DIFFRACTION',2.220,'VIRAL PROTEIN',12,24,1),(5194,'4wih','CRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS','X-RAY DIFFRACTION',1.140,'TRANSFERASE',1,1,1),(5195,'4wj5','STRUCTURE OF HLA-A2 IN COMPLEX WITH AN ALTERED PEPTIDE LIGANDS BASED ON MART-1 VARIANT EPITOPE','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',2,2,1),(5196,'4wjn','CRYSTAL STRUCTURE OF SUMO1 IN COMPLEX WITH PHOSPHORYLATED PML','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING/SIGNALING PROTEIN',1,1,1),(5197,'4wjo','CRYSTAL STRUCTURE OF SUMO1 IN COMPLEX WITH PML','X-RAY DIFFRACTION',1.460,'PROTEIN BINDING/SIGNALING PROTEIN',1,1,1),(5198,'4wjp','CRYSTAL STRUCTURE OF SUMO1 IN COMPLEX WITH PHOSPHORYLATED DAXX','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING/SIGNALING PROTEIN',2,2,1),(5199,'4wjq','CRYSTAL STRUCTURE OF SUMO1 IN COMPLEX WITH DAXX','X-RAY DIFFRACTION',1.350,'PROTEIN BINDING/SIGNALING PROTEIN',2,2,1),(5200,'4wk0','METAL ION AND LIGAND BINDING OF INTEGRIN','X-RAY DIFFRACTION',1.780,'CELL ADHESION/IMMUNE SYSTEM',1,2,1),(5201,'4wk2','METAL ION AND LIGAND BINDING OF INTEGRIN','X-RAY DIFFRACTION',2.500,'CELL ADHESION/IMMUNE SYSTEM',1,2,1),(5202,'4wk4','METAL ION AND LIGAND BINDING OF INTEGRIN','X-RAY DIFFRACTION',2.500,'CELL ADHESION/IMMUNE SYSTEM',1,2,1),(5203,'4wkm','AMPR EFFECTOR BINDING DOMAIN FROM CITROBACTER FREUNDII BOUND TO UDP- MURNAC-PENTAPEPTIDE','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',8,8,1),(5204,'4wlb','CRYSTAL STRUCTURE OF RORC IN COMPLEX WITH A PARTIAL INVERSE AGONIST COMPOUND','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION',2,2,1),(5205,'4wm0','CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH ACCEPTOR LIGAND','X-RAY DIFFRACTION',2.370,'TRANSFERASE/PROTEIN BINDING',1,1,1),(5206,'4wm7','CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS D68 IN COMPLEX WITH PLECONARIL','X-RAY DIFFRACTION',2.320,'VIRUS',1,3,1),(5207,'4wm8','CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS D68','X-RAY DIFFRACTION',2.000,'VIRUS',1,3,1),(5208,'4wma','CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE,ACCEPTOR LIGAND AND UDP-GLUCOSE','X-RAY DIFFRACTION',1.620,'TRANSFERASE/PROTEIN BINDING',1,1,1),(5209,'4wmb','CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE, ACCEPTOR LIGAND AND UDP','X-RAY DIFFRACTION',2.050,'TRANSFERASE/PROTEIN BINDING',1,1,1),(5210,'4wmi','CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE, PRODUCT LIGAND AND UDP (PRODUCT COMPLEX I)','X-RAY DIFFRACTION',1.870,'TRANSFERASE/PROTEIN BINDING',1,1,1),(5211,'4wmk','CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE, PRODUCT LIGAND AND UDP (PRODUCT COMPLEX II)','X-RAY DIFFRACTION',2.080,'TRANSFERASE/PROTEIN BINDING',1,1,1),(5212,'4wn2','CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE, PRODUCT LIGAND AND UDP (PRODUCT COMPLEX III)','X-RAY DIFFRACTION',1.950,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5213,'4wnd','CRYSTAL STRUCTURE OF THE TPR DOMAIN OF LGN IN COMPLEX WITH FRMPD4/PRESO1 AT 1.5 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',1.500,'SIGNALING PROTEIN/PROTEIN BINDING',1,1,1),(5214,'4wne','CRYSTAL STRUCTURE OF THE TPR DOMAIN OF LGN IN COMPLEX WITH FRMPD4/PRESO1 AT 2.0 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN/PROTEIN BINDING',1,1,1),(5215,'4wng','CRYSTAL STRUCTURE OF THE TPR DOMAIN OF LGN IN COMPLEX WITH FRMPD4/PRESO1 AT 2.1 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',2.110,'SIGNALING PROTEIN/PROTEIN BINDING',1,1,1),(5216,'4wnh','CRYSTAL STRUCTURE OF MOUSE XYLOSIDE XYLOSYLTRANSFERASE 1 COMPLEXED WITH MANGANESE,ACCEPTOR LIGAND AND UDP-XYLOSE','X-RAY DIFFRACTION',1.950,'TRANSFERASE/PROTEIN BINDING',1,1,1),(5217,'4wnn','SPT16-H2A-H2B FACT HISTONE COMPLEX','X-RAY DIFFRACTION',1.800,'DNA BINDING PROTEIN',1,2,1),(5218,'4wpf','CRYSTAL STRUCTURE OF RORC IN COMPLEX WITH A PHENYL SULFONAMIDE AGONIST','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(5219,'4wqp','CRYSTAL STRUCTURE OF RORC IN COMPLEX WITH A BENZYL SULFONAMIDE INVERSE AGONIST','X-RAY DIFFRACTION',1.990,'TRANSCRIPTION',1,2,1),(5220,'4wrq','CRYSTAL STRUCTURE OF 14-3-3 ZETA WITH CHIBBY PEPTIDE','X-RAY DIFFRACTION',2.410,'SIGNALING PROTEIN',2,2,1),(5221,'4wsf','FALAFEL EVH1 DOMAIN BOUND TO CENP-C FIM','X-RAY DIFFRACTION',1.500,'SIGNALING PROTEIN',1,1,1),(5222,'4wu5','HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(WT)','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,2,1),(5223,'4wu7','HLA-A24 IN COMPLEX WITH HIV-1 NEF134-8(2F)','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(5224,'4wv6','HETERODIMER OF IMPORTIN ALPHA 1 WITH NUCLEAR LOCALIZATION SIGNAL OF TAF8','X-RAY DIFFRACTION',1.750,'TRANSPORT PROTEIN',2,1,1),(5225,'4wvh','CRYSTAL STRUCTURE OF THE TYPE-I SIGNAL PEPTIDASE FROM STAPHYLOCOCCUS AUREUS (SPSB) IN COMPLEX WITH A SUBSTRATE PEPTIDE (PEP1).','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN',1,1,1),(5226,'4wvi','CRYSTAL STRUCTURE OF THE TYPE-I SIGNAL PEPTIDASE FROM STAPHYLOCOCCUS AUREUS (SPSB) IN COMPLEX WITH A SUBSTRATE PEPTIDE (PEP2).','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(5227,'4wvj','CRYSTAL STRUCTURE OF THE TYPE-I SIGNAL PEPTIDASE FROM STAPHYLOCOCCUS AUREUS (SPSB) IN COMPLEX WITH AN INHIBITOR PEPTIDE (PEP3).','X-RAY DIFFRACTION',1.950,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5228,'4wvs','CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH (S)-3-(4- METHOXYPHENYL)-2-((S)-2-((S)-1-((S)-2-((S)-2-(METHYLAMINO) PROPANAMIDO)PENT-4-YNOYL)PYRROLIDINE-2-CARBOXAMIDO)-3- PHENYLPROPANAMIDO)PROPANOIC ACID','X-RAY DIFFRACTION',2.090,'APOPTOSIS',1,1,1),(5229,'4wvt','CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH LIGAND BOUND','X-RAY DIFFRACTION',1.960,'APOPTOSIS',2,2,1),(5230,'4wvu','CRYSTAL STRUCTURE OF XIAP-BIR2 DOMAIN COMPLEXED WITH LIGAND BOUND','X-RAY DIFFRACTION',2.020,'APOPTOSIS',1,1,1),(5231,'4wx4','CRYSTAL STRUCTURE OF ADENOVIRUS 8 PROTEASE IN COMPLEX WITH A NITRILE INHIBITOR','X-RAY DIFFRACTION',1.030,'HYDROLASE',1,1,1),(5232,'4wx6','CRYSTAL STRUCTURE OF HUMAN ADENOVIRUS 8 PROTEASE WITH AN IRREVERSIBLE VINYL SULFONE INHIBITOR','X-RAY DIFFRACTION',2.150,'HYDROLASE',2,2,1),(5233,'4wx7','CRYSTAL STRUCTURE OF ADENOVIRUS 8 PROTEASE WITH A NITRILE INHIBITOR','X-RAY DIFFRACTION',2.400,'HYDROLASE',2,2,1),(5234,'4wxa','CRYSTAL STRUCTURE OF BINARY COMPLEX GON7-PCC1','X-RAY DIFFRACTION',2.440,'TRANSCRIPTION',1,2,1),(5235,'4wy7','CRYSTAL STRUCTURE OF RECOMBINANT 4E10 EXPRESSED IN ESCHERICHIA COLI WITH EPITOPE BOUND','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,2,1),(5236,'4wyu','CRYSTAL STRUCTURE OF SCRIBBLE PDZ34 TANDEM IN COMPLEX WITH ITS TARGET PEPTIDE','X-RAY DIFFRACTION',2.500,'STRUCTURAL PROTEIN/PEPTIDE',2,2,1),(5237,'4wzx','ULK3 REGULATES CYTOKINETIC ABSCISSION BY PHOSPHORYLATING ESCRT-III PROTEINS','X-RAY DIFFRACTION',1.390,'CELL CYCLE',1,1,1),(5238,'4x0w','THE CRYSTAL STRUCTURE OF MUPAIN-1-17 IN COMPLEX WITH MURINISED HUMAN UPA','X-RAY DIFFRACTION',2.100,'HYDROLASE INHIBITOR/HYDROLASE',1,1,1),(5239,'4x1h','OPSIN/G(ALPHA) PEPTIDE COMPLEX STABILIZED BY NONYL-GLUCOSIDE','X-RAY DIFFRACTION',2.290,'SIGNALING PROTEIN',1,1,1),(5240,'4x1n','THE CRYSTAL STRUCTURE OF MUPAIN-1-16 IN COMPLEX WITH MURINISED HUMAN UPA AT PH7.4','X-RAY DIFFRACTION',1.800,'HYDROLASE INHIBITOR/HYDROLASE',1,1,1),(5241,'4x1p','THE CRYSTAL STRUCTURE OF MUPAIN-1-17 IN COMPLEX WITH MURINISED HUMAN UPA AT PH4.6','X-RAY DIFFRACTION',1.600,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5242,'4x1q','THE CRYSTAL STRUCTURE OF MUPAIN-1 IN COMPLEX WITH MURINISED HUMAN UPA AT PH7.4','X-RAY DIFFRACTION',2.280,'HYDROLASE INHIBITOR/HYDROLASE',1,1,1),(5243,'4x1r','THE CRYSTAL STRUCTURE OF MUPAIN-1-12 IN COMPLEX WITH MURINISED HUMAN UPA AT PH7.4','X-RAY DIFFRACTION',2.100,'HYDROLASE INHIBITOR/HYDROLASE',1,1,1),(5244,'4x1s','THE CRYSTAL STRUCTURE OF MUPAIN-1-16-D9A IN COMPLEX WITH MURINISED HUMAN UPA AT PH7.4','X-RAY DIFFRACTION',1.900,'HYDROLASE INHIBITOR/HYDROLASE',1,1,1),(5245,'4x1v','CRYSTAL STRUCTURE OF THE 2ND SH3 DOMAIN FROM HUMAN CD2AP (CMS) IN COMPLEX WITH A PROLINE-RICH PEPTIDE (AA 76-91) FROM HUMAN ARAP1','X-RAY DIFFRACTION',1.580,'SIGNALING PROTEIN',1,1,1),(5246,'4x2h','SAC3N PEPTIDE BOUND TO MEX67:MTR2','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',1,1,1),(5247,'4x2o','SAC3N PEPTIDE BOUND TO MEX67:MTR2','X-RAY DIFFRACTION',1.850,'TRANSPORT PROTEIN',1,1,1),(5248,'4x2v','CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS NS6 PROTEASE (INACTIVE C139A MUTANT) WITH A C-TERMINAL EXTENSION TO INCLUDE RESIDUE P1 PRIME OF NS7','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(5249,'4x34','CRYSTAL STRUCTURE OF THE 53BP1 TANDEM TUDOR DOMAIN IN COMPLEX WITH P53K381ACK382ME2','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',2,2,1),(5250,'4x3e','CRYSTAL STRUCTURE OF EED IN COMPLEX WITH A TRIMETHYLATED JARID2 PEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(5251,'4x3g','CRYSTAL STRUCTURE OF SIAH1 SINA DOMAIN IN COMPLEX WITH A USP19 PEPTIDE','X-RAY DIFFRACTION',2.340,'LIGASE',2,2,1),(5252,'4x3h','CRYSTAL STRUCTURE OF ARC N-LOBE COMPLEXED WITH STARGAZIN PEPTIDE','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',1,1,1),(5253,'4x3i','THE CRYSTAL STRUCTURE OF ARC N-LOBE COMPLEXED WITH CAMK2A FRAGMENT','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(5254,'4x3k','CRYSTAL STRUCTURE OF CHROMOBOX HOMOLOG 7 (CBX7) CHROMODOMAIN WITH H3K27ME3 PEPTIDE','X-RAY DIFFRACTION',1.450,'TRANSCRIPTION',2,2,1),(5255,'4x3o','SIRT2 IN COMPLEX WITH A MYRISTOYL PEPTIDE','X-RAY DIFFRACTION',1.500,'HYDROLASE/PEPTIDE',1,1,1),(5256,'4x3p','SIRT2 IN COMPLEX WITH A MYRISTOYL PEPTIDE','X-RAY DIFFRACTION',1.800,'HYDROLASE/PEPTIDE',1,1,1),(5257,'4x3s','CRYSTAL STRUCTURE OF CHROMOBOX HOMOLOGY 7 (CBX7) WITH SETDB1-1170ME3 PEPTIDE','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',2,2,1),(5258,'4x5k','HUMAN NAA50 COMPLEX WITH COENZYME A AND AN ACETYLATED PEPTIDE','X-RAY DIFFRACTION',2.490,'TRANSFERASE/PEPTIDE',1,1,1),(5259,'4x5w','HLA-DR1 WITH CLIP102-120(M107W)','X-RAY DIFFRACTION',1.340,'IMMUNE SYSTEM',1,2,1),(5260,'4x6n','FACTOR XIA IN COMPLEX WITH THE INHIBITOR 1-{(1S)-1-[4-(3-AMINO-1H- INDAZOL-6-YL)-5-CHLORO-1H-IMIDAZOL-2-YL]-2-PHENYLETHYL}-3-[5-CHLORO- 2-(1H-TETRAZOL-1-YL)BENZYL]UREA','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5261,'4x8k','MYCOBACTERIUM TUBERCULOSIS RBPA-SID IN COMPLEX WITH SIGMAA DOMAIN 2','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION ACTIVATOR',1,1,1),(5262,'4x8n','CRYSTAL STRUCTURE OF ASH2L SPRY DOMAIN IN COMPLEX WITH PHOSPHORYLATED RBBP5','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING',1,1,1),(5263,'4x8p','CRYSTAL STRUCTURE OF ASH2L SPRY DOMAIN IN COMPLEX WITH RBBP5','X-RAY DIFFRACTION',2.200,'PROTEIN BINDING',1,1,1),(5264,'4x9r','PLK-1 POLO-BOX DOMAIN IN COMPLEX WITH BIOACTIVE IMIDAZOLIUM-CONTAINING PHOSPHOPEPTIDE MACROCYCLE 3B','X-RAY DIFFRACTION',1.400,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5265,'4x9v','PLK-1 POLO-BOX DOMAIN IN COMPLEX WITH BIOACTIVE IMIDAZOLIUM-CONTAINING PHOSPHOPEPTIDE MACROCYCLE 3C','X-RAY DIFFRACTION',1.430,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5266,'4x9w','PLK-1 POLO-BOX DOMAIN IN COMPLEX WITH BIOACTIVE IMIDAZOLIUM-CONTAINING PHOSPHOPEPTIDE MACROCYCLE 4C','X-RAY DIFFRACTION',1.800,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5267,'4xal','CRYSTAL STRUCTURE OF THE CONSERVED CORE DOMAIN OF VP22 FROM HSV-1','X-RAY DIFFRACTION',1.870,'VIRAL PROTEIN',1,1,1),(5268,'4xaw','CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH PHOSPHATIDIC ACID (08:0 PA)','X-RAY DIFFRACTION',1.470,'IMMUNE SYSTEM',1,2,1),(5269,'4xbe','CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN (02:0 SM (D18:1/2:0)).','X-RAY DIFFRACTION',1.760,'IMMUNE SYSTEM',1,2,1),(5270,'4xbu','IN VITRO CRYSTAL STRUCTURE OF PAK4 IN COMPLEX WITH INKA PEPTIDE','X-RAY DIFFRACTION',2.060,'TRANSFERASE/PEPTIDE',1,1,1),(5271,'4xc1','CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE','X-RAY DIFFRACTION',1.630,'IMMUNE SYSTEM',1,2,1),(5272,'4xc2','CRYSTAL STRUCTURE OF GABARAP IN COMPLEX WITH KBTBD6 LIR PEPTIDE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',4,4,1),(5273,'4xc3','CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH RAC-GLYCEROL 1- PHOSPHATE','X-RAY DIFFRACTION',1.630,'IMMUNE SYSTEM',1,2,1),(5274,'4xcf','CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC)','X-RAY DIFFRACTION',1.430,'IMMUNE SYSTEM',1,2,1),(5275,'4xef','PYK2-FAT COMPLEXED WITH LEUPAXIN LD MOTIF LD1','X-RAY DIFFRACTION',2.500,'CELL ADHESION',4,2,1),(5276,'4xek','PYK2-FAT DOMAIN IN COMPLEX WITH LEUPAXIN LD4 MOTIF','X-RAY DIFFRACTION',1.790,'CELL ADHESION',1,1,1),(5277,'4xev','FUSION OF PYK2-FAT DOMAIN WITH LEUPAXIN LD1 MOTIF, COMPLEXED WITH LEUPAXIN LD4 PEPTIDE','X-RAY DIFFRACTION',2.010,'CELL ADHESION',2,2,1),(5278,'4xgz','CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD2 MOTIF IN COMPLEX WITH FAB FRAGMENT','X-RAY DIFFRACTION',2.500,'CELL ADHESION',12,24,1),(5279,'4xh2','CRYSTAL STRUCTURE OF HUMAN PAXILLIN LD4 MOTIF IN COMPLEX WITH FAB FRAGMENT','X-RAY DIFFRACTION',2.000,'CELL ADHESION',6,12,1),(5280,'4xhv','CRYSTAL STRUCTURE OF DROSOPHILA SPINOPHILIN-PDZ AND A C-TERMINAL PEPTIDE OF NEUREXIN','X-RAY DIFFRACTION',1.230,'SIGNALING PROTEIN',1,1,1),(5281,'4xi7','CRYSTAL STRUCTURE OF THE MZM-REP DOMAINS OF MIND BOMB 1 IN COMPLEX WITH JAGGED1 N-BOX PEPTIDE','X-RAY DIFFRACTION',2.050,'LIGASE',1,1,1),(5282,'4xib','CRYSTAL STRUCTURE OF THE MZM-REP DOMAINS OF MIND BOMB 1 IN COMPLEX WITH FLY DELTA N-BOX PEPTIDE','X-RAY DIFFRACTION',2.150,'LIGASE',1,1,1),(5283,'4xkl','CRYSTAL STRUCTURE OF NDP52 ZF2 IN COMPLEX WITH MONO-UBIQUITIN','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING/METAL BINDING PROTEIN',2,2,1),(5284,'4xmh','CRYSTAL STRUCTURE OF NITROPHORIN 7 FROM RHODNIUS PROLIXUS AT PH 7.8 COMPLEXED WITH GLY-GLY-GLY','X-RAY DIFFRACTION',1.290,'TRANSPORT PROTEIN',1,1,1),(5285,'4xnh','CRYSTAL STRUCTURE OF YEAST N-TERMINAL ACETYLTRANSFERASE NATE (IP6) IN COMPLEX WITH A BISUBSTRATE','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,2,1),(5286,'4xo9','CRYSTAL STRUCTURE OF A FIMH*DSG COMPLEX FROM E.COLI K12 IN SPACE GROUP C2','X-RAY DIFFRACTION',1.140,'CELL ADHESION',1,1,1),(5287,'4xod','CRYSTAL STRUCTURE OF A FIMH*DSG COMPLEX FROM E.COLI F18','X-RAY DIFFRACTION',1.140,'CELL ADHESION',1,1,1),(5288,'4xoe','CRYSTAL STRUCTURE OF A FIMH*DSG COMPLEX FROM E.COLI F18 WITH BOUND HEPTYL ALPHA-D-MANNOPYRANNOSIDE','X-RAY DIFFRACTION',2.400,'CELL ADHESION',1,1,1),(5289,'4xoj','STRUCTURE OF BOVINE TRYPSIN IN COMPLEX WITH ANALOGUES OF SUNFLOWER INHIBITOR 1 (SFTI-1)','X-RAY DIFFRACTION',0.910,'HYDROLASE',1,1,1),(5290,'4xpm','CRYSTAL STRUCTURE OF EGO-TC','X-RAY DIFFRACTION',2.400,'PROTEIN BINDING',1,2,1),(5291,'4xpn','CRYSTAL STRUCTURE OF PROTEIN PHOSPHATE 1 COMPLEXED WITH PP1 BINDING DOMAIN OF GADD34','X-RAY DIFFRACTION',2.290,'HYDROLASE',2,2,1),(5292,'4xt9','RORGAMMA (263-509) COMPLEXED WITH GSK2435341A AND SRC2','X-RAY DIFFRACTION',2.250,'UNKNOWN PROTEIN',1,1,1),(5293,'4xtr','STRUCTURE OF GET3 BOUND TO THE TRANSMEMBRANE DOMAIN OF PEP12','X-RAY DIFFRACTION',2.050,'HYDROLASE/TRANSPORT PROTEIN',1,2,1),(5294,'4xvj','STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC 2 REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC33.1','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(5295,'4xw4','X-RAY STRUCTURE OF PKAC WITH AMPPNP, SP20, CALCIUM IONS','X-RAY DIFFRACTION',1.820,'TRANSFERASE',1,1,1),(5296,'4xw5','X-RAY STRUCTURE OF PKAC WITH ATP, CP20, CALCIUM IONS','X-RAY DIFFRACTION',1.950,'TRANSFERASE',1,1,1),(5297,'4xw6','X-RAY STRUCTURE OF PKAC WITH ADP, FREE PHOSPHATE ION, CP20, MAGNESIUM IONS','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(5298,'4xxb','CRYSTAL STRUCTURE OF HUMAN MDM2-RPL11','X-RAY DIFFRACTION',2.400,'RNA BINDING PROTEIN/METAL BINDING PRO',1,1,1),(5299,'4xxc','HLA-B*1801 IN COMPLEX WITH A SELF-PEPTIDE, DELEIKAY','X-RAY DIFFRACTION',1.430,'IMMUNE SYSTEM',1,1,1),(5300,'4xxd','CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB','X-RAY DIFFRACTION',2.410,'IMMUNE SYSTEM',2,4,1),(5301,'4xzr','STRUCTURE OF YEAST IMPORTIN A BOUND TO THE MEMBRANE PROTEIN NUCLEAR LOCALIZATION SIGNAL SEQUENCE OF INM PROTEIN HEH1','X-RAY DIFFRACTION',2.250,'MEMBRANE PROTEIN/NUCLEAR PROTEIN',1,1,1),(5302,'4y19','IMMUNE COMPLEX','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,4,1),(5303,'4y1c','CYCLIC HEXAPEPTIDE CYC[NDPOPPKID] IN COMPLEX WITH HIV-1 INTEGRASE CORE DOMAIN','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE BINDING PROTE',1,2,1),(5304,'4y1d','CYCLIC HEXAPEPTIDE CYC[NDPOPPKID] IN COMPLEX WITH HIV-1 INTEGRASE CORE DOMAIN','X-RAY DIFFRACTION',1.930,'TRANSFERASE/TRANSFERASE BINDING PROTE',1,2,1),(5305,'4y29','IDENTIFICATION OF A NOVEL PPARG LIGAND THAT REGULATES METABOLISM','X-RAY DIFFRACTION',1.980,'DNA BINDING PROTEIN/TRANSCRIPTION',1,1,1),(5306,'4y2g','STRUCTURE OF BRCA1 BRCT DOMAINS IN COMPLEX WITH ABRAXAS SINGLE PHOSPHORYLATED PEPTIDE','X-RAY DIFFRACTION',2.500,'ANTITUMOR PROTEIN',1,1,1),(5307,'4y32','CRYSTAL STRUCTURE OF C-TERMINAL MODIFIED TAU PEPTIDE-HYBRID 109B WITH 14-3-3SIGMA','X-RAY DIFFRACTION',1.700,'SIGNALING PROTEIN',2,2,1),(5308,'4y3b','CRYSTAL STRUCTURE OF C-TERMINAL MODIFIED TAU PEPTIDE-HYBRID 201D WITH 14-3-3SIGMA','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',2,2,1),(5309,'4y3o','CRYSTAL STRUCTURE OF RIBOSOMAL OXYGENASE NO66 IN COMPLEX WITH SUBSTRATE RPL8 PEPTIDE AND NI(II) AND COFACTOR N-OXALYGLYCINE','X-RAY DIFFRACTION',2.200,'OXIDOREDUCTASE/PEPTIDE',2,2,1),(5310,'4y5i','CRYSTAL STRUCTURE OF C-TERMINAL MODIFIED TAU PEPTIDE-HYBRID 126B WITH 14-3-3SIGMA','X-RAY DIFFRACTION',1.400,'SIGNALING PROTEIN',2,2,1),(5311,'4y6l','HUMAN SIRT2 IN COMPLEX WITH MYRISTOYLATED PEPTIDE (H3K9MYR)','X-RAY DIFFRACTION',1.600,'HYDROLASE/PEPTIDE',2,2,1),(5312,'4y6o','HUMAN SIRT2 IN COMPLEX WITH MYRISTOYLATED PEPTIDE (TNF-ALPHAK20MYR)','X-RAY DIFFRACTION',1.600,'HYDROLASE/PEPTIDE',2,2,1),(5313,'4y70','YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',4,8,1),(5314,'4y77','YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',6,10,1),(5315,'4y7r','CRYSTAL STRUCTURE OF WDR5 IN COMPLEX WITH MYC MBIIIB PEPTIDE','X-RAY DIFFRACTION',1.900,'DNA BINDING PROTEIN',1,1,1),(5316,'4y7w','YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',6,10,1),(5317,'4y7y','YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',4,8,1),(5318,'4y80','YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',6,11,1),(5319,'4y8h','YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',6,10,1),(5320,'4y8l','YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',4,8,1),(5321,'4y9w','ASPARTIC PROTEINASE SAPP2 SECRETED FROM CANDIDA PARAPSILOSIS AT 0.82 A RESOLUTION.','X-RAY DIFFRACTION',0.830,'HYDROLASE',1,1,1),(5322,'4ya5','YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(5323,'4ycu','CRYSTAL STRUCTURE OF CLADOSPORIN IN COMPLEX WITH HUMAN LYSYL-TRNA SYNTHETASE','X-RAY DIFFRACTION',2.100,'LIGASE/ LIGASE INHIBITOR',1,2,1),(5324,'4yec','CRYSTAL STRUCTURE OF A CLOSTRIPAIN (PARMER_00083) FROM PARABACTEROIDES MERDAE ATCC 43184 IN COMPLEX WITH PEPTIDE INHIBITOR AC-VLTK-AOMK','X-RAY DIFFRACTION',1.120,'UNKNOWN FUNCTION/INHIBITOR',1,2,1),(5325,'4yes','THROMBIN IN COMPLEX WITH (S)-(4-CHLORO-2-((1-(5-METHYL-1H-PYRROLE-2- CARBONYL)PYRROLIDINE-2-CARBOXAMIDO)METHYL)PHENYL)METHANAMINIUM','X-RAY DIFFRACTION',1.500,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(5326,'4yfa','STRUCTURE OF N-ACYLHOMOSERINE LACTONE ACYLASE MACQ IN COMPLEX WITH DECANOIC ACID','X-RAY DIFFRACTION',2.200,'HYDROLASE',4,8,1),(5327,'4yfb','STRUCTURE OF N-ACYLHOMOSERINE LACTONE ACYLASE MACQ IN COMPLEX WITH PHENYLACETIC ACID','X-RAY DIFFRACTION',1.750,'HYDROLASE',4,8,1),(5328,'4ygm','VACCINIA VIRUS HIS-D4/A20(1-50) IN COMPLEX WITH URACIL','X-RAY DIFFRACTION',1.850,'HYDROLASE',1,1,1),(5329,'4ygw','RNASE S IN COMPLEX WITH STABILIZED S PEPTIDE','X-RAY DIFFRACTION',2.180,'HYDROLASE',1,1,1),(5330,'4ygy','CRYSTAL STRUCTURE OF HUMAN SCP1 BOUND TO TRANS-PROLINE PEPTIDOMIMETIC CTD PHOSPHO-SER5 PEPTIDE','X-RAY DIFFRACTION',2.360,'HYDROLASE',2,2,1),(5331,'4yh1','STRUCTURE OF HUMAN SCP1 BOUND TO CIS-PROLINE PEPTIDOMIMETIC CTD PHOSPHO-SER5 PEPTIDE','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(5332,'4yhz','CRYSTAL STRUCTURE OF 304M3-B FAB IN COMPLEX WITH H3K4ME3 PEPTIDE','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(5333,'4yi0','STRUCTURE OF MOUSE IMPORTIN A1 BOUND TO POM121NLS','X-RAY DIFFRACTION',1.810,'PROTEIN TRANSPORT',1,1,1),(5334,'4yia','STRUCTURAL MECHANISM OF HORMONE RELEASE IN THYROXINE BINDING GLOBULIN','X-RAY DIFFRACTION',1.580,'SIGNALING PROTEIN',1,1,1),(5335,'4yiz','CRYSTAL STRUCTURE OF ENGINEERED TGAMA1 LACKING THE DII LOOP IN COMPLEX WITH AN EIMERIA TENELLA RON2D3 PEPTIDE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',3,3,1),(5336,'4yj4','CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH THE BIM BH3 DOMAIN CONTAINING ILE155-TO-ARG AND GLU158-TO-PHOSPHOSERINE MUTATIONS','X-RAY DIFFRACTION',2.100,'APOPTOSIS',1,1,1),(5337,'4yje','CRYSTAL STRUCTURE OF APC-ARM IN COMPLEXED WITH AMER1-A1','X-RAY DIFFRACTION',1.900,'CELL ADHESION/PROTEIN BINDING',1,1,1),(5338,'4yjl','CRYSTAL STRUCTURE OF APC-ARM IN COMPLEXED WITH AMER1-A2','X-RAY DIFFRACTION',2.100,'CELL ADHESION/PROTEIN BINDING',6,6,1),(5339,'4yk6','CRYSTAL STRUCTURE OF APC-ARM IN COMPLEXED WITH AMER1-A4','X-RAY DIFFRACTION',1.700,'PROTEIN BINDING/CELL ADHESION',1,1,1),(5340,'4yk9','COMPLEX STRUCTURE OF BCL-XL AND MUTATED BIM BH3 DOMAIN','X-RAY DIFFRACTION',1.700,'APOPTOSIS',2,2,1),(5341,'4yl6','CRYSTAL STRUCTURE OF TRUNCATED CEREBRAL CAVERNOUS MALFORMATION 2 C- TERMINAL ADAPTOR DOMAIN IN COMPLEX WITH AN INTERNAL HELIX OF MITOGEN- ACTIVATED PROTEIN KINASE KINASE KINASE 3','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING',1,1,1),(5342,'4yl8','CRYSTAL STRUCTURE OF THE CRUMBS/MOESIN COMPLEX','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING',1,1,1),(5343,'4ynk','CRYSTAL STRUCTURE OF VITAMIN D RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH A 19-NORVITAMIN D COMPOUND','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(5344,'4ynl','CRYSTAL STRUCTURE OF THE HOOD DOMAIN OF ANABAENA HETR IN COMPLEX WITH THE HEXAPEPTIDE ERGSGR DERIVED FROM PATS','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',4,4,1),(5345,'4yo0','CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE','X-RAY DIFFRACTION',1.560,'IMMUNE SYSTEM',2,4,1),(5346,'4yoo','P107 POCKET DOMAIN IN COMPLEX WITH LIN52 P29A PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(5347,'4yos','P107 POCKET DOMAIN COMPLEXED WITH LIN52 PEPTIDE','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(5348,'4yoz','P107 POCKET DOMAIN IN COMPLEX WITH HPV E7 PEPTIDE','X-RAY DIFFRACTION',2.250,'TRANSCRIPTION',1,1,1),(5349,'4yr6','FAB FRAGMENT OF 5G6 IN COMPLEX WITH EPITOPE PEPTIDE','X-RAY DIFFRACTION',2.380,'IMMUNE SYSTEM',2,4,1),(5350,'4ysi','STRUCTURE OF USP7 WITH A NOVEL VIRAL PROTEIN','X-RAY DIFFRACTION',1.020,'HYDROLASE/PEPTIDE',1,1,1),(5351,'4yv8','CRYSTAL STRUCTURE OF CATHEPSIN K BOUND TO THE COVALENT INHIBITOR LICHOSTATINAL','X-RAY DIFFRACTION',2.000,'HYDROLASE/INHIBITOR',1,1,1),(5352,'4yv9','X-RAY CRYSTAL STRUCTURE OF STREPTOCOCCUS DYSGALACTIAE SHP PHEROMONE RECEPTOR RGG2','X-RAY DIFFRACTION',1.950,'DNA BINDING PROTEIN/INHIBITOR',4,4,1),(5353,'4ywc','CRYSTAL STRUCTURE OF MYC3(5-242) FRAGMENT IN COMPLEX WITH JAZ9(218- 239) PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION REGULATOR',2,2,1),(5354,'4yxr','CRYSTAL STRUCTURE OF PKA IN COMPLEX WITH INHIBITOR.','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(5355,'4yxs','CAMP-DEPENDENT PROTEIN KINASE PKA CATALYTIC SUBUNIT WITH PKI-5-24','X-RAY DIFFRACTION',2.110,'TRANSFERASE/INHIBITOR',1,1,1),(5356,'4yy6','CRYSTAL STRUCTURE OF BRD9 BROMODOMAIN BOUND TO A BUTYRYLLYSINE PEPTIDE','X-RAY DIFFRACTION',1.450,'PROTEIN BINDING',1,1,1),(5357,'4yyd','CRYSTAL STRUCTURE OF BRD9 BROMODOMAIN BOUND TO A CROTONYLLYSINE PEPTIDE','X-RAY DIFFRACTION',1.520,'PROTEIN BINDING',1,1,1),(5358,'4yyg','CRYSTAL STRUCTURE OF BRD9 BROMODOMAIN BOUND TO A BUTYRYLLYSINE PEPTIDE','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING',1,1,1),(5359,'4yyh','CRYSTAL STRUCTURE OF BRD9 BROMODOMAIN BOUND TO A CROTONYLLYSINE PEPTIDE','X-RAY DIFFRACTION',1.740,'PROTEIN BINDING',2,2,1),(5360,'4yyi','CRYSTAL STRUCTURE OF BRD9 BROMODOMAIN BOUND TO AN ACETYLATED PEPTIDE','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING',2,4,1),(5361,'4yyj','CRYSTAL STRUCTURE OF BRD9 BROMODOMAIN BOUND TO A BUTYRYLLYSINE PEPTIDE','X-RAY DIFFRACTION',1.850,'PROTEIN BINDING',2,4,1),(5362,'4yyk','CRYSTAL STRUCTURE OF BRD9 BROMODOMAIN BOUND TO A CROTONYLLYSINE PEPTIDE','X-RAY DIFFRACTION',1.790,'PROTEIN BINDING',2,4,1),(5363,'4yym','CRYSTAL STRUCTURE OF TAF1 BD2 BROMODOMAIN BOUND TO A BUTYRYLLYSINE PEPTIDE','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING',1,2,1),(5364,'4yyn','CRYSTAL STRUCTURE OF TAF1 BD2 BROMODOMAIN BOUND TO A CROTONYLLYSINE PEPTIDE','X-RAY DIFFRACTION',1.850,'PROTEIN BINDING',1,2,1),(5365,'4yz6','CRYSTAL STRUCTURE OF MYC3[44-238] FROM ARABIDOPSIS IN COMPLEX WITH JAZ1 PEPTIDE [200-221]','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION REGULATOR',1,1,1),(5366,'4yzh','STRUCTURE OF THE ARABIDOPSIS TAP38/PPH1 IN COMPLEX WITH PLHCB1 PHOSPHOPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE SUBSTRATE',1,1,1),(5367,'4z09','CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [THR2040ALA] PEPTIDE','X-RAY DIFFRACTION',2.000,'CELL INVASION',1,1,1),(5368,'4z0d','CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038TRP] PEPTIDE','X-RAY DIFFRACTION',2.100,'CELL INVASION',1,1,1),(5369,'4z0e','CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038TRN] PEPTIDE','X-RAY DIFFRACTION',1.900,'CELL INVASION',1,1,1),(5370,'4z0f','CRYSTAL STRUCTURE OF FVO STRAIN PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH THE RON2HP [PHE2038(6CW)] PEPTIDE','X-RAY DIFFRACTION',2.300,'CELL INVASION',1,1,1),(5371,'4z0r','CRYSTAL STRUCTURE OF THE CW DOMAIN OF ZCWPW2 MUTANT F78R IN COMPLEX WITH HISTONE H3 PEPTIDE','X-RAY DIFFRACTION',1.750,'PROTEIN BINDING/STRUCTURAL PROTEIN',1,1,1),(5372,'4z0u','RNASE HI/SSB-CT COMPLEX','X-RAY DIFFRACTION',2.000,'HYDROLASE/PEPTIDE',2,2,1),(5373,'4z0x','STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 434-446 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC26AM','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(5374,'4z0y','ACTIVE AURONE SYNTHASE (POLYPHENOL OXIDASE), COPPER B : SULFOHISTIDINE ~ 1.4 : 1','X-RAY DIFFRACTION',1.600,'OXIDOREDUCTASE',4,4,1),(5375,'4z0z','INACTIVE AURONE SYNTHASE (POLYPHENOL OXIDASE) FROM NATURAL SOURCE, SULFOHISTIDINE ~ 90 %','X-RAY DIFFRACTION',1.600,'OXIDOREDUCTASE',4,4,1),(5376,'4z10','INACTIVE AURONE SYNTHASE (POLYPHENOL OXIDASE) CO-CRYSTALLIZED WITH 1, 4-RESORCINOL','X-RAY DIFFRACTION',1.930,'OXIDOREDUCTASE',6,6,1),(5377,'4z2o','HIGH RESOLUTION CRYSTAL STRUCTURE OF SHORT HOEFAVIDIN-HOEF-PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.170,'BIOTIN BINDING PROTEIN',1,1,1),(5378,'4z2p','CRYSTAL STRUCTURE OF SHORT HOEFAVIDIN-HOEF-PEPTIDE(L9F) COMPLEX','X-RAY DIFFRACTION',1.600,'BIOTIN BINDING PROTEIN',2,2,1),(5379,'4z2v','CRYSTAL STRUCTURE OF SHORT HOEFAVIDIN-HOEF-PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.390,'BIOTIN BINDING PROTEIN',2,2,1),(5380,'4z33','CRYSTAL STRUCTURE OF THE SYNTENIN PDZ1 AND PDZ2 TANDEM IN COMPLEX WITH THE FRIZZLED 7 C-TERMINAL FRAGMENT AND PIP2','X-RAY DIFFRACTION',2.450,'SIGNALING PROTEIN',2,2,1),(5381,'4z5w','THE PLANT PEPTIDE HORMONE RECEPTOR','X-RAY DIFFRACTION',2.200,'HORMONE',2,2,1),(5382,'4z68','HYBRID STRUCTURAL ANALYSIS OF THE ARP2/3 REGULATOR ARPIN IDENTIFIES ITS ACIDIC TAIL AS A PRIMARY BINDING EPITOPE','X-RAY DIFFRACTION',1.860,'PROTEIN BINDING',1,1,1),(5383,'4z76','WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES','X-RAY DIFFRACTION',1.880,'IMMUNE SYSTEM',2,2,1),(5384,'4z77','WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',2,2,1),(5385,'4z78','WEAK TCR BINDING TO AN UNSTABLE INSULIN EPITOPE DRIVES TYPE 1 DIABETES','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',3,3,1),(5386,'4z80','CRYSTAL STRUCTURE OF TOXOPLASMA GONDII AMA4 DI-DII-EGF1 IN COMPLEX WITH A 33 AA TGRON2L1 PEPTIDE','X-RAY DIFFRACTION',1.530,'MEMBRANE PROTEIN',2,2,1),(5387,'4z83','PKAB3 IN COMPLEX WITH PYRROLIDINE INHIBITOR 47A','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(5388,'4z84','PKAB3 IN COMPLEX WITH PYRROLIDINE INHIBITOR 34A','X-RAY DIFFRACTION',1.550,'TRANSFERASE',1,1,1),(5389,'4z88','SH3-II OF DROSOPHILA RIM-BINDING PROTEIN WITH APLIP1 PEPTIDE','X-RAY DIFFRACTION',2.090,'RIM-BINDING PROTEIN',12,12,1),(5390,'4z8a','SH3-III OF DROSOPHILA RIM-BINDING PROTEIN BOUND TO A CACOPHONY DERIVED PEPTIDE','X-RAY DIFFRACTION',1.760,'RIM-BINDING PROTEIN',1,1,1),(5391,'4z8j','CRYSTAL STRUCTURE OF THE SNX27 PDZ DOMAIN BOUND TO THE C-TERMINAL PTHR PDZ BINDING MOTIF','X-RAY DIFFRACTION',0.950,'PROTEIN TRANSPORT',1,1,1),(5392,'4z9v','TCTP CONTAINS A BH3-LIKE DOMAIN, WHICH INSTEAD OF INHIBITING, ACTIVATES BCL-XL','X-RAY DIFFRACTION',2.100,'APOPTOSIS',6,2,1),(5393,'4zar','CRYSTAL STRUCTURE OF PROTEINASE K FROM ENGYODONTIUM ALBUMINHIBITED BY METHOXYSUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYL KETONE AT 1.15 A RESOLUTION','X-RAY DIFFRACTION',1.150,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5394,'4zbj','UBN1 PEPTIDE BOUND TO H3.3/H4/ASF1','X-RAY DIFFRACTION',2.250,'STRUCTURAL PROTEIN',1,2,1),(5395,'4zdu','CRYSTAL STRUCTURE OF IMPORTIN-ALPHA BOUND TO A NON-CLASSICAL NUCLEAR LOCALIZATION SIGNAL OF THE INFLUENZA A VIRUS NUCLEOPROTEIN','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT/SIGNALING PROTEIN',1,1,1),(5396,'4zeq','CRYSTAL STRUCTURE OF HUMAN BFL-1 IN COMPLEX WITH TBID BH3 PEPTIDE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HX9247','X-RAY DIFFRACTION',1.800,'APOPTOSIS',1,1,1),(5397,'4zfo','J22.9-XI: CHIMERIC MOUSE/HUMAN ANTIBODY AGAINST HUMAN BCMA (CD269)','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,4,1),(5398,'4zfz','CRYSTAL STRUCTURE OF RHESUS MACAQUE MHC CLASS I MOLECULE MAMU-B*098 COMPLEXED WITH MYRISTOYLATED 5-MER LIPOPEPTIDE DERIVED FROM SIV NEF PROTEIN','X-RAY DIFFRACTION',1.760,'IMMUNE SYSTEM',4,4,1),(5399,'4zgm','CRYSTAL STRUCTURE OF SEMAGLUTIDE PEPTIDE BACKBONE IN COMPLEX WITH THE GLP-1 RECEPTOR EXTRACELLULAR DOMAIN','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(5400,'4zhb','N-TERMINAL STRUCTURE OF ANKYRIN REPEAT-CONTAINING PROTEIN LEGA11 FROM LEGIONELLA PNEUMOPHILA','X-RAY DIFFRACTION',1.300,'STRUCTURAL GENOMICS, UNKNOWN FUNCTION',1,1,1),(5401,'4zhl','THE CRYSTAL STRUCTURE OF MUPAIN-1-IG IN COMPLEX WITH MURINISED HUMAN UPA AT PH7.4','X-RAY DIFFRACTION',2.060,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5402,'4zhm','THE CRYSTAL STRUCTURE OF MUPAIN-1--16-IG IN COMPLEX WITH MURINISED HUMAN UPA AT PH7.4','X-RAY DIFFRACTION',1.900,'HYDROLASE INHIBITOR/HYDROLASE',1,1,1),(5403,'4zi1','HUMAN ESTROGEN RECEPTOR BETA LIGAND-BINDING DOMAIN IN COMPLEX WITH KB095285 AND CIA12 COACTIVATOR PEPTIDE','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN',1,1,1),(5404,'4zie','CRYSTAL STRUCTURE OF CORE/LATCH DIMER OF BAX IN COMPLEX WITH BIMBH3','X-RAY DIFFRACTION',1.800,'APOPTOSIS',1,1,1),(5405,'4zif','CRYSTAL STRUCTURE OF CORE/LATCH DIMER OF BAX IN COMPLEX WITH BIMBH3MINI','X-RAY DIFFRACTION',2.400,'APOPTOSIS',1,1,1),(5406,'4zig','CRYSTAL STRUCTURE OF CORE/LATCH DIMER OF BAX IN COMPLEX WITH BIDBH3MINI','X-RAY DIFFRACTION',2.200,'APOPTOSIS',1,1,1),(5407,'4zih','CRYSTAL STRUCTURE OF CORE/LATCH DIMER OF BAX IN COMPLEX WITH BIMBH3MINI','X-RAY DIFFRACTION',2.500,'APOPTOSIS',1,1,1),(5408,'4zii','CRYSTAL STRUCTURE OF CORE/LATCH DIMER OF BAXI66A IN COMPLEX WITH BIDBH3','X-RAY DIFFRACTION',2.190,'APOPTOSIS',1,1,1),(5409,'4zj7','CRYSTAL STRUCTURE OF THE KARYOPHERIN KAP121P BOUND TO THE EXTREME C- TERMINUS OF THE PROTEIN PHOSPHATASE CDC14P','X-RAY DIFFRACTION',2.400,'PROTEIN TRANSPORT/HYDROLASE',1,1,1),(5410,'4zjx','CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF BOTULINUM NEUROTOXIN SEROTYPE A WITH A NOVEL CYCLIC PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.940,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5411,'4zkn','THE CRYSTAL STRUCTURE OF UPAIN-1-W3A IN COMPLEX WITH UPA AT PH5.5','X-RAY DIFFRACTION',1.360,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5412,'4zko','THE CRYSTAL STRUCTURE OF UPAIN-1-W3A IN COMPLEX WITH UPA AT PH7.4','X-RAY DIFFRACTION',1.290,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(5413,'4zks','THE CRYSTAL STRUCTURE OF UPAIN-1-W3A IN COMPLEX WITH INACTIVE UPA (UPA-S195A) AT PH7.4','X-RAY DIFFRACTION',1.850,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5414,'4zn7','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH DIETHYLSTILBESTROL','X-RAY DIFFRACTION',1.930,'TRANSCRIPTION',2,2,1),(5415,'4zn9','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH OXABICYCLIC HEPTENE SULFONATE (OBHS)','X-RAY DIFFRACTION',2.220,'TRANSCRIPTION',2,2,1),(5416,'4znh','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-FLUORO-SUBSTITUTED OBHS DERIVATIVE','X-RAY DIFFRACTION',1.930,'TRANSCRIPTION',2,2,1),(5417,'4zns','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 3-FLUORO-SUBSTITUTED OBHS DERIVATIVE','X-RAY DIFFRACTION',1.860,'TRANSCRIPTION',2,2,1),(5418,'4znt','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 3-BROMO-SUBSTITUTED OBHS DERIVATIVE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(5419,'4znu','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-METHYL-SUBSTITUTED OBHS DERIVATIVE','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(5420,'4znv','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 2-METHOXY-SUBSTITUTED OBHS DERIVATIVE','X-RAY DIFFRACTION',1.770,'TRANSCRIPTION',2,2,1),(5421,'4znw','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A 4-BROMO-SUBSTITUTED OBHS DERIVATIVE','X-RAY DIFFRACTION',2.310,'TRANSCRIPTION',2,2,1),(5422,'4zny','STRUCTURE OF THE HUMAN TSG101-UEV DOMAIN IN COMPLEX WITH THE PTAP MOTIF OF THE P19 GAG PROTEIN OF THE HUMAN T-CELL LEUKEMIA TYPE I VIRUS','X-RAY DIFFRACTION',2.400,'PROTEIN TRANSPORT',1,1,1),(5423,'4zox','CRYSTAL STRUCTURE OF THE SACCHAROMYCES CEREVISIAE SQT1 BOUND TO THE N- TERMINUS OF THE RIBOSOMAL PROTEIN L10','X-RAY DIFFRACTION',1.600,'CHAPERONE',1,1,1),(5424,'4zoz','CRYSTAL STRUCTURE OF THE CHAETOMIUM THERMOPHILUM SQT1 BOUND TO THE N- TERMINUS OF THE RIBOSOMAL PROTEIN L10','X-RAY DIFFRACTION',1.700,'CHAPERONE',2,2,1),(5425,'4zqw','CDII FROM ESCHERICHIA COLI EC869 IN COMPLEX WITH A MACROCYCLIC PEPTIDE','X-RAY DIFFRACTION',2.000,'TOXIN/INHIBITOR',2,2,1),(5426,'4zrk','MERLIN-FERM AND LATS1 COMPLEX','X-RAY DIFFRACTION',2.320,'SIGNALING PROTEIN/TRANSFERASE',4,4,1),(5427,'4zro','2.1 A X-RAY STRUCTURE OF FIPV-3CLPRO BOUND TO COVALENT INHIBITOR','X-RAY DIFFRACTION',2.060,'HYDROLASE/HYDROLASE INHIBITOR',4,4,1),(5428,'4zrt','PTP1BC215S BOUND TO NEPHRIN PEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.740,'HYDROLASE',1,1,1),(5429,'4zsh','RXR LBD IN COMPLEX WITH 9-CIS-13,14-DIHYDRORETINOIC ACID','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',1,1,1),(5430,'4ztd','CRYSTAL STRUCTURE OF HUMAN PCNA IN COMPLEX WITH A TRAIP PEPTIDE','X-RAY DIFFRACTION',2.200,'REPLICATION',3,3,1),(5431,'4zto','FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,4,1),(5432,'4zu1','CRYSTAL STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH O-ACETYL SERINE AND PEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.200,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5433,'4zu6','CRYSTAL STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH PRE-REACTIVE O-ACETYL SERINE, ALPHA- AMINOACRYLATE REACTION INTERMEDIATE AND PEPTIDE INHIBITOR AT THE RESOLUTION OF 2.25A','X-RAY DIFFRACTION',2.030,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5434,'4zuh','COMPLEX STRUCTURE OF PEDV 3CLPRO MUTANT (C144A) WITH A PEPTIDE SUBSTRATE.','X-RAY DIFFRACTION',2.390,'HYDROLASE/PEPTIDE',1,2,1),(5435,'4zuu','CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE GAG-CF9','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,1,1),(5436,'4zuv','CRYSTAL STRUCTURE OF EQUINE MHC I(EQCA-N*00602) IN COMPLEXED WITH EQUINE INFECTIOUS ANAEMIA VIRUS (EIAV) DERIVED PEPTIDE ENV-RW12','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',2,2,1),(5437,'4zvp','CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO DEVD INHIBITOR.','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(5438,'4zvq','CASPASE-7 VARIANT 2 (V2) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232M/Q276C SUBSTITUTIONS BOUND TO VEID INHIBITOR.','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(5439,'4zvr','CASPASE-7 VARIANT 4 (V4) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230V/W232Y/S234V/Q276D SUBSTITUTIONS BOUND TO DEVD INHIBITOR.','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(5440,'4zvs','CASPASE-7 VARIANT 1 (V1) WITH REPROGRAMMED SUBSTRATE SPECIFICITY DUE TO Y230A/W232M/S234N SUBSTITUTIONS, BOUND TO DEVD INHIBITOR.','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(5441,'4zw2','CRYSTAL STRUCTURE OF THE MOUSE VOLTAGE GATED CALCIUM CHANNEL BETA SUBUNIT ISOFORM 1A IN COMPLEX WITH ALPHA INTERACTION DOMAIN PEPTIDE.','X-RAY DIFFRACTION',1.860,'METAL TRANSPORT',1,1,1),(5442,'5a0e','CRYSTAL STRUCTURE OF CYCLOPHILIN D IN COMPLEX WITH CSA ANALOGUE, JW47.','X-RAY DIFFRACTION',1.250,'ISOMERASE',2,2,1),(5443,'5a0r','PRODUCT PEPTIDE-BOUND STRUCTURE OF METALLOPROTEASE ZMP1 VARIANT E143A FROM CLOSTRIDIUM DIFFICILE','X-RAY DIFFRACTION',1.250,'HYDROLASE',2,2,1),(5444,'5a0x','SUBSTRATE PEPTIDE-BOUND STRUCTURE OF METALLOPROTEASE ZMP1 VARIANT E143AY178F FROM CLOSTRIDIUM DIFFICILE','X-RAY DIFFRACTION',1.700,'HYDROLASE',2,2,1),(5445,'5a29','FAMILY 2 PECTATE LYASE FROM VIBRIO VULNIFICUS','X-RAY DIFFRACTION',1.900,'LYASE',1,1,1),(5446,'5a2i','CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH APD-SGALNAC-RP','X-RAY DIFFRACTION',1.880,'IMMUNE SYSTEM',1,1,1),(5447,'5a2j','CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH THE NAKED PEPTIDE APDTRP','X-RAY DIFFRACTION',1.650,'PEPTIDE BINDING PROTEIN',1,1,1),(5448,'5a2k','CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH APD-TGALNAC-RP','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(5449,'5a2l','CRYSTAL STRUCTURE OF SCFV-SM3 IN COMPLEX WITH APD-CGALNAC-RP','X-RAY DIFFRACTION',1.790,'IMMUNE SYSTEM',1,1,1),(5450,'5a2m','THROMBIN INHIBITOR','X-RAY DIFFRACTION',1.400,'HYDROLASE',2,1,1),(5451,'5a2p','THE COMPLEX STRUCTURE OF PDZ DOMAINS IN SYNTENIN-1 WITH 4L PEPTIDE','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',4,4,1),(5452,'5a53','CRYSTAL STRUCTURE OF THE RPF2-RRS1 COMPLEX','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,2,1),(5453,'5a86','STRUCTURE OF PREGNANE X RECEPTOR IN COMPLEX WITH A SPHINGOSINE 1- PHOSPHATE RECEPTOR 1 ANTAGONIST','X-RAY DIFFRACTION',2.250,'SIGNALING PROTEIN',2,2,1),(5454,'5ab0','CRYSTAL STRUCTURE OF AMINOPEPTIDASE ERAP2 WITH LIGAND','X-RAY DIFFRACTION',2.500,'HYDROLASE',2,2,1),(5455,'5abx','COMPLEX OF C. ELEGANS EIF4E-3 WITH THE 4E-BINDING PROTEIN MEXTLI AND CAP ANALOG','X-RAY DIFFRACTION',1.660,'TRANSLATION',1,1,1),(5456,'5aby','COMPLEX OF C. ELEGANS EIF4E-3 WITH THE 4E-BINDING PROTEIN MEXTLI','X-RAY DIFFRACTION',1.950,'TRANSLATION',3,3,1),(5457,'5adq','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH JW55','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(5458,'5adr','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH OD38','X-RAY DIFFRACTION',2.100,'TRANSFERASE',1,1,1),(5459,'5ads','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH OD39','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(5460,'5adt','CRYSTAL STRUCTURE OF HUMAN TANKYRASE 2 IN COMPLEX WITH OD73','X-RAY DIFFRACTION',2.150,'TRANSFERASE',1,1,1),(5461,'5aei','DESIGNED ARMADILLO REPEAT PROTEIN YIIIM5AII IN COMPLEX WITH PEPTIDE (KR)5','X-RAY DIFFRACTION',1.830,'DE NOVO PROTEIN',3,3,1),(5462,'5aer','NEURONAL CALCIUM SENSOR-1 (NCS-1)FROM RATTUS NORVEGICUS COMPLEX WITH D2 DOPAMINE RECEPTOR PEPTIDE FROM HOMO SAPIENS','X-RAY DIFFRACTION',2.190,'SIGNALING PROTEIN',2,1,1),(5463,'5af9','THROMBIN IN COMPLEX WITH 4-METHOXY-N-(2-PYRIDINYL)BENZAMIDE','X-RAY DIFFRACTION',1.180,'HYDROLASE',2,1,1),(5464,'5afg','STRUCTURE OF THE STAPLED PEPTIDE BOUND TO MDM2','X-RAY DIFFRACTION',1.900,'LIGASE',1,1,1),(5465,'5afp','NEURONAL CALCIUM SENSOR-1 (NCS-1)FROM RATTUS NORVEGICUS COMPLEX WITH RHODOPSIN KINASE PEPTIDE FROM HOMO SAPIENS','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',2,2,1),(5466,'5afw','ASSEMBLY OF METHYLATED LSD1 AND CHD1 DRIVES AR-DEPENDENT TRANSCRIPTION AND TRANSLOCATION','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(5467,'5afy','THROMBIN IN COMPLEX WITH 3-CHLORO-BENZAMIDE','X-RAY DIFFRACTION',1.120,'BLOOD CLOTTING',2,1,1),(5468,'5afz','THROMBIN IN COMPLEX WITH (2R)-2-(BENZYLSULFONYLAMINO)-N-(2-( (4-CARBAMIMIDOYLPHENYL)METHYLAMINO)-2-OXO-PROPYL)-3-PHENYL- PROPANAMIDE','X-RAY DIFFRACTION',1.530,'BLOOD CLOTTING',2,1,1),(5469,'5agu','THE SLIDING CLAMP OF MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH A NATURAL PRODUCT.','X-RAY DIFFRACTION',2.170,'TRANSFERASE',2,2,1),(5470,'5agv','THE SLIDING CLAMP OF MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH A NATURAL PRODUCT.','X-RAY DIFFRACTION',1.930,'TRANSFERASE/ANTIBIOTIC',2,2,1),(5471,'5agx','BCL-2 ALPHA BETA-1 LINEAR COMPLEX','X-RAY DIFFRACTION',2.240,'APOPTOSIS',2,2,1),(5472,'5ah2','THE SLIDING CLAMP OF MYCOBACTERIUM SMEGMATIS IN COMPLEX WITH A NATURAL PRODUCT.','X-RAY DIFFRACTION',2.130,'TRANSFERASE/ANTIBIOTIC',4,4,1),(5473,'5ah4','THE SLIDING CLAMP OF MYCOBACTERIUM SMEGMATIS IN COMPLEX WITH A NATURAL PRODUCT.','X-RAY DIFFRACTION',2.310,'TRANSFERASE/ANTIBIOTIC',2,2,1),(5474,'5ahg','THROMBIN IN COMPLEX WITH ((4-CHLOROPHENYL)SULFAMOYL))DIEMETHYLAMINE','X-RAY DIFFRACTION',1.240,'HYDROLASE',2,1,1),(5475,'5ajj','CRYSTAL STRUCTURE OF VARIOLA VIRUS VIRULENCE FACTOR F1L IN COMPLEX WITH HUMAN BID BH3 DOMAIN','X-RAY DIFFRACTION',1.750,'VIRAL PROTEIN',1,1,1),(5476,'5ajn','CRYSTAL STRUCTURE OF THE INACTIVE FORM OF GALNAC-T2 IN COMPLEX WITH THE GLYCOPEPTIDE MUC5AC-CYS13','X-RAY DIFFRACTION',1.670,'TRANSFERASE',1,1,1),(5477,'5ajo','CRYSTAL STRUCTURE OF THE INACTIVE FORM OF GALNAC-T2 IN COMPLEX WITH THE GLYCOPEPTIDE MUC5AC-3,13','X-RAY DIFFRACTION',1.480,'TRANSFERASE',1,1,1),(5478,'5ajp','CRYSTAL STRUCTURE OF THE ACTIVE FORM OF GALNAC-T2 IN COMPLEX WITH UDP AND THE GLYCOPEPTIDE MUC5AC-13','X-RAY DIFFRACTION',1.650,'TRANSFERASE',1,1,1),(5479,'5am8','CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N- DOMAIN IN COMPLEX WITH AMYLOID-BETA 4-10','X-RAY DIFFRACTION',1.900,'HYDROLASE',4,4,1),(5480,'5amb','CRYSTAL STRUCTURE OF THE ANGIOTENSIN-1 CONVERTING ENZYME N- DOMAIN IN COMPLEX WITH AMYLOID-BETA 35-42','X-RAY DIFFRACTION',1.550,'HYDROLASE',2,2,1),(5481,'5anr','STRUCTURE OF A HUMAN 4E-T - DDX6 - CNOT1 COMPLEX','X-RAY DIFFRACTION',2.100,'RNA BINDING PROTEIN',1,2,1),(5482,'5aph','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',1.540,'TRANSCRIPTION',1,1,1),(5483,'5apj','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',2.080,'TRANSCRIPTION',1,1,1),(5484,'5apk','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,2,1),(5485,'5apr','STRUCTURES OF COMPLEXES OF RHIZOPUSPEPSIN WITH PEPSTATIN AND OTHER STATINE-CONTAINING INHIBITORS','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5486,'5aul','PI3K P85 C-TERMINAL SH2 DOMAIN/CD28-DERIVED PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.100,'SIGNALING PROTEIN',1,1,1),(5487,'5aum','CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE','X-RAY DIFFRACTION',2.050,'IMMUNE SYSTEM/PEPTIDE',2,4,1),(5488,'5awj','CRYSTAL STRUCTURE OF VDR-LBD/PARTIAL AGONIST COMPLEX: 22S-HEXYL ANALOGUE','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(5489,'5axi','CRYSTAL STRUCTURE OF CBL-B TKB DOMAIN IN COMPLEX WITH CBLIN','X-RAY DIFFRACTION',2.500,'LIGASE/LIGASE INHIBITOR',1,1,1),(5490,'5az8','CRYSTAL STRUCTURE OF MBP-TOM20 FUSION PROTEIN TETHERED WITH ALDH PRESEQUENCE VIA A DISULFIDE BOND','X-RAY DIFFRACTION',1.700,'SUGAR BINDING PROTEIN, PEPTIDE BINDIN',1,1,1),(5491,'5azf','CRYSTAL STRUCTURE OF LGG-1 COMPLEXED WITH A WEEL PEPTIDE','X-RAY DIFFRACTION',1.600,'PROTEIN BINDING',2,2,1),(5492,'5azg','CRYSTAL STRUCTURE OF LGG-1 COMPLEXED WITH A UNC-51 PEPTIDE','X-RAY DIFFRACTION',1.810,'PROTEIN BINDING',2,2,1),(5493,'5b1a','BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',1.500,'OXIDOREDUCTASE',6,11,1),(5494,'5b1b','BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',1.600,'OXIDOREDUCTASE',6,10,1),(5495,'5b1z','CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH HBX-BH3 MOTIF','X-RAY DIFFRACTION',2.150,'APOPTOSIS',2,2,1),(5496,'5b38','KIR3DL1*005 IN COMPLEX WITH HLA-B*57:01','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,2,1),(5497,'5b39','KIR3DL1*015 IN COMPLEX WITH HLA-B*57:01','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(5498,'5b3s','BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)','X-RAY DIFFRACTION',1.680,'OXIDOREDUCTASE',6,10,1),(5499,'5b41','CRYSTAL STRUCTURE OF VDR-LBD COMPLEXED WITH 2-METHYLIDENE-19-NOR-1A, 25-DIHYDROXYVITAMIN D3','X-RAY DIFFRACTION',1.890,'TRANSCRIPTION',1,1,1),(5500,'5b56','CRYSTAL STRUCTURE OF HIV-1 VPR C-TERMINAL DOMAIN AND DIBB-M-IMPORTIN- ALPHA2 COMPLEX','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT/VIRAL PROTEIN',4,2,1),(5501,'5b5b','CRYSTAL STRUCTURE OF VDR-LBD COMPLEXED WITH 2-METHYLIDENE-26,27- DIPHENYL-19-NOR-1,25-DIHYDROXYVITAMIN D3','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(5502,'5b5e','CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX','X-RAY DIFFRACTION',1.870,'ELECTRON TRANSPORT, PHOTOSYNTHESIS',18,16,1),(5503,'5b5v','STRUCTURE OF FULL-LENGTH MOB1B','X-RAY DIFFRACTION',2.190,'METAL BINDING PROTEIN',2,4,1),(5504,'5b66','CRYSTAL STRUCTURE ANALYSIS OF PHOTOSYSTEM II COMPLEX','X-RAY DIFFRACTION',1.850,'ELECTRON TRANSPORT, PHOTOSYNTHESIS',18,17,1),(5505,'5b6c','STRUCTURAL DETAILS OF UFD1 BINDING TO P97','X-RAY DIFFRACTION',1.550,'HYDROLASE/PROTEIN BINDING',1,1,1),(5506,'5b6g','PROTEIN-PROTEIN INTERACTION','X-RAY DIFFRACTION',1.990,'PROTEIN BINDING/INHIBITOR',1,1,1),(5507,'5b74','CRYSTAL STRUCTURE OF CONJOINED PYROCOCCUS FURIOSUS L-ASPARAGINASE WITH PEPTIDE','X-RAY DIFFRACTION',2.040,'HYDROLASE',1,1,1),(5508,'5b75','CRYSTAL STRUCTURE OF MOZ DOUBLE PHD FINGER IN COMPLEX WITH HISTONE H3 BUTYRYLATION AT K14','X-RAY DIFFRACTION',1.700,'TRANSFERASE',1,1,1),(5509,'5b76','CRYSTAL STRUCTURE OF MOZ DOUBLE PHD FINGER DOMAIN IN COMPLEX WITH HISTONE H3 CROTONYLATION AT K14','X-RAY DIFFRACTION',1.650,'TRANSFERASE',1,1,1),(5510,'5b77','CRYSTAL STRUCTRUE OF MOZ DOUBLE PHD FINGER IN COMPLEX WITH HISTONE H3 PROPIONYLATION AT K14','X-RAY DIFFRACTION',1.550,'TRANSFERASE',1,1,1),(5511,'5b78','CRYSTAL STRUCTURE OF MOZ DOUBLE PHD FINGER MUTANT-S210D/N235R IN COMPLEX WITH HISTONE H3 CROTONYLATION AT K14','X-RAY DIFFRACTION',1.400,'TRANSFERASE',1,1,1),(5512,'5bn6','CRYSTAL STRUCTURE OF FRUTALIN FROM ARTOCARPUS INCISA IN COMPLEX WITH GALACTOSE','X-RAY DIFFRACTION',1.650,'SUGAR BINDING PROTEIN',4,4,1),(5513,'5bnn','CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS D68 IN COMPLEX WITH 6\'SL','X-RAY DIFFRACTION',2.320,'VIRUS',1,3,1),(5514,'5bno','CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS D68 IN COMPLEX WITH 6\'SLN','X-RAY DIFFRACTION',2.150,'VIRUS',1,3,1),(5515,'5bnp','CRYSTAL STRUCTURE OF HUMAN ENTEROVIRUS D68 IN COMPLEX WITH 3\'SLN','X-RAY DIFFRACTION',2.150,'VIRUS',1,3,1),(5516,'5bnw','THE ACTIVE SITE OF O-GLCNAC TRANSFERASE IMPOSES CONSTRAINTS ON SUBSTRATE SEQUENCE','X-RAY DIFFRACTION',2.400,'TRANSFERASE',1,1,1),(5517,'5bpu','CRYSTAL STRUCTURE OF NORRIN, A WNT SIGNALLING ACTIVATOR, CRYSTAL FORM I','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',2,4,1),(5518,'5bs0','MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,3,1),(5519,'5bs2','CRYSTAL STRUCTURE OF RBCX-IIA FROM CHLAMYDOMONAS REINHARDTII IN COMPLEX WITH RBCL C-TERMINAL TAIL','X-RAY DIFFRACTION',1.970,'CHAPERONE',1,2,1),(5520,'5btv','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH A TAU-PROTEIN PEPTIDE SURROUNDING PS324','X-RAY DIFFRACTION',1.700,'STRUCTURAL PROTEIN',1,1,1),(5521,'5buo','A RECEPTOR MOLECULE','X-RAY DIFFRACTION',2.310,'METAL TRANSPORT',1,1,1),(5522,'5bwd','BENZYLSUCCINATE ALPHA-GAMMA BOUND TO FUMARATE','X-RAY DIFFRACTION',2.000,'LYASE',1,1,1),(5523,'5bwl','CRYSTAL STRUCTURE OF SIRT5 IN COMPLEX WITH A COUMARIN-LABELLED SUCCINYL PEPTIDE','X-RAY DIFFRACTION',1.550,'HYDROLASE',1,1,1),(5524,'5bwn','CRYSTAL STRUCTURE OF SIRT3 WITH A H3K9 PEPTIDE CONTAINING A MYRISTOYL LYSINE','X-RAY DIFFRACTION',1.940,'PEPTIDE/HYDROLASE',1,1,1),(5525,'5bwo','CRYSTAL STRUCTURE OF HUMAN SIRT3 IN COMPLEX WITH A PALMITOYL H3K9 PEPTIDE','X-RAY DIFFRACTION',2.380,'PEPTIDE/HYDROLASE',1,1,1),(5526,'5bx6','PKA IN COMPLEX WITH A HALOGENATED PHTHALAZINONE FRAGMENT COMPOUND.','X-RAY DIFFRACTION',1.890,'TRANSFERASE',1,1,1),(5527,'5bx7','PKA IN COMPLEX WITH A BENZOTHIOPHENE FRAGMENT COMPOUND.','X-RAY DIFFRACTION',1.890,'TRANSFERASE',1,1,1),(5528,'5bxo','HUMAN TANKYRASE-2 IN COMPLEX WITH MACROCYCLISED EXTENDED PEPTIDE CP4N2M3','X-RAY DIFFRACTION',1.330,'TRANSFERASE',2,2,1),(5529,'5bxu','HUMAN TANKYRASE-2 IN COMPLEX WITH MACROCYCLISED EXTENDED PEPTIDE CP4N4M5','X-RAY DIFFRACTION',1.350,'TRANSFERASE',1,1,1),(5530,'5bxv','EIF4E COMPLEX','X-RAY DIFFRACTION',2.100,'TRANSLATION',2,2,1),(5531,'5c07','1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING YQFGPDFPIA','X-RAY DIFFRACTION',2.110,'IMMUNE SYSTEM',2,6,1),(5532,'5c08','1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV','X-RAY DIFFRACTION',2.330,'IMMUNE SYSTEM',2,6,1),(5533,'5c09','HLA CLASS I HISTOCOMPATIBILITY ANTIGEN','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,6,1),(5534,'5c0a','1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING MVW PEPTIDE','X-RAY DIFFRACTION',2.460,'IMMUNE SYSTEM',2,6,1),(5535,'5c0b','1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDFPTI','X-RAY DIFFRACTION',2.030,'IMMUNE SYSTEM',2,6,1),(5536,'5c0c','1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING RQFGPDWIVA','X-RAY DIFFRACTION',1.970,'IMMUNE SYSTEM',2,6,1),(5537,'5c0d','HLA-A02 CARRYING AQWGPDPAAA','X-RAY DIFFRACTION',1.680,'IMMUNE SYSTEM',1,1,1),(5538,'5c0e','HLA-A02 CARRYING YLGGPDFPTI','X-RAY DIFFRACTION',1.490,'IMMUNE SYSTEM',1,1,1),(5539,'5c0f','HLA-A02 CARRYING RQWGPDPAAV','X-RAY DIFFRACTION',1.460,'IMMUNE SYSTEM',1,1,1),(5540,'5c0g','HLA-A02 CARRYING YLGGPDFPTI','X-RAY DIFFRACTION',1.370,'IMMUNE SYSTEM',1,1,1),(5541,'5c0i','HAL-A02 CARRYING RQFGPDFPTI','X-RAY DIFFRACTION',1.530,'IMMUNE SYSTEM',1,1,1),(5542,'5c0j','HLA-A02 CARRYING RQFGPDWIVA','X-RAY DIFFRACTION',1.640,'IMMUNE SYSTEM',1,1,1),(5543,'5c0m','CRYSTAL STRUCTURE OF SGF29 TANDEM TUDOR DOMAIN IN COMPLEX WITH A CARBA CONTAINING PEPTIDE','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',2,2,1),(5544,'5c13','CRYSTAL STRUCTURE OF TAF3 PHD FINGER BOUND TO HISTONE H3C4ME3 PEPTIDE','X-RAY DIFFRACTION',2.100,'HYDROLASE',4,4,1),(5545,'5c1d','HUMAN OGT IN COMPLEX WITH UDP-5S-GLCNAC AND SUBSTRATE PEPTIDE (RB2L)','X-RAY DIFFRACTION',2.050,'TRANSFERASE',1,1,1),(5546,'5c26','CRYSTAL STRUCTURE OF SYK IN COMPLEX WITH COMPOUND 1','X-RAY DIFFRACTION',1.950,'TRANSFERASE/INHIBITOR',1,1,1),(5547,'5c27','CRYSTAL STRUCTURE OF SYK IN COMPLEX WITH COMPOUND 2','X-RAY DIFFRACTION',2.150,'TRANSFERASE/INHIBITOR',1,1,1),(5548,'5c3f','CRYSTAL STRUCTURE OF MCL-1 BOUND TO BID-MM','X-RAY DIFFRACTION',1.430,'APOPTOSIS',1,1,1),(5549,'5c3g','CRYSTAL STRUCTURE OF BCL-XL BOUND TO BIM-MM','X-RAY DIFFRACTION',2.450,'APOPTOSIS',1,1,1),(5550,'5c5p','CRYSTAL STRUCTURE OF HUMAN TANKYRASE-2 IN COMPLEX WITH A PYRANOPYRIDONE INHIBITOR','X-RAY DIFFRACTION',1.750,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(5551,'5c5q','CRYSTAL STRUCTURE OF HUMAN TANKYRASE-2 IN COMPLEX WITH A PYRANOPYRIDONE INHIBITOR','X-RAY DIFFRACTION',2.000,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(5552,'5c5r','CRYSTAL STRUCTURE OF HUMAN TANKYRASE-2 IN COMPLEX WITH A PYRANOPYRIDONE INHIBITOR','X-RAY DIFFRACTION',1.550,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(5553,'5c6d','CRYSTAL STRUCTURE OF USP7 IN COMPLEX WITH UHRF1','X-RAY DIFFRACTION',2.290,'HYDROLASE/LIGASE',2,2,1),(5554,'5c6h','MCL-1 COMPLEXED WITH MULE','X-RAY DIFFRACTION',2.050,'APOPTOSIS/APOPTOSIS REGULATOR',12,12,1),(5555,'5cfa','CRYSTAL STRUCTURES OF BBP FROM STAPHYLOCOCCUS AUREUS WITH PEPTIDE LIGAND','X-RAY DIFFRACTION',1.450,'PROTEIN BINDING/PEPTIDE',2,2,1),(5556,'5cfc','CRYSTAL STRUCTURE OF HUMAN CARDIOVIRUS SAFV-3','X-RAY DIFFRACTION',2.500,'VIRUS',1,3,1),(5557,'5cfd','CRYSTAL STRUCTURE OF DTT TREATED HUMAN CARDIOVIRUS SAFV-3','X-RAY DIFFRACTION',2.500,'VIRUS',1,3,1),(5558,'5cgh','YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5','X-RAY DIFFRACTION',2.500,'HYDROLASE/HYDROLASE INHIBITOR',2,4,1),(5559,'5cha','THE REFINEMENT AND THE STRUCTURE OF THE DIMER OF ALPHA- *CHYMOTRYPSIN AT 1.67-*ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',1.670,'HYDROLASE (SERINE PROTEINASE)',2,4,1),(5560,'5cil','CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (WDWD) WITH EPITOPE BOUND','X-RAY DIFFRACTION',1.810,'IMMUNE SYSTEM',1,2,1),(5561,'5cin','CRYSTAL STRUCTURE OF NON-NEUTRALIZING VERSION OF 4E10 (DELTALOOP) WITH EPITOPE BOUND','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,2,1),(5562,'5ciu','STRUCTURAL BASIS OF THE RECOGNITION OF H3K36ME3 BY DNMT3B PWWP DOMAIN','X-RAY DIFFRACTION',2.240,'TRANSFERASE',2,2,1),(5563,'5cj6','CRYSTAL STRUCTURE OF A SELECTIVE ANDROGEN RECEPTOR MODULATOR BOUND TO THE LIGAND BINDING DOMAIN OF THE HUMAN ANDROGEN RECEPTOR','X-RAY DIFFRACTION',2.070,'SIGNALING PROTEIN',1,1,1),(5564,'5cjb','HUMAN OSTEOCLAST ASSOCIATED RECEPTOR (OSCAR) IN COMPLEX WITH A COLLAGEN-LIKE PEPTIDE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM/STRUCTURAL PROTEIN',2,1,1),(5565,'5cno','CRYSTAL STRUCTURE OF THE EGFR KINASE DOMAIN MUTANT V924R','X-RAY DIFFRACTION',1.550,'TRANSFERASE',1,2,1),(5566,'5co5','CRYSTAL STRUCTURE OF AC-ACHBP IN COMPLEX WITH CONOTOXIN GIC','X-RAY DIFFRACTION',2.100,'METAL BINDING PROTEIN/TOXIN',5,5,1),(5567,'5cp0','MAS COMPLEX STRUCTURE OF PEPTIDE DEFORMYLASE FROM XANTHOMONAS ORYZAE PV ORYZAE','X-RAY DIFFRACTION',2.000,'HYDROLASE/SUBSTRATE',1,1,1),(5568,'5cq2','CRYSTAL STRUCTURE OF TANDEM WW DOMAINS OF ITCH IN COMPLEX WITH TXNIP PEPTIDE','X-RAY DIFFRACTION',1.400,'LIGASE',2,1,1),(5569,'5cqx','E. COLI MAZF MUTANT E24A IN COMPLEX WITH MAZE RESIDUES 68-82 FORM I','X-RAY DIFFRACTION',1.630,'HYDROLASE',1,2,1),(5570,'5cqy','E. COLI MAZF MUTANT E24A IN COMPLEX WITH MAZE RESIDUES 68-82 FORM II','X-RAY DIFFRACTION',2.480,'HYDROLASE',1,2,1),(5571,'5crv','CRYSTAL STRUCTURE OF THE BRO DOMAIN OF HD-PTP IN A COMPLEX WITH THE CORE REGION OF STAM2','X-RAY DIFFRACTION',2.000,'PROTEIN TRANSPORT',2,2,1),(5572,'5crw','CRYSTAL STRUCTURE OF THE B\'-A\' DOMAIN OF OXIDIZED PROTEIN DISULFIDE ISOMERASE COMPLEXED WITH ALPHA-SYNUCLEIN PEPTIDE (31-41)','X-RAY DIFFRACTION',1.600,'ISOMERASE/METAL BINDING PROTEIN',1,1,1),(5573,'5cs2','CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM DIADENOSINE TRIPHOSPHATE HYDROLASE IN COMPLEX WITH CYCLOMARIN A','X-RAY DIFFRACTION',1.650,'HYDROLASE',1,1,1),(5574,'5csf','S100B-RSK1 CRYSTAL STRUCTURE A','X-RAY DIFFRACTION',2.400,'TRANSFERASE',1,2,1),(5575,'5csi','S100B-RSK1 CRYSTAL STRUCTURE A\'','X-RAY DIFFRACTION',2.130,'TRANSFERASE',1,2,1),(5576,'5csz','CRYSTAL STRUCTURE OF GANTENERUMAB FAB FRAGMENT IN COMPLEX WITH ABETA 1-11','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',2,4,1),(5577,'5ctt','CRYSTAL STRUCTURE OF HUMAN SART3/TIP110 NLS-MOUSE IMPORTIN ALPHA COMPLEX','X-RAY DIFFRACTION',1.700,'TRANSPORT PROTEIN,IMMUNE SYSTEM,NUCLE',1,1,1),(5578,'5ctv','CATALYTIC DOMAIN OF LYTA, THE MAJOR AUTOLYSIN OF STREPTOCOCCUS PNEUMONIAE, (C60A, H133A, C136A MUTANT) COMPLEXED WITH PEPTIDOGLYCAN FRAGMENT','X-RAY DIFFRACTION',1.050,'HYDROLASE',2,1,1),(5579,'5cva','CRYSTAL STRUCTURE OF THE TYPE IX COLLAGEN NC2 HETERO-TRIMERIZATION DOMAIN WITH A GUEST FRAGMENT A1A2A1 OF TYPE I COLLAGEN','X-RAY DIFFRACTION',2.100,'STRUCTURAL PROTEIN',1,3,1),(5580,'5cvd','CRYSTAL STRUCTURE OF HUMAN NRMT1 IN COMPLEX WITH ALPHA-N-DIMETHYLATED HUMAN CENP-A PEPTIDE','X-RAY DIFFRACTION',1.300,'TRANSFERASE/PEPTIDE',2,2,1),(5581,'5cve','CRYSTAL STRUCTURE OF HUMAN NRMT1 IN COMPLEX WITH DIMETHYLATED FLY H2B PEPTIDE AND SAH','X-RAY DIFFRACTION',1.500,'TRANSFERASE/PEPTIDE',2,2,1),(5582,'5cww','CRYSTAL STRUCTURE OF THE CHAETOMIUM THERMOPHILUM HETEROTRIMERIC NUP82 NTD-NUP159 TAIL-NUP145N APD COMPLEX','X-RAY DIFFRACTION',2.200,'TRANSPORT PROTEIN',1,1,1),(5583,'5cx3','CRYSTAL STRUCTURE OF FYCO1 LIR IN COMPLEX WITH LC3A','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING',4,4,1),(5584,'5cxt','CRYSTAL STRUCTURE OF A RNA-BINDING PROTEIN 39 (RBM39) IN COMPLEX WITH FRAGMENT OF SPLICING FACTOR (U2AF) FROM UNKNOWN AT 2.20 A RESOLUTION','X-RAY DIFFRACTION',2.200,'RNA BINDING PROTEIN',9,9,1),(5585,'5d13','THIRD PDZ DOMAIN (PDZ3) OF PSD-95 COMPLEXED WITH CFMOC-KKETEV PEPTIDE','X-RAY DIFFRACTION',2.150,'SIGNALING PROTEIN/INHIBITOR',4,4,1),(5586,'5d1c','CRYSTAL STRUCTURE OF D233G-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.420,'HYDROLASE',2,2,1),(5587,'5d1d','CRYSTAL STRUCTURE OF P91L-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',2.010,'HYDROLASE',2,2,1),(5588,'5d2a','BIFUNCTIONAL DENDRIMERS','X-RAY DIFFRACTION',2.130,'SUGAR BINDING PROTEIN',3,2,1),(5589,'5d2d','CRYSTAL STRUCTURE OF HUMAN 14-3-3 ZETA IN COMPLEX WITH CFTR R-DOMAIN PEPTIDE PS753-PS768','X-RAY DIFFRACTION',2.100,'PEPTIDE BINDING PROTEIN',1,2,1),(5590,'5d2m','COMPLEX BETWEEN HUMAN SUMO2-RANGAP1, UBC9 AND ZNF451','X-RAY DIFFRACTION',2.400,'LIGASE,PROTEIN BINDING',1,3,1),(5591,'5d2n','CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,6,1),(5592,'5d5k','CRYSTAL STRUCTURE NLS FROM HUMAN PARP-2 COMPLEXED WITH IMPORTIN ALPHA DELTA IBB','X-RAY DIFFRACTION',1.900,'PROTON TRANSPORT',1,1,1),(5593,'5d61','MOA-Z-VAD-FMK COMPLEX, DIRECT ORIENTATION','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(5594,'5d62','MOA-Z-VAD-FMK COMPLEX, INVERTED ORIENTATION','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(5595,'5d63','MOA-Z-VAD-FMK INHIBITOR COMPLEX, DIRECT/INVERTED DUAL ORIENTATION','X-RAY DIFFRACTION',1.650,'HYDROLASE',1,1,1),(5596,'5d6y','CRYSTAL STRUCTURE OF DOUBLE TUDOR DOMAIN OF HUMAN LYSINE DEMETHYLASE KDM4A COMPLEXED WITH HISTONE H3K23ME3','X-RAY DIFFRACTION',2.290,'OXIDOREDUCTASE',4,4,1),(5597,'5d7e','CRYSTAL STRUCTURE OF TAF14 YEATS DOMAIN IN COMPLEX WITH H3K9AC','X-RAY DIFFRACTION',1.900,'NUCLEAR PROTEIN',1,1,1),(5598,'5d7f','X-RAY STRUCTURE OF CA(2+)-S100B WITH HUMAN RAGE-DERIVED W72 PEPTIDE','X-RAY DIFFRACTION',1.300,'PROTEIN BINDING',1,2,1),(5599,'5d8a','CRYSTAL STRUCTURE OF RECOMBINANT FOOT-AND-MOUTH-DISEASE VIRUS A22- H2093F EMPTY CAPSID','X-RAY DIFFRACTION',2.400,'VIRUS',1,3,1),(5600,'5d94','CRYSTAL STRUCTURE OF LC3-LIR PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.530,'PROTEIN BINDING/PEPTIDE',1,1,1),(5601,'5d9g','CRYSTAL STRUCTURE OF TIPRL, TOR SIGNALING PATHWAY REGULATOR-LIKE, IN COMPLEX WITH PEPTIDE','X-RAY DIFFRACTION',2.150,'PROTEIN BINDING',2,2,1),(5602,'5d9s','STRUCTURE OF HLA-A2:01 WITH THE 11-MER PEPTIDE F11V','X-RAY DIFFRACTION',1.870,'IMMUNE SYSTEM',1,1,1),(5603,'5dai','PROLIFERATING CELL NUCLEAR ANTIGEN HOMOLOG 1 BOUND TO FEN-1 PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(5604,'5dbe','CRYSTAL STRUCTURE OF O-ACETYLSERINE SULFHYDRYLASE FROM HAEMOPHILUS INFLUENZAE IN COMPLEX WITH PRE-REACTIVE O-ACETYL SERINE, ALPHA- AMINOACRYLATE REACTION INTERMEDIATE AND PEPTIDE INHIBITOR AT THE RESOLUTION OF 2.25A','X-RAY DIFFRACTION',2.250,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5605,'5dbr','CA2+ CAM WITH HUMAN CARDIAC NA+ CHANNEL (NAV1.5) INACTIVATION GATE','X-RAY DIFFRACTION',2.250,'METAL BINDING PROTEIN/TRANSPORT PROTE',1,1,1),(5606,'5dc6','CRYSTAL STRUCTURE OF D176N-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.550,'HYDROLASE',2,2,1),(5607,'5dc7','CRYSTAL STRUCTURE OF D176A-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,2,1),(5608,'5dc8','CRYSTAL STRUCTURE OF H142A-Y306F HDAC8 IN COMPLEX WITH A TETRAPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.300,'HYDROLASE',2,2,1),(5609,'5dd0','CRYSTAL STRUCTURES IN AN ANTI-HIV ANTIBODY LINEAGE FROM IMMUNIZATION OF RHESUS MACAQUES','X-RAY DIFFRACTION',2.490,'IMMUNE SYSTEM',1,2,1),(5610,'5ddh','STRUCTURE OF HLA-A2:01 WITH THE 12-MER PEPTIDE F12K','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,1,1),(5611,'5ddp','L-GLUTAMINE RIBOSWITCH BOUND WITH L-GLUTAMINE','X-RAY DIFFRACTION',2.300,'RNA BINDING PROTEIN/RNA',1,1,1),(5612,'5ddq','L-GLUTAMINE RIBOSWITCH BOUND WITH L-GLUTAMINE SOAKED WITH MN2+','X-RAY DIFFRACTION',2.400,'RNA BINDING PROTEIN/RNA',2,2,1),(5613,'5ddz','CRYSTAL STRUCTURE OF THE RTA-C10-P2 COMPLEX','X-RAY DIFFRACTION',1.500,'HYDROLASE/PEPTIDE',1,1,1),(5614,'5def','CRYSTAL STRUCTURE OF B*27:04 COMPLEX BOUND TO THE PVIPR PEPTIDE','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(5615,'5deg','CRYSTAL STRUCTURE OF B*27:06 BOUND TO THE PVIPR PEPTIDE','X-RAY DIFFRACTION',1.830,'IMMUNE SYSTEM',1,1,1),(5616,'5df6','CRYSTAL STRUCTURE OF PTPN11 TANDEM SH2 DOMAINS IN COMPLEX WITH A TXNIP PEPTIDE','X-RAY DIFFRACTION',1.780,'HYDROLASE',2,1,1),(5617,'5dhf','CRYSTAL STRUCTURE OF HRIO2 NES PEPTIDE IN COMPLEX WITH CRM1-RAN-RANBP1','X-RAY DIFFRACTION',2.290,'TRANSPORT PROTEIN',1,1,1),(5618,'5dhm','CRYSTAL STRUCTURE OF THE FIMBRIAL PROTEIN MFA4 FROM PORPHYROMONAS GINGIVALIS','X-RAY DIFFRACTION',1.900,'CELL ADHESION',2,2,1),(5619,'5di7','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH AN METHYL-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S,3AR,5S, 7AS)-5-(4-HYDROXY-2-METHYLPHENYL)-7A-METHYLOCTAHYDRO-1H-INDEN-1-OL','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(5620,'5di8','FC KNOB-HOLE HETERODIMER T366W + T366S/L368A/Y407V','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(5621,'5di9','CRYSTAL STRUCTURE OF HRIO2 NES REVERSE MUTANT PEPTIDE IN COMPLEX WITH CRM1-RAN-RANBP1','X-RAY DIFFRACTION',2.280,'TRANSPORT PROTEIN',1,1,1),(5622,'5did','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DIFLUORO-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S,3AR,5S, 7AS)-5-(2,3-DIFLUORO-4-HYDROXYPHENYL)-7A-METHYLOCTAHYDRO-1H-INDEN-1- OL','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(5623,'5die','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TRIFLUORO-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S,3AR, 5S,7AS)-7A-METHYL-5-(2,3,5-TRIFLUORO-4-HYDROXYPHENYL)OCTAHYDRO-1H- INDEN-1-OL','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(5624,'5dif','CRYSTAL STRUCTURE OF CPEB4 NES PEPTIDE IN COMPLEX WITH CRM1-RAN-RANBP1','X-RAY DIFFRACTION',2.090,'TRANSPORT PROTEIN',1,1,1),(5625,'5dig','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TRIFLUOROMETHYL-SUBSTITUTED A-CD RING ESTROGEN DERIVATIVE (1S, 3AR,5S,7AS)-5-[4-HYDROXY-2-(TRIFLUOROMETHYL)PHENYL]-7A- METHYLOCTAHYDRO-1H-INDEN-1-OL','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(5626,'5diy','THERMOBACULUM TERRENUM O-GLCNAC HYDROLASE MUTANT - D120N','X-RAY DIFFRACTION',2.060,'HYDROLASE',2,2,1),(5627,'5dj0','FC HETERODIMER DESIGN 11.2 Y349S/K370Y + E357D/S364Q','X-RAY DIFFRACTION',2.280,'IMMUNE SYSTEM',1,1,1),(5628,'5dj6','FC HETERODIMER DESIGN 6.1 F405W/Y407A + T366M','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(5629,'5dj8','FC HETERODIMER DESIGN 7.7 D399M/Y407A + T366V/K409I','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(5630,'5djc','FC HETERODIMER DESIGN 8.1 L368V/Y407A + T366V/K409F','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,2,1),(5631,'5djd','FC HETERODIMER DESIGN 5.1 T366V + Y407F','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(5632,'5djx','FC HETERODIMER DESIGN 2.9 L368M/K370E + E357A/S364G','X-RAY DIFFRACTION',2.250,'IMMUNE SYSTEM',2,2,1),(5633,'5djy','FC HETERODIMER DESIGN 20.8 Y349S/T366V/K370Y/K409V + E357D/S364Q/Y407A','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM',1,1,1),(5634,'5djz','FC HETERODIMER DESIGN 7.8 D399M/Y407A + T366V/K409V','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(5635,'5dk0','FC HETERODIMER DESIGN 20.8.34 Y349S/T366M/K370Y/K409V + E356G/E357D/S364Q/Y407A','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(5636,'5dk9','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A PHENYLAMINO-SUBSTITUTED ETHYL TRIARYL-ETHYLENE DERIVATIVE 4, 4\'-{2-[3-(PHENYLAMINO)PHENYL]BUT-1-ENE-1,1-DIYL}DIPHENOL','X-RAY DIFFRACTION',2.280,'TRANSCRIPTION',2,2,1),(5637,'5dkb','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 3-METHYLPHENYLAMINO-SUBSTITUTED ETHYL TRIARYL-ETHYLENE DERIVATIVE 4,4\'-(2-{3-[(3-METHYLPHENYL)AMINO]PHENYL}BUT-1-ENE-1,1- DIYL)DIPHENOL','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(5638,'5dkg','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A T-BUTYL-SUBSTITUTED, METHYL, TRIARYL-ETHYLENE DERIVATIVE 4,4\'- [2-(4-TERT-BUTYLPHENYL)PROP-1-ENE-1,1-DIYL]DIPHENOL','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',2,2,1),(5639,'5dkp','CRYSTAL STRUCTURE OF N. MENINGITIDIS CLPP IN COMPLEX WITH AGONIST ADEP A54556.','X-RAY DIFFRACTION',2.380,'HYDROLASE/ANTIBIOTIC',28,28,1),(5640,'5dl4','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A PHENYLAMINO-SUBSTITUTED, METHYL, TRIARYL-ETHYLENE DERIVATIVE 4,4\'-{2-[3-(PHENYLAMINO)PHENYL]PROP-1-ENE-1,1-DIYL}DIPHENOL','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(5641,'5dlm','COMPLEX OF INFLUENZA M2E AND ANTIBODY','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,4,1),(5642,'5dlr','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A TRIARYL-ETHYLENE COMPOUND 4,4\'-(2-PHENYLETHENE-1,1-DIYL) DIPHENOL','X-RAY DIFFRACTION',2.260,'TRANSCRIPTION',2,2,1),(5643,'5dmc','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A NITRILE-SUBSTITUTED TRIARYL-ETHYLENE DERIVATIVE 3,3-BIS(4- HYDROXYPHENYL)-2-PHENYLPROP-2-ENENITRILE','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(5644,'5dmf','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 4-FLUOROPHENYLAMINO-SUBSTITUTED, METHYL TRIARYL-ETHYLENE DERIVATIVE 4,4\'-(2-{3-[(4-FLUOROPHENYL)AMINO]PHENYL}PROP-1-ENE-1,1- DIYL)DIPHENOL','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(5645,'5dmg','X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',3,6,1),(5646,'5dms','MOUSE POLO-BOX DOMAIN AND EMI2 (169-177)','X-RAY DIFFRACTION',1.900,'TRANSFERASE/METAL BINDING PROTEIN',2,2,1),(5647,'5dmv','POLO-BOX DOMAIN OF MOUSE POLO-LIKE KINASE 1 COMPLEXED WITH EMI2 (146- 177)','X-RAY DIFFRACTION',2.500,'TRANSFERASE/METAL BINDING PROTEIN',1,1,1),(5648,'5dn2','HUMAN NRP2 B1 DOMAIN IN COMPLEX WITH THE PEPTIDE CORRESPONDING TO THE C-TERMINUS OF VEGF-A','X-RAY DIFFRACTION',1.950,'SIGNALING PROTEIN',3,3,1),(5649,'5dnj','MOUSE POLO-BOX DOMAIN AND PEPTIDE ANALOG 702','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5650,'5do4','THROMBIN-RNA APTAMER COMPLEX','X-RAY DIFFRACTION',1.860,'HYDROLASE/RNA',1,1,1),(5651,'5dow','SOLUTION OF THE VARIABLY-TWINNED STRUCTURE OF A NOVEL CALMODULIN- PEPTIDE COMPLEX IN A NOVEL CONFIGURATION','X-RAY DIFFRACTION',1.700,'CALCIUM BINDING PROTEIN',4,4,1),(5652,'5dp0','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 4-FLUOROPHENYLAMINO-SUBSTITUTED TRIARYL-ETHYLENE DERIVATIVE 4, 4\'-(2-{3-[(4-FLUOROPHENYL)AMINO]PHENYL}ETHENE-1,1-DIYL)DIPHENOL','X-RAY DIFFRACTION',2.380,'TRANSCRIPTION',2,2,1),(5653,'5dpw','CRYSTAL STRUCTURE OF PLEKHM1 LIR IN COMPLEX WITH HUMAN LC3C_8-125','X-RAY DIFFRACTION',2.190,'PROTEIN BINDING',8,8,1),(5654,'5drj','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DICHLORO-SUBSTITUTED, 3-METHYL 2,5-DIARYLTHIOPHENE-CORE LIGAND 4,4\'-(3-METHYLTHIENE-2,5-DIYL)BIS(3-CHLOROPHENOL)','X-RAY DIFFRACTION',2.070,'TRANSCRIPTION',2,2,1),(5655,'5drm','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DICHLORO-SUBSTITUTED, 2,5-DIARYLTHIOPHENE-CORE LIGAND 4,4\'- THIENE-2,5-DIYLBIS(3-CHLOROPHENOL)','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(5656,'5ds8','CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH HYPUSINE','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,2,1),(5657,'5dsc','CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24.B IN COMPLEX WITH HYPUSINE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',4,8,1),(5658,'5dtf','CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,2,1),(5659,'5dtv','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DIMETHYL-SUBSTITUTED, 3,4-DIARYLTHIOPHENE DIOXIDE CORE LIGAND','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(5660,'5du5','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A DICHLORO-SUBSTITUTED, 3,4-DIARYLTHIOPHENE DIOXIDE CORE LIGAND','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(5661,'5dub','CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(5662,'5due','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A PARA-HYDROXYL-SUBSTITUTED, SULFOXIDE-BRIDGED OXABICYCLIC HEPTENE SULFONATE (SOBHS)-2 ANALOG 4-HYDROXYPHENYL (1S,2S,4S,5S,6R, 7S)-5,6-BIS(4-HYDROXY-2-METHYLPHENYL)-7-THIABICYCLO[2.2.1]HEPTANE-2- SULFONATE 7-OXIDE','X-RAY DIFFRACTION',2.090,'TRANSCRIPTION',2,2,1),(5663,'5dug','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SULFOXIDE-BRIDGED OXABICYCLIC HEPTENE SULFONATE (SOBHS)-2 ANALOG PHENYL (1S,2S,4S,7S)-5,6-BIS(4-HYDROXY-2-METHYLPHENYL)-7- THIABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONATE 7-OXIDE','X-RAY DIFFRACTION',2.250,'TRANSCRIPTION',2,2,1),(5664,'5duh','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A SULFOXIDE-BRIDGED OXABICYCLIC HEPTENE SULFONATE (SOBHS)-3 ANALOG PHENYL (1S,2S,4S,7S)-5,6-BIS(4-HYDROXY-3-METHYLPHENYL)-7- THIABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONATE 7-OXIDE','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(5665,'5dvc','HUMAN PPARGAMMA LIGAND BINDING DMAIN COMPLEXED WITH SB1453 IN A COVALENT BONDED FORM','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION/TRANSFERASE',1,1,1),(5666,'5dvl','FC DESIGN 20.8.37 A CHAIN HOMODIMER Y349S/T366M/K370Y/K409V','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(5667,'5dvn','FC K392D/K409D HOMODIMER','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,1,1),(5668,'5dvs','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 2-METHYL-SUBSTITUTED TRIARYL-IMINE 4,4\'-[(2-METHYLPHENYL) CARBONIMIDOYL]DIPHENOL','X-RAY DIFFRACTION',2.280,'TRANSCRIPTION',2,2,1),(5669,'5dwe','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A 2-CHLORO-SUBSTITUTED TRIARYL-IMINE ANALOG 4,4\'-[(2- CHLOROPHENYL)CARBONIMIDOYL]DIPHENOL','X-RAY DIFFRACTION',1.920,'TRANSCRIPTION',2,2,1),(5670,'5dwg','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE TRIARYL-SUBSTITUTED IMINE ANALOG, 4-{(E)-(4-HYDROXYPHENYL) [(2-METHYLPHENYL)IMINO]METHYL}BENZENE-1,3-DIOL','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(5671,'5dwi','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A RESORCINYL 2-CHLORO-SUBSTITUTED DIARYL-IMINE ANALOG 4-[(E)- [(2-CHLOROPHENYL)IMINO](4-HYDROXYPHENYL)METHYL]BENZENE-1,3-DIOL','X-RAY DIFFRACTION',2.430,'TRANSCRIPTION',2,2,1),(5672,'5dwj','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH A RESORCINYL 4-FLUORO-SUBSTITUTED DIARYL-IMINE ANALOG 4-[(E)- [(4-FLUOROPHENYL)IMINO](4-HYDROXYPHENYL)METHYL]BENZENE-1,3-DIOL','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(5673,'5dwl','HUMAN PPARGAMMA LIGAND BINDING DMAIN IN COMPLEX WITH SR1664','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION/TRANSFERASE',1,1,1),(5674,'5dwq','CRYSTAL STRUCTURE OF CARM1, SINEFUNGIN, AND METHYLATED H3 PEPTIDE (R17)','X-RAY DIFFRACTION',2.360,'TRANSFERASE',2,4,1),(5675,'5dx0','CRYSTAL STRUCTURE OF CARM1, SINEFUNGIN, AND H3 PEPTIDE (R17)','X-RAY DIFFRACTION',2.050,'TRANSFERASE',4,4,1),(5676,'5dx1','CRYSTAL STRUCTURE OF CARM1, SINEFUNGIN, AND PABP1 PEPTIDE (R455)','X-RAY DIFFRACTION',1.930,'TRANSFERASE',4,4,1),(5677,'5dx3','ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P3 AND ESTRADIOL','X-RAY DIFFRACTION',2.090,'HORMONE RECEPTOR/PEPTIDE',2,2,1),(5678,'5dx8','CRYSTAL STRUCTURE OF CARM1, SINEFUNGIN, AND METHYLATED PABP1 PEPTIDE (R455)','X-RAY DIFFRACTION',1.940,'TRANSFERASE',4,4,1),(5679,'5dxa','CRYSTAL STRUCTURE OF CARM1, SINEFUNGIN, AND METHYLATED PABP1 PEPTIDE (R460)','X-RAY DIFFRACTION',2.070,'TRANSFERASE',3,3,1),(5680,'5dxb','ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P1 AND ESTRADIOL','X-RAY DIFFRACTION',2.080,'HORMONE RECEPTOR/PEPTIDE',2,2,1),(5681,'5dxe','ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P4 AND ESTRADIOL','X-RAY DIFFRACTION',1.500,'HORMONE RECEPTOR/PEPTIDE',2,2,1),(5682,'5dxg','ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-P5','X-RAY DIFFRACTION',1.860,'HORMONE RECEPTOR/PEPTIDE',2,2,1),(5683,'5dxk','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-[(9S)-BICYCLO[3.3.1]NON-9- YLMETHANEDIYL]DIPHENOL','X-RAY DIFFRACTION',2.230,'TRANSCRIPTION',2,2,1),(5684,'5dxm','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 3-[(E)-(1S,5S)-BICYCLO[3.3.1]NON-9- YLIDENE(4-HYDROXYPHENYL)METHYL]PHENOL','X-RAY DIFFRACTION',2.370,'TRANSCRIPTION',2,2,1),(5685,'5dxp','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4-[(E)-(1S,5S)-BICYCLO[3.3.1]NON-9- YLIDENE(PHENYL)METHYL]PHENOL','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(5686,'5dxq','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-[(1S,5S)-BICYCLO[3.3.1]NON-9- YLIDENEMETHANEDIYL]DIPHENOL','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(5687,'5dxr','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[(3R)-3- METHYLCYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',2.280,'TRANSCRIPTION',2,2,1),(5688,'5dy8','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[(3S)-3- ETHYLCYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',2.030,'TRANSCRIPTION',2,2,1),(5689,'5dyb','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-(3,4-DIHYDRONAPHTHALEN-2(1H)- YLIDENEMETHANEDIYL)DIPHENOL','X-RAY DIFFRACTION',2.270,'TRANSCRIPTION',2,2,1),(5690,'5dyd','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[(3S)-3-(METHYLSULFANYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',2.490,'TRANSCRIPTION',2,2,1),(5691,'5dz0','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-[(4-METHYLCYCLOHEXYLIDENE) METHANEDIYL]DIPHENOL','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(5692,'5dz1','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-[(4-ETHYLCYCLOHEXYLIDENE) METHANEDIYL]DIPHENOL','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(5693,'5dz3','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[4-(FLUOROMETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',2,2,1),(5694,'5dzh','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[4-(2-HYDROXYETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',2.110,'TRANSCRIPTION',2,2,1),(5695,'5dzi','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[(3S)-3-(2-HYDROXYETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(5696,'5e00','STRUCTURE OF HLA-A2 P130','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(5697,'5e0l','LC8 - CHICA (415-424) COMPLEX','X-RAY DIFFRACTION',1.310,'TRANSPORT PROTEIN',1,1,1),(5698,'5e0m','LC8 - CHICA (468-476) COMPLEX','X-RAY DIFFRACTION',1.650,'TRANSPORT PROTEIN',1,1,1),(5699,'5e0u','HUMAN PCNA VARIANT (S228I) COMPLEXED WITH P21 AT 1.9 ANGSTROMS','X-RAY DIFFRACTION',1.930,'DNA BINDING PROTEIN',3,3,1),(5700,'5e0v','HUMAN PCNA VARIANT (S228I) COMPLEXED WITH FEN1 AT 2.1 ANGSTROMS','X-RAY DIFFRACTION',2.070,'DNA BINDING PROTEIN',2,2,1),(5701,'5e0w','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[(3S)-3-(4-HYDROXYPHENYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(5702,'5e0x','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[(3S)-3-(4-METHOXYPHENYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',2.010,'TRANSCRIPTION',2,2,1),(5703,'5e14','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[(3R)-3- PHENYLCYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',2.220,'TRANSCRIPTION',2,2,1),(5704,'5e15','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-{[4-(2-HYDROXYETHYL) CYCLOHEXYLIDENE]METHANEDIYL}DIPHENOL','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(5705,'5e19','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE METHYL {4-[BIS(4-HYDROXYPHENYL) METHYLIDENE]CYCLOHEXYL}ACETATE','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(5706,'5e1b','CRYSTAL STRUCTURE OF NRMT1 IN COMPLEX WITH SPKRIA PEPTIDE','X-RAY DIFFRACTION',1.650,'TRANSFERASE',2,2,1),(5707,'5e1c','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE DIMETHYL {(1S)-3-[BIS(4- HYDROXYPHENYL)METHYLIDENE]CYCLOHEXYL}PROPANEDIOATE','X-RAY DIFFRACTION',1.980,'TRANSCRIPTION',2,2,1),(5708,'5e1d','NTMT1 IN COMPLEX WITH YPKRIA PEPTIDE','X-RAY DIFFRACTION',1.450,'TRANSFERASE',2,2,1),(5709,'5e1m','CRYSTAL STRUCTURE OF NTMT1 IN COMPLEX WITH PPKRIA PEPTIDE','X-RAY DIFFRACTION',1.750,'TRANSFERASE',2,2,1),(5710,'5e1o','CRYSTAL STRUCTURE OF NTMT1 IN COMPLEX WITH RPKRIA PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSFERASE',2,2,1),(5711,'5e24','STRUCTURE OF THE SU(H)-HAIRLESS-DNA REPRESSOR COMPLEX','X-RAY DIFFRACTION',2.140,'TRANSPORT/DNA BINDING/DNA',2,4,1),(5712,'5e2a','CRYSTAL STRUCTURE OF NTMT1 IN COMPLEX WITH N-TERMINALLY METHYLATED SPKRIA PEPTIDE','X-RAY DIFFRACTION',1.750,'TRANSFERASE',2,2,1),(5713,'5e2b','CRYSTAL STRUCTURE OF NTMT1 IN COMPLEX WITH N-TERMINALLY METHYLATED PPKRIA PEPTIDE','X-RAY DIFFRACTION',1.950,'TRANSFERASE',2,2,1),(5714,'5e2q','STRUCTURE OF HUMAN DPP3 IN COMPLEX WITH ANGIOTENSIN-II','X-RAY DIFFRACTION',2.400,'HYDROLASE',1,1,1),(5715,'5e2v','ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE','X-RAY DIFFRACTION',1.640,'IMMUNE SYSTEM',1,2,1),(5716,'5e2w','ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,2,1),(5717,'5e33','STRUCTURE OF HUMAN DPP3 IN COMPLEX WITH MET-ENKEPHALIN','X-RAY DIFFRACTION',1.840,'HYDROLASE',1,1,1),(5718,'5e3a','STRUCTURE OF HUMAN DPP3 IN COMPLEX WITH OPIOID PEPTIDE LEU-ENKEPHALIN','X-RAY DIFFRACTION',2.050,'HYDROLASE',1,1,1),(5719,'5e50','APLF/XRCC4 COMPLEX','X-RAY DIFFRACTION',1.380,'LYASE',2,2,1),(5720,'5e6o','CRYSTAL STRUCTURE OF C. ELEGANS LGG-2 BOUND TO AN AIM/LIR MOTIF','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING/PEPTIDE',4,4,1),(5721,'5e6q','IMPORTIN ALPHA BINDING TO XRCC1 NLS PEPTIDE','X-RAY DIFFRACTION',2.310,'PROTEIN BINDING',1,1,1),(5722,'5e7v','POTENT VITAMIN D RECEPTOR AGONIST','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(5723,'5e8d','CRYSTAL STRUCTURE OF HUMAN EPIREGULIN IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY 9E5','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,2,1),(5724,'5e8e','CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM/HYDROLASE',1,1,1),(5725,'5e8f','STRUCTURE OF FULLY MODIFIED GERANYLGERANYLATED PDE6C PEPTIDE IN COMPLEX WITH PDE6D','X-RAY DIFFRACTION',2.100,'HYDROLASE',2,2,1),(5726,'5e8j','CRYSTAL STRUCTURE OF MRNA CAP GUANINE-N7 METHYLTRANSFERASE IN COMPLEX WITH RAM','X-RAY DIFFRACTION',2.350,'TRANSLATION',2,2,1),(5727,'5e8n','THE STRUCTURE OF THE TEIPP ASSOCIATED TRH4 PEPTIDE IN COMPLEX WITH H- 2D(B)','X-RAY DIFFRACTION',2.250,'IMMUNE SYSTEM',4,4,1),(5728,'5e8o','THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P2ABU IN COMPLEX WITH H-2D(B)','X-RAY DIFFRACTION',1.980,'IMMUNE SYSTEM',2,2,1),(5729,'5e8p','THE STRUCTURE OF THE TEIPP ASSOCIATED ALTERED PEPTIDE LIGAND TRH4- P5NLE IN COMPLEX WITH H-2D(B)','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(5730,'5ea0','STRUCTURE OF THE ANTIBODY 7968 WITH HUMAN COMPLEMENT FACTOR H-DERIVED PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(5731,'5eay','CRYSTAL STRUCTURE OF A DNA2 PEPTIDE IN COMPLEX WITH RPA 70N','X-RAY DIFFRACTION',1.550,'DNA BINDING PROTEIN',4,4,1),(5732,'5ec9','RETINOIC ACID RECEPTOR ALPHA IN COMPLEX WITH CHIRAL DIHYDROBENZOFURAN BENZOIC ACID 9A AND A FRAGMENT OF THE COACTIVATOR TIF2','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(5733,'5eel','GRB7 SH2 WITH BICYCLIC PEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.470,'SIGNALING PROTEIN/PEPTIDE',6,6,1),(5734,'5eeq','GRB7 SH2 WITH THE G7-B1 BICYCLIC PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.600,'SIGNALING PROTEIN/INHIBITOR',2,2,1),(5735,'5efi','CRYSTAL STRUCTURE OF MOUSE CD1D IN COMPLEX WITH THE P99P LIPOPEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(5736,'5efj','CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 6 CATALYTIC DOMAIN 2 IN COMPLEX WITH HC TOXIN','X-RAY DIFFRACTION',1.730,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5737,'5efk','CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 6 CATALYTIC DOMAIN 2 (Y745F MUTANT) IN COMPLEX WITH ALPHA TUBULIN K40 TRIPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.820,'HYDROLASE',1,1,1),(5738,'5efn','CRYSTAL STRUCTURE OF DANIO RERIO HISTONE DEACETYLASE 6 CATALYTIC DOMAIN 2 (H574A) IN COMPLEX WITH HISTONE H4 LYS6 TRIPEPTIDE SUBSTRATE','X-RAY DIFFRACTION',1.800,'HYDROLASE',2,2,1),(5739,'5eft','STRUCTURAL BASIS FOR SPECIFIC RECOGNITION OF SSDNA BY SRBSDV P9-1 OCTAMERS','X-RAY DIFFRACTION',2.500,'VIRAL PROTEIN',4,4,1),(5740,'5efw','CRYSTAL STRUCTURE OF LOV2-ZDK1 - THE COMPLEX OF OAT LOV2 AND THE AFFIBODY PROTEIN ZDARK1','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN',1,1,1),(5741,'5eg2','SET7/9 N265A IN COMPLEX WITH ADOHCY AND TAF10 PEPTIDE','X-RAY DIFFRACTION',1.550,'TRANSFERASE/TRANSCRIPTION FACTOR',1,1,1),(5742,'5eg6','CSL-RITA COMPLEX BOUND TO DNA','X-RAY DIFFRACTION',2.090,'TRANSCRIPTION/DNA BINDING PROTEIN/DNA',1,1,1),(5743,'5ehc','CO-CRYSTAL STRUCTURE OF EIF4E WITH NUCLEOTIDE MIMETIC INHIBITOR.','X-RAY DIFFRACTION',2.400,'TRANSLATION',1,1,1),(5744,'5ehh','STRUCTURE OF HUMAN DPP3 IN COMPLEX WITH ENDOMORPHIN-2.','X-RAY DIFFRACTION',2.380,'HYDROLASE',1,1,1),(5745,'5ehj','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN IN COMPLEX WITH THE CYCLOFENIL DERIVATIVE 4,4\'-[(4AR,8AR)-OCTAHYDRONAPHTHALEN- 2(1H)-YLIDENEMETHANEDIYL]DIPHENOL','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,2,1),(5746,'5ei1','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE IMIDAZOPYRIDINE DERIVATIVE 2-(4-HYDROXYPHENYL)-3- IODANYL-IMIDAZO[1,2-A]PYRIDIN-6-OL','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(5747,'5ei3','CO-CRYSTAL STRUCTURE OF EIF4E WITH NUCLEOTIDE MIMETIC INHIBITOR.','X-RAY DIFFRACTION',1.710,'TRANSLATION',1,1,1),(5748,'5eib','CRYSTAL STRUCTURE OF CPAP PN2-3 C-TERMINAL LOOP-HELIX IN COMPLEX WITH DARPIN-TUBULIN','X-RAY DIFFRACTION',2.100,'CELL CYCLE',1,2,1),(5749,'5eio','CRYSTAL STRUCTURE OF LYSY FROM THERMUS THERMOPHILUS COMPLEXED WITH NADP+ AND LYSW-GAMMA-AMINOADIPIC SEMIALDEHYDE','X-RAY DIFFRACTION',1.800,'OXIDOREDUCTASE/BIOSYNTHETIC PROTEIN',1,1,1),(5750,'5eiv','CRYSTAL STRUCTURE OF COMPLEX OF OSTEOCLAST-ASSOCIATED IMMUNOGLOBULIN- LIKE RECEPTOR (OSCAR) AND A SYNTHETIC COLLAGEN CONSENSUS PEPTIDE','X-RAY DIFFRACTION',2.410,'IMMUNE SYSTEM',9,2,1),(5751,'5ekf','CRYSTALLIZATION AND X-RAY DIFFRACTION DATA COLLECTION OF IMPORTIN- ALPHA FROM MUS MUSCULUS COMPLEXED WITH A XPG NLS PEPTIDE, FRAGMENT 1','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',2,1,1),(5752,'5elq','CRYSTAL STRUCTURE OF THE SNX27 PDZ DOMAIN BOUND TO THE C-TERMINAL DGKZETA PDZ BINDING MOTIF','X-RAY DIFFRACTION',1.100,'PROTEIN TRANSPORT',2,2,1),(5753,'5em9','CRYSTAL STRUCTURE OF THE SNX27 PDZ DOMAIN BOUND TO THE PHOSPHORYLATED C-TERMINAL 5HT4(A)R PDZ BINDING MOTIF','X-RAY DIFFRACTION',1.600,'PROTEIN TRANSPORT',1,1,1),(5754,'5ema','CRYSTAL STRUCTURE OF THE SNX27 PDZ DOMAIN BOUND TO THE PHOSPHORYLATED C-TERMINAL LRRC3B PDZ BINDING MOTIF','X-RAY DIFFRACTION',1.320,'PROTEIN TRANSPORT',1,1,1),(5755,'5emb','CRYSTAL STRUCTURE OF THE SNX27 PDZ DOMAIN BOUND TO THE C-TERMINAL PHOSPHORYLATED PTHR PDZ BINDING MOTIF','X-RAY DIFFRACTION',0.850,'PROTEIN TRANSPORT',1,1,1),(5756,'5enw','STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9L','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(5757,'5eo0','CRYSTAL STRUCTURE OF HLA-B0702-RFL9','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(5758,'5eo1','CRYSTAL STRUCTURE OF HLA-B0702-RL9','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(5759,'5eoa','CRYSTAL STRUCTURE OF OPTN E50K MUTANT AND TBK1 COMPLEX','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING/TRANSFERASE',2,2,1),(5760,'5eoc','CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I','X-RAY DIFFRACTION',1.980,'IMMUNE SYSTEM',2,4,1),(5761,'5eof','CRYSTAL STRUCTURE OF OPTN NTD AND TBK1 CTD COMPLEX','X-RAY DIFFRACTION',2.050,'PROTEIN BINDING/TRANSFERASE',2,2,1),(5762,'5eoq','STRUCTURE OF THE MURINE FAB 1G6 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 31-40','X-RAY DIFFRACTION',1.950,'VIRAL PROTEIN/IMMUNE SYSTEM',1,2,1),(5763,'5eor','STRUCTURE OF THE MURINE ANTIBODY FAB 8E3 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 101-110','X-RAY DIFFRACTION',2.270,'VIRAL PROTEIN/IMMUNE SYSTEM',1,2,1),(5764,'5eot','STRUCTURE OF HLA-A2:01 WITH PEPTIDE G13E','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(5765,'5epj','CRYSTAL STRUCTURE OF CHROMODOMAIN OF CBX7 IN COMPLEX WITH INHIBITOR UNC3866','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',1,1,1),(5766,'5epk','CRYSTAL STRUCTURE OF CHROMODOMAIN OF CBX2 IN COMPLEX WITH INHIBITOR UNC3866','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',1,1,1),(5767,'5epl','CRYSTAL STRUCTURE OF CHROMODOMAIN OF CBX4 IN COMPLEX WITH INHIBITOR UNC3866','X-RAY DIFFRACTION',1.810,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',2,1,1),(5768,'5epm','CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT','X-RAY DIFFRACTION',1.750,'TOXIN/IMMUNE SYSTEM',2,4,1),(5769,'5epp','STRUCTURAL INSIGHTS INTO THE INTERACTION OF P97 N-TERMINUS DOMAIN AND VBM MOTIF IN RHOMBOID PROTEASE, RHBDL4','X-RAY DIFFRACTION',1.880,'HYDROLASE',1,1,1),(5770,'5eq0','CRYSTAL STRUCTURE OF CHROMODOMAIN OF CBX8 IN COMPLEX WITH INHIBITOR UNC3866','X-RAY DIFFRACTION',1.180,'TRANSCRIPTION/TRANSCRIPTION INHIBITOR',1,1,1),(5771,'5et0','CRYSTAL STRUCTURE OF MYO3B-ARB2 IN COMPLEX WITH ESPIN1-AR','X-RAY DIFFRACTION',2.300,'PROTEIN BINDING/MOTOR PROTEIN',2,2,1),(5772,'5et1','CRYSTAL STRUCTURE OF MYO3B-ARB1 IN COMPLEX WITH ESPIN1-AR','X-RAY DIFFRACTION',1.650,'PROTEIN BINDING/MOTOR PROTEIN',2,2,1),(5773,'5etf','STRUCTURE OF DEAD KINASE MAPK14 WITH BOUND THE KIM DOMAIN OF MKK6','X-RAY DIFFRACTION',2.400,'TRANSFERASE',1,1,1),(5774,'5eu3','HLA CLASS I ANTIGEN','X-RAY DIFFRACTION',1.970,'IMMUNE SYSTEM',1,1,1),(5775,'5eu4','HLA CLASS I ANTIGEN','X-RAY DIFFRACTION',2.120,'IMMUNE SYSTEM',2,3,1),(5776,'5eu5','HLA CLASS I ANTIGEN','X-RAY DIFFRACTION',1.540,'IMMUNE SYSTEM',1,1,1),(5777,'5eu6','HLA CLASS I ANTIGEN','X-RAY DIFFRACTION',2.020,'IMMUNE SYSTEM',1,3,1),(5778,'5eu8','STRUCTURE OF FIPV MAIN PROTEASE IN COMPLEX WITH DUAL INHIBITORS','X-RAY DIFFRACTION',2.450,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5779,'5euk','CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(5780,'5euo','PF6-M1-HLA-A2','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',2,6,1),(5781,'5ev0','CRYSTAL STRUCTURE OF RAGWEED PROFILIN AMB A 8 IN COMPLEX WITH POLY- PRO14','X-RAY DIFFRACTION',2.100,'ALLERGEN',2,2,1),(5782,'5ewz','SMALL-MOLECULE STABILIZATION OF THE 14-3-3/GAB2 PPI INTERFACE','X-RAY DIFFRACTION',2.340,'SIGNALING PROTEIN',2,2,1),(5783,'5ex3','CRYSTAL STRUCTURE OF HUMAN SMYD3 IN COMPLEX WITH A VEGFR1 PEPTIDE','X-RAY DIFFRACTION',2.410,'TRANSFERASE',1,1,1),(5784,'5exa','SMALL-MOLECULE STABILIZATION OF THE 14-3-3/GAB2 PPI INTERFACE','X-RAY DIFFRACTION',1.950,'SIGNALING PROTEIN',2,2,1),(5785,'5exk','CRYSTAL STRUCTURE OF M. TUBERCULOSIS LIPOYL SYNTHASE WITH 6- THIOOCTANOYL PEPTIDE INTERMEDIATE','X-RAY DIFFRACTION',1.860,'TRANSFERASE',6,6,1),(5786,'5eyk','CRYSTAL STRUCTURE OF AURORA B IN COMPLEX WITH BI 847325','X-RAY DIFFRACTION',1.930,'TRANSFERASE',2,2,1),(5787,'5eyz','CRYSTAL STRUCTURE OF THE PTPN4 PDZ DOMAIN COMPLEXED WITH THE TAILORED PEPTIDE CYTO8-RETEV','X-RAY DIFFRACTION',2.090,'APOPTOSIS',4,4,1),(5788,'5ez0','CRYSTAL STRUCTURE OF THE PTPN4 PDZ DOMAIN COMPLEXED WITH THE PDZ BINDING MOTIF OF THE MITOGEN ACTIVATED PROTEIN KINASE P38GAMMA.','X-RAY DIFFRACTION',2.350,'APOPTOSIS',4,4,1),(5789,'5f1n','MHC COMPLEXED TO 11MER PEPTIDE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',2,2,1),(5790,'5f2u','STRUCTURE OF FULLY MODIFIED FARNESYLATED INPP5E PEPTIDE IN COMPLEX WITH PDE6D','X-RAY DIFFRACTION',1.850,'LIPID BINDING PROTEIN',2,2,1),(5791,'5f56','STRUCTURE OF RECJ COMPLEXED WITH DNA AND SSB-CT','X-RAY DIFFRACTION',2.300,'DNA BINDING PROTEIN/DNA',1,1,1),(5792,'5f5b','STRUCTURE OF E.COLI GLPG COMPLEXED WITH PEPTIDIC INHIBITOR AC-VRMA-CHO','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5793,'5f5g','STRUCTURE OF E.COLI GLPG Y205F MUTANT COMPLEXED WITH PEPTIDIC INHIBITOR AC-RMA-CHO IN THE DMPC/CHAPSO BICELLE','X-RAY DIFFRACTION',2.300,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5794,'5f5j','E.COLI GLPG Y205F MUTANT COMPLEXED WITH ALDEHYDE INHIBITOR IN DMPC/CHAPSO BICELLE','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5795,'5f5k','E.COLI GLPG Y205F MUTANT COMPLEXED WITH ALDEHYDE INHIBITOR IN DMPC/CHAPSO BICELLE','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5796,'5f5o','CRYSTAL STRUCTURE OF MARBURG VIRUS NUCLEOPROTEIN CORE DOMAIN BOUND TO VP35 REGULATION PEPTIDE','X-RAY DIFFRACTION',2.200,'NUCLEAR PROTEIN/PEPTIDE',3,3,1),(5797,'5f67','AN EXQUISITELY SPECIFIC PDZ/TARGET RECOGNITION REVEALED BY THE STRUCTURE OF INAD PDZ3 IN COMPLEX WITH TRP CHANNEL TAIL','X-RAY DIFFRACTION',1.760,'PROTEIN BINDING',2,2,1),(5798,'5f6k','CRYSTAL STRUCTURE OF THE MLL3-ASH2L-RBBP5 COMPLEX','X-RAY DIFFRACTION',2.410,'TRANSFERASE/PROTEIN BINDING',3,2,1),(5799,'5f6l','THE CRYSTAL STRUCTURE OF MLL1 (N3861I/Q3867L) IN COMPLEX WITH RBBP5 AND ASH2L','X-RAY DIFFRACTION',1.900,'PROTEIN BINDING/TRANSFERASE',1,2,1),(5800,'5f74','CRYSTAL STRUCTURE OF CHREBP:14-3-3 COMPLEX BOUND WITH AMP','X-RAY DIFFRACTION',2.350,'TRANSCRIPTION',1,1,1),(5801,'5f7d','STRUCTURE OF HLA-A2:01 WITH PEPTIDE G11N','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(5802,'5f84','CRYSTAL STRUCTURE OF DROSOPHILA POGLUT1 (RUMI) COMPLEXED WITH ITS GLYCOPROTEIN PRODUCT (GLUCOSYLATED EGF REPEAT) AND UDP','X-RAY DIFFRACTION',2.500,'TRANSFERASE/HYDROLASE',1,1,1),(5803,'5f85','CRYSTAL STRUCTURE OF DROSOPHILA POGLUT1 (RUMI) COMPLEXED WITH ITS SUBSTRATE PROTEIN (EGF REPEAT) AND UDP','X-RAY DIFFRACTION',2.150,'TRANSFERASE/HYDROLASE',1,1,1),(5804,'5f86','CRYSTAL STRUCTURE OF DROSOPHILA POGLUT1 (RUMI) COMPLEXED WITH ITS SUBSTRATE PROTEIN (EGF REPEAT)','X-RAY DIFFRACTION',1.900,'TRANSFERASE/HYDROLASE',1,1,1),(5805,'5f88','CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,4,1),(5806,'5f8t','THE CRYSTAL STRUCTURE OF HUMAN PLASMA KALLIKREIN IN COMPLEX WITH ITS PEPTIDE INHIBITOR PKALIN-2','X-RAY DIFFRACTION',1.750,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5807,'5f8x','THE CRYSTAL STRUCTURE OF HUMAN PLASMA KALLIKREIN IN COMPLEX WITH ITS PEPTIDE INHIBITOR PKALIN-3','X-RAY DIFFRACTION',1.550,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5808,'5f8z','THE CRYSTAL STRUCTURE OF HUMAN PLASMA KALLIKREIN IN COMPLEX WITH ITS PEPTIDE INHIBITOR PKALIN-1','X-RAY DIFFRACTION',1.500,'HYDROLASE-HYDROLASE INHIBITOR',1,1,1),(5809,'5fa3','STRUCTURE OF HLA-A2:01 WITH PEPTIDE G9V','X-RAY DIFFRACTION',1.860,'IMMUNE SYSTEM',1,1,1),(5810,'5fa4','STRUCTURE OF HLA-A2:01 WITH PEPTIDE Y16R','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(5811,'5fb1','CRYSTAL STRUCTURE OF A PHD FINGER BOUND TO HISTONE H3 K9ME3 PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION/STRUCTURAL PROTEIN',1,1,1),(5812,'5fby','CRYSTAL STRUCTURE OF CTSPD','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(5813,'5fbz','STRUCTURE OF SUBTILASE SUBHAL FROM BACILLUS HALMAPALUS - COMPLEX WITH CHYMOTRYPSIN INHIBITOR CI2A','X-RAY DIFFRACTION',1.900,'HYDROLASE',1,1,1),(5814,'5fc2','STRUCTURE OF A SEPARASE IN COMPLEX WITH A PAMK PEPTIDE CONTAINING A PHOSPHO-SERINE','X-RAY DIFFRACTION',1.840,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5815,'5fc8','MOUSE IMPORTIN ALPHA: DENGUE 3 NS5 C-TERMINAL NLS PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.100,'PROTEIN TRANSPORT/VIRAL PROTEIN',1,1,1),(5816,'5fcf','CRYSTAL STRUCTURE OF XAA-PRO DIPEPTIDASE FROM XANTHOMONAS CAMPESTRIS, PHOSPHATE AND MN BOUND','X-RAY DIFFRACTION',1.850,'HYDROLASE',1,2,1),(5817,'5fcg','CRYSTAL STRUCTURE OF BCL-2 IN COMPLEX WITH HBX-BH3 MOTIF','X-RAY DIFFRACTION',2.100,'APOPTOSIS',1,1,1),(5818,'5fch','CRYSTAL STRUCTURE OF XAA-PRO DIPEPTIDASE FROM XANTHOMONAS CAMPESTRIS, PHOSPHATE AND ZN BOUND','X-RAY DIFFRACTION',1.950,'HYDROLASE',1,2,1),(5819,'5ff6','CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(5820,'5ffv','CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BRPF1 IN COMPLEX WITH H3K14AC HISTONE PEPTIDE','X-RAY DIFFRACTION',1.300,'TRANSCRIPTION',2,2,1),(5821,'5ffw','CRYSTAL STRUCTURE OF THE BROMODOMAIN OF HUMAN BRPF1 IN COMPLEX WITH H4K5ACK8AC HISTONE PEPTIDE','X-RAY DIFFRACTION',1.500,'TRANSCRIPTION',1,2,1),(5822,'5fg8','DROSOPHILA CAMKII-WT IN COMPLEX WITH A FRAGMENT OF THE EAG POTASSIUM CHANNEL AND MG2+/ADP','X-RAY DIFFRACTION',1.960,'TRANSFERASE',1,1,1),(5823,'5fgb','THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.4','X-RAY DIFFRACTION',1.650,'IMMUNE SYSTEM',2,4,1),(5824,'5fgc','THREE DIMENSIONAL STRUCTURE OF BROADLY NEUTRALIZING HUMAN ANTI - HEPATITIS C VIRUS (HCV) GLYCOPROTEIN E2 FAB FRAGMENT HC33.8','X-RAY DIFFRACTION',1.900,'VIRAL PROTEIN',1,2,1),(5825,'5fgy','STRUCTURE OF HUMAN ADENOVIRUS 2 PROTEASE WITH COFACTOR PVIC','X-RAY DIFFRACTION',2.100,'HYDROLASE',1,1,1),(5826,'5fjx','YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH GCS1 WXXF PEPTIDE','X-RAY DIFFRACTION',2.450,'PROTEIN TRANSPORT',2,2,1),(5827,'5fjz','YEAST DELTA-COP-I MU-HOMOLOGY DOMAIN COMPLEXED WITH DSL1 WXWXV PEPTIDE','X-RAY DIFFRACTION',1.900,'PROTEIN TRANSPORT',4,4,1),(5828,'5fkp','CRYSTAL STRUCTURE OF THE MOUSE CD1D IN COMPLEX WITH THE P99 PEPTIDE','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(5829,'5fmj','BCL-XL WITH MOUSE BAK BH3 Q75L COMPLEX','X-RAY DIFFRACTION',2.430,'APOPTOSIS',1,1,1),(5830,'5fmk','BCL-XL WITH BAK BH3 COMPLEX','X-RAY DIFFRACTION',1.730,'APOPTOSIS',1,1,1),(5831,'5fml','CRYSTAL STRUCTURE OF THE ENDONUCLEASE FROM THE PA SUBUNIT OF INFLUENZA B VIRUS BOUND TO THE PB2 SUBUNIT NLS PEPTIDE','X-RAY DIFFRACTION',1.700,'VIRAL PROTEIN',1,1,1),(5832,'5fos','HUMANISED MONOMERIC RADA IN COMPLEX WITH OLIGOMERISATION PEPTIDE','X-RAY DIFFRACTION',1.350,'HYDROLASE',1,1,1),(5833,'5fot','HUMANISED MONOMERIC RADA IN COMPLEX WITH FHTU TETRAPEPTIDE','X-RAY DIFFRACTION',1.190,'HYDROLASE',1,1,1),(5834,'5fou','HUMANISED MONOMERIC RADA IN COMPLEX WITH FHPA TETRAPEPTIDE','X-RAY DIFFRACTION',1.500,'HYDROLASE',1,1,1),(5835,'5fov','HUMANISED MONOMERIC RADA IN COMPLEX WITH FHTG TETRAPEPTIDE','X-RAY DIFFRACTION',1.740,'HYDROLASE',2,2,1),(5836,'5fow','HUMANISED MONOMERIC RADA IN COMPLEX WITH WHTA TETRAPEPTIDE','X-RAY DIFFRACTION',1.800,'HYDROLASE',2,2,1),(5837,'5fox','HUMANISED MONOMERIC RADA IN COMPLEX WITH FHAA TETRAPEPTIDE','X-RAY DIFFRACTION',1.300,'HYDROLASE',1,1,1),(5838,'5fpk','MONOMERIC RADA IN COMPLEX WITH FATA TETRAPEPTIDE','X-RAY DIFFRACTION',1.340,'HYDROLASE',1,1,1),(5839,'5fpx','THE STRUCTURE OF KDGF FROM YERSINIA ENTEROCOLITICA.','X-RAY DIFFRACTION',1.500,'HYDROLASE',2,2,1),(5840,'5fq0','THE STRUCTURE OF KDGF FROM HALOMONAS SP.','X-RAY DIFFRACTION',2.350,'LYASE',1,2,1),(5841,'5fv6','KPFLO11 PRESENTS A NOVEL MEMBER OF THE FLO11 FAMILY WITH A UNIQUE RECOGNITION PATTERN FOR HOMOPHILIC INTERACTIONS','X-RAY DIFFRACTION',2.000,'CELL ADHESION',1,1,1),(5842,'5fvd','HUMAN METAPNEUMOVIRUS N0-P COMPLEX','X-RAY DIFFRACTION',1.860,'VIRAL PROTEIN',2,2,1),(5843,'5fvk','CRYSTAL STRUCTURE OF VPS4-VFA1 COMPLEX FROM S.CEREVISIAE AT 1.66 A RESOLUTION.','X-RAY DIFFRACTION',1.660,'HYDROLASE',2,2,1),(5844,'5fvl','CRYSTAL STRUCTURE OF VPS4-VPS20 COMPLEX FROM S.CEREVISIAE','X-RAY DIFFRACTION',1.970,'VIRAL PROTEIN',2,2,1),(5845,'5fw5','CRYSTAL STRUCTURE OF HUMAN G3BP1 IN COMPLEX WITH SEMLIKI FOREST VIRUS NSP3-25 COMPRISING TWO FGDF MOTIVES','X-RAY DIFFRACTION',1.920,'HYDROLASE',1,1,1),(5846,'5fwe','JMJD2A COMPLEXED WITH NI(II), NOG AND HISTONE H4(1-15)R3ME2S PEPTIDE','X-RAY DIFFRACTION',2.050,'OXIDOREDUCTASE',2,2,1),(5847,'5fxc','CRYSTAL STRUCTURE OF GLYCOPEPTIDE 22 IN COMPLEX WITH SCFV-SM3','X-RAY DIFFRACTION',2.050,'IMMUNE SYSTEM',1,1,1),(5848,'5fzt','THE CRYSTAL STRUCTURE OF R7R8 IN COMPLEX WITH A DLC1 FRAGMENT.','X-RAY DIFFRACTION',2.100,'STRUCTURAL PROTEIN',1,1,1),(5849,'5g1x','CRYSTAL STRUCTURE OF AURORA-A KINASE IN COMPLEX WITH N-MYC','X-RAY DIFFRACTION',1.720,'TRANSFERASE',1,1,1),(5850,'5g3j','DISCOVERY OF NEW SELECTIVE GLUCOCORTICOID RECEPTOR AGONIST LEADS','X-RAY DIFFRACTION',2.400,'DNA BINDING PROTEIN',1,1,1),(5851,'5g42','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',1.720,'DNA BINDING PROTEIN',1,1,1),(5852,'5g44','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',1.840,'DNA BINDING PROTEIN',1,1,1),(5853,'5g45','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',2.070,'DNA BINDING PROTEIN',1,1,1),(5854,'5g46','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',1.760,'DNA BINDING PROTEIN',1,1,1),(5855,'5g4c','HUMAN SIRT2 CATALYSE SHORT CHAIN FATTY ACYL LYSINE','X-RAY DIFFRACTION',2.100,'HYDROLASE',2,2,1),(5856,'5g5w','STRUCTURE GUIDED DESIGN AND DISCOVERY OF INDAZOLE ETHERS AS HIGHLY POTENT, NON-STEROIDAL GLUCOCORTICOID RECEPTOR MODULATORS','X-RAY DIFFRACTION',2.200,'HORMONE',1,1,1),(5857,'5gds','HIRUNORMS ARE TRUE HIRUDIN MIMETICS. THE CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN:HIRUNORM V COMPLEX','X-RAY DIFFRACTION',2.100,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(5858,'5ggp','CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF HUMAN PROTEIN O-MANNOSE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE IN COMPLEX WITH GLCNAC- BETA1,2-MAN-PEPTIDE','X-RAY DIFFRACTION',1.600,'SUGAR BINDING PROTEIN',2,2,1),(5859,'5gh9','CRYSTAL STRUCTURE OF CBP BROMODOMAIN WITH H3K56AC PEPTIDE','X-RAY DIFFRACTION',1.450,'TRANSCRIPTION',1,1,1),(5860,'5ghw','CRYSTAL STRUCTURE OF BROAD NEUTRALIZING ANTIBODY 10E8 WITH LONG EPITOPE BOUND','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,2,1),(5861,'5gic','CRYSTAL STRUCTURE OF VDR IN COMPLEX WITH DLAM-2P','X-RAY DIFFRACTION',2.350,'TRANSCRIPTION',1,1,1),(5862,'5gid','CRYSTAL STRUCTURE OF VDR IN COMPLEX WITH DLAM-4 (C2 FORM)','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',1,1,1),(5863,'5gie','CRYSTAL STRUCTURE OF VDR IN COMPLEX WITH DLAM-4P (P21 FORM)','X-RAY DIFFRACTION',2.390,'TRANSCRIPTION',2,2,1),(5864,'5gim','CRYSTAL STRUCTURE OF THROMBIN-AVATHRIN COMPLEX','X-RAY DIFFRACTION',2.090,'HYDROLASE/HYDROLASE INHIBITOR',3,1,1),(5865,'5gir','CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE','X-RAY DIFFRACTION',1.930,'IMMUNE SYSTEM',2,4,1),(5866,'5gis','CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE','X-RAY DIFFRACTION',1.930,'IMMUNE SYSTEM',1,2,1),(5867,'5gj4','STRUCTURE OF NS2B-NS3 PROTEASE FROM ZIKA VIRUS CAUGHT AFTER SELF- CLEAVAGE','X-RAY DIFFRACTION',1.840,'HYDROLASE',4,4,1),(5868,'5gjh','GADS SH2 DOMAIN/CD28-DERIVED PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.200,'SIGNALING PROTEIN',2,2,1),(5869,'5gji','PI3K P85 N-TERMINAL SH2 DOMAIN/CD28-DERIVED PEPTIDE COMPLEX','X-RAY DIFFRACTION',0.900,'SIGNALING PROTEIN',1,1,1),(5870,'5gjx','CRYSTAL STRUCTURE OF DUCK MHC I FOR 2.06 ANGSTROM','X-RAY DIFFRACTION',2.060,'IMMUNE SYSTEM',1,1,1),(5871,'5gjy','CRYSTAL STRUCTURE OF DUCK MHC CLASS I FOR 1.71 ANGSTROM','X-RAY DIFFRACTION',1.710,'IMMUNE SYSTEM',1,1,1),(5872,'5gk9','CRYSTAL STRUCTURE OF HUMAN HBO1 IN COMPLEX WITH BRPF2','X-RAY DIFFRACTION',2.400,'TRANSFERASE/METAL BINDING PROTEIN',1,1,1),(5873,'5glf','STRUCTURAL INSIGHTS INTO THE INTERACTION OF P97 N-TERMINAL DOMAIN AND SHP MOTIF IN DERLIN-1 RHOMBOID PSEUDOPROTEASE','X-RAY DIFFRACTION',2.250,'HYDROLASE/TRANSPORT PROTEIN',4,4,1),(5874,'5gmv','LC3B-FUNDC1 COMPLEX','X-RAY DIFFRACTION',2.250,'PROTEIN BINDING',2,2,1),(5875,'5gnd','STRUCTURE OF DEG PROTEASE HHOA FROM SYNECHOCYSTIS SP. PCC 6803','X-RAY DIFFRACTION',2.500,'HYDROLASE',1,1,1),(5876,'5gow','SOLUTION STRUCTURE OF THE COMPLEX BETWEEN DP1 ACIDIC REGION AND TFIIH P62 PH DOMAIN','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(5877,'5gp7','STRUCTURAL BASIS FOR THE BINDING BETWEEN TANKYRASE-1 AND USP25','X-RAY DIFFRACTION',1.500,'TRANSFERASE',1,1,1),(5878,'5gpi','CRYSTAL STRUCTURES OF UNLINKED NS2B-NS3 PROTEASE FROM ZIKA VIRUS AND ITS COMPLEX WITH A REVERSE PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.580,'VIRAL PROTEIN',4,4,1),(5879,'5gr7','MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 37-1','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',1,1,1),(5880,'5grd','CRYSTAL STRUCTURE OF 10-MER PEPTIDE FROM EBV IN COMPLEX WITH HLA- A1101.','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(5881,'5grg','CRYSTAL STRUCTURE OF DUAL PEPTIDE FROM EBV IN COMPLEX WITH HLA-A*11:01','X-RAY DIFFRACTION',1.940,'IMMUNE SYSTEM',2,1,1),(5882,'5grq','CRYSTAL STRUCTURE OF DHB DOMAIN OF DAXX IN COMPLEX WITH AN ATRX PEPTIDE','X-RAY DIFFRACTION',1.580,'HYDROLASE',2,2,1),(5883,'5gs4','CRYSTAL STRUCTURE OF ESTROGEN RECEPTOR ALPHA IN COMPLEX WITH A STABILIZED PEPTIDE ANTAGONIST','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(5884,'5gsa','EED IN COMPLEX WITH AN ALLOSTERIC PRC2 INHIBITOR','X-RAY DIFFRACTION',2.490,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(5885,'5gsb','MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 37-3','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(5886,'5gsd','CRYSTAL STRUCTURE OF LMP2 PEPTIDE FROM EBV IN COMPLEX WITH HLA-A*11:01','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(5887,'5gsr','MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE I5A','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,2,1),(5888,'5gsv','MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 142-5','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(5889,'5gsx','MOUSE MHC CLASS I H-2KD WITH A MERS-COV-DERIVED PEPTIDE 142-2','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,2,1),(5890,'5gth','NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (DARK DATASET)','X-RAY DIFFRACTION',2.500,'PHOTOSYNTHESIS',19,16,1),(5891,'5gti','NATIVE XFEL STRUCTURE OF PHOTOSYSTEM II (TWO FLASH DATASET)','X-RAY DIFFRACTION',2.500,'PHOTOSYNTHESIS',19,16,1),(5892,'5gtn','HUMAN PPARGAMMA LIGAND BINDING DMAIN COMPLEXED WITH R35','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',1,1,1),(5893,'5gto','HUMAN PPARGAMMA LIGAND BINDING DMAIN COMPLEXED WITH S35','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(5894,'5gtp','THE AGONIST-FREE STRUCTURE OF HUMAN PPARGAMMA LIGAND BINDING DOMAIN IN THE PRESENCE OF THE SRC-1 COACTIVATOR PEPTIDE','X-RAY DIFFRACTION',2.350,'TRANSCRIPTION',1,1,1),(5895,'5gtu','STRUCTURAL AND MECHANISTIC INSIGHTS INTO REGULATION OF THE RETROMER COAT BY TBC1D5','X-RAY DIFFRACTION',1.500,'HYDROLASE',1,1,1),(5896,'5gu4','RRNA N-GLYCOSYLASE RTA','X-RAY DIFFRACTION',1.550,'HYDROLASE',2,2,1),(5897,'5gwz','THE STRUCTURE OF PORCINE EPIDEMIC DIARRHEA VIRUS MAIN PROTEASE IN COMPLEX WITH AN INHIBITOR','X-RAY DIFFRACTION',2.440,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5898,'5gxw','IMPORTIN AND NUMA COMPLEX','X-RAY DIFFRACTION',2.390,'PROTEIN BINDING',1,1,1),(5899,'5h0u','CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF MEMBRANE TYPE 1 MATRIX METALLOPROTEINASE','X-RAY DIFFRACTION',2.240,'HYDROLASE',1,1,1),(5900,'5h14','EED IN COMPLEX WITH AN ALLOSTERIC PRC2 INHIBITOR EED666','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(5901,'5h15','EED IN COMPLEX WITH PRC2 ALLOSTERIC INHIBITOR EED709','X-RAY DIFFRACTION',2.270,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(5902,'5h17','EED IN COMPLEX WITH PRC2 ALLOSTERIC INHIBITOR EED210','X-RAY DIFFRACTION',2.300,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5903,'5h19','EED IN COMPLEX WITH PRC2 ALLOSTERIC INHIBITOR EED162','X-RAY DIFFRACTION',1.900,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(5904,'5h24','EED IN COMPLEX WITH PRC2 ALLOSTERIC INHIBITOR COMPOUND 8','X-RAY DIFFRACTION',2.500,'TRANSFERASE/TRANSFERASE INHIBITOR',2,2,1),(5905,'5h2f','CRYSTAL STRUCTURE OF THE PSBM-DELETION MUTANT OF PHOTOSYSTEM II','X-RAY DIFFRACTION',2.200,'PHOTOSYNTHESIS',16,17,1),(5906,'5h2w','CRYSTAL STRUCTURE OF THE KARYOPHERIN KAP60P BOUND TO THE SUMO PROTEASE ULP1P (150-340)','X-RAY DIFFRACTION',2.500,'PROTEIN TRANSPORT/HYDROLASE',2,2,1),(5907,'5h2x','CRYSTAL STRUCTURE OF THE KARYOPHERIN KAP60P BOUND TO THE SUMO PROTEASE ULP1P (150-172)','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT/HYDROGENASE',1,1,1),(5908,'5h3j','CRYSTAL STRUCTURE OF GRASP DOMAIN OF GRASP55 COMPLEXED WITH THE GOLGIN45 C-TERMINUS','X-RAY DIFFRACTION',1.330,'PROTEIN TRANSPORT',1,1,1),(5909,'5h43','STRUCTURAL AND MECHANISTICAL STUDIES OF THE NUCLEAR IMPORT BY IMPORTIN-ALPHA','X-RAY DIFFRACTION',2.300,'PROTEIN TRANSPORT/TRANSFERASE',2,1,1),(5910,'5h4i','UNLINKED NS2B-NS3 PROTEASE FROM ZIKA VIRUS IN COMPLEX WITH A COMPOUND FRAGMENT','X-RAY DIFFRACTION',2.000,'VIRAL PROTEIN',1,1,1),(5911,'5h5q','CRYSTAL STRUCTURE OF HUMAN GPX4 IN COMPLEX WITH GXPEP-1','X-RAY DIFFRACTION',1.100,'OXIDOREDUCTASE/OXIDOREDUCTASE INHIBIT',1,1,1),(5912,'5h5r','CRYSTAL STRUCTURE OF HUMAN GPX4 IN COMPLEX WITH GXPEP-2','X-RAY DIFFRACTION',1.200,'OXIDOREDUCTASE/OXIDOREDUCTASE INHIBIT',1,1,1),(5913,'5h5s','CRYSTAL STRUCTURE OF HUMAN GPX4 IN COMPLEX WITH GXPEP-3','X-RAY DIFFRACTION',1.850,'OXIDOREDUCTASE/OXIDOREDUCTASE INHIBIT',1,1,1),(5914,'5h5z','CRYSTAL STRUCTURE OF BONY FISH MHC CLASS I, PEPTIDE AND B2M II','X-RAY DIFFRACTION',1.740,'PEPTIDE BINDING PROTEIN/IMMUNE SYSTEM',1,1,1),(5915,'5h6v','STRUCTURE OF ZIKA VIRUS PROTEASE IN COMPLEX WITH A DIPEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.420,'VIRAL PROTEIN/INHIBITOR',1,1,1),(5916,'5h6y','THE BPTF BROMODOMAIN RECOGNISING H4K12CR PEPTIDE','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(5917,'5h7g','CRYSTAL STRUCTURE OF THE BCL6 BTB DOMAIN IN COMPLEX WITH F1324','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION/INHIBITOR',2,2,1),(5918,'5h7h','CRYSTAL STRUCTURE OF THE BCL6 BTB DOMAIN IN COMPLEX WITH F1324(10-13)','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION/INHIBITOR',2,1,1),(5919,'5h7p','NMR STRUCTURE OF THE VTA1NTD-DID2(176-204) COMPLEX','SOLUTION NMR',NULL,'PROTEIN TRANSPORT',1,1,1),(5920,'5h7y','STRUCTURE OF IMMUNITY PROTEIN TPLEI OF T6SS FROM PSEUDOMONAS AERUGINOSA COMPLEXED WITH \"L\" PEPTIDE','X-RAY DIFFRACTION',2.200,'HYDROLASE INHIBITOR/PEPTIDE',1,1,1),(5921,'5h94','CRYSTAL STRUCTURE OF SWINE MHC CLASSI FOR 1.48 ANGSTROMS','X-RAY DIFFRACTION',1.480,'IMMUNE SYSTEM',2,3,1),(5922,'5h9b','DROSOPHILA CAMKII-WT IN COMPLEX WITH A FRAGMENT OF THE EAG POTASSIUM CHANNEL AND MG2+/AMPPN','X-RAY DIFFRACTION',2.250,'TRANSFERASE',1,1,1),(5923,'5haw','STRUCTURES OF THE NO FACTOR SLMA BOUND TO DNA AND THE CYTOSKELETAL CELL DIVISION PROTEIN FTSZ','X-RAY DIFFRACTION',1.890,'CELL CYCLE/DNA',2,2,1),(5924,'5hax','CRYSTAL STRUCTURE OF CHAETOMIUM THERMOPHILUM NUP170 NTD-NUP53 COMPLEX','X-RAY DIFFRACTION',2.100,'TRANSPORT PROTEIN',1,1,1),(5925,'5hda','CRYSTAL STRUCTURE OF THE BS69 COILED COIL-MYND DOMAINS BOUND TO AN EBNA2 PXLXP MOTIF','X-RAY DIFFRACTION',2.390,'IMMUNE SYSTEM',2,2,1),(5926,'5heb','THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM CRIPT','X-RAY DIFFRACTION',1.650,'PEPTIDE BINDING PROTEIN',1,1,1),(5927,'5hed','THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 IN COMPLEX WITH A MUTANT C-TERMINAL PEPTIDE DERIVED FROM CRIPT (T-2F)','X-RAY DIFFRACTION',1.700,'PEPTIDE BINDING PROTEIN',1,1,1),(5928,'5hey','THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 (G330T MUTANT) IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM CRIPT','X-RAY DIFFRACTION',1.500,'PEPTIDE BINDING PROTEIN',1,1,1),(5929,'5hf1','THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 (G330T MUTANT) IN COMPLEX WITH A MUTANT C-TERMINAL PEPTIDE DERIVED FROM CRIPT (T-2F)','X-RAY DIFFRACTION',1.750,'PEPTIDE BINDING PROTEIN',1,1,1),(5930,'5hf3','CRYSTAL STRUCTURE OF C-TERMINAL MODIFIED TAU PEPTIDE-HYBRID 201D WITH 14-3-3SIGMA','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(5931,'5hfb','THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 (H372A MUTANT) IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM CRIPT','X-RAY DIFFRACTION',1.620,'PEPTIDE BINDING PROTEIN',1,1,1),(5932,'5hfc','THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 (H372A MUTANT) IN COMPLEX WITH A MUTANT C-TERMINAL PEPTIDE DERIVED FROM CRIPT (T-2F)','X-RAY DIFFRACTION',1.850,'PEPTIDE BINDING PROTEIN',1,1,1),(5933,'5hfe','THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 (G330T, H372A DOUBLE MUTANT) IN COMPLEX WITH A C-TERMINAL PEPTIDE DERIVED FROM CRIPT','X-RAY DIFFRACTION',1.800,'PEPTIDE BINDING PROTEIN',1,1,1),(5934,'5hff','THE THIRD PDZ DOMAIN FROM THE SYNAPTIC PROTEIN PSD-95 (G330T, H372A DOUBLE MUTANT) IN COMPLEX WITH A MUTANT C-TERMINAL PEPTIDE DERIVED FROM CRIPT (T-2F)','X-RAY DIFFRACTION',1.750,'PEPTIDE BINDING PROTEIN',1,1,1),(5935,'5hga','HLA*A2402 COMPLEX WITH HIV NEF138 Y2F-8MER MUTANT EPITOPE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,2,1),(5936,'5hgb','HLA*A2402 COMPLEXED WITH HIV NEF138 8MER EPITOPE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',4,4,1),(5937,'5hgd','HLA*A2402 COMPLEXED WITH HIV NEF138 Y2F MUTANT 10MER EPITOPE','X-RAY DIFFRACTION',2.070,'IMMUNE SYSTEM',2,2,1),(5938,'5hgh','HLA*A2402 COMPLEXED WITH HIV NEF138 10MER EPITOPE','X-RAY DIFFRACTION',2.390,'IMMUNE SYSTEM',1,1,1),(5939,'5hgv','STRUCTURE OF AN O-GLCNAC TRANSFERASE POINT MUTANT, D554N IN COMPLEX WITH PEPTIDE','X-RAY DIFFRACTION',2.050,'TRANSFERASE/PEPTIDE',2,2,1),(5940,'5hh7','CRYSTAL STRUCTURE OF ARABIDOPSIS ORC1B BAH-PHD CASSETTE IN COMPLEX WITH UNMODIFIED H3 PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(5941,'5hhg','MOUSE IMPORTIN ALPHA: DENGUE 2 NS5 C-TERMINAL NLS PEPTIDE COMPLEX','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT/VIRAL PROTEIN',1,1,1),(5942,'5hhm','CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,6,1),(5943,'5hhn','CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-F5L','X-RAY DIFFRACTION',2.030,'IMMUNE SYSTEM',1,1,1),(5944,'5hhp','CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-G4E','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(5945,'5hhq','CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH M1-L3W','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,1,1),(5946,'5hhv','INHIBITING COMPLEX IL-17A AND IL-17RA INTERACTIONS WITH A LINEAR PEPTIDE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM/INHIBITOR',2,1,1),(5947,'5hi3','BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS','X-RAY DIFFRACTION',2.150,'IMMUNE SYSTEM/INHIBITOR',1,2,1),(5948,'5hi4','BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM/INHIBITOR',1,2,1),(5949,'5hi5','BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM/INHIBITOR',1,2,1),(5950,'5hjs','IDENTIFICATION OF LXRBETA SELECTIVE AGONISTS FOR THE TREATMENT OF ALZHEIMER\'S DISEASE','X-RAY DIFFRACTION',1.720,'SIGNALING PROTEIN',2,2,1),(5951,'5hkp','CRYSTAL STRUCTURE OF MOUSE TANKYRASE/HUMAN TRF1 COMPLEX','X-RAY DIFFRACTION',2.200,'TRANSFERASE / SIGNALING PROTEIN',2,2,1),(5952,'5hky','CRYSTAL STRUCTURE OF C-CBL TKBD DOMAIN IN COMPLEX WITH SPRY2 PEPTIDE (36-60, PY55) REFINED TO 1.8A RESOLUTION (P6 FORM)','X-RAY DIFFRACTION',1.800,'LIGASE',1,1,1),(5953,'5hkz','CRYSTAL STRUCTURE OF C-CBL TKBD IN COMPLEX WITH SPRY2 PEPTIDE (36-60, PY55) REFINED TO 1.8 A RESOLUTION (P21 FORM)','X-RAY DIFFRACTION',1.800,'LIGASE',1,1,1),(5954,'5hl0','CRYSTAL STRUCTURE OF C-CBL TKBD IN COMPLEX WITH SPRY2 PEPTIDE (54-60, PY55) REFINED TO 2.2A RESOLUTION','X-RAY DIFFRACTION',2.200,'LIGASE',1,1,1),(5955,'5hq8','CO-CRYSTAL STRUCTURE OF HUMAN SMYD3 WITH A MEKK2 PEPTIDE AT 2.13A','X-RAY DIFFRACTION',1.720,'TRANSFERASE',2,2,1),(5956,'5hsp','MAMM CTD M250L','X-RAY DIFFRACTION',1.790,'METAL TRANSPORT',1,1,1),(5957,'5hsv','X-RAY STRUCTURE OF A CYPA-ALISPORIVIR COMPLEX AT 1.5 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',1.500,'ISOMERASE',4,4,1),(5958,'5hsz','STRUCTURE OF THE K. PNEUMONIA SLMA PROTEIN BOUND TO THE C-TERMINAL TAIL OF THE CYTOSKELETAL CELL DIVISION PROTEIN FTSZ','X-RAY DIFFRACTION',2.300,'CELL CYCLE',1,1,1),(5959,'5htb','CRYSTAL STRUCTURE OF HASPIN (GSG2) IN COMPLEX WITH BISUBSTRATE INHIBITOR ARC-3353','X-RAY DIFFRACTION',1.700,'TRANSFERASE',1,1,1),(5960,'5htc','CRYSTAL STRUCTURE OF HASPIN (GSG2) IN COMPLEX WITH BISUBSTRATE INHIBITOR ARC-3372','X-RAY DIFFRACTION',1.500,'TRANSFERASE',1,1,1),(5961,'5hu3','DROSOPHILA CAMKII-D136N IN COMPLEX WITH A PHOSPHORYLATED FRAGMENT OF THE EAG POTASSIUM CHANNEL AND MG2+/ADP','X-RAY DIFFRACTION',1.890,'TRANSFERASE',1,1,1),(5962,'5huw','STRUCTURE OF HSV-1 LARGE TERMINASE NLS BOUND TO IMPORTIN ALPHA','X-RAY DIFFRACTION',1.950,'TRANPORT PROTEIN, VIRAL PROTEIN',2,1,1),(5963,'5huy','STRUCTURE OF HCMV SMALL TERMINASE NLS BOUND TO IMPORTIN ALPHA','X-RAY DIFFRACTION',1.980,'TRANSPORT PROTEIN/VIRAL PROTEIN',2,1,1),(5964,'5hvp','CRYSTALLOGRAPHIC ANALYSIS OF A COMPLEX BETWEEN HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 PROTEASE AND ACETYL-PEPSTATIN AT 2.0-ANGSTROMS RESOLUTION','X-RAY DIFFRACTION',2.000,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(5965,'5hyc','STRUCTURE BASED FUNCTION ANNOTATION OF A HYPOTHETICAL PROTEIN MGG_01005 RELATED TO THE DEVELOPMENT OF RICE BLAST FUNGUS','X-RAY DIFFRACTION',2.400,'UNKNOWN FUNCTION',1,2,1),(5966,'5hyq','CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,4,1),(5967,'5hyr','ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH STAPLED PEPTIDE SRC2-SP2 AND ESTRADIOL','X-RAY DIFFRACTION',2.270,'GENE REGULATION',2,2,1),(5968,'5i0q','STRUCTURE OF HUMAN C4B-BINDING PROTEIN ALPHA CHAIN CCP DOMAINS 1 AND 2 IN COMPLEX WITH THE HYPERVARIABLE REGION OF MUTANT GROUP A STREPTOCOCCUS M2 (K65A, N66A) PROTEIN','X-RAY DIFFRACTION',2.290,'IMMUNE SYSTEM',1,1,1),(5969,'5i22','AMPHIPHYSIN SH3 IN COMPLEX WITH CHIKUNGUNYA VIRUS NSP3 PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(5970,'5i3l','DPF3B IN COMPLEX WITH H3K14AC PEPTIDE','X-RAY DIFFRACTION',1.850,'PEPTIDE BINDING PROTEIN',1,2,1),(5971,'5i7z','CRYSTAL STRUCTURE OF A PAR-6 PDZ-CRUMBS 3 C-TERMINAL PEPTIDE COMPLEX','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(5972,'5i8c','CRYSTAL STRUCTURE OF HIV-1 CLADE A BG505 FUSION PEPTIDE (RESIDUE 512- 520) IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC34.01 FAB','X-RAY DIFFRACTION',1.540,'IMMUNE SYSTEM',1,2,1),(5973,'5i8m','BICYCLIC ANTIMIBROCIAL PEPTIDES','X-RAY DIFFRACTION',2.130,'SUGAR BINDING PROTEIN',1,3,1),(5974,'5i8x','BICYCLIC ANTIMIBROCIAL PEPTIDES','X-RAY DIFFRACTION',1.890,'SUGAR BINDING PROTEIN',1,2,1),(5975,'5i9b','CASPASE 3 V266A','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5976,'5i9t','CASPASE 3 V266C','X-RAY DIFFRACTION',1.950,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5977,'5iab','CASPASE 3 V266D','X-RAY DIFFRACTION',1.790,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5978,'5iae','CASPASE 3 V266F','X-RAY DIFFRACTION',1.550,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5979,'5iag','CASPASE 3 V266Q','X-RAY DIFFRACTION',1.980,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(5980,'5iaj','CASPASE 3 V266L','X-RAY DIFFRACTION',1.580,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5981,'5iak','CASPASE 3 V266S','X-RAY DIFFRACTION',1.820,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5982,'5iar','CASPASE 3 V266W','X-RAY DIFFRACTION',1.760,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5983,'5ias','CASPASE 3 V266Y','X-RAY DIFFRACTION',1.540,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5984,'5iay','NMR STRUCTURE OF UHRF1 TANDEM TUDOR DOMAINS IN A COMPLEX WITH SPACER PEPTIDE','SOLUTION NMR',NULL,'LIGASE',1,1,1),(5985,'5ib1','CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR MEASURED AT 295 K','X-RAY DIFFRACTION',1.910,'IMMUNE SYSTEM',1,1,1),(5986,'5ib2','CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR','X-RAY DIFFRACTION',1.440,'IMMUNE SYSTEM',1,1,1),(5987,'5ib3','CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND COPPER','X-RAY DIFFRACTION',1.910,'IMMUNE SYSTEM',1,1,1),(5988,'5ib4','CRYSTAL STRUCTURE OF HLA-B*27:05 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND NICKEL','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,1,1),(5989,'5ib5','CRYSTAL STRUCTURE OF HLA-B*27:09 COMPLEXED WITH THE SELF-PEPTIDE PVIPR AND COPPER','X-RAY DIFFRACTION',2.490,'IMMUNE SYSTEM',2,2,1),(5990,'5ibc','CASPASE 3 V266I','X-RAY DIFFRACTION',1.660,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5991,'5ibk','SKP1-F-BOX IN COMPLEX WITH A UBIQUITIN VARIANT','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING',2,4,1),(5992,'5ibp','CASPASE 3 V266M','X-RAY DIFFRACTION',1.380,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(5993,'5ibr','CASPASE 3 V266K','X-RAY DIFFRACTION',1.740,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(5994,'5ibw','COMPLEX OF MLCC BOUND TO THE TANDEM IQ MOTIF OF MYOC','X-RAY DIFFRACTION',1.900,'MOTOR PROTEIN',1,2,1),(5995,'5ic3','CAL PDZ DOMAIN WITH PEPTIDE AND INHIBITOR','X-RAY DIFFRACTION',1.700,'PEPTIDE BINDING PROTEIN/INHIBITOR',2,2,1),(5996,'5ick','A UNIQUE BINDING MODEL OF FXR LBD WITH FEROLINE','X-RAY DIFFRACTION',2.470,'TRANSCRIPTION',2,2,1),(5997,'5icv','CRYSTAL STRUCTURE OF HUMAN NATF (HNAA60) BOUND TO A BISUBSTRATE ANALOGUE','X-RAY DIFFRACTION',1.530,'TRANSFERASE',2,2,1),(5998,'5icy','CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(5999,'5id0','CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,4,1),(6000,'5id1','CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE','X-RAY DIFFRACTION',2.490,'IMMUNE SYSTEM',2,4,1),(6001,'5ieh','STRUCTURE OF HLA-B*40:02 IN COMPLEX WITH THE PHOSPHORYLATED ENDOGENOUS PEPTIDE REF(P)SKEPEL','X-RAY DIFFRACTION',1.500,'IMMUNE SYSTEM',1,1,1),(6002,'5iek','STRUCTURE OF HLA-B*40:02 IN COMPLEX WITH THE ENDOGENOUS PEPTIDE REFSKEPEL','X-RAY DIFFRACTION',1.800,'IMMUNE SYSTEM',1,1,1),(6003,'5ifj','CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',4,8,1),(6004,'5ig7','CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP','X-RAY DIFFRACTION',1.970,'IMMUNE SYSTEM',4,8,1),(6005,'5igo','WD40 DOMAIN OF ARABIDOPSIS THALIANA E3 UBIQUITIN LIGASE COP1 IN COMPLEX WITH PEPTIDE FROM TRIB1','X-RAY DIFFRACTION',1.600,'HYDROLASE/PEPTIDE',4,4,1),(6006,'5ih2','STRUCTURE, THERMODYNAMICS, AND THE ROLE OF CONFORMATIONAL DYNAMICS IN THE INTERACTIONS BETWEEN THE N-TERMINAL SH3 DOMAIN OF CRKII AND PROLINE-RICH MOTIFS IN CABL','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(6007,'5ii0','CRYSTAL STRUCTURE OF THE HUMAN CALCITONIN RECEPTOR ECTODOMAIN IN COMPLEX WITH A TRUNCATED SALMON CALCITONIN ANALOGUE','X-RAY DIFFRACTION',2.100,'HORMONE',3,3,1),(6008,'5ijk','CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(6009,'5im7','CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,2,1),(6010,'5inb','REPOMAN-PP1G (PROTEIN PHOSPHATASE 1, GAMMA ISOFORM) HOLOENZYME COMPLEX','X-RAY DIFFRACTION',1.300,'HYDROLASE/PROTEIN BINDING',1,1,1),(6011,'5ind','CRYSTAL STRUCTURE OF HLA-B5801, A PROTECTIVE HLA ALLELE FOR HIV-1 INFECTION','X-RAY DIFFRACTION',2.130,'IMMUNE SYSTEM',2,2,1),(6012,'5iok','CRYSTAL STRUCTURE OF TAF14 YEATS DOMAIN IN COMPLEX WITH HISTONE H3K9CR','X-RAY DIFFRACTION',2.220,'TRANSCRIPTION',1,1,1),(6013,'5iop','CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',2,4,1),(6014,'5iq9','CRYSTAL STRUCTURE OF 10E8V4 FAB IN COMPLEX WITH AN HIV-1 GP41 PEPTIDE.','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,4,1),(6015,'5iql','CRYSTAL STRUCTURE OF YEATS2 YEATS BOUND TO H3K27CR PEPTIDE','X-RAY DIFFRACTION',2.100,'PROTEIN BINDING',1,1,1),(6016,'5iqm','CRYSTAL STRUCTURE OF THE E. COLI TYPE 1 PILUS SUBUNIT FIMG (ENGINEERED VARIANT WITH SUBSTITUTION Q134E; N-TERMINAL FIMG RESIDUES 1-12 TRUNCATED) IN COMPLEX WITH THE DONOR STRAND PEPTIDE DSF_T4R-T6R-D13N','X-RAY DIFFRACTION',1.500,'CELL ADHESION',2,2,1),(6017,'5iqn','CRYSTAL STRUCTURE OF THE E. COLI TYPE 1 PILUS SUBUNIT FIMG (ENGINEERED VARIANT WITH SUBSTITUTION Q134E; N-TERMINAL FIMG RESIDUES 1-12 TRUNCATED) IN COMPLEX WITH THE DONOR STRAND PEPTIDE DSF_SRIRIRGYVR','X-RAY DIFFRACTION',1.000,'CELL ADHESION',2,2,1),(6018,'5iqo','CRYSTAL STRUCTURE OF THE E. COLI TYPE 1 PILUS SUBUNIT FIMG (ENGINEERED VARIANT WITH SUBSTITUTIONS Q134E AND S138E; N-TERMINAL FIMG RESIDUES 1-12 TRUNCATED) IN COMPLEX WITH THE DONOR STRAND PEPTIDE DSF_T4R-T6R- D13N','X-RAY DIFFRACTION',1.300,'CELL ADHESION',2,2,1),(6019,'5ir1','CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,4,1),(6020,'5isz','CRYSTAL STRUCTURE OF LS01-TCR/M1-HLA-A*02 COMPLEX','X-RAY DIFFRACTION',2.060,'IMMUNE SYSTEM',1,3,1),(6021,'5itz','CRYSTAL STRUCTURE OF THE SAC DOMAIN OF CPAP IN A COMPLEX WITH TUBULIN AND DARPIN','X-RAY DIFFRACTION',2.200,'STRUCTURAL PROTEIN',1,2,1),(6022,'5iv2','CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,4,1),(6023,'5ivn','BC2 NANOBODY IN COMPLEX WITH THE BC2 PEPTIDE TAG','X-RAY DIFFRACTION',1.000,'PEPTIDE BINDING PROTEIN',1,1,1),(6024,'5ivx','CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,3,1),(6025,'5ivz','CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,4,1),(6026,'5ixf','SOLUTION STRUCTURE OF THE STAM2 SH3 WITH AMSH DERIVED PEPTIDE COMPLEX','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(6027,'5ixq','CRYSTAL STRUCTURE OF THE ARABIDOPSIS RECEPTOR KINASE HAESA LRR ECTDOMAIN IN COMPLEX WITH THE PEPTIDE HORMONE IDA.','X-RAY DIFFRACTION',1.860,'SIGNALING PROTEIN',1,1,1),(6028,'5ixt','THE CRYSTAL STRUCTURE OF THE ARABIDOPSIS RECEPTOR KINASE HAESA LRR ECTDOMAIN IN COMPLEX WITH A N-TERMINAL EXTENDED IDA PEPTIDE HORMONE LIGAND.','X-RAY DIFFRACTION',1.940,'SIGNALING PROTEIN',1,1,1),(6029,'5iy5','ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION','X-RAY DIFFRACTION',2.000,'OXIDOREDUCTASE',6,14,1),(6030,'5iyx','CRYSTAL STRUCTURE OF THE ARABIDOPSIS RECEPTOR KINASE HAESA IN COMPLEX WITH THE PEPTIDE HORMONE IDA AND THE CO-RECEPTOR SERK1','X-RAY DIFFRACTION',2.430,'SIGNALING PROTEIN',1,2,1),(6031,'5iz2','CRYSTAL STRUCTURE OF THE N. CLAVIPES SPIDROIN NTD AT PH 6.5','X-RAY DIFFRACTION',2.020,'STRUCTURAL PROTEIN',1,1,1),(6032,'5iz6','PROTEIN-PROTEIN INTERACTION','X-RAY DIFFRACTION',2.150,'PROTEIN BINDING/INHIBITOR',1,1,1),(6033,'5iza','PROTEIN-PROTEIN INTERACTION','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING/INHIBITOR',1,1,1),(6034,'5izu','A NEW BINDING SITE OUTSIDE THE CANONICAL PDZ DOMAIN DETERMINES THE SPECIFIC INTERACTION BETWEEN SHANK AND SAPAP AND THEIR FUNCTION','X-RAY DIFFRACTION',2.490,'PROTEIN BINDING',2,2,1),(6035,'5j19','PHOSPHO-PON BINDING-INDUCED PLK1 DIMERIZATION','X-RAY DIFFRACTION',2.000,'CELL CYCLE',2,2,1),(6036,'5j28','KI67-PP1G (PROTEIN PHOSPHATASE 1, GAMMA ISOFORM) HOLOENZYME COMPLEX','X-RAY DIFFRACTION',2.000,'HYDROLASE/PROTEIN BINDING',2,2,1),(6037,'5j31','CRYSTAL STRUCTURE OF 14-3-3ZETA IN COMPLEX WITH AN ALKYNE CROSS-LINKED CYCLIC PEPTIDE DERIVED FROM EXOS','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',2,2,1),(6038,'5j3q','CRYSTAL STRUCTURE OF S. POMBE DCP1:EDC1 MRNA DECAPPING COMPLEX','X-RAY DIFFRACTION',1.870,'HYDROLASE',2,2,1),(6039,'5j3t','CRYSTAL STRUCTURE OF S. POMBE DCP2:DCP1:EDC1 MRNA DECAPPING COMPLEX','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,2,1),(6040,'5j4t','STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH GLCNAC BETA-(1,3) GAL- BETA-OME','X-RAY DIFFRACTION',1.940,'SUGAR BINDING PROTEIN',4,4,1),(6041,'5j4x','STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH GAL BETA-(1,3) GAL- BETA-OME','X-RAY DIFFRACTION',1.650,'SUGAR BINDING PROTEIN',4,4,1),(6042,'5j50','STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH GAL BETA-(1,3) GALNAC- ALPHA-OPNP','X-RAY DIFFRACTION',2.050,'SUGAR BINDING PROTEIN',4,4,1),(6043,'5j51','STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH GAL ALPHA-(1,4) GAL','X-RAY DIFFRACTION',1.670,'SUGAR BINDING PROTEIN',4,4,1),(6044,'5j6h','RECOGNITION OF THE MHC CLASS IB MOLECULE H2-Q10 BY THE NATURAL KILLER CELL RECEPTOR LY49C','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(6045,'5j6z','STRUCTURE OF ANASTELLIN BOUND TO BETA-STRANDS A AND B FROM THE THIRD TYPE III DOMAIN OF FIBRONECTIN','SOLUTION NMR',NULL,'CELL ADHESION',1,1,1),(6046,'5j7j','NMR DERIVED STRUCTURE OF CA2+ CALMODULIN BOUND TO PHOSPHORYLATED PSD- 95','SOLUTION NMR',NULL,'METAL BINDING PROTEIN',1,1,1),(6047,'5j8h','STRUCTURE OF CALMODULIN IN A COMPLEX WITH A PEPTIDE DERIVED FROM A CALMODULIN-DEPENDENT KINASE','SOLUTION NMR',NULL,'METAL BINDING PROTEIN/TRANSFERASE',1,1,1),(6048,'5ja5','CRYSTAL STRUCTURE OF THE RICE TOPLESS RELATED PROTEIN 2 (TPR2) N- TERMINAL TOPLESS DOMAIN (1-209) L111A AND L130A MUTANT IN COMPLEX WITH RICE D53 REPRESSOR EAR PEPTIDE MOTIF','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(6049,'5jbq','EF-TU (ESCHERICHIA COLI) IN COMPLEX WITH THIOMURACIN ANALOG','X-RAY DIFFRACTION',2.010,'RNA BINDING PROTEIN/ANTIMICROBIAL',1,1,1),(6050,'5jbt','MESOTRYPSIN IN COMPLEX WITH CLEAVED AMYLOID PRECURSOR LIKE PROTEIN 2 INHIBITOR (APLP2)','X-RAY DIFFRACTION',1.400,'HYDROLASE/HYDROLASE INHIBITOR',2,1,1),(6051,'5jcy','SPIR2-GTBM BOUND TO MYOVA-GTD','X-RAY DIFFRACTION',1.800,'MOTOR PROTEIN',1,1,1),(6052,'5jdu','CRYSTAL STRUCTURE FOR HUMAN THROMBIN MUTANT D189A','X-RAY DIFFRACTION',1.700,'HYDROLASE',2,2,1),(6053,'5jej','PHOSPHORYLATED STING IN COMPLEX WITH IRF-3 CTD','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',3,2,1),(6054,'5jek','PHOSPHORYLATED MAVS IN COMPLEX WITH IRF-3','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,2,1),(6055,'5jel','PHOSPHORYLATED TRIF IN COMPLEX WITH IRF-3','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,1,1),(6056,'5jem','COMPLEX OF IRF-3 WITH CBP','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',4,4,1),(6057,'5jeo','PHOSPHORYLATED ROTAVIRUS NSP1 IN COMPLEX WITH IRF-3','X-RAY DIFFRACTION',1.720,'IMMUNE SYSTEM',1,1,1),(6058,'5jez','CRYSTAL STRUCTURE OF TYPE 2 PDF FROM STREPTOCOCCUS AGALACTIAE IN COMPLEX WITH TRIPEPTIDE MET-ALA-SER','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(6059,'5jf0','CRYSTAL STRUCTURE OF TYPE 2 PDF FROM STREPTOCOCCUS AGALACTIAE IN COMPLEX WITH TRIPEPTIDE MET-ALA-ARG','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(6060,'5jfd','THROMBIN IN COMPLEX WITH (S)-N-(2-(AMINOMETHYL)-5-CHLOROBENZYL)-1- ((BENZYLSULFONYL)-D-ARGINYL)PYRROLIDINE-2-CARBOXAMIDE','X-RAY DIFFRACTION',1.460,'HYDROLASE',2,1,1),(6061,'5jfg','STRUCTURE OF HUMANISED RADA-MUTANT HUMRADA22F IN COMPLEX WITH PEPTIDE FHTA','X-RAY DIFFRACTION',1.770,'HYDROLASE',1,1,1),(6062,'5jft','ZEBRA FISH CASPASE-3','X-RAY DIFFRACTION',2.280,'HYDROLASE/HYDROLASE INHIBITOR',2,2,1),(6063,'5jfz','E. COLI ECFICT IN COMPLEX WITH ECFICA MUTANT E28G','X-RAY DIFFRACTION',2.400,'TRANSFERASE',3,3,1),(6064,'5jhd','CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX','X-RAY DIFFRACTION',2.460,'IMMUNE SYSTEM',2,6,1),(6065,'5jhn','STRUCTURE OF G9A SET-DOMAIN WITH HISTONE H3K9ALA MUTANT PEPTIDE AND BOUND S-ADENOSYLMETHIONINE','X-RAY DIFFRACTION',1.670,'TRANSFERASE',2,2,1),(6066,'5ji0','PPARGAMMA-RXRALPHA(S427F) HETERODIMER IN COMPLEX WITH SRC-1, ROSIGLITAZONE, AND 9-CIS-RETANOIC ACID','X-RAY DIFFRACTION',1.980,'TRANSFERASE',2,2,1),(6067,'5jin','STRUCTURE OF G9A SET-DOMAIN WITH HISTONE H3K9M MUTANT PEPTIDE AND BOUND S-ADENOSYLMETHIONINE','X-RAY DIFFRACTION',1.850,'TRANSFERASE',2,2,1),(6068,'5jiu','THE CRYSTAL STRUCTURE OF RANBPM/9 IUS-SPRY DOMAIN IN COMPLEX WITH DDX- 4 PEPTIDE','X-RAY DIFFRACTION',2.050,'RAN BINDING PROTEIN/PEPTIDE',2,2,1),(6069,'5jiy','STRUCTURE OF G9A SET-DOMAIN WITH HISTONE H3K9NORLEUCINE MUTANT PEPTIDE AND BOUND S-ADENOSYLMETHIONINE','X-RAY DIFFRACTION',1.480,'TRANSFERASE',2,2,1),(6070,'5jj0','STRUCTURE OF G9A SET-DOMAIN WITH HISTONE H3K9M PEPTIDE AND EXCESS SAH','X-RAY DIFFRACTION',1.720,'TRANSFERASE',2,2,1),(6071,'5jja','CRYSTAL STRUCTURE OF A PP2A B56GAMMA/BUBR1 COMPLEX','X-RAY DIFFRACTION',2.350,'SIGNALING PROTEIN',2,2,1),(6072,'5jjm','CRYSTAL STRUCTURE OF HOMODIMERIC ANDROGEN RECEPTOR LIGAND-BINDING DOMAIN BOUND TO DHT AND LXXLL PEPTIDE','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',8,4,1),(6073,'5jjy','CRYSTAL STRUCTURE OF SETD2 BOUND TO HISTONE H3.3 K36M PEPTIDE','X-RAY DIFFRACTION',2.050,'TRANSFERASE',1,1,1),(6074,'5jlb','CRYSTAL STRUCTURE OF SETD2 BOUND TO HISTONE H3.3 K36I PEPTIDE','X-RAY DIFFRACTION',1.500,'TRANSFERASE',1,1,1),(6075,'5jlz','CRYSTAL STRUCTURE OF HLA-DRB1*04:01 IN COMPLEX WITH MODIFIED ALPHA- ENOLASE PEPTIDE 26-40 WITH CITRULLINE AT THE POSITION 32','X-RAY DIFFRACTION',1.990,'IMMUNE SYSTEM',2,4,1),(6076,'5jm1','STRUCTURE OF TETRAMERIC JACALIN COMPLEXED WITH A TRISACCHARIDE, GAL ALPHA-(1,3) GAL BETA-(1,4) GAL','X-RAY DIFFRACTION',1.950,'SUGAR BINDING PROTEIN',4,4,1),(6077,'5jm4','CRYSTAL STRUCTURE OF 14-3-3ZETA IN COMPLEX WITH A CYCLIC PEPTIDE INVOLVING AN ADAMANTYL AND A DICARBOXY SIDE CHAIN','X-RAY DIFFRACTION',2.340,'SIGNALING PROTEIN',2,2,1),(6078,'5jme','CRYSTAL STRUCTURE OF ACETYLCHOLINE BINDING PROTEIN (ACHBP) FROM APLYSIA CALIFORNICA IN COMPLEX WITH ALPHA-CONOTOXIN PEIA','X-RAY DIFFRACTION',2.340,'ACETYLCHOLINE BINDING PROTEIN',4,5,1),(6079,'5jmm','CRYSTAL STRUCTURE OF HERA-LBD (Y537S) IN COMPLEX WITH BIOCHANIN A','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(6080,'5jmo','X-RAY STRUCTURE OF FURIN IN COMPLEX WITH THE INHIBITORY ANTIBODY NB14','X-RAY DIFFRACTION',2.000,'HYDROLASE/ANTIBODY',2,2,1),(6081,'5jnb','STRUCTURE OF GLD-2/RNP-8 COMPLEX','X-RAY DIFFRACTION',2.490,'TRANSFERASE',4,4,1),(6082,'5jp2','FCHO1 MU HOMOLOGY DOMAIN (DANIO RERIO) WITH BOUND EPS15 PEPTIDE','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',2,2,1),(6083,'5jp4','CRYSTAL STRUCTURE OF S. POMBE DCP1 IN COMPLEX WITH THE DECAPPING ENHANCER EDC','X-RAY DIFFRACTION',2.040,'PEPTIDE BINDING PROTEIN',1,1,1),(6084,'5jpf','SERINE/THREONINE PHOSPHATASE Z1 (CANDIDA ALBICANS) BINDS TO INHIBITOR MICROCYSTIN-LR','X-RAY DIFFRACTION',2.400,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(6085,'5jpo','COMPLEX STRUCTURE OF HUMAN ELONGATION FACTOR 1B GAMMA GST-LIKED DOMAIN AND DELTA N-TERMINAL DOMAIN','X-RAY DIFFRACTION',2.000,'TRANSLATION',1,3,1),(6086,'5jqa','CAM:RM20 COMPLEX','X-RAY DIFFRACTION',1.800,'CALCIUM BINDING PROTEIN/PROTEIN BINDI',1,1,1),(6087,'5jqi','CRYSTAL STRUCTURE OF FIMH A62S FROM E. COLI UTI89 BOUND TO FIMG N- TERMINAL EXTENSION','X-RAY DIFFRACTION',1.960,'SUGAR BINDING PROTEIN',4,4,1),(6088,'5jqy','ASPARTYL/ASPARAGINYL BETA-HYDROXYLASE (ASPH)OXYGENASE AND TPR DOMAINS IN COMPLEX WITH MANGANESE, N-OXALYLGLYCINE AND FACTOR X SUBSTRATE PEPTIDE FRAGMENT(39MER-4SER)','X-RAY DIFFRACTION',1.990,'OXIDOREDUCTASE',1,1,1),(6089,'5jr2','CRYSTAL STRUCTURE OF THE EPHA4 LBD IN COMPLEX WITH APYD3 PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.750,'TRANSFERASE/INHIBITOR',4,4,1),(6090,'5jr6','THE XRAY CRYSTAL STRUCTURE OF P. FALCIPARUM AMINOPEPTIDASE P IN COMPLEX WITH APSTATIN','X-RAY DIFFRACTION',2.300,'HYDROLASE',1,1,1),(6091,'5jtc','ASPARTYL/ASPARAGINYL BETA-HYDROXYLASE (ASPH)OXYGENASE AND TPR DOMAINS IN COMPLEX WITH MANGANESE, 2,4-PYRIDINE DICARBOXYLATE AND FACTOR X SUBSTRATE PEPTIDE FRAGMENT(39MER-4SER)','X-RAY DIFFRACTION',2.240,'OXIDOREDUCTASE',1,1,1),(6092,'5jth','CRYSTAL STRUCTURE OF E67A CALMODULIN - CAM:RM20 COMPLEX','X-RAY DIFFRACTION',1.840,'TRANSFERASE',1,1,1),(6093,'5jtm','THE STRUCTURE OF CHAPERONE SECB IN COMPLEX WITH UNSTRUCTURED PHOA BINDING SITE A','SOLUTION NMR',NULL,'CHAPERONE/HYDROLASE',4,4,1),(6094,'5jto','THE STRUCTURE OF CHAPERONE SECB IN COMPLEX WITH UNSTRUCTURED PROPHOA BINDING SITE D','SOLUTION NMR',NULL,'CHAPERONE/HYDROLASE',4,4,1),(6095,'5jtp','THE STRUCTURE OF CHAPERONE SECB IN COMPLEX WITH UNSTRUCTURED PROPHOA BINDING SITE E','SOLUTION NMR',NULL,'CHAPERONE/HYDROLASE',4,4,1),(6096,'5jtq','THE STRUCTURE OF CHAPERONE SECB IN COMPLEX WITH UNSTRUCTURED MBP BINDING SITE D','SOLUTION NMR',NULL,'CHAPERONE/PROTEIN BINDING',2,4,1),(6097,'5jtr','THE STRUCTURE OF CHAPERONE SECB IN COMPLEX WITH UNSTRUCTURED MBP BINDING SITE E','SOLUTION NMR',NULL,'CHAPERONE/PROTEIN BINDING',4,4,1),(6098,'5jw9','THE CRYSTAL STRUCTURE OF ELL2 OCLLUDIN DOMAIN AND AFF4 PEPTIDE','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',1,1,1),(6099,'5jwd','CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP392-401 PEPTIDE','X-RAY DIFFRACTION',2.500,'IMMUNE SYSTEM',1,1,1),(6100,'5jwe','CRYSTAL STRUCTURE OF H-2DB IN COMPLEX WITH THE LCMV-DERIVED GP92-101 PEPTIDE','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',4,4,1),(6101,'5jwp','CRYSTAL STRUCTURE OF HUMAN FIH D201E VARIANT IN COMPLEX WITH ZN, ALPHA-KETOGLUTARATE, AND HIF1 ALPHA PEPTIDE.','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',1,1,1),(6102,'5jxh','STRUCTURE THE PROPROTEIN CONVERTASE FURIN IN COMPLEX WITH META- GUANIDINOMETHYL-PHAC-RVR-AMBA AT 2.0 ANGSTROM RESOLUTION.','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(6103,'5jxj','STRUCTURE OF THE PROPROTEIN CONVERTASE FURIN COMPLEXED TO META- GUANIDINOMETHYL-PHAC-RVR-AMBA IN PRESENCE OF EDTA','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(6104,'5jz8','ASPARTYL/ASPARAGINYL BETA-HYDROXYLASE (ASPH)OXYGENASE AND TPR DOMAINS IN COMPLEX WITH MANGANESE, N-OXALYLGLYCINE, AND FACTOR X SUBSTRATE PEPTIDE FRAGMENT (39MER)','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',1,1,1),(6105,'5jzi','CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE','X-RAY DIFFRACTION',2.500,'PROTEIN BINDING/IMMUNE SYSTEM',2,6,1),(6106,'5jzu','ASPARTYL/ASPARAGINYL BETA-HYDROXYLASE (ASPH)OXYGENASE AND TPR DOMAINS IN COMPLEX WITH MANGANESE, N-OXALYLGLYCINE AND FACTOR X SUBSTRATE PEPTIDE FRAGMENT (26MER)','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE',1,1,1),(6107,'5jzy','THROMBIN IN COMPLEX WITH (S)-1-((R)-2-AMINO-3-CYCLOHEXYLPROPANOYL)-N- (4-CARBAMIMIDOYLBENZYL)PYRROLIDINE-2-CARBOXAMIDE','X-RAY DIFFRACTION',1.270,'HYDROLASE',2,1,1),(6108,'5k2m','BIFUNCTIONAL LYSX/ARGX FROM THERMOCOCCUS KODAKARENSIS WITH LYSW-GAMMA- AAA','X-RAY DIFFRACTION',2.180,'BIOSYNTHETIC PROTEIN',4,4,1),(6109,'5k3y','CRYSTAL STRUCTURE OF AURORAB/INCENP IN COMPLEX WITH BI 811283','X-RAY DIFFRACTION',1.600,'TRANSFERASE',2,2,1),(6110,'5k4f','CAL PDZ MUTANT C319A WITH A PEPTIDE','X-RAY DIFFRACTION',1.360,'PEPTIDE BINDING PROTEIN',2,2,1),(6111,'5k8q','CRYSTAL STRUCTURE OF CALCIUM-LOADED CALMODULIN IN COMPLEX WITH STRA6 CAMBP2-SITE PEPTIDE.','X-RAY DIFFRACTION',1.740,'METAL BINDING PROTEIN',1,1,1),(6112,'5k99','CRYSTAL STRUCTURE OF MICROCIN IMMUNITY PROTEIN MCCF FROM BACILLUS ANTHRACIS IN COMPLEX WITH MCC','X-RAY DIFFRACTION',1.500,'HYDROLASE/ANTIBIOTIC',2,2,1),(6113,'5k9s','IMPORTIN-ALPHA IN COMPLEX WITH HNF1-BETA PEPTIDE','X-RAY DIFFRACTION',2.400,'TRANSPORT PROTEIN',2,1,1),(6114,'5kc1','STRUCTURE OF THE C-TERMINAL DIMERIZATION DOMAIN OF ATG38','X-RAY DIFFRACTION',2.200,'ENDOCYTOSIS',5,2,1),(6115,'5kcc','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH OXABICYCLIC HEPTENE SULFONAMIDE (OBHS-N)','X-RAY DIFFRACTION',2.390,'TRANSCRIPTION',2,2,1),(6116,'5kcd','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-METHYL SUBSTITUTED OBHS-N DERIVATIVE','X-RAY DIFFRACTION',1.820,'TRANSCRIPTION',2,2,1),(6117,'5kce','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-METHYL, 2-CHLOROBENZYL OBHS-N DERIVATIVE','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',2,2,1),(6118,'5kcf','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, 4-METHOXYBENZYL OBHS-N DERIVATIVE','X-RAY DIFFRACTION',2.070,'TRANSCRIPTION',2,2,1),(6119,'5kct','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, 4-CHLOROBENZYL OBHS-N DERIVATIVE','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',2,2,1),(6120,'5kcu','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-ETHYL, ALPHA-NAPHTHYL OBHS-N DERIVATIVE','X-RAY DIFFRACTION',2.030,'TRANSCRIPTION',2,2,1),(6121,'5kcw','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-TRIFLUOROETHYL OBHS-N DERIVATIVE','X-RAY DIFFRACTION',1.910,'TRANSCRIPTION',2,2,1),(6122,'5kd7','CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PV9) OF HIV GP120 MN ISOLATE (IGPGRAFYV)','X-RAY DIFFRACTION',2.350,'IMMUNE SYSTEM',4,4,1),(6123,'5kd9','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH AN N-TRIFLUOROETHYL 4-CHLOROBENZYL OBHS-N DERIVATIVE','X-RAY DIFFRACTION',1.780,'TRANSCRIPTION',2,2,1),(6124,'5kds','ZMPB METALLOPEPTIDASE IN COMPLEX WITH AN O-GLYCOPEPTIDE (A2,6- SIALYLATED CORE-3 PENTAPEPTIDE).','X-RAY DIFFRACTION',1.600,'HYDROLASE',1,1,1),(6125,'5kez','SELECTIVE AND POTENT INHIBITION OF THE GLYCOSIDASE HUMAN AMYLASE BY THE SHORT AND EXTREMELY COMPACT PEPTIDE PIHA FROM MRNA DISPLAY','X-RAY DIFFRACTION',1.830,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(6126,'5kgn','1.95A RESOLUTION STRUCTURE OF INDEPENDENT PHOSPHOGLYCERATE MUTASE FROM C. ELEGANS IN COMPLEX WITH A MACROCYCLIC PEPTIDE INHIBITOR (2D)','X-RAY DIFFRACTION',1.950,'ISOMERASE',2,2,1),(6127,'5kjh','CRYSTAL STRUCTURE OF AN ACTIVE POLYCOMB REPRESSIVE COMPLEX 2 IN THE STIMULATED STATE','X-RAY DIFFRACTION',2.270,'TRANSFERASE',1,2,1),(6128,'5klr','PROTOTYPICAL P4[R]CNLS','X-RAY DIFFRACTION',2.200,'PROTEIN TRANSPORT/VIRAL PROTEIN',1,1,1),(6129,'5kr9','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH COUMESTROL','X-RAY DIFFRACTION',2.250,'TRANSCRIPTION',2,2,1),(6130,'5kra','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH DDT AND DDE','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',4,4,1),(6131,'5krc','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH ZEARALENONE','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(6132,'5krf','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE DYNAMIC WAY DERIVATIVE, 1A','X-RAY DIFFRACTION',2.190,'TRANSCRIPTION',2,2,1),(6133,'5krh','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 16-BENZYLIDENE ESTRONE','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(6134,'5kri','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 16B-BENZYL 17B-ESTRADIOL','X-RAY DIFFRACTION',2.250,'TRANSCRIPTION',2,2,1),(6135,'5krk','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 4,4\'-((5-BROMO-2,3-DIHYDRO-1H-INDEN-1-YLIDENE) METHYLENE)DIPHENOL','X-RAY DIFFRACTION',2.390,'TRANSCRIPTION',2,2,1),(6136,'5krl','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE A-CD RING ESTROGEN, (1S,7AS)-5-(2-CHLORO-4- HYDROXYPHENYL)-7A-METHYL-2,3,3A,4,7,7A-HEXAHYDRO-1H-INDEN-1-OL','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(6137,'5krm','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE A-CD RING ESTROGEN, (1S,7AS)-5-(2,5-DIFLUORO-4- HYDROXYPHENYL)-7A-METHYL-2,3,3A,4,7,7A-HEXAHYDRO-1H-INDEN-1-OL','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(6138,'5kro','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE METHYL(PHENYL)AMINO-SUBSTITUTED ESTROGEN, (8R,9S, 13S,14S,17S)-13-METHYL-17-(METHYL(PHENYL)AMINO)-7,8,9,11,12,13,14,15, 16,17-DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-3-OL','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(6139,'5ksa','BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,4,1),(6140,'5ksv','CRYSTAL STRUCTURE OF HLA-DQ2.5-CLIP2','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',1,2,1),(6141,'5kvm','EXTRACELLULAR REGION OF MOUSE GPR56/ADGRG1 IN COMPLEX WITH FN3 MONOBODY','X-RAY DIFFRACTION',2.450,'CELL ADHESION',1,1,1),(6142,'5kwn','THE WD DOMAIN OFARABIDOPSIS THALIANA E3 UBIQUITIN LIGASE COP1 IN COMPLEX WITH PEPTIDE FROM HY5','X-RAY DIFFRACTION',1.420,'LIGASE/PEPTIDE',1,1,1),(6143,'5kxh','MOUSE POFUT1 IN COMPLEX WITH MOUSE FACTOR VII EGF1 AND GDP','X-RAY DIFFRACTION',1.330,'TRANSFERASE',1,1,1),(6144,'5ky0','MOUSE POFUT1 IN COMPLEX WITH MOUSE NOTCH1 EGF12(D464G) AND GDP','X-RAY DIFFRACTION',1.530,'TRANSFERASE',1,1,1),(6145,'5ky2','MOUSE POFUT1 IN COMPLEX WITH O-GLUCOSYLATED MOUSE FACTOR VII EGF1 AND GDP','X-RAY DIFFRACTION',1.470,'TRANSFERASE',1,1,1),(6146,'5ky3','MOUSE POFUT1 IN COMPLEX WITH MOUSE FACTOR VII EGF1 MUTANT (T101A) AND GDP-FUCOSE','X-RAY DIFFRACTION',1.530,'TRANSFERASE',1,1,1),(6147,'5ky4','MOUSE POFUT1 IN COMPLEX WITH MOUSE NOTCH1 EGF26 AND GDP','X-RAY DIFFRACTION',1.470,'TRANSFERASE',1,1,1),(6148,'5ky5','MOUSE POFUT1 IN COMPLEX WITH EGF(+) AND GDP','X-RAY DIFFRACTION',1.500,'TRANSFERASE',1,1,1),(6149,'5ky7','MOUSE POFUT1 IN COMPLEX WITH O-GLUCOSYLATED EGF(+) AND GDP','X-RAY DIFFRACTION',1.600,'TRANSFERASE',1,1,1),(6150,'5ky8','MOUSE POFUT1 IN COMPLEX WITH O-GLUCOSYLATED MOUSE NOTCH1 EGF12 MUTANT (D464G) AND GDP','X-RAY DIFFRACTION',1.650,'TRANSFERASE',1,1,1),(6151,'5ky9','MOUSE POFUT1 IN COMPLEX WITH MOUSE NOTCH1 EGF12 MUTANT (D464G/A465G) AND GDP','X-RAY DIFFRACTION',1.830,'TRANSFERASE',1,1,1),(6152,'5kzp','STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX','X-RAY DIFFRACTION',2.260,'VIRAL PROTEIN/IMMUNE SYSTEM',4,8,1),(6153,'5kzt','LISTERIA MONOCYTOGENES OPPA BOUND TO PEPTIDE','X-RAY DIFFRACTION',1.850,'PEPTIDE BINDING PROTEIN',2,2,1),(6154,'5l04','STRUCTURE OF INTERFERON LAMBDA 1 RECEPTOR WITH HUMAN KINASE JAK1','X-RAY DIFFRACTION',2.100,'TRANSFERASE/TRANSFERASE INHIBITOR',1,1,1),(6155,'5l0r','HUMAN POGLUT1 IN COMPLEX WITH NOTCH1 EGF12 AND UDP','X-RAY DIFFRACTION',1.500,'TRANSFERASE',1,1,1),(6156,'5l0s','HUMAN POGLUT1 IN COMPLEX WITH FACTOR VII EGF1 AND UDP','X-RAY DIFFRACTION',1.450,'TRANSFERASE',1,1,1),(6157,'5l0t','HUMAN POGLUT1 IN COMPLEX WITH EGF(+) AND UDP','X-RAY DIFFRACTION',1.430,'TRANSFERASE',1,1,1),(6158,'5l0u','HUMAN POGLUT1 IN COMPLEX WITH EGF(+) AND UDP-PHOSPHONO-GLUCOSE','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(6159,'5l0v','HUMAN POGLUT1 IN COMPLEX WITH 2F-GLUCOSE MODIFIED EGF(+) AND UDP','X-RAY DIFFRACTION',1.310,'TRANSFERASE',1,1,1),(6160,'5l11','HUMAN LIVER RECEPTOR HOMOLOGUE-1 (LRH-1) BOUND TO RJW100 AND A FRAGMENT OF TIF-2','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION/INHIBITOR',1,1,1),(6161,'5l20','CRYSTAL STRUCTURE OF A CLOSTRIPAIN (BT_0727) FROM BACTEROIDES THETAIOTAOMICRON ATCC 29148 IN COMPLEX WITH PEPTIDE INHIBITOR BTN- VLTK-AOMK','X-RAY DIFFRACTION',1.450,'HYDROLASE/HYDROLASE INHIBITOR',1,2,1),(6162,'5l23','CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE N-TERMINAL SH3 DOMAIN OF CRKII AND A PROLINE-RICH LIGAND','X-RAY DIFFRACTION',1.770,'PROTEIN BINDING',1,1,1),(6163,'5l6n','DISULFATED MADANIN-THROMBIN COMPLEX','X-RAY DIFFRACTION',1.630,'HYDROLASE',2,1,1),(6164,'5l7e','MCR IN COMPLEX WITH LIGAND','X-RAY DIFFRACTION',1.860,'SIGNALING PROTEIN',1,1,1),(6165,'5l7g','MCR IN COMPLEX WITH LIGAND','X-RAY DIFFRACTION',2.010,'SIGNALING PROTEIN',1,1,1),(6166,'5l7h','MCR IN COMPLEX WITH LIGAND','X-RAY DIFFRACTION',1.840,'SIGNALING PROTEIN',1,1,1),(6167,'5l7k','THE CRYSTAL STRUCTURE OF MYRISTOYLATED NPHP3 PEPTIDE IN COMPLEX WITH UNC119A','X-RAY DIFFRACTION',2.100,'LIPID BINDING PROTEIN',1,1,1),(6168,'5l83','COMPLEX OF POTATO ATG8 PROTEIN WITH A PEPTIDE FROM IRISH POTATO FAMINE PATHOGEN EFFECTOR PROTEIN PEXRD54','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',2,2,1),(6169,'5l85','SOLUTION STRUCTURE OF THE COMPLEX BETWEEN HUMAN ZNHIT3 AND NUFIP1 PROTEINS','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(6170,'5l9b','HIF PROLYL HYDROXYLASE 2 (PHD2/ EGLN1) IN COMPLEX WITH 2-OXOGLUTARATE (2OG) AND HIF-1ALPHA CODD (556-574)','X-RAY DIFFRACTION',1.950,'OXIDOREDUCTASE',2,2,1),(6171,'5l9v','HIF PROLYL HYDROXYLASE 2 (PHD2-R281C/P317C) CROSS-LINKED TO HIF-1ALPHA NODD-L397C/D412C AND N-OXALYLGLYCINE (NOG) (COMPLEX-1)','X-RAY DIFFRACTION',1.830,'OXIDOREDUCTASE',2,2,1),(6172,'5lak','LIGAND-BOUND STRUCTURE OF CAVALLY VIRUS 3CL PROTEASE','X-RAY DIFFRACTION',2.300,'HYDROLASE',3,3,1),(6173,'5las','HIF PROLYL HYDROXYLASE 2 (PHD2-R281C/P317C/R396T) CROSS-LINKED TO HIF- 1ALPHA NODD-L397C/D412C AND N-OXALYLGLYCINE (NOG) (COMPLEX-3)','X-RAY DIFFRACTION',2.100,'OXIDOREDUCTASE',2,2,1),(6174,'5lb7','COMPLEX STRUCTURE BETWEEN P60N/P80C KATANIN AND A PEPTIDE DERIVED FROM ASPM','X-RAY DIFFRACTION',1.500,'HYDROLASE',1,2,1),(6175,'5lce','THROMBIN IN COMPLEX WITH (S)-1-((R)-2-AMINO-3-CYCLOHEXYLPROPANOYL)-N- (5-CHLORO-2-(HYDROXYMETHYL)BENZY L)PYRROLIDINE-2-CARBOXAMIDE','X-RAY DIFFRACTION',1.390,'HYDROLASE',2,1,1),(6176,'5lcp','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH FASUDIL (M77)','X-RAY DIFFRACTION',1.430,'TRANSFERASE',1,1,1),(6177,'5lcq','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH LONG-CHAIN FASUDIL-DERIVATIVE (LIGAND 05)','X-RAY DIFFRACTION',1.420,'TRANSFERASE',1,1,1),(6178,'5lcr','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH OPEN-CHAIN FASUDIL-DERIVATIVE (LIGAND 04)','X-RAY DIFFRACTION',1.570,'TRANSFERASE',1,1,1),(6179,'5lct','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A R-METHYL-PIPERAZINE SUBSTITUTED FASUDIL-DERIVATIVE (LIGAND 02)','X-RAY DIFFRACTION',1.620,'TRANSFERASE',1,1,1),(6180,'5lcu','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A S-METHYL-PIPERAZINE SUBSTITUTED FASUDIL-DERIVATIVE (LIGAND 01)','X-RAY DIFFRACTION',1.580,'TRANSFERASE',1,1,1),(6181,'5lef','RAB6A:KIF20A COMPLEX','X-RAY DIFFRACTION',2.090,'PROTEIN TRANSPORT',2,2,1),(6182,'5leo','COMPLEX STRUCTURE OF LYSOSTAPHIN SH3B DOMAIN WITH PEPTIDOGLYCAN FRAGMENT','X-RAY DIFFRACTION',1.600,'CELL ADHESION',2,2,1),(6183,'5lf0','HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM','X-RAY DIFFRACTION',2.410,'HYDROLASE',6,11,1),(6184,'5lf6','HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM','X-RAY DIFFRACTION',2.070,'HYDROLASE',2,4,1),(6185,'5lga','STRUCTURAL ANALYSIS AND BIOLOGICAL ACTIVITIES OF BXL0124, A GEMINI ANALOG OF VITAMIN D','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',1,1,1),(6186,'5lgp','CRYSTAL STRUCTURE OF MOUSE CARM1 IN COMPLEX WITH LIGAND P1C3S','X-RAY DIFFRACTION',2.040,'TRANSFERASE',4,4,1),(6187,'5lgq','CRYSTAL STRUCTURE OF MOUSE CARM1 IN COMPLEX WITH LIGAND P2C3S','X-RAY DIFFRACTION',2.110,'TRANSFERASE',4,4,1),(6188,'5lgr','CRYSTAL STRUCTURE OF MOUSE CARM1 IN COMPLEX WITH LIGAND P1C3U','X-RAY DIFFRACTION',2.000,'TRANSFERASE',4,4,1),(6189,'5lgs','CRYSTAL STRUCTURE OF MOUSE CARM1 IN COMPLEX WITH LIGAND P2C3U','X-RAY DIFFRACTION',2.100,'TRANSFERASE',4,4,1),(6190,'5li1','STRUCTURE OF A PAR3-INHIBITORY PEPTIDE BOUND TO PKCIOTA CORE KINASE DOMAIN','X-RAY DIFFRACTION',2.000,'TRANSFERASE',1,1,1),(6191,'5lmf','STRUCTURE OF C-TERMINAL DOMAIN FROM S. CEREVISIAE PAT1 DECAPPING ACTIVATOR BOUND TO DCP2 HLM3 PEPTIDE (REGION 484-500)','X-RAY DIFFRACTION',2.150,'RNA BINDING PROTEIN',2,2,1),(6192,'5lmg','STRUCTURE OF C-TERMINAL DOMAIN FROM S. CEREVISIAE PAT1 DECAPPING ACTIVATOR BOUND TO DCP2 HLM10 PEPTIDE (REGION 954-970)','X-RAY DIFFRACTION',1.890,'RNA BINDING PROTEIN',2,2,1),(6193,'5lpd','THROMBIN IN COMPLEX WITH (S)-1-((R)-2-AMINO-3-CYCLOHEXYLPROPANOYL)-N- (2-(AMINOMETHYL)-5-CHLOROBENZYL) PYRROLIDINE-2-CARBOXAMIDE','X-RAY DIFFRACTION',1.500,'HYDROLASE',2,1,1),(6194,'5lpr','STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS','X-RAY DIFFRACTION',2.130,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(6195,'5lrg','CRYSTAL STRUCTURE OF THE PORCINE CARBOXYPEPTIDASE B - ANABAENOPEPTIN B COMPLEX','X-RAY DIFFRACTION',2.020,'HYDROLASE',3,3,1),(6196,'5lrj','CRYSTAL STRUCTURE OF THE PORCINE CARBOXYPEPTIDASE B - ANABAENOPEPTIN C COMPLEX','X-RAY DIFFRACTION',2.200,'HYDROLASE',3,3,1),(6197,'5lrk','CRYSTAL STRUCTURE OF THE PORCINE CARBOXYPEPTIDASE B - ANABAENOPEPTIN F COMPLEX','X-RAY DIFFRACTION',2.300,'HYDROLASE',3,3,1),(6198,'5ls7','COMPLEX OF WILD TYPE E. COLI ALPHA ASPARTATE DECARBOXYLASE WITH ITS PROCESSING FACTOR PANZ','X-RAY DIFFRACTION',1.160,'LYASE',1,2,1),(6199,'5lsf','SACBROOD HONEYBEE VIRUS','X-RAY DIFFRACTION',2.100,'VIRUS',1,3,1),(6200,'5lso','CRYSTAL STRUCTURE OF SPF45 UHM DOMAIN WITH CYCLIC PEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.220,'SPLICING/INHIBITOR',2,2,1),(6201,'5lsw','A CAF40-BINDING MOTIF FACILITATES RECRUITMENT OF THE CCR4-NOT COMPLEX TO MRNAS TARGETED BY DROSOPHILA ROQUIN','X-RAY DIFFRACTION',2.150,'GENE REGULATION',2,2,1),(6202,'5lu1','HUMAN 14-3-3 SIGMA CLU3 MUTANT COMPLEXED WITH SHORT HSPB6 PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',4,4,1),(6203,'5lu2','HUMAN 14-3-3 SIGMA COMPLEXED WITH LONG HSPB6 PHOSPHOPEPTIDE','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',2,2,1),(6204,'5lu8','CRYSTAL STRUCTURE OF YVAD-CMK BOUND HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11B','X-RAY DIFFRACTION',1.950,'HYDROLASE',1,1,1),(6205,'5lu9','CRYSTAL STRUCTURE OF YVAD-CMK BOUND HUMAN LEGUMAIN (AEP) IN COMPLEX WITH COMPOUND 11','X-RAY DIFFRACTION',2.270,'HYDROLASE',1,1,1),(6206,'5lug','CRYSTAL STRUCTURE OF HUMAN SPINDLIN-2B PROTEIN IN COMPLEX WITH ART(M3L)QTA(2MR)KS PEPTIDE','X-RAY DIFFRACTION',1.700,'CELL CYCLE',4,4,1),(6207,'5lvf','SOLUTION STRUCTURE OF RTT103 CTD-INTERACTING DOMAIN BOUND TO A THR4 PHOSPHORYLATED CTD PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(6208,'5lvp','HUMAN PDK1 KINASE DOMAIN IN COMPLEX WITH AN HM-PEPTIDE BOUND TO THE PIF-POCKET','X-RAY DIFFRACTION',2.500,'TRANSFERASE',4,4,1),(6209,'5lxh','GABARAP-L1 ATG4B LIR COMPLEX','X-RAY DIFFRACTION',1.580,'SIGNALING PROTEIN',3,3,1),(6210,'5lxi','GABARAP-L1 ATG4B LIR COMPLEX','X-RAY DIFFRACTION',1.440,'SIGNALING PROTEIN',2,2,1),(6211,'5lxm','CRYSTAL STRUCTURE OF AURORA-A BOUND TO A HYDROCARBON-STAPLED PROTEOMIMETIC OF TPX2','X-RAY DIFFRACTION',2.080,'TRANSFERASE',1,1,1),(6212,'5lxr','STRUCTURE OF THE MINIMAL RBM7 - ZCCHC8 COMPLEX','X-RAY DIFFRACTION',2.000,'RNA BINDING PROTEIN',1,1,1),(6213,'5ly1','JMJD2A/ KDM4A COMPLEXED WITH NI(II) AND MACROCYCLIC PEPTIDE INHIBITOR CP2 (13-MER)','X-RAY DIFFRACTION',2.500,'OXIDOREDUCTASE',1,2,1),(6214,'5ly2','JMJD2A/ KDM4A COMPLEXED WITH NI(II), NOG AND MACROCYCLIC PEPTIDE INHIBITOR CP2_R6KME3 (13-MER)','X-RAY DIFFRACTION',2.430,'OXIDOREDUCTASE',4,4,1),(6215,'5ly3','P. CALIDIFONTIS CRENACTIN IN COMPLEX WITH ARCADIN-2 C-TERMINAL PEPTIDE','X-RAY DIFFRACTION',1.600,'STRUCTURAL PROTEIN',1,1,1),(6216,'5lyn','STRUCTURE OF THE TPR DOMAIN OF SGT2 IN COMPLEX WITH YEAST SSA1 PEPTIDE FRAGMENT','X-RAY DIFFRACTION',2.000,'CHAPERONE',2,2,1),(6217,'5lyq','CRYSTAL STRUCTURE OF THE RETINOIC ACID RECEPTOR ALPHA IN COMPLEX WITH A SYNTHETIC SPIROKETAL AGONIST AND A FRAGMENT OF THE TIF2 CO- ACTIVATOR.','X-RAY DIFFRACTION',2.170,'TRANSCRIPTION',1,1,1),(6218,'5m00','CRYSTAL STRUCTURE OF MURINE P14 TCR COMPLEX WITH H-2DB AND Y4A, MODIFIED GP33 PEPTIDE FROM LCMV','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,3,1),(6219,'5m01','CRYSTAL STRUCTURE OF MURINE P14 TCR/ H-2DB COMPLEX WITH PA, MODIFIED GP33 PEPTIDE FROM LCMV','X-RAY DIFFRACTION',1.950,'IMMUNE SYSTEM',1,3,1),(6220,'5m02','CRYSTAL STRUCTURE OF MURINE P14 TCR / H-2DB WITH PF, MODIFIED GP33 PEPTIDE FROM LCMV','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',1,3,1),(6221,'5m0b','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A SHORT-CHAINED N-(2-AMINOETHYL)ISOQUINOLINE-5-SULFONAMIDE) FASUDIL-DERIVATIVE (LIGAND 03)','X-RAY DIFFRACTION',1.510,'TRANSFERASE',1,1,1),(6222,'5m0c','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH THE FASUDIL-FRAGMENT ISOQUINOLINE-5-SULFONAMIDE','X-RAY DIFFRACTION',1.730,'TRANSFERASE',1,1,1),(6223,'5m0i','CRYSTAL STRUCTURE OF THE NUCLEAR COMPLEX WITH SHE2P AND THE ASH1 MRNA E3-LOCALIZATION ELEMENT','X-RAY DIFFRACTION',2.410,'TRANSPORT PROTEIN',3,3,1),(6224,'5m0l','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH THE METHYLATED FASUDIL-DERIVED FRAGMENT N-METHYLISOQUINOLINE-5- SULFONAMIDE (LIGAND 02)','X-RAY DIFFRACTION',1.470,'TRANSFERASE',1,1,1),(6225,'5m0u','APOSTRUCTURE STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) FROM CHO CELLS WITH A PEPTIDIC INHIBITOR FRAGMENT','X-RAY DIFFRACTION',1.670,'TRANSFERASE',1,1,1),(6226,'5m35','THE MOLECULAR TWEEZER CLR01 STABILIZES A DISORDERED PROTEIN-PROTEIN INTERFACE','X-RAY DIFFRACTION',2.380,'HYDROLASE',2,2,1),(6227,'5m36','THE MOLECULAR TWEEZER CLR01 STABILIZES A DISORDERED PROTEIN-PROTEIN INTERFACE','X-RAY DIFFRACTION',2.450,'HYDROLASE',2,2,1),(6228,'5m37','THE MOLECULAR TWEEZER CLR01 STABILIZES A DISORDERED PROTEIN-PROTEIN INTERFACE','X-RAY DIFFRACTION',2.350,'HYDROLASE',2,2,1),(6229,'5m3h','BAT INFLUENZA A/H17N10 POLYMERASE BOUND TO FOUR HEPTAD REPEATS OF SERINE 5 PHOSPHORYLATED POL II CTD','X-RAY DIFFRACTION',2.500,'TRANSFERASE',2,2,1),(6230,'5m5g','CRYSTAL STRUCTURE OF THE CHAETOMIUM THERMOPHILUM POLYCOMB REPRESSIVE COMPLEX 2 (PRC2)','X-RAY DIFFRACTION',2.270,'TRANSFERASE',2,2,1),(6231,'5m5r','CLATHRIN HEAVY CHAIN N-TERMINAL DOMAIN BOUND TO BETA2 ADAPTIN CLATHRIN BOX MOTIF','X-RAY DIFFRACTION',1.760,'ENDOCYTOSIS',2,1,1),(6232,'5m5s','CLATHRIN HEAVY CHAIN N-TERMINAL DOMAIN BOUND TO AMPHIPHYSIN CLATHRIN- BOX MOTIF','X-RAY DIFFRACTION',1.880,'ENDOCYTOSIS',4,2,1),(6233,'5m5t','CLATHRIN HEAVY CHAIN N-TERMINAL DOMAIN BOUND TO A NON-NATURAL CLATHRIN-BOX MOTIF PEPTIDE (AMPH4T1)','X-RAY DIFFRACTION',1.700,'ENDOCYTOSIS',6,2,1),(6234,'5m5u','CLATHRIN HEAVY CHAIN N-TERMINAL DOMAIN BOUND TO A CLATHRIN-BOX MOTIF FROM HEPATITIS D VIRUS LARGE ANTIGEN (CLADE 1)','X-RAY DIFFRACTION',2.150,'ENDOCYTOSIS',4,2,1),(6235,'5m5v','CLATHRIN HEAVY CHAIN N-TERMINAL DOMAIN BOUND TO A CLATHRIN-BOX MOTIF FROM HEPATITIS D VIRUS LARGE ANTIGEN (CLADE 2)','X-RAY DIFFRACTION',1.960,'ENDOCYTOSIS',6,2,1),(6236,'5m61','CLATHRIN HEAVY CHAIN N-TERMINAL DOMAIN BOUND TO AN EXTENDED AMPHIPHYSIN CLATHRIN-BOX MOTIF','X-RAY DIFFRACTION',1.840,'ENDOCYTOSIS',4,2,1),(6237,'5m6v','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A DOUBLE METHYLATED FASUDIL-DERIVATIVE','X-RAY DIFFRACTION',1.420,'TRANSFERASE',1,1,1),(6238,'5m6y','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A METHYLISOQUINOLINE FASUDIL-DERIVATIVE','X-RAY DIFFRACTION',1.370,'TRANSFERASE',1,1,1),(6239,'5m71','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH AN (R)-METHYL SUBSTITUED FASUDIL-DERIVATIVE.','X-RAY DIFFRACTION',1.490,'TRANSFERASE',1,1,1),(6240,'5m72','STRUCTURE OF THE HUMAN SRP68-72 PROTEIN-BINDING DOMAIN COMPLEX','X-RAY DIFFRACTION',1.600,'PROTEIN TRANSPORT',1,1,1),(6241,'5m75','COCRYSTAL STRUCTURE OF CAMP-DEPENDENT PROTEIN KINASE (PKA) IN COMPLEX WITH A (S)-METHYL SUBSTITUED FASUDIL-DERIVATIVE','X-RAY DIFFRACTION',1.540,'TRANSFERASE',1,1,1),(6242,'5m9d','SOLUTION STRUCTURE OF RTT103 CTD-INTERACTING DOMAIN BOUND TO A SER2SER7 PHOSPHORYLATED CTD PEPTIDE','SOLUTION NMR',NULL,'TRANSCRIPTION',1,1,1),(6243,'5m9n','CRYSTAL STRUCTURE OF HUMAN TDRD1 EXTENDED TUDOR DOMAIN IN COMPLEX WITH A SYMMETRICALLY DIMETHYLATED E2F PEPTIDE','X-RAY DIFFRACTION',1.950,'STRUCTURAL PROTEIN',1,1,1),(6244,'5m9o','CRYSTAL STRUCTURE OF HUMAN SND1 EXTENDED TUDOR DOMAIN IN COMPLEX WITH A SYMMETRICALLY DIMETHYLATED E2F PEPTIDE','X-RAY DIFFRACTION',1.450,'TRANSCRIPTION',1,1,1),(6245,'5mco','CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE INHIBITOR GRL- 8234 AND EXOSITE PEPTIDE','X-RAY DIFFRACTION',2.490,'HYDROLASE',1,1,1),(6246,'5mcq','CRYSTAL STRUCTURE OF BACE-1 IN COMPLEX WITH ACTIVE SITE AND EXOSITE BINDING PEPTIDE INHIBITOR','X-RAY DIFFRACTION',1.820,'HYDROLASE',1,1,1),(6247,'5me5','CRYSTAL STRUCTURE OF EIF4E FROM C. MELO BOUND TO A EIF4G PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSLATION',1,1,1),(6248,'5meo','HUMAN LEUKOCYTE ANTIGEN PRESENTING ILGKFLHRL','X-RAY DIFFRACTION',1.770,'IMMUNE SYSTEM',1,1,1),(6249,'5meq','HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHTL','X-RAY DIFFRACTION',2.270,'IMMUNE SYSTEM',1,1,1),(6250,'5mer','HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHEL','X-RAY DIFFRACTION',1.880,'IMMUNE SYSTEM',2,2,1),(6251,'5mf9','SOLUTION STRUCTURE OF THE RBM5 OCRE DOMAIN IN COMPLEX WITH POLYPROLINE SMN PEPTIDE.','SOLUTION NMR',NULL,'SPLICING',1,1,1),(6252,'5mfe','DESIGNED ARMADILLO REPEAT PROTEIN YIIIM5AII IN COMPLEX WITH (RR)4 PEPTIDE','X-RAY DIFFRACTION',1.950,'DE NOVO PROTEIN',1,2,1),(6253,'5mff','DESIGNED ARMADILLO REPEAT PROTEIN YIIIM5AII IN COMPLEX WITH PEPTIDE (RR)5','X-RAY DIFFRACTION',1.900,'DE NOVO PROTEIN',2,4,1),(6254,'5mfg','DESIGNED ARMADILLO REPEAT PROTEIN YIIIM5AII IN COMPLEX WITH PEPTIDE (RR)4','X-RAY DIFFRACTION',1.900,'DE NOVO PROTEIN',1,3,1),(6255,'5mfh','DESIGNED ARMADILLO REPEAT PROTEIN YIIIM5AII IN COMPLEX WITH PEPTIDE (RR)5','X-RAY DIFFRACTION',2.000,'DE NOVO PROTEIN',2,4,1),(6256,'5mfi','DESIGNED ARMADILLO REPEAT PROTEIN YIII(DQ.V2)4CQI IN COMPLEX WITH PEPTIDE (KR)4','X-RAY DIFFRACTION',1.450,'DE NOVO PROTEIN',2,2,1),(6257,'5mfj','DESIGNED ARMADILLO REPEAT PROTEIN YIII(DQ.V2)4CQI IN COMPLEX WITH PEPTIDE (KR)5','X-RAY DIFFRACTION',1.530,'DE NOVO PROTEIN',2,2,1),(6258,'5mfk','DESIGNED ARMADILLO REPEAT PROTEIN YIII(DQ.V1)4CPAF IN COMPLEX WITH PEPTIDE (KR)4','X-RAY DIFFRACTION',2.300,'DE NOVO PROTEIN',1,2,1),(6259,'5mfm','DESIGNED ARMADILLO REPEAT PROTEIN PEPTIDE FUSION YIIIM6AII_GS11_(KR)5','X-RAY DIFFRACTION',2.300,'DE NOVO PROTEIN',2,4,1),(6260,'5mgx','THE STRUCTURE OF FKBP38 IN COMPLEX WITH THE MEEVD TETRATRICOPEPTIDE BINDING-MOTIF OF HSP90','X-RAY DIFFRACTION',2.180,'ISOMERASE',4,4,1),(6261,'5mhc','CRYSTAL STRUCTURE OF 14-3-3SIGMA AND A P53 C-TERMINAL 12-MER SYNTHETIC PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.200,'ANTITUMOR PROTEIN',1,1,1),(6262,'5mhi','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE (5-CHLORO-2-METHOXYPHENYL)METHANAMINE','X-RAY DIFFRACTION',1.490,'TRANSFERASE',1,1,1),(6263,'5mhl','FXIIIA IN COMPLEX WITH THE INHIBITOR MI0621','X-RAY DIFFRACTION',2.400,'TRANSFERASE',2,2,1),(6264,'5mhm','FXIIIA IN COMPLEX WITH THE INHIBITOR ZED1630','X-RAY DIFFRACTION',2.120,'HYDROLASE',2,2,1),(6265,'5mhn','FXIIIA IN COMPLEX WITH THE INHIBITOR ZED2360','X-RAY DIFFRACTION',2.480,'TRANSFERASE',2,2,1),(6266,'5mj5','CRYSTAL STRUCTURE OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH SYNTHETICHONOKIOL DERIVATIVE 3 AND A FRAGMENT OF THE TIF2 CO- ACTIVATOR.','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(6267,'5mjt','THROMBIN MUTANT A190S IN COMPLEX WITH (S) -1 - ((R) -2-AMINO-3,3- DIPHENYLPROPANOYL) -N- (3-CHLOROBENZYL) PYRROLIDINE-2-CARBOXAMIDE','X-RAY DIFFRACTION',1.400,'HYDROLASE',2,1,1),(6268,'5mjy','CRYSTAL STRUCTURE OF THE HIS DOMAIN PROTEIN TYROSINE PHOSPHATASE (HD- PTP/PTPN23) BRO1 DOMAIN (SARA COMPLEX STRUCTURE)','X-RAY DIFFRACTION',2.250,'HYDROLASE',2,4,1),(6269,'5mk0','CRYSTAL STRUCTURE OF THE HIS DOMAIN PROTEIN TYROSINE PHOSPHATASE (HD- PTP/PTPN23) BRO1 DOMAIN (ENDOFIN PEPTIDE COMPLEX)','X-RAY DIFFRACTION',1.770,'HYDROLASE',2,2,1),(6270,'5mk1','CRYSTAL STRUCTURE OF THE HIS DOMAIN PROTEIN TYROSINE PHOSPHATASE (HD- PTP/PTPN23) BRO1 DOMAIN (CHMP4A PEPTIDE COMPLEX STRUCTURE)','X-RAY DIFFRACTION',2.500,'HYDROLASE',4,4,1),(6271,'5mk2','CRYSTAL STRUCTURE OF THE HIS DOMAIN PROTEIN TYROSINE PHOSPHATASE (HD- PTP/PTPN23) BRO1 DOMAIN (CHMP4B PEPTIDE COMPLEX STRUCTURE)','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,2,1),(6272,'5mk3','CRYSTAL STRUCTURE OF THE HIS DOMAIN PROTEIN TYROSINE PHOSPHATASE (HD- PTP/PTPN23) BRO 1 DOMAIN (CHMP4C PEPTIDE COMPLEX STRUCTURE)','X-RAY DIFFRACTION',2.000,'HYDROLASE',4,4,1),(6273,'5mk4','CRYSTAL STRUCTURE OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH SYNTHETIC HONOKIOL DERIVATIVE 7 AND A FRAGMENT OF THE TIF2 CO- ACTIVATOR.','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(6274,'5mkj','CRYSTAL STRUCTURE OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH SYNTHETIC HONOKIOL DERIVATIVE 9 AND A FRAGMENT OF THE TIF2 CO- ACTIVATOR.','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',1,1,1),(6275,'5mku','CRYSTAL STRUCTURE OF THE RETINOID X RECEPTOR ALPHA IN COMPLEX WITH SYNTHETIC HONOKIOL DERIVATIVE 4 AND A FRAGMENT OF THE TIF2 CO- ACTIVATOR.','X-RAY DIFFRACTION',1.780,'TRANSCRIPTION',1,1,1),(6276,'5mlo','CRYSTAL STRUCTURE OF HUMAN PCNA IN COMPLEX WITH ZRANB3 PIP BOX PEPTIDE','X-RAY DIFFRACTION',1.960,'HYDROLASE',3,3,1),(6277,'5mls','THROMBIN MUTANT A190S IN COMPLEX WITH (S)-1-(D-PHENYLALANYL)-N-(3- CHLOROBENZYL)PYRROLIDINE-2-CARBOXAMIDE','X-RAY DIFFRACTION',1.620,'HYDROLASE',2,1,1),(6278,'5mlw','CRYSTAL STRUCTURE OF HUMAN PCNA IN COMPLEX WITH ZRANB3 APIM MOTIF PEPTIDE','X-RAY DIFFRACTION',2.450,'HYDROLASE',3,3,1),(6279,'5mm6','THROMBIN MUTANT A190S IN COMPLEX WITH (S)-1-(D-PHENYLALANYL)-N-(4- CARBAMIMIDOYLBENZYL)PYRROLIDINE-2-CARBOXAMIDE','X-RAY DIFFRACTION',1.290,'BLOOD CLOTTING',2,1,1),(6280,'5mn9','CRYSTAL STRUCTURE OF MINDY-1 TMIU IN COMPLEX WITH K48-DIUB','X-RAY DIFFRACTION',2.050,'HYDROLASE',1,2,1),(6281,'5mo3','CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5','X-RAY DIFFRACTION',1.690,'IMMUNE SYSTEM',1,2,1),(6282,'5moc','CRYSTAL STRUCTURE OF 14-3-3SIGMA AND A P53 C-TERMINAL 12-MER SYNTHETIC PHOSPHOPEPTIDE','X-RAY DIFFRACTION',1.800,'ANTITUMOR PROTEIN',1,1,1),(6283,'5mp5','CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5','X-RAY DIFFRACTION',2.310,'IMMUNE SYSTEM',3,6,1),(6284,'5mr8','CRYSTAL STRUCTURE OF TRIM33 PHD-BROMODOMAIN ISOFORM B IN COMPLEX WITH H3K9AC HISTONE PEPTIDE','X-RAY DIFFRACTION',1.740,'TRANSCRIPTION',1,1,1),(6285,'5ms4','KALLIKREIN-RELATED PEPTIDASE 8 LEUPEPTIN INHIBITOR COMPLEX','X-RAY DIFFRACTION',2.100,'HYDROLASE/INHIBITOR',4,4,1),(6286,'5msm','STRUCTURE OF THE DCC1-CTF8-CTF18C TRIMER','X-RAY DIFFRACTION',2.290,'CELL CYCLE',2,4,1),(6287,'5mt6','STRUCTURE OF E.COLI GLPG IN COMPLEX WITH PEPTIDE DERIVED INHIBITOR AC- RVRHA-PHENYLETHYL-KETOAMIDE','X-RAY DIFFRACTION',2.160,'HYDROLASE',1,1,1),(6288,'5mt7','STRUCTURE OF E.COLI GLPG IN COMPLEX WITH PEPTIDE DERIVED INHIBITOR AC- VRHA-CMK','X-RAY DIFFRACTION',2.050,'HYDROLASE',1,1,1),(6289,'5mt8','STRUCTURE OF E.COLI GLPG IN COMPLEX WITH PEPTIDE DERIVED INHIBITOR AC- RVRHA-CMK','X-RAY DIFFRACTION',1.950,'HYDROLASE',1,1,1),(6290,'5mtf','A MODULAR ROUTE TO NOVEL POTENT AND SELECTIVE INHIBITORS OF RHOMBOID INTRAMEMBRANE PROTEASES','X-RAY DIFFRACTION',1.790,'HYDROLASE',1,1,1),(6291,'5mtw','MYCOBACTERIUM TUBERCULOSIS RV1957 SECB-LIKE CHAPERONE IN COMPLEX WITH A CHAD PEPTIDE FROM RV1956 HIGA1 ANTITOXIN','X-RAY DIFFRACTION',1.840,'CHAPERONE',3,4,1),(6292,'5mu3','CRYSTAL STRUCTURE OF CTF19-MCM21 KINETOCHORE ASSEMBLY BOUND WITH CTF19-MCM21 BINDING MOTIF OF CENTRAL KINETOCHORE SUBUNIT OKP1','X-RAY DIFFRACTION',2.100,'CELL CYCLE',2,4,1),(6293,'5mvw','COMPLEX BETWEEN THE LEUCINE ZIPPER (LZ) AND CENTROSOMIN-MOTIF 2 (CM2) DOMAINS OF DROSOPHILA MELANOGASTER CENTROSOMIN (CNN)','X-RAY DIFFRACTION',1.820,'CELL CYCLE',2,2,1),(6294,'5mw0','COMPLEX BETWEEN THE LEUCINE ZIPPER (LZ) AND CENTROSOMIN-MOTIF 2 (CM2) DOMAINS OF DROSOPHILA MELANOGASTER CENTROSOMIN (CNN) - L535E MUTANT FORM','X-RAY DIFFRACTION',2.000,'CELL CYCLE',1,2,1),(6295,'5mw9','COMPLEX BETWEEN THE LEUCINE ZIPPER (LZ) AND CENTROSOMIN-MOTIF 2 (CM2) DOMAINS OF DROSOPHILA MELANOGASTER CENTROSOMIN (CNN) - L535E MUTANT FORM','X-RAY DIFFRACTION',2.200,'CELL CYCLE',2,2,1),(6296,'5mwe','COMPLEX BETWEEN THE LEUCINE ZIPPER (LZ, RESIDUES 490-567) AND CENTROSOMIN-MOTIF 2 (CM2) DOMAINS OF DROSOPHILA MELANOGASTER CENTROSOMIN (CNN)','X-RAY DIFFRACTION',2.020,'CELL CYCLE',2,2,1),(6297,'5mwp','THE STRUCTURE OF MR IN COMPLEX WITH AZD9977.','X-RAY DIFFRACTION',1.820,'SIGNALING PROTEIN',1,1,1),(6298,'5mwy','THE STRUCTURE OF MR IN COMPLEX WITH EPLERENONE.','X-RAY DIFFRACTION',1.750,'SIGNALING PROTEIN',1,1,1),(6299,'5mx2','PHOTOSYSTEM II DEPLETED OF THE MN4CAO5 CLUSTER AT 2.55 A RESOLUTION','X-RAY DIFFRACTION',2.200,'OXIDOREDUCTASE',20,16,1),(6300,'5mxo','CRYSTAL STRUCTURE OF 14-3-3SIGMA AND A P53 C-TERMINAL 12-MER SYNTHETIC PHOSPHOPEPTIDE STABILIZED BY FUSICOCCIN-A','X-RAY DIFFRACTION',1.200,'ANTITUMOR PROTEIN',1,1,1),(6301,'5my4','STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C#17 IN COMPLEX WITH HUMAN ABETA-PE3-12PEGB','X-RAY DIFFRACTION',2.210,'IMMUNE SYSTEM',1,2,1),(6302,'5my9','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH LRRK2 PEPTIDE PS935','X-RAY DIFFRACTION',1.330,'TRANSFERASE',1,1,1),(6303,'5myc','CRYSTAL STRUCTURE OF HUMAN 14-3-3 SIGMA IN COMPLEX WITH LRRK2 PEPTIDE PS910','X-RAY DIFFRACTION',1.460,'TRANSFERASE',1,1,1),(6304,'5myk','STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C#17 IN COMPLEX WITH MURINE ABETA-PE3-18PEGB','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,2,1),(6305,'5myo','STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C#6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB','X-RAY DIFFRACTION',1.590,'IMMUNE SYSTEM',1,2,1),(6306,'5myx','STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C#24 IN COMPLEX WITH HUMAN ABETA-PE3-18','X-RAY DIFFRACTION',1.490,'IMMUNE SYSTEM',2,4,1),(6307,'5mzl','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE N-QUINOLIN-5-YLPYRIDINE- 3-CARBOXAMIDE','X-RAY DIFFRACTION',1.960,'TRANSFERASE',1,1,1),(6308,'5mzm','STRUCTURE OF H-2DB IN COMPLEX WITH TEIPP APL TRH4 P3P','X-RAY DIFFRACTION',2.400,'IMMUNE SYSTEM',2,2,1),(6309,'5n10','CUCURBIT[8]URIL AND 14-3-3 BASED BINARY BIVALENT SUPRAMOLECULAR- PROTEIN ASSEMBLY PLATFORM','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',2,2,1),(6310,'5n1d','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-METHYL-1-(5-PYRIDIN-3-YLOXYFURAN-2-YL) METHANAMINE','X-RAY DIFFRACTION',1.610,'TRANSFERASE',1,1,1),(6311,'5n1e','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-(1,3-BENZODIOXOL-5-YL)-2-PIPERIDIN-1- YLACETAMIDE','X-RAY DIFFRACTION',1.530,'TRANSFERASE',1,1,1),(6312,'5n1k','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-AMINO-1-(4-FLUOROPHENYL)ETHANOL','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(6313,'5n1l','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2,5-DIMETHYL-N-PYRIDIN-4-YLFURAN-3- CARBOXAMIDE','X-RAY DIFFRACTION',1.490,'TRANSFERASE',1,1,1),(6314,'5n1m','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE (5-CHLORO-2-METHOXYPHENYL)METHANAMINE','X-RAY DIFFRACTION',1.440,'TRANSFERASE',1,1,1),(6315,'5n1n','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-CHLORO-9-PROPAN-2-YLPURINE','X-RAY DIFFRACTION',1.410,'TRANSFERASE',1,1,1),(6316,'5n1o','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-CHLORO-4-(CHLOROMETHYL)-5- HYDROXYPHENYL)ETHAN-1-ONE','X-RAY DIFFRACTION',1.800,'TRANSFERASE',1,1,1),(6317,'5n1w','STRUCTURE OF XECO2 ACETYLTRANSFERASE DOMAIN BOUND TO K105-COA CONJUGATE','X-RAY DIFFRACTION',2.300,'CELL CYCLE',2,2,1),(6318,'5n1y','HLA-A02 CARRYING MVWGPDPLYV','X-RAY DIFFRACTION',1.390,'IMMUNE SYSTEM',1,1,1),(6319,'5n22','STRUCTURE OF XECO2 ACETYLTRANSFERASE DOMAIN BOUND TO K106-COA CONJUGATE','X-RAY DIFFRACTION',1.990,'CELL CYCLE',4,4,1),(6320,'5n23','PROTEIN KINASE A MUTANTS AS SURROGATE MODEL FOR AURORA B WITH AT9283 INHIBITOR','X-RAY DIFFRACTION',2.090,'TRANSFERASE',1,1,1),(6321,'5n32','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-CHLOROBENZYL CARBAMIMIDOTHIOATE','X-RAY DIFFRACTION',1.830,'TRANSFERASE',1,1,1),(6322,'5n33','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-AMINO-5-(TRIFLUOROMETHYL)-1H-PYRIDIN-2- ONE','X-RAY DIFFRACTION',1.430,'TRANSFERASE',1,1,1),(6323,'5n36','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3H-ISOINDOL-2-IUM-1-AMINE','X-RAY DIFFRACTION',1.580,'TRANSFERASE',1,1,1),(6324,'5n37','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-(1,3-BENZODIOXOL-5-YLMETHYL) CYCLOPENTANAMINE','X-RAY DIFFRACTION',1.590,'TRANSFERASE',1,1,1),(6325,'5n39','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-(2,3-DIHYDROBENZO[B][1,4]DIOXIN-6-YL) PYRROLIDINE','X-RAY DIFFRACTION',1.450,'TRANSFERASE',1,1,1),(6326,'5n3a','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-METHYL-5-(1-METHYLIMIDAZOL-2-YL)-1,3- THIAZOL-2-AMINE','X-RAY DIFFRACTION',1.400,'TRANSFERASE',1,1,1),(6327,'5n3b','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 2-(PYRIDIN-3-YL)ETHANAMINE','X-RAY DIFFRACTION',1.640,'TRANSFERASE',1,1,1),(6328,'5n3c','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE THIOPHENE-3-CARBOXIMIDAMIDE','X-RAY DIFFRACTION',1.770,'TRANSFERASE',1,1,1),(6329,'5n3d','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-(TRIFLUOROMETHYL)BENZENECARBOXIMIDAMIDE','X-RAY DIFFRACTION',1.770,'TRANSFERASE',1,1,1),(6330,'5n3e','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 6-DIMETHYLAMINOPYRIDINE-3-CARBOXYLIC ACID','X-RAY DIFFRACTION',1.530,'TRANSFERASE',1,1,1),(6331,'5n3f','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE N-[3-(AMINOMETHYL)PHENYL]ACETAMIDE','X-RAY DIFFRACTION',1.680,'TRANSFERASE',1,1,1),(6332,'5n4b','PROLYL OLIGOPEPTIDASE B FROM GALERINA MARGINATA BOUND TO 25MER MACROCYCLIZATION SUBSTRATE - S577A MUTANT','X-RAY DIFFRACTION',1.440,'HYDROLASE',2,2,1),(6333,'5n4c','PROLYL OLIGOPEPTIDASE B FROM GALERINA MARGINATA BOUND TO 35MER HYDROLYSIS AND MACROCYCLIZATION SUBSTRATE - S577A MUTANT','X-RAY DIFFRACTION',2.190,'HYDROLASE',4,4,1),(6334,'5n4d','PROLYL OLIGOPEPTIDASE B FROM GALERINA MARGINATA BOUND TO 25MER MACROCYCLIZATION SUBSTRATE - D661A MUTANT','X-RAY DIFFRACTION',1.620,'HYDROLASE',2,2,1),(6335,'5n4n','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 3,4-DIMETHYL-5-(1H-1,2,4-TRIAZOL- 3-YL)THIOPHENE-2-CARBONITRILE','X-RAY DIFFRACTION',2.090,'TRANSFERASE',1,1,1),(6336,'5n4o','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE (E)-3-(P-TOLYL)ACRYLIC ACID','X-RAY DIFFRACTION',2.220,'TRANSFERASE',1,1,1),(6337,'5n4r','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 2-(AZEPAN-1-YL)-1-(1H-INDOL-3-YL) PROPAN-1-ONE','X-RAY DIFFRACTION',2.130,'TRANSFERASE',1,1,1),(6338,'5n4u','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE 5-(2-AMINO-1,3-THIAZOL-4- YL)-1,3-DIHYDROBENZIMIDAZOL-2-ONE','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(6339,'5n4v','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE 2-CYCLOPROPYL-4,5- DIMETHYLTHIENO[5,4-D]PYRIMIDINE-6-CARBOXYLIC ACID','X-RAY DIFFRACTION',1.850,'TRANSFERASE',1,1,1),(6340,'5n4x','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND FRAGMENT LIKE MOLEKULE 4,5-DIBROMOTHIOPHENE-2- CARBOHYDRAZIDE','X-RAY DIFFRACTION',2.200,'TRANSFERASE',1,1,1),(6341,'5n4z','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE (E)-4-(4-HYDROXYPHENYL)BUT-3-EN-2- ONE','X-RAY DIFFRACTION',2.260,'TRANSFERASE',1,1,1),(6342,'5n50','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 2-(4-CHLOROPHENYL) SULFANYLACETOHYDRAZIDE','X-RAY DIFFRACTION',1.920,'TRANSFERASE',1,1,1),(6343,'5n51','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE 3,4-DIBROMOTHIOPHENE-2-CARBOXYLIC ACID','X-RAY DIFFRACTION',2.120,'TRANSFERASE',1,1,1),(6344,'5n52','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE (E)-3-(2,3-DIMETHOXYPHENYL)ACRYLIC ACID','X-RAY DIFFRACTION',2.250,'TRANSFERASE',1,1,1),(6345,'5n5l','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND [2-OXO-2-(1H-PYRROL-2-YL)ETHYL] 5-BROMO-1H- INDOLE-3-CARBOXYLATE','X-RAY DIFFRACTION',1.970,'TRANSFERASE',1,1,1),(6346,'5n5m','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUSPEPTIDE AND (R)-3-(2-((ISOQUINOLIN-5-YLMETHYL)(METHYL) CARBAMOYL)PHENYL)PYRROLIDIN-1-IUM','X-RAY DIFFRACTION',2.210,'TRANSFERASE',1,1,1),(6347,'5n5r','14-3-3 SIGMA IN COMPLEX WITH TAZ PS89 PEPTIDE AND FRAGMENT NV1','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(6348,'5n5t','14-3-3 SIGMA IN COMPLEX WITH TAZ PS89 PEPTIDE AND FRAGMENT NV2','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',1,1,1),(6349,'5n5w','14-3-3 SIGMA IN COMPLEX WITH TAZ PS89 PEPTIDE AND FRAGMENT NV3','X-RAY DIFFRACTION',1.370,'PROTEIN BINDING',1,1,1),(6350,'5n6b','HUMAN LEUKOCYTE ANTIGEN CLASS I A02 CARRYING LLWNPGMAV','X-RAY DIFFRACTION',1.710,'IMMUNE SYSTEM',2,2,1),(6351,'5n70','CRYSTAL STRUCTURE OF MATURE CATHEPSIN D FROM THE TICK IXODES RICINUS (IRCD1) IN COMPLEX WITH THE N-TERMINAL OCTAPEPTIDE OF THE PROPEPTID','X-RAY DIFFRACTION',1.810,'HYDROLASE',1,1,1),(6352,'5n75','14-3-3 SIGMA IN COMPLEX WITH TAZ PS89 PEPTIDE','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',1,1,1),(6353,'5n7b','UNDERSTANDING THE SINGULAR CONFORMATIONAL LANDSCAPE OF THE TN ANTIGENS: SULFUR-FOR- OXYGEN SUBSTITUTION IN THE GLYCOSIDIC LINKAGE PROVIDES NEW INSIGHTS INTO MOLECULAR RECOGNITION BY AN ANTIBODY','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(6354,'5n7d','MAGI-1 COMPLEXED WITH A RSK1 PEPTIDE','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',1,1,1),(6355,'5n7f','MAGI-1 COMPLEXED WITH A PRSK1 PEPTIDE','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',1,1,1),(6356,'5n7p','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 3-AMINO-5-(PYRROLIDIN-1-YL)-1H-PYRAZOLE- 4-CARBONITRILE','X-RAY DIFFRACTION',1.500,'TRANSFERASE',1,1,1),(6357,'5n7q','CRYSTAL STRUCTURE OF MATURE CATHEPSIN D FROM THE TICK IXODES RICINUS (IRCD1) IN COMPLEX WITH THE INHIBITOR PEPSTATIN A','X-RAY DIFFRACTION',1.450,'HYDROLASE',2,2,1),(6358,'5n7u','CAMP-DEPENDENT PROTEIN KINASE A FROM CRICETULUS GRISEUS IN COMPLEX WITH FRAGMENT LIKE MOLECULE 4-BROMO-3,5-DIMETHYL-1H-PYRAZOLE','X-RAY DIFFRACTION',1.370,'TRANSFERASE',1,1,1),(6359,'5n7x','CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE EWVHPQFEQKAK','X-RAY DIFFRACTION',1.120,'BIOTIN BINDING PROTEIN',8,8,1),(6360,'5n85','STRUCTURE OF RPA70N IN COMPLEX WITH PRIMPOL (FRAGMENT 514-525)','X-RAY DIFFRACTION',2.000,'PROTEIN BINDING',1,1,1),(6361,'5n89','CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE GNSFDDWLASKG','X-RAY DIFFRACTION',1.270,'BIOTIN BINDING PROTEIN',8,8,1),(6362,'5n8a','STRUCTURE OF RPA70N IN COMPLEX WITH PRIMPOL (FRAGMENT 480-560)','X-RAY DIFFRACTION',1.280,'PROTEIN BINDING',1,1,1),(6363,'5n8b','CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE AFPDYLAEYHGG','X-RAY DIFFRACTION',1.030,'BIOTIN BINDING PROTEIN',4,4,1),(6364,'5n8e','CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE RDPAPAWAHGGG','X-RAY DIFFRACTION',1.100,'BIOTIN BINDING PROTEIN',3,4,1),(6365,'5n8j','CRYSTAL STRUCTURE OF STREPTAVIDIN WITH PEPTIDE D-AMINO ACID CONTAINING PEPTIDE GYGLANVDESSG','X-RAY DIFFRACTION',1.050,'STREPTAVIDIN PEPTIDE 11101 COMPLEX',2,4,1),(6366,'5n8w','CRYSTAL STRUCTURE OF STREPTAVIDIN WITH D-AMINO ACID CONTAINING PEPTIDE GGWHDEATWKPG','X-RAY DIFFRACTION',1.100,'BIOTIN BINDING PROTEIN',2,2,1),(6367,'5n91','ENAH EVH1 IN COMPLEX WITH AC-[2-CL-F]-PPPP-OH','X-RAY DIFFRACTION',1.490,'CELL ADHESION',3,2,1),(6368,'5n99','CRYSTAL STRUCTURE OF STREPTAVIDIN WITH CYCLIC PEPTIDE NQPWQ','X-RAY DIFFRACTION',1.500,'BIOTIN BINDING PROTEIN',12,12,1),(6369,'5n9c','ENAH EVH1 IN COMPLEX WITH AC-[2-CL-F]-PP-[PROM-1]-OH','X-RAY DIFFRACTION',1.160,'CELL ADHESION',4,2,1),(6370,'5n9p','ENAH EVH1 IN COMPLEX WITH AC-[2-CL-F]-PP-[PROM-1]-NH2','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',3,2,1),(6371,'5naf','CO-CRYSTAL STRUCTURE OF AN MECP2 PEPTIDE WITH TBLR1 WD40 DOMAIN','X-RAY DIFFRACTION',2.490,'TRANSCRIPTION',2,2,1),(6372,'5nas','CRYSTAL STRUCTURE OF HUMAN 14-3-3 ZETA IN COMPLEX WITH PI4KIIIB PEPTIDE','X-RAY DIFFRACTION',2.080,'TRANSFERASE',2,2,1),(6373,'5nc2','ENAH EVH1 IN COMPLEX WITH AC-[2-CL-F]-PPPPTEDEL-NH2','X-RAY DIFFRACTION',1.580,'CELL ADHESION',2,2,1),(6374,'5nct','STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR, MIROPIN.','X-RAY DIFFRACTION',1.600,'HYDROLASE INHIBITOR',1,1,1),(6375,'5ncu','STRUCTURE OF THE SUBTILISIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR, MIROPIN.','X-RAY DIFFRACTION',1.700,'HYDROLASE INHIBITOR',1,1,1),(6376,'5ncw','STRUCTURE OF THE TRYPSIN INDUCED SERPIN-TYPE PROTEINASE INHIBITOR, MIROPIN (V367K/K368A MUTANT).','X-RAY DIFFRACTION',1.500,'HYDROLASE',1,1,1),(6377,'5nd0','ENAH EVH1 IN COMPLEX WITH AC-[2-CL-F]-PP-[PROM-1]-TEDEL-NH2','X-RAY DIFFRACTION',1.450,'CELL ADHESION',2,2,1),(6378,'5ndc','STRUCTURE OF BA3-TYPE CYTOCHROME C OXIDASE FROM THERMUS THERMOPHILUS BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY','X-RAY DIFFRACTION',2.300,'OXIDOREDUCTASE',1,2,1),(6379,'5ndt','CRYSTAL STRUCTURE OF HUMAN PIM-1 KINASE IN COMPLEX WITH A CONSENSUS PEPTIDE AND FRAGMENT LIKE MOLECULE (E)-3-(2-(THIOPHEN-2-YL)VINYL)-3, 4-DIHYDROQUINOXALIN-2(1H)-ONE','X-RAY DIFFRACTION',1.990,'TRANSFERASE',1,1,1),(6380,'5ne4','CRYSTAL STRUCTURE OF FOOT AND MOUTH DISEASE VIRUS O PANASIA','X-RAY DIFFRACTION',2.300,'VIRUS',1,3,1),(6381,'5nes','DISCOVERY, CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED D,L-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA','X-RAY DIFFRACTION',1.610,'SUGAR BINDING PROTEIN',1,2,1),(6382,'5ney','DISCOVERY, CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED D,L-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA','X-RAY DIFFRACTION',1.550,'SUGAR BINDING PROTEIN',1,2,1),(6383,'5nf0','DISCOVERY, CRYSTAL STRUCTURES AND ATOMIC FORCE MICROSCOPY STUDY OF THIOETHER LIGATED D,L-CYCLIC ANTIMICROBIAL PEPTIDES AGAINST MULTIDRUG RESISTANT PSEUDOMONAS AERUGINOSA','X-RAY DIFFRACTION',1.270,'ANTIMICROBIAL PROTEIN',3,4,1),(6384,'5nfp','GLUCOCORTICOID RECEPTOR IN COMPLEX WITH BUDESONIDE','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN',1,1,1),(6385,'5nft','GLUCOCORTICOID RECEPTOR IN COMPLEX WITH AZD5423','X-RAY DIFFRACTION',2.300,'HORMONE',1,1,1),(6386,'5nfu','THE STRUCTURE OF THE POLO-BOX DOMAIN (PBD) OF POLO-LIKE KINASE 1 (PLK1) IN COMPLEX WITH LHSPTA PEPTIDE.','X-RAY DIFFRACTION',1.810,'TRANSFERASE',1,1,1),(6387,'5ngq','BICYCLIC ANTIMICROBIAL PEPTIDES','X-RAY DIFFRACTION',1.170,'SUGAR BINDING PROTEIN',4,4,1),(6388,'5nhu','HUMAN ALPHA THROMBIN COMPLEXED WITH ANOPHELES GAMBIAE CE5 ANTICOAGULANT','X-RAY DIFFRACTION',1.450,'HYDROLASE',6,3,1),(6389,'5ni5','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',1,1,1),(6390,'5ni7','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',2.450,'TRANSCRIPTION',1,1,1),(6391,'5ni8','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',1.940,'RAR-RELATED ORPHAN RECEPTOR-G (RORG)',1,1,1),(6392,'5ni9','CRYSTAL STRUCTURE OF HLA-DRB1*04:01 WITH THE ALPHA-ENOLASE PEPTIDE 326-340','X-RAY DIFFRACTION',1.330,'IMMUNE SYSTEM',1,2,1),(6393,'5nib','LIGAND COMPLEX OF RORG LBD','X-RAY DIFFRACTION',1.820,'RAR-RELATED ORPHAN RECEPTOR-G (RORG)',1,1,1),(6394,'5nig','CRYSTAL STRUCTURE OF HLA-DRB1*04:01 WITH MODIFIED ALPHA-ENOLASE PEPTIDE 326-340 (ARGININE 327 TO CITRULLINE)','X-RAY DIFFRACTION',1.350,'IMMUNE SYSTEM',1,2,1),(6395,'5nin','CRYSTAL STRUCTURE OF AKAP79 CALMODULIN BINDING DOMAIN PEPTIDE IN COMPLEX WITH CA2+/CALMODULIN','X-RAY DIFFRACTION',1.700,'SIGNALING PROTEIN',2,2,1),(6396,'5nj9','E. COLI MICROCIN-PROCESSING METALLOPROTEASE TLDD/E WITH DRVY ANGIOTENSIN FRAGMENT BOUND','X-RAY DIFFRACTION',1.250,'HYDROLASE',2,4,1),(6397,'5nja','E. COLI MICROCIN-PROCESSING METALLOPROTEASE TLDD/E WITH ANGIOTENSIN ANALOGUE BOUND','X-RAY DIFFRACTION',1.400,'HYDROLASE',2,4,1),(6398,'5njc','E. COLI MICROCIN-PROCESSING METALLOPROTEASE TLDD/E (TLDD E263A MUTANT) WITH HEXAPEPTIDE BOUND','X-RAY DIFFRACTION',1.350,'HYDROLASE',2,3,1),(6399,'5njf','E. COLI MICROCIN-PROCESSING METALLOPROTEASE TLDD/E (TLDD H262A MUTANT) WITH PENTAPEPTIDE BOUND','X-RAY DIFFRACTION',1.420,'HYDROLASE',2,2,1),(6400,'5njx','HUMAN FKBP51 PROTEIN IN COMPLEX WITH C-TERMINAL PEPTIDE OF HUMAN HSP 90-ALPHA','X-RAY DIFFRACTION',2.490,'ISOMERASE',1,1,1),(6401,'5nky','STRUCTURE-ACTIVITY RELATIONSHIP STUDY OF VITAMIN D ANALOGS WITH OXOLANE GROUP IN THEIR SIDE CHAIN','X-RAY DIFFRACTION',2.100,'GENE REGULATION',1,1,1),(6402,'5nl1','SHIGELLA IPAA-VBS3/TBS IN COMPLEX WITH THE TALIN VBS1 DOMAIN 488-512','X-RAY DIFFRACTION',2.500,'STRUCTURAL PROTEIN',6,6,1),(6403,'5nmh','HLA A02 PRESENTING SLYNTIATL','X-RAY DIFFRACTION',1.550,'IMMUNE SYSTEM',1,1,1),(6404,'5nmk','HLA A02 PRESENTING SLFNTIAVL','X-RAY DIFFRACTION',1.660,'IMMUNE SYSTEM',1,1,1),(6405,'5nnc','CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H3K9AC/K14AC)','X-RAY DIFFRACTION',2.220,'TRANSCRIPTION',2,2,1),(6406,'5nnd','CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED HISTONE 4 PEPTIDE (H3K9AC/K14AC)','X-RAY DIFFRACTION',1.820,'TRANSCRIPTION',2,2,1),(6407,'5nne','CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH A DIACETYLATED TOP2A PEPTIDE (K1201AC/K1204AC)','X-RAY DIFFRACTION',1.150,'TRANSCRIPTION',1,1,1),(6408,'5nnf','CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH AN ACETYLATED BAZ1B PEPTIDE (K221AC)','X-RAY DIFFRACTION',1.150,'TRANSCRIPTION',1,1,1),(6409,'5nng','CRYSTAL STRUCTURE OF THE FIRST BROMODOMAIN OF HUMAN BRD4 IN COMPLEX WITH AN ACETYLATED SRPK1 PEPTIDE (K585AC)','X-RAY DIFFRACTION',1.200,'TRANSCRIPTION',1,1,1),(6410,'5nph','STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,2,1),(6411,'5npi','STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5','X-RAY DIFFRACTION',2.000,'VIRAL PROTEIN',2,2,1),(6412,'5npj','STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5','X-RAY DIFFRACTION',1.900,'VIRAL PROTEIN',2,2,1),(6413,'5npr','THE HUMAN O-GLCNAC TRANSFERASE IN COMPLEX WITH A THIOL-LINKED BISUBSTRATE INHIBITOR','X-RAY DIFFRACTION',1.850,'TRANSFERASE',1,1,1),(6414,'5nps','THE HUMAN O-GLCNAC TRANSFERASE IN COMPLEX WITH A BISUBSTRATE INHIBITOR','X-RAY DIFFRACTION',1.680,'TRANSFERASE',1,1,1),(6415,'5npz','PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, PRESENTING EFEDLTFLA','X-RAY DIFFRACTION',1.430,'IMMUNE SYSTEM',1,1,1),(6416,'5nq0','PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, PRESENTING DFEREGYSL','X-RAY DIFFRACTION',1.100,'IMMUNE SYSTEM',1,1,1),(6417,'5nq1','PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, WITH HUMAN BETA2 MICRO GLOBULIN, PRESENTING DFEREGYSL','X-RAY DIFFRACTION',2.140,'IMMUNE SYSTEM',2,2,1),(6418,'5nq2','\'PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, PRESENTING IAYERMCNI','X-RAY DIFFRACTION',1.540,'IMMUNE SYSTEM',1,1,1),(6419,'5nq3','\'PORCINE (SUS SCROFA) MAJOR HISTOCOMPATIBILITY COMPLEX, CLASS I, WITH HUMAN BETA2 MICRO GLOBULIN, PRESENTING EFEDLTFLA','X-RAY DIFFRACTION',1.570,'IMMUNE SYSTEM',2,2,1),(6420,'5nqa','CRYSTAL STRUCTURE OF GALNAC-T4 IN COMPLEX WITH THE MONOGLYCOPEPTIDE 3','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(6421,'5nqf','CRYSTAL STRUCTURE OF PLASMODIUM FALCIPARUM AMA1 IN COMPLEX WITH A 39 AA PVRON2 PEPTIDE','X-RAY DIFFRACTION',1.900,'CELL INVASION',1,1,1),(6422,'5nqg','CRYSTAL STRUCTURE OF PLASMODIUM VIVAX AMA1 IN COMPLEX WITH A 39 AA PVRON2 PEPTIDE','X-RAY DIFFRACTION',2.150,'CELL INVASION',1,1,1),(6423,'5nqv','STRUCTURE OF THE ARABIDOPSIS THALIANA TOPLESS N-TERMINAL DOMAIN','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',4,4,1),(6424,'5nsc','FC DEKK HETERODIMER VARIANT','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',1,1,1),(6425,'5nsp','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH OD334','X-RAY DIFFRACTION',2.300,'TRANSFERASE',2,2,1),(6426,'5nsx','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-(1H-INDAZOL-5-YL)-3,4- DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.800,'TRANSFERASE',2,2,1),(6427,'5nt0','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-(3-AMINOPHENYL)-3,4- DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.750,'TRANSFERASE',2,2,1),(6428,'5nt4','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-[4-(MORPHOLIN-4-YL) PHENYL]-3,4-DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.900,'HYDROLASE',2,2,1),(6429,'5nti','STRUCTURAL STATES OF RORGT: X-RAY ELUCIDATION OF MOLECULAR MECHANISMS AND BINDING INTERACTIONS FOR NATURAL AND SYNTHETIC COMPOUNDS','X-RAY DIFFRACTION',2.400,'SIGNALING PROTEIN',4,4,1),(6430,'5ntj','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUND RKP032','X-RAY DIFFRACTION',1.560,'TRANSFERASE',1,1,1),(6431,'5ntn','STRUCTURAL STATES OF RORGT: X-RAY ELUCIDATION OF MOLECULAR MECHANISMS AND BINDING INTERACTIONS FOR NATURAL AND SYNTHETIC COMPOUNDS','X-RAY DIFFRACTION',1.900,'SIGNALING PROTEIN',4,4,1),(6432,'5ntw','STRUCTURAL STATES OF RORGT: X-RAY ELUCIDATION OF MOLECULAR MECHANISMS AND BINDING INTERACTIONS FOR NATURAL AND SYNTHETIC COMPOUNDS','X-RAY DIFFRACTION',1.640,'SIGNALING PROTEIN',4,4,1),(6433,'5nu1','STRUCTURAL STATES OF RORGT: X-RAY ELUCIDATION OF MOLECULAR MECHANISMS AND BINDING INTERACTIONS FOR NATURAL AND SYNTHETIC COMPOUNDS','X-RAY DIFFRACTION',1.850,'SIGNALING PROTEIN',2,2,1),(6434,'5nvc','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-(3-HYDROXYPHENYL)-3,4- DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.600,'TRANSFERASE',2,2,1),(6435,'5nve','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-(4-ETHOXYPHENYL)-3,4- DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.500,'TRANSFERASE',2,2,1),(6436,'5nvf','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-[4-(PYRIDIN-2-YL)PHENYL]- 3,4-DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.550,'TRANSFERASE',2,2,1),(6437,'5nvh','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-[4-(PIPERIDIN-1-YL) PHENYL]-3,4-DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.600,'TRANSFERASE',2,2,1),(6438,'5nvm','CRYSTAL STRUCTURE OF THE HUMAN 4EHP-GIGYF2 COMPLEX LACKING THE AUXILIARY SEQUENCES','X-RAY DIFFRACTION',2.000,'TRANSLATION',2,2,1),(6439,'5nvn','CRYSTAL STRUCTURE OF THE HUMAN 4EHP-4E-BP1 COMPLEX','X-RAY DIFFRACTION',1.900,'TRANSLATION',2,2,1),(6440,'5nw8','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP032 AND FASUDIL','X-RAY DIFFRACTION',2.090,'TRANSFERASE',1,1,1),(6441,'5nwb','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-{4-[(2-HYDROXYETHYL) (METHYL)AMINO]PHENYL}-3,4-DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.600,'TRANSFERASE',2,2,1),(6442,'5nwc','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-(2-AMINOPHENYL)-3,4- DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.500,'TRANSFERASE',2,2,1),(6443,'5nwd','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-[4-(DIETHYLAMINO)PHENYL]- 3,4-DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.450,'TRANSFERASE',2,2,1),(6444,'5nwg','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 7-CHLORO-2-{4-[(2- HYDROXYETHYL)(METHYL)AMINO]PHENYL}-3,4-DIHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.400,'TRANSFERASE',2,2,1),(6445,'5nwi','14-3-3C IN COMPLEX WITH CPP','X-RAY DIFFRACTION',2.350,'SIGNALING PROTEIN',1,1,1),(6446,'5nwj','14-3-3C IN COMPLEX WITH CPP7','X-RAY DIFFRACTION',2.070,'SIGNALING PROTEIN',1,1,1),(6447,'5nwm','INSIGHT INTO THE MOLECULAR RECOGNITION MECHANISM OF THE COACTIVATOR NCOA1 BY STAT6','SOLUTION NMR',NULL,'SIGNALING PROTEIN',1,1,1),(6448,'5nx1','COMBINATORIAL ENGINEERING OF PROTEOLYTICALLY RESISTANT APPI VARIANTS THAT SELECTIVELY INHIBIT HUMAN KALLIKREIN 6 FOR CANCER THERAPY','X-RAY DIFFRACTION',1.850,'HYDROLASE',2,1,1),(6449,'5nx3','COMBINATORIAL ENGINEERING OF PROTEOLYTICALLY RESISTANT APPI VARIANTS THAT SELECTIVELY INHIBIT HUMAN KALLIKREIN 6 FOR CANCER THERAPY','X-RAY DIFFRACTION',2.300,'HYDROLASE',2,1,1),(6450,'5nxe','CRYSTAL STRUCTURE OF TNKS2 IN COMPLEX WITH 2-{4-[(2-HYDROXYETHYL) (METHYL)AMINO]PHENYL}-1,2,3,4-TETRAHYDROQUINAZOLIN-4-ONE','X-RAY DIFFRACTION',1.600,'TRANSFERASE',2,2,1),(6451,'5nxq','CRYSTAL STRUCTURE OF THE CARBOXY-TERMINAL DOMAIN OF YEAST CTF4 BOUND TO A STAPLED SLD5 CIP','X-RAY DIFFRACTION',2.410,'REPLICATION',2,2,1),(6452,'5o0e','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP120 AND FASUDIL','X-RAY DIFFRACTION',1.500,'TRANSFERASE',1,1,1),(6453,'5o3u','STRUCTURAL CHARACTERIZATION OF THE FAST AND PROMISCUOUS MACROCYCLASE FROM PLANT - PCY1-S562A BOUND TO PRESEGETALIN F1','X-RAY DIFFRACTION',1.860,'HYDROLASE',4,4,1),(6454,'5o3v','STRUCTURAL CHARACTERIZATION OF THE FAST AND PROMISCUOUS MACROCYCLASE FROM PLANT - PCY1-S562A BOUND TO PRESEGETALIN B1','X-RAY DIFFRACTION',2.170,'HYDROLASE',2,2,1),(6455,'5o3w','STRUCTURAL CHARACTERIZATION OF THE FAST AND PROMISCUOUS MACROCYCLASE FROM PLANT - PCY1-S562A BOUND TO PRESEGETALIN A1','X-RAY DIFFRACTION',2.000,'HYDROLASE',4,4,1),(6456,'5o45','STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',0.990,'CELL CYCLE',1,1,1),(6457,'5o4y','STRUCTURE OF HUMAN PD-L1 IN COMPLEX WITH INHIBITOR','X-RAY DIFFRACTION',2.300,'CELL CYCLE',3,3,1),(6458,'5o5m','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP120 AND RKP117','X-RAY DIFFRACTION',1.580,'TRANSFERASE',1,1,1),(6459,'5o76','STRUCTURE OF PHOSPHOY371 C-CBL IN COMPLEX WITH ZAP70-PEPTIDE AND UBV.PCBL UBIQUITIN VARIANT','X-RAY DIFFRACTION',2.470,'LIGASE',2,2,1),(6460,'5o8k','CRYSTAL STRUCTURE OF MAMMALIAN REV7 IN COMPLEX WITH REV3 1875-1895','X-RAY DIFFRACTION',1.800,'REPLICATION',1,1,1),(6461,'5o90','CRYSTAL STRUCTURE OF A P38ALPHA T185G MUTANT IN COMPLEX WITH TAB1 PEPTIDE.','X-RAY DIFFRACTION',2.490,'TRANSFERASE',1,1,1),(6462,'5o9t','HSNMT1 IN COMPLEX WITH COA AND ACETYLATED-NCFSKPK PEPTIDE','X-RAY DIFFRACTION',2.150,'TRANSFERASE',2,2,1),(6463,'5o9u','HSNMT1 IN COMPLEX WITH COA AND MYRISTOYLATED-GCSVSKKK OCTAPEPTIDE','X-RAY DIFFRACTION',1.850,'TRANSFERASE',2,2,1),(6464,'5o9v','HSNMT1 IN COMPLEX WITH COA AND MYRISTOYLATED-GGCFSKPK OCTAPEPTIDE','X-RAY DIFFRACTION',2.200,'TRANSFERASE',2,2,1),(6465,'5oak','STRUCTURE OF THE DMPAR3 PDZ1 DOMAIN IN COMPLEX WITH THE DMPAR6 PBM','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING',2,2,1),(6466,'5oaq','TEAD4 COMPLEXED WITH YAP PEPTIDE AND MYRISTATE (COVALENTLY BOUND)','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',1,1,1),(6467,'5obt','FULLY ACTIVATED A. THALIANA LEGUMAIN ISOFORM GAMMA IN COMPLEX WITH AC- YVAD-CMK','X-RAY DIFFRACTION',1.500,'HYDROLASE',4,2,1),(6468,'5ock','CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CEP1','X-RAY DIFFRACTION',1.600,'IMMUNE SYSTEM',1,2,1),(6469,'5ocx','CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-13-CIT','X-RAY DIFFRACTION',1.750,'IMMUNE SYSTEM',1,2,1),(6470,'5odt','AURORA-A IN COMPLEX WITH TACC3','X-RAY DIFFRACTION',2.020,'TRANSFERASE',1,1,1),(6471,'5oh8','CEREBLON ISOFORM 4 FROM MAGNETOSPIRILLUM GRYPHISWALDENSE IN COMPLEX WITH ROLIPRAM','X-RAY DIFFRACTION',1.950,'UNKNOWN FUNCTION',1,2,1),(6472,'5ohg','ENOLASE IN COMPLEX WITH RNASE E','X-RAY DIFFRACTION',2.000,'LYASE',2,4,1),(6473,'5oj5','YCF48 BOUND TO D1 PEPTIDE','X-RAY DIFFRACTION',1.080,'PHOTOSYNTHESIS',1,1,1),(6474,'5ojr','YCF48 BOUND TO D1 PEPTIDE','X-RAY DIFFRACTION',1.960,'PHOTOSYNTHESIS',2,2,1),(6475,'5ok3','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP241 AND FASUDIL','X-RAY DIFFRACTION',1.590,'TRANSFERASE',1,1,1),(6476,'5ok6','UBIQUITIN SPECIFIC PROTEASE 11 USP11 - PEPTIDE F COMPLEX','X-RAY DIFFRACTION',1.300,'PROTEIN BINDING',2,2,1),(6477,'5okc','CRYSTAL STRUCTURE OF THE CTF18-1-8 MODULE FROM CTF18-RFC','X-RAY DIFFRACTION',2.300,'REPLICATION',2,4,1),(6478,'5ol0','STRUCTURE OF LEISHMANIA INFANTUM SILENT INFORMATION REGULATOR 2 RELATED PROTEIN 1 (LISIR2RP1) IN COMPLEX WITH ACETYLATED P53 PEPTIDE','X-RAY DIFFRACTION',1.990,'HYDROLASE',2,2,1),(6479,'5ol3','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP013 AND RKP117','X-RAY DIFFRACTION',1.580,'TRANSFERASE',1,1,1),(6480,'5om2','CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I1: A DRUG- BINDING SERPIN FOR DOXYCYCLINE','X-RAY DIFFRACTION',1.470,'TRANSPORT PROTEIN',1,1,1),(6481,'5om3','CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I5: A MMP14- CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN',1,1,1),(6482,'5om5','CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO1: AN ALLOSTERICALLY TRIGGERED DRUG-BINDING SERPIN FOR DOXYCYCLINE','X-RAY DIFFRACTION',1.600,'TRANSPORT PROTEIN',1,1,1),(6483,'5om6','CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-I-ALLO2: A MMP9-CLEAVABLE DRUG-BINDING SERPIN FOR DOXYCYCLINE','X-RAY DIFFRACTION',1.850,'TRANSPORT PROTEIN',2,2,1),(6484,'5om7','CRYSTAL STRUCTURE OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II: A DRUG- BINDING SERPIN FOR DOXORUBICIN','X-RAY DIFFRACTION',1.730,'TRANSPORT PROTEIN',1,1,1),(6485,'5om8','CRYSTAL FORM 2 OF ALPHA1-ANTICHYMOTRYPSIN VARIANT DBS-II-ALLO: AN ALLOSTERICALLY MODULATED DRUG-BINDING SERPIN FOR DOXORUBICIN','X-RAY DIFFRACTION',2.200,'TRANSPORT PROTEIN',1,1,1),(6486,'5onj','YNDL IN COMPLEX WITH 5 AMINO ACID (PGA) COMPLEX','X-RAY DIFFRACTION',1.700,'HYDROLASE',1,1,1),(6487,'5onp','ALZHEIMER\'S AMYLOID-BETA PEPTIDE FRAGMENT 1-40 IN COMPLEX WITH CD- SUBSTITUTED THERMOLYSIN','X-RAY DIFFRACTION',1.340,'HYDROLASE',1,1,1),(6488,'5onq','ALZHEIMER\'S AMYLOID-BETA PEPTIDE FRAGMENT 29-40 IN COMPLEX WITH CD- SUBSTITUTED THERMOLYSIN','X-RAY DIFFRACTION',1.170,'HYDROLASE',1,1,1),(6489,'5onr','ALZHEIMER\'S AMYLOID-BETA PEPTIDE FRAGMENT 1-40 IN COMPLEX WITH THERMOLYSIN','X-RAY DIFFRACTION',1.390,'HYDROLASE',1,1,1),(6490,'5ons','CRYSTAL STRUCTURE OF THE MINIMAL DENR-MCTS1 COMPLEX','X-RAY DIFFRACTION',2.140,'TRANSLATION',1,1,1),(6491,'5osn','CRYSTAL STRUCTURE OF BOVINE ENTEROVIRUS 2 DETERMINED WITH SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY','X-RAY DIFFRACTION',2.300,'VIRUS',1,3,1),(6492,'5ot3','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP191 AND RKP117','X-RAY DIFFRACTION',2.040,'TRANSFERASE',1,1,1),(6493,'5otg','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP013 AND RKP190','X-RAY DIFFRACTION',1.730,'TRANSFERASE',1,1,1),(6494,'5ott','EXTRACELLULAR DOMAIN OF GLP-1 RECEPTOR IN COMPLEX WITH EXENDIN-4 VARIANT GLY2HCS/THR5HCS','X-RAY DIFFRACTION',1.920,'SIGNALING PROTEIN',1,1,1),(6495,'5otu','EXTRACELLULAR DOMAIN OF GLP-1 RECEPTOR IN COMPLEX WITH GLP-1 VARIANT ALA8HCS/THR11HCS','X-RAY DIFFRACTION',1.800,'SIGNALING PROTEIN',2,2,1),(6496,'5otv','EXTRACELLULAR DOMAIN OF GLP-1 RECEPTOR IN COMPLEX WITH GLP-1 VARIANT ALA8CYC/THR11HCS','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',2,2,1),(6497,'5otw','EXTRACELLULAR DOMAIN OF GLP-1 RECEPTOR IN COMPLEX WITH GLP-1 VARIANT ALA8HCS/THR11CYS','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN',2,2,1),(6498,'5otx','EXTRACELLULAR DOMAIN OF GLP-1 RECEPTOR IN COMPLEX WITH GLP-1 VARIANT ALA8CYS/THR11CYS','X-RAY DIFFRACTION',2.000,'SIGNALING PROTEIN',2,2,1),(6499,'5ou8','CRYSTAL STRUCTURE OF GLYCOPROTEIN VI IN COMPLEX WITH COLLAGEN-PEPTIDE (GPO)5','X-RAY DIFFRACTION',2.500,'BLOOD CLOTTING',3,2,1),(6500,'5ou9','CRYSTAL STRUCTURE OF GLYCOPROTEIN VI IN COMPLEX WITH COLLAGEN-PEPTIDE (GPO)3','X-RAY DIFFRACTION',2.500,'BLOOD CLOTTING',3,2,1),(6501,'5oua','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUND RKP017','X-RAY DIFFRACTION',1.670,'TRANSFERASE',1,1,1),(6502,'5ouc','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP191 AND RKP190','X-RAY DIFFRACTION',1.460,'TRANSFERASE',1,1,1),(6503,'5ous','CRYSTAL STRUCTURE OF THE PROTEIN-KINASE A CATALYTIC SUBUNIT FROM CRITECULUS GRISEUS IN COMPLEX WITH COMPOUNDS RKP193','X-RAY DIFFRACTION',2.210,'TRANSFERASE',1,1,1),(6504,'5ov3','STRUCTURE OF THE RBBP5 BETA-PROPELLER DOMAIN','X-RAY DIFFRACTION',2.450,'STRUCTURAL PROTEIN',1,2,1),(6505,'5ovc','PDZ DOMAIN FROM RAT SHANK3 BOUND TO THE C TERMINUS OF GKAP','X-RAY DIFFRACTION',1.550,'PROTEIN BINDING',1,1,1),(6506,'5ovp','PDZ DOMAIN FROM RAT SHANK3 BOUND TO THE C TERMINUS OF CIRL','X-RAY DIFFRACTION',1.500,'PROTEIN BINDING',1,1,1),(6507,'5ovv','PDZ DOMAIN FROM RAT SHANK3 BOUND TO THE C TERMINUS OF PROSAPIP1','X-RAY DIFFRACTION',1.400,'PROTEIN BINDING',1,1,1),(6508,'5ow5','P60P80-CAMSAP COMPLEX','X-RAY DIFFRACTION',1.700,'HYDROLASE',2,4,1),(6509,'5ow7','VDR COMPLEX','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(6510,'5ow9','VITAMIN D RECEPTOR COMPLEX','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(6511,'5owd','VITAMIN D RECEPTOR COMPLEX','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',1,1,1),(6512,'5owp','CRYSTAL STRUCTURE OF GLYCOPEPTIDE \"GVTSAFPDT*RPAP\" IN COMPLEX WITH SCFV-SM3','X-RAY DIFFRACTION',1.850,'IMMUNE SYSTEM',1,1,1),(6513,'5owu','KAP95:NUP1 COMPLEX','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN',1,1,1),(6514,'5ox2','CRYSTAL STRUCTURE OF THYMOLIGASE, A SUBSTRATE-TAILORED PEPTILIGASE VARIANT','X-RAY DIFFRACTION',2.240,'LIGASE',1,1,1),(6515,'5oxx','CRYSTAL STRUCTURE OF NEQN/NEQC COMPLEX FROM NANOARCHEAUM EQUITANS AT 1.7A','X-RAY DIFFRACTION',1.740,'SPLICING',1,1,1),(6516,'5oxz','CRYSTAL STRUCTURE OF NEQN/NEQC COMPLEX FROM NANOARCHEAUM EQUITANS AT 1.2A','X-RAY DIFFRACTION',1.200,'SPLICING',1,1,1),(6517,'5oy0','STRUCTURE OF SYNECHOCYSTIS PHOTOSYSTEM I TRIMER AT 2.5A RESOLUTION','X-RAY DIFFRACTION',2.500,'PHOTOSYNTHESIS',9,12,1),(6518,'5oy3','THE STRUCTURAL BASIS OF THE HISTONE DEMETHYLASE KDM6B HISTONE 3 LYSINE 27 SPECIFICITY','X-RAY DIFFRACTION',2.140,'OXIDOREDUCTASE',1,1,1),(6519,'5oyl','VSV G CR2','X-RAY DIFFRACTION',2.250,'VIRAL PROTEIN',1,1,1),(6520,'5q0f','FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL [(4R,5E,8S)-8-({(2E)- 3-[5-CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]PROP-2-ENOYL}AMINO)-4-METHYL- 2-OXO-1,3,4,7,8,10-HEXAHYDRO-2H-12,9-(AZENO)-1,10- BENZODIAZACYCLOTETRADECIN-15-YL]CARBAMATE','X-RAY DIFFRACTION',2.120,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(6521,'5q0i','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION',1,1,1),(6522,'5q0j','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(6523,'5q0k','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',1,1,1),(6524,'5q0l','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,2,1),(6525,'5q0m','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(6526,'5q0n','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(6527,'5q0o','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(6528,'5q0p','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.800,'TRANSCRIPTION',2,2,1),(6529,'5q0r','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.910,'TRANSCRIPTION',1,1,1),(6530,'5q0s','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,2,1),(6531,'5q0t','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.140,'TRANSCRIPTION',1,1,1),(6532,'5q0u','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(6533,'5q0v','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.870,'TRANSCRIPTION',2,2,1),(6534,'5q0w','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(6535,'5q0x','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.260,'TRANSCRIPTION',1,1,1),(6536,'5q0y','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(6537,'5q0z','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.260,'TRANSCRIPTION',2,2,1),(6538,'5q10','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(6539,'5q11','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',1,1,1),(6540,'5q12','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(6541,'5q13','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(6542,'5q14','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',2,2,1),(6543,'5q15','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(6544,'5q16','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(6545,'5q17','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',1,1,1),(6546,'5q18','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(6547,'5q19','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.980,'TRANSCRIPTION',2,2,1),(6548,'5q1a','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(6549,'5q1b','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(6550,'5q1c','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(6551,'5q1d','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.890,'TRANSCRIPTION',2,2,1),(6552,'5q1e','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.850,'TRANSCRIPTION',1,1,1),(6553,'5q1f','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(6554,'5q1g','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',1,1,1),(6555,'5q1h','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',4,4,1),(6556,'5q1i','LIGAND BINDING TO FARNESOID-X-RECEPTOR','X-RAY DIFFRACTION',1.950,'TRANSCRIPTION',1,1,1),(6557,'5qqo','FACTOR XIA IN COMPLEX WITH THE INHIBITOR METHYL [(5E,8S)-8-[(6R)-6-(3- CHLOROPHENYL)-2-OXO-1,3-OXAZINAN-3-YL]-2-OXO-1,3,4,7,8,10-HEXAHYDRO- 2H-12,9-(AZENO)-1,10-BENZODIAZACYCLOTETRADECIN-15-YL]CARBAMATE','X-RAY DIFFRACTION',2.000,'HYDROLASE',1,1,1),(6558,'5qtx','FACTOR XIA IN COMPLEX WITH THE INHIBITOR ETHYL (2R,7S)-7-({(2E)-3-[5- CHLORO-2-(1H-TETRAZOL-1-YL)PHENYL]PROP-2-ENOYL}AMINO)-14- [(METHOXYCARBONYL)AMINO]-1,2,3,4,5,6,7,9-OCTAHYDRO-11,8-(AZENO)-1,9- BENZODIAZACYCLOTRIDECINE-2-CARBOXYLATE','X-RAY DIFFRACTION',2.070,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(6559,'5sga','STRUCTURES OF PRODUCT AND INHIBITOR COMPLEXES OF STREPTOMYCES GRISEUS PROTEASE A AT 1.8 ANGSTROMS RESOLUTION. A MODEL FOR SERINE PROTEASE CATALYSIS','X-RAY DIFFRACTION',1.800,'HYDROLASE/HYDROLASE INHIBITOR',1,1,1),(6560,'5svh','CRYSTAL STRUCTURE OF THE KIX DOMAIN OF CBP IN COMPLEX WITH A MLL/C-MYB CHIMERA','X-RAY DIFFRACTION',2.050,'TRANSCRIPTION',1,1,1),(6561,'5svz','HIV-1 TAT NLS IN COMPLEX WITH IMPORTIN ALPHA','X-RAY DIFFRACTION',2.000,'TRANSPORT PROTEIN/VIRAL PROTEIN',1,1,1),(6562,'5swq','CRYSTAL STRUCTURE OF HLA-A*0201 IN COMPLEX WITH NA231, AN INFLUENZA EPITOPE','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,1,1),(6563,'5sxm','WDR5 IN COMPLEX WITH MLL WIN MOTIF PEPTIDOMIMETIC','X-RAY DIFFRACTION',2.000,'TRANSCRIPTION',2,2,1),(6564,'5sxp','STRUCTURAL BASIS FOR THE INTERACTION BETWEEN ITCH PRR AND BETA-PIX','X-RAY DIFFRACTION',1.650,'SIGNALING PROTEIN/LIGASE',2,4,1),(6565,'5syz','HUMAN LIVER RECEPTOR HOMOLOGUE-1 (LRH-1) BOUND TO A RJW100 STEREOISOMER AND A FRAGMENT OF TIF-2','X-RAY DIFFRACTION',1.930,'NUCLEAR PROTEIN',1,1,1),(6566,'5szb','STRUCTURE OF HUMAN DPF3 DOUBLE-PHD DOMAIN BOUND TO HISTONE H3 TAIL PEPTIDE WITH ACETYLATED K14','X-RAY DIFFRACTION',1.200,'PEPTIDE BINDING PROTEIN',1,1,1),(6567,'5szc','STRUCTURE OF HUMAN DPF3 DOUBLE-PHD DOMAIN BOUND TO HISTONE H3 TAIL PEPTIDE WITH MONOMETHYLATED K4 AND ACETYLATED K14','X-RAY DIFFRACTION',1.190,'PEPTIDE BINDING PROTEIN',1,1,1),(6568,'5t0f','CRYSTAL STRUCTURE OF THE MYC3 N-TERMINAL DOMAIN [44-242] IN COMPLEX WITH JAZ10 CMID DOMAIN [16-58] FROM ARABIDOPSIS','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',1,1,1),(6569,'5t0k','STRUCTURE OF G9A SET-DOMAIN WITH H3K9M MUTANT PEPTIDE AND SAM','X-RAY DIFFRACTION',1.700,'TRANSFERASE',2,2,1),(6570,'5t0m','A HISTONE H3K9M MUTATION TRAPS HISTONE METHYLTRANSFERASE CLR4 TO PREVENT HETEROCHROMATIN SPREADING','X-RAY DIFFRACTION',1.900,'TRANSFERASE',2,2,1),(6571,'5t0q','CRYSTAL STRUCTURE OF THE MYC3 N-TERMINAL DOMAIN [44-242] IN COMPLEX WITH JAZ10 JAS DOMAIN [166-192] FROM ARABIDOPSIS','X-RAY DIFFRACTION',2.150,'TRANSCRIPTION',1,1,1),(6572,'5t0x','SOLUTION NMR-DERIVED STRUCTURE OF CALMODULIN BOUND WITH ER ALPHA PEPTIDES','SOLUTION NMR',NULL,'CALCIUM-BINDING PROTEIN/HORMONE RECEP',2,1,1),(6573,'5t1g','CHROMO SHADOW DOMAIN OF CBX1 IN COMPLEX WITH A HISTONE PEPTIDE','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',1,1,1),(6574,'5t1i','CBX3 CHROMO SHADOW DOMAIN IN COMPLEX WITH HISTONE H3 PEPTIDE','X-RAY DIFFRACTION',1.600,'TRANSCRIPTION',1,2,1),(6575,'5t1k','CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,4,1),(6576,'5t1l','CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE','X-RAY DIFFRACTION',2.480,'IMMUNE SYSTEM',2,4,1),(6577,'5t1z','ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN Y537S MUTANT IN COMPLEX WITH ETHOXYTRIPHENYLETHYLENE AND GRIP PEPTIDE','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(6578,'5t2s','STRUCTURE OF THE FHA1 DOMAIN OF RAD53 BOUND SIMULTANEOUSLY TO THE BRCT DOMAIN OF DBF4 AND A PHOSPHOPEPTIDE.','X-RAY DIFFRACTION',2.400,'CELL CYCLE',2,2,1),(6579,'5t46','CRYSTAL STRUCTURE OF THE HUMAN EIF4E-EIF4G COMPLEX','X-RAY DIFFRACTION',1.530,'TRANSLATION',2,2,1),(6580,'5t47','CRYSTAL STRUCTURE OF THE D. MELANOGASTER EIF4E-EIF4G COMPLEX','X-RAY DIFFRACTION',2.200,'TRANSLATION',1,2,1),(6581,'5t48','CRYSTAL STRUCTURE OF THE D. MELANOGASTER EIF4E-EIF4G COMPLEX WITHOUT LATERAL CONTACT','X-RAY DIFFRACTION',2.190,'TRANSLATION',1,1,1),(6582,'5t59','STRUCTURE OF THE MIND COMPLEX SHOWS A REGULATORY FOCUS OF YEAST KINETOCHORE ASSEMBLY','X-RAY DIFFRACTION',2.410,'CELL CYCLE',2,4,1),(6583,'5t5j','LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE','X-RAY DIFFRACTION',1.350,'SUGAR BINDING PROTEIN',2,2,1),(6584,'5t5l','LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE','X-RAY DIFFRACTION',1.170,'SUGAR BINDING PROTEIN',2,2,1),(6585,'5t5p','LECTIN FROM BAUHINIA FORFICATA IN COMPLEX WITH TN-PEPTIDE','X-RAY DIFFRACTION',1.660,'SUGAR BINDING PROTEIN',2,2,1),(6586,'5t63','THE HHOA PROTEASE FROM SYNECHOCYSTIS SP. PCC 6803','X-RAY DIFFRACTION',2.500,'HYDROLASE',1,1,1),(6587,'5t6j','STRUCTURE OF THE MIND COMPLEX SHOWS A REGULATORY FOCUS OF YEAST KINETOCHORE ASSEMBLY','X-RAY DIFFRACTION',1.750,'CELL CYCLE',1,1,1),(6588,'5t6p','CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE','X-RAY DIFFRACTION',1.970,'IMMUNE SYSTEM',2,4,1),(6589,'5t6w','HLA-B*57:01 PRESENTING SSTRGISQLW','X-RAY DIFFRACTION',1.900,'IMMUNE SYSTEM',1,1,1),(6590,'5t6x','HLA-B*57:01 PRESENTING TSTTSVASSW','X-RAY DIFFRACTION',1.690,'IMMUNE SYSTEM',1,1,1),(6591,'5t6y','HLA-B*57:01 PRESENTING TSTFEDVKILAF','X-RAY DIFFRACTION',1.760,'IMMUNE SYSTEM',1,1,1),(6592,'5t6z','KIR3DL1 IN COMPLEX WITH HLA-B*57:01-TW10','X-RAY DIFFRACTION',2.000,'IMMUNE SYSTEM',1,2,1),(6593,'5t70','KIR3DL1 IN COMPLEX WITH HLA-B*57:01 PRESENTING TSNLQEQIGW','X-RAY DIFFRACTION',2.100,'IMMUNE SYSTEM',1,2,1),(6594,'5t78','CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',2,4,1),(6595,'5t7g','CRYSTAL STRUCTURE OF MURINE MHC-I H-2DD IN COMPLEX WITH MURINE BETA2- MICROGLOBULIN AND A VARIANT OF PEPTIDE (PT9) OF HIV GP120 MN ISOLATE (IGPGRAFYT)','X-RAY DIFFRACTION',1.960,'IMMUNE SYSTEM',2,2,1),(6596,'5tbd','CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB4D11) IN COMPLEX WITH 3D7-MSP2 215-222','X-RAY DIFFRACTION',2.200,'IMMUNE SYSTEM',4,8,1),(6597,'5tda','CRYSTAL STRUCTURE OF THE UBR-BOX DOMAIN FROM UBR2 IN COMPLEX WITH RLWS N-DEGRON','X-RAY DIFFRACTION',0.790,'LIGASE',1,1,1),(6598,'5tdb','CRYSTAL STRUCTURE OF THE HUMAN UBR-BOX DOMAIN FROM UBR2 IN COMPLEX WITH ASYMMETRICALLY DOUBLE METHYLATED ARGININE PEPTIDE','X-RAY DIFFRACTION',1.100,'LIGASE',1,1,1),(6599,'5tdc','CRYSTAL STRUCTURE OF THE HUMAN UBR-BOX DOMAIN FROM UBR1 IN COMPLEX WITH MONOMETHYLATED ARGININE PEPTIDE.','X-RAY DIFFRACTION',1.610,'LIGASE',2,2,1),(6600,'5tdd','HUMAN UBR-BOX FROM UBR2 IN COMPLEX WITH HIFS PEPTIDE','X-RAY DIFFRACTION',1.550,'LIGASE',1,1,1),(6601,'5tdr','SET3 PHD FINGER IN COMPLEX WITH HISTONE H3K4ME2','X-RAY DIFFRACTION',1.420,'TRANSCRIPTION',1,1,1),(6602,'5tdw','SET3 PHD FINGER IN COMPLEX WITH HISTONE H3K4ME3','X-RAY DIFFRACTION',1.700,'TRANSCRIPTION',1,1,1),(6603,'5tdy','STRUCTURE OF COFOLDED FLIFC:FLIGN COMPLEX FROM THERMOTOGA MARITIMA','X-RAY DIFFRACTION',2.110,'MOTOR PROTEIN',2,2,1),(6604,'5ted','EFFECTOR BINDING DOMAIN OF QUIR IN COMPLEX WITH SHIKIMATE','X-RAY DIFFRACTION',1.890,'TRANSCRIPTION',1,1,1),(6605,'5teg','CRYSTAL STRUCTURE OF HSETD8 IN COMPLEX WITH HISTONE H4K20 NORLEUCINE MUTANT PEPTIDE AND S-ADENOSYLMETHIONINE','X-RAY DIFFRACTION',1.300,'TRANSFERASE',2,2,1),(6606,'5tez','TCR F50 RECGONIZING M1-HLA-A2','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,3,1),(6607,'5tgi','STRUCTURE OF THE SNX5 PX DOMAIN IN COMPLEX WITH CHLAMYDIAL PROTEIN INCE IN SPACE GROUP P212121','X-RAY DIFFRACTION',1.980,'PROTEIN TRANSPORT',2,2,1),(6608,'5th2','CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT','X-RAY DIFFRACTION',1.840,'IMMUNE SYSTEM',2,4,1),(6609,'5tis','ROOM TEMPERATURE XFEL STRUCTURE OF THE NATIVE, DOUBLY-ILLUMINATED PHOTOSYSTEM II COMPLEX','X-RAY DIFFRACTION',2.250,'PHOTOSYNTHESIS',20,17,1),(6610,'5tkj','STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519','X-RAY DIFFRACTION',2.120,'IMMUNE SYSTEM',4,8,1),(6611,'5tkk','STRUCTURE OF MOUSE VACCINATION-ELICITED HIV NEUTRALIZING ANTIBODY VFP5.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519','X-RAY DIFFRACTION',1.550,'IMMUNE SYSTEM',1,2,1),(6612,'5tld','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE PHENYLAMINO-SUBSTITUTED ESTROGEN, (8R,9S,13S,14S, 17S)-13-METHYL-17-(PHENYLAMINO)-7,8,9,11,12,13,14,15,16,17-DECAHYDRO- 6H-CYCLOPENTA[A]PHENANTHREN-3-OL','X-RAY DIFFRACTION',2.380,'TRANSCRIPTION',2,2,1),(6613,'5tlf','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE CONSTRAINED WAY DERIVATIVE, 4-(2-(3-METHYLBUT-2-EN- 1-YL)-7-(TRIFLUOROMETHYL)-2H-INDAZOL-3-YL)BENZENE-1,3-DIOL','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(6614,'5tlg','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH (E)-4,4\'\'-DIHYDROXY-3\'-((HYDROXYIMINIO)METHYL)-[1,1\':2\', 1\'\'-TERPHENYL]-4\'-OLATE','X-RAY DIFFRACTION',2.230,'TRANSCRIPTION',2,2,1),(6615,'5tll','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH (E)-2-CHLORO-4\'-HYDROXY-4-((HYDROXYIMINIO)METHYL)-[1,1\'- BIPHENYL]-3-OLATE','X-RAY DIFFRACTION',2.420,'TRANSCRIPTION',2,2,1),(6616,'5tlm','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 4,4\',4\'\'-(THIOPHENE-2,3,5-TRIYL)TRIPHENOL','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,2,1),(6617,'5tlo','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH A SQUARIC ACID-LINKED DIMERIC ESTROGEN','X-RAY DIFFRACTION',2.280,'TRANSCRIPTION',2,2,1),(6618,'5tlp','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS-BSC ANALOG, 3-FLUOROPHENYL (1R,2R,4S)-5-(4- HYDROXYPHENYL)-6-(4-(2-(PIPERIDIN-1-YL)ETHOXY)PHENYL)-7- OXABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONATE AND 3-METHYL-6-PHENYL-3H- IMIDAZO[4,5-B]PYRIDIN-2-AMINE','X-RAY DIFFRACTION',2.080,'TRANSCRIPTION',2,2,1),(6619,'5tlt','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH OCTANE-1,8-DIYL BIS(2,3-BIS(4-HYDROXYPHENYL)PENTANOATE)','X-RAY DIFFRACTION',1.900,'TRANSCRIPTION',2,2,1),(6620,'5tlu','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE PEG-LINKED DIMERIC ESTROGEN, EE2-(EG)6-EE2-AMINE','X-RAY DIFFRACTION',2.220,'TRANSCRIPTION',2,2,1),(6621,'5tlv','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 4,4\'-(THIOPHENE-2,3-DIYL)BIS(3-FLUOROPHENOL)','X-RAY DIFFRACTION',2.320,'TRANSCRIPTION',2,2,1),(6622,'5tlx','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 3,4-BIS(4-HYDROXYPHENYL)THIOPHENE 1,1-DIOXIDE','X-RAY DIFFRACTION',2.100,'TRANSCRIPTION',2,2,1),(6623,'5tly','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 3,4-BIS(2-FLUORO-4-HYDROXYPHENYL)THIOPHENE 1,1-DIOXIDE','X-RAY DIFFRACTION',2.140,'TRANSCRIPTION',2,2,1),(6624,'5tm1','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 2,5-BIS(2-FLUORO-4-HYDROXYPHENYL)THIOPHENE 1-OXIDE','X-RAY DIFFRACTION',2.230,'TRANSCRIPTION',2,2,1),(6625,'5tm3','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 2,3-BIS(2-CHLORO-4-HYDROXYPHENYL)THIOPHENE 1-OXIDE','X-RAY DIFFRACTION',2.190,'TRANSCRIPTION',2,2,1),(6626,'5tm4','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS-ASC ANALOG, 5-(4-((1R,4S,6R)-6-((3- CHLOROPHENOXY)SULFONYL)-3-(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT- 2-EN-2-YL)PHENOXY)PENTANOIC ACID','X-RAY DIFFRACTION',2.250,'TRANSCRIPTION',2,2,1),(6627,'5tm5','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS-ASC COMPOUND, 5-(4-((1R,4S,6R)-6-((4- BROMOPHENOXY)SULFONYL)-3-(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-2- EN-2-YL)PHENOXY)PENTANOIC ACID','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(6628,'5tm7','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS-ASC COMPOUND, 7-(4-((1R,4S,6R)-6-((3- CHLOROPHENOXY)SULFONYL)-3-(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT- 2-EN-2-YL)PHENOXY)HEPTANOIC ACID','X-RAY DIFFRACTION',2.400,'TRANSCRIPTION',2,2,1),(6629,'5tm8','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS-ASC COMPOUND, 7-(4-((1R,4S,6R)-6-((4- BROMOPHENOXY)SULFONYL)-3-(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-2- EN-2-YL)PHENOXY)HEPTANOIC ACID','X-RAY DIFFRACTION',1.990,'TRANSCRIPTION',2,2,1),(6630,'5tm9','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS-ASC ANALOG, (E)-3-(4-((1R,4S,6R)-6-((3- CHLOROPHENOXY)SULFONYL)-3-(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT- 2-EN-2-YL)PHENYL)ACRYLIC ACID','X-RAY DIFFRACTION',2.500,'TRANSCRIPTION',2,2,1),(6631,'5tml','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS-ASC COMPOUND, (E)-6-(4-((1R,4S,6R)-6-((3- CHLOROPHENOXY)SULFONYL)-3-(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT- 2-EN-2-YL)PHENYL)HEX-5-ENOIC ACID','X-RAY DIFFRACTION',2.250,'TRANSCRIPTION',2,2,1),(6632,'5tmm','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS-ASC ANALOG, (E)-6-(4-((1R,4S,6R)-6-((4- BROMOPHENOXY)SULFONYL)-3-(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-2- EN-2-YL)PHENYL)HEX-5-ENOIC ACID','X-RAY DIFFRACTION',2.200,'TRANSCRIPTION',2,2,1),(6633,'5tmo','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE ARENE CORE OBHS DERIVATIVE, PHENYL 4,4\'\'-DIHYDROXY- [1,1\':2\',1\'\'-TERPHENYL]-4\'-SULFONATE','X-RAY DIFFRACTION',2.170,'TRANSCRIPTION',2,2,1),(6634,'5tmq','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE ARENE CORE OBHS DERIVATIVE, 4-BROMOPHENYL 4,4\'\'- DIHYDROXY-[1,1\':2\',1\'\'-TERPHENYL]-4\'-SULFONATE','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(6635,'5tmr','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE CYCLOFENIL-ASC DERIVATIVE, ETHYL (E)-3-(4- (CYCLOHEXYLIDENE(4-HYDROXYPHENYL)METHYL)PHENYL)ACRYLATE','X-RAY DIFFRACTION',2.300,'TRANSCRIPTION',2,2,1),(6636,'5tms','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE CYCLOFENIL-ASC DERIVATIVE, ETHYL (E)-3-(4- (BICYCLO[3.3.1]NONAN-9-YLIDENE(4-HYDROXYPHENYL)METHYL)PHENYL)ACRYLATE','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(6637,'5tmt','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 4,4\'-((1,3-DIHYDRO-2H-INDEN-2-YLIDENE)METHYLENE)DIPHENOL','X-RAY DIFFRACTION',2.050,'TRANSCRIPTION',2,2,1),(6638,'5tmu','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH 4,4\'-(CYCLOHEPTYLIDENEMETHYLENE)DIPHENOL','X-RAY DIFFRACTION',2.430,'TRANSCRIPTION',2,2,1),(6639,'5tmv','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS ANALOG, 4-IODOPHENYL (1S,2R,4S)-5,6-BIS(4- HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONATE','X-RAY DIFFRACTION',2.380,'TRANSCRIPTION',2,2,1),(6640,'5tmw','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE OBHS DERIVATIVE, 4-ACETAMIDOPHENYL (1S,2R,4S)-5,6- BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2-SULFONATE','X-RAY DIFFRACTION',2.290,'TRANSCRIPTION',2,2,1),(6641,'5tmz','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE ESTRADIOL DERIVATIVE, (8S,9S,13S,14S,17S)-16-(3- METHOXYBENZYL)-13-METHYL-7,8,9,11,12,13,14,15,16,17-DECAHYDRO-6H- CYCLOPENTA[A]PHENANTHRENE-3,17-DIOL','X-RAY DIFFRACTION',2.210,'TRANSCRIPTION',2,2,1),(6642,'5tn1','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE ESTRADIOL DERIVATIVE, (8S,9S,13S,14S,E)-17-((4- ISOPROPYLPHENYL)IMINO)-13-METHYL-7,8,9,11,12,13,14,15,16,17- DECAHYDRO-6H-CYCLOPENTA[A]PHENANTHREN-3-OL','X-RAY DIFFRACTION',2.060,'TRANSCRIPTION',2,2,1),(6643,'5tn4','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE ACD-RING ESTROGEN, (S)-5-(4-HYDROXY-3,5- DIMETHYLPHENYL)-2,3-DIHYDRO-1H-INDEN-1-OL','X-RAY DIFFRACTION',1.860,'TRANSCRIPTION',2,2,1),(6644,'5tn5','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE AC-RING ESTROGEN, (1S,3AS,5S,7AS)-5-(4- HYDROXYPHENYL)-7A-METHYLOCTAHYDRO-1H-INDEN-1-OL','X-RAY DIFFRACTION',1.890,'TRANSCRIPTION',2,2,1),(6645,'5tn6','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH THE SPIRO BC-ESTRADIOL, (1S,1\'S,3A\'S,7A\'S)-7A\'-METHYL- 1\',2,2\',3,3\',3A\',4\',6\',7\',7A\'-DECAHYDRO-1,5\'-SPIROBI[INDENE]-1\',5- DIOL','X-RAY DIFFRACTION',2.090,'TRANSCRIPTION',2,2,1),(6646,'5tn7','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH (E)-3\'-FLUORO-4\'-HYDROXY-3-((HYDROXYIMINIO)METHYL)-[1, 1\'-BIPHENYL]-4-OLATE','X-RAY DIFFRACTION',2.240,'TRANSCRIPTION',2,2,1),(6647,'5to3','CRYSTAL STRUCTURE OF THROMBIN MUTANT W215A/E217A FUSED TO EGF456 OF THROMBOMODULIN VIA A 31-RESIDUE LINKER AND BOUND TO PPACK','X-RAY DIFFRACTION',2.340,'HYDROLASE',1,1,1),(6648,'5tp1','THE STRUCTURE OF THE C-TERMINUS OF VIRULENCE PROTEIN INCE FROM CHLAMYDIA TRACHOMATIS BOUND TO MUS MUSCULUS SNX5-PX DOMAIN','X-RAY DIFFRACTION',2.310,'PROTEIN TRANSPORT',4,4,1),(6649,'5tp6','SOLUTION STRUCTURE OF THE CAM34 WITH THE INOS CAM BINDING DOMAIN PEPTIDE','SOLUTION NMR',NULL,'OXIDOREDUCTASE',1,1,1),(6650,'5tq1','PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE DERIVED FROM THE INSULIN RECEPTOR','X-RAY DIFFRACTION',1.490,'HYDROLASE',1,1,1),(6651,'5tqs','PHOSPHOLIPASE C GAMMA-1 C-TERMINAL SH2 DOMAIN BOUND TO A PHOSPHOPEPTIDE DERIVED FROM THE RECEPTOR TYROSINE KINASE ERBB2','X-RAY DIFFRACTION',1.880,'HYDROLASE',4,4,1),(6652,'5trz','CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YQSGLSIVM)','X-RAY DIFFRACTION',2.250,'IMMUNE SYSTEM',2,2,1),(6653,'5ts1','CRYSTAL STRUCTURE OF MHC-I H2-KD COMPLEXED WITH PEPTIDES OF MYCOBACTERIAL TUBERCULOSIS (YYQSGLSIV)','X-RAY DIFFRACTION',2.300,'IMMUNE SYSTEM',4,4,1),(6654,'5tsv','HIV-1 CA HEXAMER WITH NUP153 PEPTIDE - R3 CRYSTAL FORM','X-RAY DIFFRACTION',2.500,'VIRAL PROTEIN',1,2,1),(6655,'5tsx','HIV-1 CA HEXAMER WITH NUP153 PEPTIDE - P1 CRYSTAL FORM','X-RAY DIFFRACTION',1.900,'VIRAL PROTEIN',6,12,1),(6656,'5ttw','CRYSTAL STRUCTURE OF EED IN COMPLEX WITH UNC4859','X-RAY DIFFRACTION',1.740,'TRANSCRIPTION REGULATOR/INHIBITOR',2,2,1),(6657,'5tu5','PAGF PRENYLTRANSFERASE WITH TYR-TYR-TYR AND DMSPP','X-RAY DIFFRACTION',1.900,'TRANSFERASE',1,1,1),(6658,'5tu6','PAGF PRENYLTRANSFERASE WITH CYCLIC[INPYLYP] AND DMSPP','X-RAY DIFFRACTION',2.220,'TRANSFERASE',1,1,1),(6659,'5twa','CRYSTAL STRUCTURE OF GEODIA CYDONIUM BHP2 IN COMPLEX WITH LUBOMIRSKIA BAICALENSIS BAK-2','X-RAY DIFFRACTION',1.850,'APOPTOSIS',2,2,1),(6660,'5twg','HUMAN MOB1A BOUND TO HUMAN MST1 PHOSPHORYLATED T353 PEPTIDE','X-RAY DIFFRACTION',2.300,'SIGNALING PROTEIN',1,1,1),(6661,'5twh','HUMAN MOB1A BOUND TO MST1 PHOSPHORYLATED T367 PEPTIDE','X-RAY DIFFRACTION',2.500,'SIGNALING PROTEIN',1,1,1),(6662,'5two','PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA LIGAND BINDING DOMAIN IN COMPLEX WITH A NOVEL SELECTIVELY PPAR GAMMA-MODULATING LIGAND VSP- 51','X-RAY DIFFRACTION',1.930,'TRANSCRIPTION',1,1,1),(6663,'5txe','ATXE2 ISOPEPTIDASE - S527A VARIANT WITH ASTEXIN3-DC4 BOUND','X-RAY DIFFRACTION',2.200,'HYDROLASE',2,2,1),(6664,'5txs','CRYSTAL STRUCTURE OF AN ANAPLASTIC LYMPHOMA KINASE-DERIVED NEUROBLASTOMA TUMOR ANTIGEN BOUND TO THE HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I MOLECULE HLA-B*1501','X-RAY DIFFRACTION',1.700,'IMMUNE SYSTEM',1,1,1),(6665,'5tyi','GRB7 SH2 WITH BICYCLIC PEPTIDE CONTAINING PY MIMETIC','X-RAY DIFFRACTION',2.150,'SIGNALING PROTEIN/PEPTIDE',4,4,1),(6666,'5tzp','CRYSTAL STRUCTURE OF FPV039:BIK BH3 COMPLEX','X-RAY DIFFRACTION',1.350,'APOPTOSIS',1,1,1),(6667,'5tzq','CRYSTAL STRUCTURE OF FPV039:BMF BH3 COMPLEX','X-RAY DIFFRACTION',1.650,'APOPTOSIS',2,2,1),(6668,'5u06','GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR CONTAINING A PY MIMETIC','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN/INHIBITOR',4,4,1),(6669,'5u1m','STRUCTURE OF THE IRS-1 PTB DOMAIN BOUND TO THE JUXTAMEMBRANE REGION OF THE INSULIN RECEPTOR','X-RAY DIFFRACTION',1.800,'PROTEIN BINDING',1,1,1),(6670,'5u1q','GRB7-SH2 WITH BICYCLIC PEPTIDE INHIBITOR','X-RAY DIFFRACTION',2.100,'SIGNALING PROTEIN/PEPTIDE INHIBITOR',4,4,1),(6671,'5u2d','CRYSTAL STRUCTURE OF THE ER-ALPHA LIGAND-BINDING DOMAIN (Y537S) IN COMPLEX WITH OXABICYCLIC HEPTENE SULFONATE (OBHS)','X-RAY DIFFRACTION',1.860,'TRANSCRIPTION',2,2,1),(6672,'5u2j','MORF DOUBLE PHD FINGER (DPF) IN COMPLEX WITH HISTONE H3K14BU','X-RAY DIFFRACTION',1.600,'HYDROLASE',2,2,1),